##CREATION_DATE=2021-07-19
##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##PIPELINE=megSAP 0.2-22-g23d3396
##SOURCE=Clair3 1.0.0
##CALLING_DATE=2023-11-03
##SAMPLE=<ID=NA12878_18,Gender=n/a,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=Neoplasms,DiseaseStatus=affected>
##VariantAnnotateASE_BAM=/mnt/storage1/projects/test//Twist_Exome_Test/Sample_NA12878x2_16/NA12878x2_16.bam
##DESCRIPTION=NA12878_18=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=coding_and_splicing_refseq=Coding and splicing details based on RefSeq (Gene, RefSeq id, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=fathmm-MKL=fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=MMSplice_DeltaLogitPSI=MMsplice delta Logit PSI score: variant's effect on the exon inclusion - positive score shows higher exon inclusion, negative higher exclusion rate. A score greater than 2 or less than -2 can be considered strong.
##DESCRIPTION=MMSplice_pathogenicity=MMsplice pathogenicity score: probability of pathogenic effect of the variant on splicing
##DESCRIPTION=SpliceAI=SpliceAI prediction of splice-site variations. Probability of the variant being splice-altering (range from 0-1). The score is the maximum value of acceptor/donor gain/loss of all effected genes.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##DESCRIPTION=ASE_af=Expressed variant allele frequency.
##DESCRIPTION=ASE_depth=Sequencing depth at the variant position.
##DESCRIPTION=ASE_alt=Expressed variant alternative observation count.
##DESCRIPTION=ASE_pval=Binomial test p-value.
##FILTER=low_conf_region=Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.
##FILTER=off-target=Variant marked as 'off-target'.
#chr	start	end	ref	obs	NA12878_18	filter	quality	gene	variant_type	coding_and_splicing	coding_and_splicing_refseq	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	fathmm-MKL	CADD	REVEL	MaxEntScan	dbscSNV	COSMIC	MMSplice_DeltaLogitPSI	MMSplice_pathogenicity	SpliceAI	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info	ASE_af	ASE_depth	ASE_alt	ASE_pval
chr1	8022801	8022801	T	-	het	low_conf_region	QUAL=388;DP=124;AF=0.22;MQM=60	PARK7	intron	PARK7:ENST00000338639.5:intron_variant:MODIFIER:intron1/6:c.-23-4del::,PARK7:ENST00000377488.1:intron_variant:MODIFIER:intron1/6:c.-23-4del::,PARK7:ENST00000377491.1:intron_variant:MODIFIER:intron1/6:c.-23-4del::,PARK7:ENST00000377493.5:intron_variant:MODIFIER:intron1/5:c.-23-4del::,PARK7:ENST00000493678.1:intron_variant:MODIFIER:intron1/6:c.-23-4del::	PARK7:NM_001123377.1:intron_variant:MODIFIER:intron1/6:c.-23-4del::,PARK7:NM_007262.5:intron_variant:MODIFIER:intron1/6:c.-23-4del::	regulatory_region_variant:promoter	602533 [GENE=PARK7 PHENOS=Parkinson disease 7,autosomal recessive early-onset,606324,Autosomal recessive];			(T)n (Simple_repeat)	rs370370394		0.3604	93,.	0.3528,0.3486,0.3450,0.3586,0.3856	1.1200				2.71					-0.092	0.097	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARK7 (inh=AR oe_syn=0.93 oe_mis=0.96 oe_lof=0.11)	0.2807	57	16	0.0013
chr1	17312592	17312592	G	A	het		QUAL=13685;DP=1138;AF=0.48;MQM=60	ATP13A2,RP1-37C10.3	3'UTR,missense,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::,ATP13A2:ENST00000341676.5:missense_variant:MODERATE:exon27/27:c.3365C>T:p.Pro1122Leu:,RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+6985G>A::,ATP13A2:ENST00000452699.1:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::	ATP13A2:NM_001141973.3:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::,ATP13A2:NM_001141974.3:missense_variant:MODERATE:exon27/27:c.3365C>T:p.Pro1122Leu:,ATP13A2:NM_022089.4:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	293763 [benign DISEASE=Kufor-Rakeb syndrome];			rs15786	0.0132	0.0467	52,.	0.0092,0.0132,0.0000,0.0598,0.0099	0.4710	 ,D(0.00), , 	 ,B(0.02), , 	0.19,0.82	10.41	0.12				-0.0153	0.8751	0	45	1796	7 / 156					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)	0.5344	305	163	0.4655
chr1	17312593	17312593	G	T	het		QUAL=13685;DP=1138;AF=0.48;MQM=60	ATP13A2,RP1-37C10.3	3'UTR,missense,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::,ATP13A2:ENST00000341676.5:missense_variant:MODERATE:exon27/27:c.3365C>T:p.Pro1122Leu:,RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+6985G>A::,ATP13A2:ENST00000452699.1:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::	ATP13A2:NM_001141973.3:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::,ATP13A2:NM_001141974.3:missense_variant:MODERATE:exon27/27:c.3365C>T:p.Pro1122Leu:,ATP13A2:NM_022089.4:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	293763 [benign DISEASE=Kufor-Rakeb syndrome];			rs15786	0.0132	0.0467	52,.	0.0092,0.0132,0.0000,0.0598,0.0099	0.4710	 ,D(0.00), , 	 ,B(0.02), , 	0.19,0.82	10.41	0.12				-0.0153	0.8751	0	45	1796	7 / 156					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)	0.5344	305	163	0.4655
chr1	17312594	17312594	A	C	het		QUAL=13685;DP=1138;AF=0.48;MQM=60	ATP13A2,RP1-37C10.3	3'UTR,missense,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::,ATP13A2:ENST00000341676.5:missense_variant:MODERATE:exon27/27:c.3365C>T:p.Pro1122Leu:,RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+6985G>A::,ATP13A2:ENST00000452699.1:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::	ATP13A2:NM_001141973.3:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::,ATP13A2:NM_001141974.3:missense_variant:MODERATE:exon27/27:c.3365C>T:p.Pro1122Leu:,ATP13A2:NM_022089.4:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	293763 [benign DISEASE=Kufor-Rakeb syndrome];			rs15786	0.0132	0.0467	52,.	0.0092,0.0132,0.0000,0.0598,0.0099	0.4710	 ,D(0.00), , 	 ,B(0.02), , 	0.19,0.82	10.41	0.12				-0.0153	0.8751	0	45	1796	7 / 156					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)	0.5344	305	163	0.4655
chr1	17312595	17312595	G	C	het		QUAL=13685;DP=1138;AF=0.48;MQM=60	ATP13A2,RP1-37C10.3	3'UTR,missense,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::,ATP13A2:ENST00000341676.5:missense_variant:MODERATE:exon27/27:c.3365C>T:p.Pro1122Leu:,RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+6985G>A::,ATP13A2:ENST00000452699.1:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::	ATP13A2:NM_001141973.3:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::,ATP13A2:NM_001141974.3:missense_variant:MODERATE:exon27/27:c.3365C>T:p.Pro1122Leu:,ATP13A2:NM_022089.4:3_prime_UTR_variant:MODIFIER:exon29/29:c.*124C>T::		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	293763 [benign DISEASE=Kufor-Rakeb syndrome];			rs15786	0.0132	0.0467	52,.	0.0092,0.0132,0.0000,0.0598,0.0099	0.4710	 ,D(0.00), , 	 ,B(0.02), , 	0.19,0.82	10.41	0.12				-0.0153	0.8751	0	45	1796	7 / 156					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)	0.5344	305	163	0.4655
chr1	17312743	17312743	C	T	hom		QUAL=34337;DP=1088;AF=1.00;MQM=60	ATP13A2,RP1-37C10.3	synonymous,missense,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:synonymous_variant:LOW:exon29/29:c.3516G>A:p.Pro1172=:,ATP13A2:ENST00000341676.5:missense_variant:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr:,RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7136C>T::,ATP13A2:ENST00000452699.1:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:,ATP13A2:NM_001141974.3:missense_variant:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon29/29:c.3516G>A:p.Pro1172=:		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128475 [benign DISEASE=Kufor-Rakeb syndrome,History of neurodevelopmental disorder,not specified,not provided];			rs3170740	0.3313	0.4703	3029,.	0.2020,0.4851,0.2946,0.5286,0.4630	-2.5490	 ,T(0.32), , 	 ,B(0.00), , 	0.02,0.13	0.10	0.24				-0.0394	0.8746	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)	1.0000	374	374	n/a (non-het)
chr1	17313157	17313157	G	A	hom		QUAL=34748;DP=1190;AF=1.00;MQM=60	ATP13A2,RP1-37C10.3	intron,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:intron_variant:MODIFIER:intron27/28:c.3236-30C>T::,ATP13A2:ENST00000341676.5:intron_variant:MODIFIER:intron26/26:c.3103+143C>T::,RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7550G>A::,ATP13A2:ENST00000452699.1:intron_variant:MODIFIER:intron27/28:c.3221-30C>T::	ATP13A2:NM_001141973.3:intron_variant:MODIFIER:intron27/28:c.3221-30C>T::,ATP13A2:NM_001141974.3:intron_variant:MODIFIER:intron26/26:c.3103+143C>T::,ATP13A2:NM_022089.4:intron_variant:MODIFIER:intron27/28:c.3236-30C>T::	regulatory_region_variant:promoter_flanking_region	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	559000 [benign DISEASE=not provided];			rs2076605	0.3468	0.4706	3051,.	0.2188,0.4839,0.2956,0.5242,0.4771	1.8880			0.04,0.13	5.20					-0.4763	0.6238	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)	1.0000	143	143	n/a (non-het)
chr1	17313343	17313343	G	A	hom		QUAL=46795;DP=1492;AF=1.00;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:synonymous_variant:LOW:exon27/29:c.3192C>T:p.Ala1064=:,ATP13A2:ENST00000341676.5:synonymous_variant:LOW:exon26/27:c.3060C>T:p.Ala1020=:,RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7736G>A::,ATP13A2:ENST00000452699.1:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon26/27:c.3060C>T:p.Ala1020=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon27/29:c.3192C>T:p.Ala1064=:	regulatory_region_variant:promoter_flanking_region	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128473 [benign DISEASE=Kufor-Rakeb syndrome,History of neurodevelopmental disorder,not specified,not provided];			rs9435659	0.3385	0.4652	3048,.	0.1875,0.4783,0.2891,0.5225,0.4729	-0.5550			0.07,0.19	0.32					-0.003	0.7625	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)	1.0000	193	193	n/a (non-het)
chr1	17313654	17313654	C	T	hom		QUAL=35663;DP=1167;AF=1.00;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:synonymous_variant:LOW:exon26/29:c.2970G>A:p.Val990=:,ATP13A2:ENST00000341676.5:synonymous_variant:LOW:exon25/27:c.2838G>A:p.Val946=:,RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+8047C>T::,ATP13A2:ENST00000452699.1:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon25/27:c.2838G>A:p.Val946=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon26/29:c.2970G>A:p.Val990=:	regulatory_region_variant:promoter_flanking_region	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128470 [benign DISEASE=Kufor-Rakeb syndrome,History of neurodevelopmental disorder,not specified,not provided];			rs761421	0.3462	0.4654	3067,.	0.2158,0.4792,0.2830,0.5203,0.4730	-0.9690			0.25,0.72	5.74					0.0079	0.0753	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)	1.0000	450	450	n/a (non-het)
chr1	17314942	17314942	G	A	hom		QUAL=20647;DP=637;AF=1.00;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:synonymous_variant:LOW:exon24/29:c.2637C>T:p.Gly879=:PF12710 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000341676.5:synonymous_variant:LOW:exon23/27:c.2505C>T:p.Gly835=:PF12710 [haloacid dehalogenase-like hydrolase],RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+9335G>A::,ATP13A2:ENST00000452699.1:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:PF12710 [haloacid dehalogenase-like hydrolase]	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon23/27:c.2505C>T:p.Gly835=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon24/29:c.2637C>T:p.Gly879=:		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128466 [benign DISEASE=Kufor-Rakeb syndrome,History of neurodevelopmental disorder,not specified,not provided];			rs9435662	0.3387	0.4633	3017,.	0.1867,0.4771,0.2888,0.5193,0.4726	-4.7600			0.06,0.67	8.61					-0.169	0.0968	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)	1.0000	289	289	n/a (non-het)
chr1	17319011	17319011	G	A	hom		QUAL=42125;DP=1495;AF=0.99;MQM=60	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:synonymous_variant:LOW:exon17/29:c.1815C>T:p.Pro605=:PF12710 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000341676.5:synonymous_variant:LOW:exon17/27:c.1800C>T:p.Pro600=:PF12710 [haloacid dehalogenase-like hydrolase],RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.188-12127G>A::,ATP13A2:ENST00000452699.1:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:PF12710 [haloacid dehalogenase-like hydrolase]	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon17/27:c.1800C>T:p.Pro600=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon17/29:c.1815C>T:p.Pro605=:		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128465 [benign DISEASE=Kufor-Rakeb syndrome,History of neurodevelopmental disorder,not specified,not provided];			rs2076603	0.4485	0.5563	4804,.	0.4404,0.5455,0.2863,0.6263,0.5184	0.1640			0.51,0.95	8.96					0.3326	0.3094	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)	1.0000	180	180	n/a (non-het)
chr1	17323449	17323449	T	C	hom		QUAL=20061;DP=659;AF=1.00;MQM=60	ATP13A2,RP1-37C10.3	intron,intron&non_coding_transcript	ATP13A2:ENST00000326735.8:intron_variant:MODIFIER:intron12/28:c.1195+66A>G::,ATP13A2:ENST00000341676.5:intron_variant:MODIFIER:intron12/26:c.1180+66A>G::,RP1-37C10.3:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.188-7689T>C::,ATP13A2:ENST00000452699.1:intron_variant:MODIFIER:intron12/28:c.1180+66A>G::	ATP13A2:NM_001141973.3:intron_variant:MODIFIER:intron12/28:c.1180+66A>G::,ATP13A2:NM_001141974.3:intron_variant:MODIFIER:intron12/26:c.1180+66A>G::,ATP13A2:NM_022089.4:intron_variant:MODIFIER:intron12/28:c.1195+66A>G::		610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];			MIR3 (SINE/MIR)	rs9435736		0.8030	10129,.		-0.8220			0.00,0.04	3.30					0.302	0.1312	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)	1.0000	84	84	n/a (non-het)
chr1	43393245	43393245	-	GGTGAGAAAT	het		QUAL=1642;DP=352;AF=0.33;MQM=60	SLC2A1	intron	SLC2A1:ENST00000426263.3:intron_variant:MODIFIER:intron9/9:c.1278+30_1278+31insATTTCTCACC::	SLC2A1:NM_006516.3:intron_variant:MODIFIER:intron9/9:c.1278+30_1278+31insATTTCTCACC::		138140 [GENE=SLC2A1 PHENOS=Dystonia 9,601042,Autosomal dominant/GLUT1 deficiency syndrome 1,infantile onset,severe,606777,Autosomal recessive,Autosomal dominant/Stomatin-deficient cryohydrocytosis with neurologic defects,608885,Autosomal dominant/GLUT1 deficiency syndrome 2,childhood onset,612126,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,12,614847,Autosomal dominant];				rs3831326		0.5517	4915,.						2.73					0.1492	0.1156	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)	0.3768	69	26	0.0533
chr1	65830298	65830298	T	-	het	low_conf_region	QUAL=1025;DP=136;AF=0.34;MQM=60	DNAJC6	intron	DNAJC6:ENST00000263441.7:intron_variant:MODIFIER:intron2/19:c.-17-6del::,DNAJC6:ENST00000371069.4:intron_variant:MODIFIER:intron1/18:c.194-6del::,DNAJC6:ENST00000395325.3:intron_variant:MODIFIER:intron1/18:c.23-6del::	DNAJC6:NM_001256864.2:intron_variant:MODIFIER:intron1/18:c.194-6del::,DNAJC6:NM_001256865.1:intron_variant:MODIFIER:intron2/19:c.-17-6del::,DNAJC6:NM_014787.4:intron_variant:MODIFIER:intron1/18:c.23-6del::		608375 [GENE=DNAJC6 PHENOS=Parkinson disease 19b,early-onset,615528,Autosomal recessive/Parkinson disease 19a,juvenile-onset,615528,Autosomal recessive];			(T)n (Simple_repeat)	rs58549467		0.1238	250,.	0.1352,0.1015,0.1054,0.0342,0.0827	0.2690				0.40					-0.0037	0.7675	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DNAJC6 (inh=AR oe_syn=0.94 oe_mis=0.80 oe_lof=0.11)	0.2925	106	31	0.0000
chr1	78578177	78578177	T	C	het		QUAL=4378;DP=568;AF=0.34;MQM=60	GIPC2	intron	GIPC2:ENST00000370759.3:intron_variant:MODIFIER:intron3/5:c.608-6900T>C::	GIPC2:NM_001304725.2:intron_variant:MODIFIER:intron3/5:c.386-6900T>C::,GIPC2:NM_017655.6:intron_variant:MODIFIER:intron3/5:c.608-6900T>C::						rs6666954	0.4489	0.3754	2617,.	0.6112,0.2545,0.6166,0.2758,0.2698	-1.2050			0.00,0.05	1.07							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GIPC2 (inh=n/a oe_syn=1.00 oe_mis=1.06 oe_lof=1.01)	n/a (no coverage)	0	n/a (no coverage)	n/a (no coverage)
chr1	181003340	181003340	-	G	het		QUAL=1039;DP=139;AF=0.38;MQM=60	MR1	intron	MR1:ENST00000282990.6:intron_variant:MODIFIER:intron1/4:c.67+131dup::,MR1:ENST00000367579.3:intron_variant:MODIFIER:intron1/5:c.67+131dup::,MR1:ENST00000367580.5:intron_variant:MODIFIER:intron1/5:c.67+131dup::,MR1:ENST00000434571.2:intron_variant:MODIFIER:intron1/3:c.67+131dup::	MR1:NM_001194999.1:intron_variant:MODIFIER:intron2/6:c.67+131dup::,MR1:NM_001195000.1:intron_variant:MODIFIER:intron2/5:c.67+131dup::,MR1:NM_001195035.1:intron_variant:MODIFIER:intron2/4:c.67+131dup::,MR1:NM_001310213.1:intron_variant:MODIFIER:intron2/6:c.-263+131dup::,MR1:NM_001531.2:intron_variant:MODIFIER:intron2/6:c.67+131dup::	regulatory_region_variant:promoter					rs61482628		0.2947	1559,.						5.72							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)	0.4444	36	16	0.6177
chr1	181018096	181018096	T	C	het		QUAL=7894;DP=998;AF=0.38;MQM=43	MR1	intron	MR1:ENST00000282990.6:intron_variant:MODIFIER:intron1/4:c.68-92T>C::,MR1:ENST00000367579.3:intron_variant:MODIFIER:intron1/5:c.68-92T>C::,MR1:ENST00000367580.5:intron_variant:MODIFIER:intron1/5:c.68-92T>C::,MR1:ENST00000434571.2:intron_variant:MODIFIER:intron1/3:c.68-92T>C::	MR1:NM_001194999.1:intron_variant:MODIFIER:intron2/6:c.68-92T>C::,MR1:NM_001195000.1:intron_variant:MODIFIER:intron2/5:c.68-92T>C::,MR1:NM_001195035.1:intron_variant:MODIFIER:intron2/4:c.68-92T>C::,MR1:NM_001310213.1:intron_variant:MODIFIER:intron3/6:c.-146-92T>C::,MR1:NM_001531.2:intron_variant:MODIFIER:intron2/6:c.68-92T>C::						rs2236412	0.0519	0.0654	76,.		-2.0610			0.00,0.07	0.62					-0.0437	0.8824	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)	0.5789	38	22	0.4177
chr1	181018180	181018180	C	G	het		QUAL=20533;DP=1256;AF=0.61;MQM=60	MR1	splice_region&intron	MR1:ENST00000282990.6:splice_region_variant&intron_variant:LOW:intron1/4:c.68-8C>G::,MR1:ENST00000367579.3:splice_region_variant&intron_variant:LOW:intron1/5:c.68-8C>G::,MR1:ENST00000367580.5:splice_region_variant&intron_variant:LOW:intron1/5:c.68-8C>G::,MR1:ENST00000434571.2:splice_region_variant&intron_variant:LOW:intron1/3:c.68-8C>G::	MR1:NM_001194999.1:splice_region_variant&intron_variant:LOW:intron2/6:c.68-8C>G::,MR1:NM_001195000.1:splice_region_variant&intron_variant:LOW:intron2/5:c.68-8C>G::,MR1:NM_001195035.1:splice_region_variant&intron_variant:LOW:intron2/4:c.68-8C>G::,MR1:NM_001310213.1:splice_region_variant&intron_variant:LOW:intron3/6:c.-146-8C>G::,MR1:NM_001531.2:splice_region_variant&intron_variant:LOW:intron2/6:c.68-8C>G::						rs2236411	0.1058	0.1088	237,.	0.1966,0.0597,0.0709,0.0850,0.0495	0.2130			0.10,0.17	0.43		10.00>9.52	0.000/0.002		-0.5706	0.97	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)	0.4634	123	57	0.4709
chr1	181018236	181018236	A	G	het		QUAL=15291;DP=1152;AF=0.51;MQM=56	MR1	missense	MR1:ENST00000282990.6:missense_variant:MODERATE:exon2/5:c.116A>G:p.His39Arg:PF00129 [Class I Histocompatibility antigen domains alpha 1 and 2],MR1:ENST00000367579.3:missense_variant:MODERATE:exon2/6:c.116A>G:p.His39Arg:PF00129 [Class I Histocompatibility antigen domains alpha 1 and 2],MR1:ENST00000367580.5:missense_variant:MODERATE:exon2/6:c.116A>G:p.His39Arg:PF00129 [Class I Histocompatibility antigen domains alpha 1 and 2],MR1:ENST00000434571.2:missense_variant:MODERATE:exon2/4:c.116A>G:p.His39Arg:PF00129 [Class I Histocompatibility antigen domains alpha 1 and 2]	MR1:NM_001194999.1:missense_variant:MODERATE:exon3/7:c.116A>G:p.His39Arg:,MR1:NM_001195000.1:missense_variant:MODERATE:exon3/6:c.116A>G:p.His39Arg:,MR1:NM_001195035.1:missense_variant:MODERATE:exon3/5:c.116A>G:p.His39Arg:,MR1:NM_001310213.1:5_prime_UTR_variant:MODIFIER:exon4/7:c.-98A>G::,MR1:NM_001531.2:missense_variant:MODERATE:exon3/7:c.116A>G:p.His39Arg:			129620 [likely benign DISEASE=not specified];			rs2236410	0.1929	0.1772	423,.	0.1328,0.2421,0.3485,0.1475,0.1755	0.4300	T(0.44),T(0.49),T(0.19),T(0.22)	B(0.08),B(0.17),B(0.27),B(0.07)	0.04,0.14	0.05	0.04			COSV51581658	0.0202	0.8722	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)	0.4937	237	117	0.9267
chr1	181021483	181021483	C	T	het		QUAL=11501;DP=959;AF=0.49;MQM=60	MR1	intron,synonymous	MR1:ENST00000282990.6:intron_variant:MODIFIER:intron3/4:c.605-1226C>T::,MR1:ENST00000367579.3:synonymous_variant:LOW:exon4/6:c.582C>T:p.Asn194=:PF07654 [Immunoglobulin C1-set domain],MR1:ENST00000367580.5:synonymous_variant:LOW:exon4/6:c.717C>T:p.Asn239=:PF07654 [Immunoglobulin C1-set domain],MR1:ENST00000434571.2:intron_variant:MODIFIER:intron3/3:c.604+2061C>T::	MR1:NM_001194999.1:synonymous_variant:LOW:exon5/7:c.582C>T:p.Asn194=:,MR1:NM_001195000.1:intron_variant:MODIFIER:intron4/5:c.605-1226C>T::,MR1:NM_001195035.1:intron_variant:MODIFIER:intron4/4:c.604+2061C>T::,MR1:NM_001310213.1:intron_variant:MODIFIER:intron5/6:c.392-1226C>T::,MR1:NM_001531.2:synonymous_variant:LOW:exon5/7:c.717C>T:p.Asn239=:						rs35223984	0.0096	0.0238	12,.	0.0066,0.0075,0.0001,0.0370,0.0015	-1.9970			0.00,0.92	6.14					-0.0726	0.144	0.06	22	1065	3 / 101					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)	0.4144	263	109	0.0542
chr1	181022518	181022518	A	-	het		QUAL=4093;DP=282;AF=0.56;MQM=60	MR1	intron	MR1:ENST00000282990.6:intron_variant:MODIFIER:intron3/4:c.605-176del::,MR1:ENST00000367579.3:intron_variant:MODIFIER:intron4/5:c.746-176del::,MR1:ENST00000367580.5:intron_variant:MODIFIER:intron4/5:c.881-176del::,MR1:ENST00000434571.2:intron_variant:MODIFIER:intron3/3:c.605-1828del::	MR1:NM_001194999.1:intron_variant:MODIFIER:intron5/6:c.746-176del::,MR1:NM_001195000.1:intron_variant:MODIFIER:intron4/5:c.605-176del::,MR1:NM_001195035.1:intron_variant:MODIFIER:intron4/4:c.605-1828del::,MR1:NM_001310213.1:intron_variant:MODIFIER:intron5/6:c.392-176del::,MR1:NM_001531.2:intron_variant:MODIFIER:intron5/6:c.881-176del::					AluJo (SINE/Alu)	rs35459172		0.4474	1919,.		-0.1470				2.27							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)	1.0000	9	9	0.0039
chr1	181022518	181022519	AA	-	het		QUAL=4093;DP=282;AF=0.16;MQM=60	MR1	intron	MR1:ENST00000282990.6:intron_variant:MODIFIER:intron3/4:c.605-177_605-176del::,MR1:ENST00000367579.3:intron_variant:MODIFIER:intron4/5:c.746-177_746-176del::,MR1:ENST00000367580.5:intron_variant:MODIFIER:intron4/5:c.881-177_881-176del::,MR1:ENST00000434571.2:intron_variant:MODIFIER:intron3/3:c.605-1829_605-1828del::	MR1:NM_001194999.1:intron_variant:MODIFIER:intron5/6:c.746-177_746-176del::,MR1:NM_001195000.1:intron_variant:MODIFIER:intron4/5:c.605-177_605-176del::,MR1:NM_001195035.1:intron_variant:MODIFIER:intron4/4:c.605-1829_605-1828del::,MR1:NM_001310213.1:intron_variant:MODIFIER:intron5/6:c.392-177_392-176del::,MR1:NM_001531.2:intron_variant:MODIFIER:intron5/6:c.881-177_881-176del::					AluJo (SINE/Alu)	rs35459172		0.0122	0,.		-0.1470				2.40							0	0	57	0 / 6					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)	0.0000	9	0	0.0039
chr1	181022895	181022895	C	A	hom		QUAL=5578;DP=188;AF=1.00;MQM=60	MR1	intron	MR1:ENST00000282990.6:intron_variant:MODIFIER:intron4/4:c.709+82C>A::,MR1:ENST00000367579.3:intron_variant:MODIFIER:intron5/5:c.850+82C>A::,MR1:ENST00000367580.5:intron_variant:MODIFIER:intron5/5:c.985+82C>A::,MR1:ENST00000434571.2:intron_variant:MODIFIER:intron3/3:c.605-1466C>A::	MR1:NM_001194999.1:intron_variant:MODIFIER:intron6/6:c.850+82C>A::,MR1:NM_001195000.1:intron_variant:MODIFIER:intron5/5:c.709+82C>A::,MR1:NM_001195035.1:intron_variant:MODIFIER:intron4/4:c.605-1466C>A::,MR1:NM_001310213.1:intron_variant:MODIFIER:intron6/6:c.496+82C>A::,MR1:NM_001531.2:intron_variant:MODIFIER:intron6/6:c.985+82C>A::						rs2275469	0.5597	0.4050	3079,.		-0.7040			0.00,0.08	0.21					-0.1109	0.2745	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)	1.0000	50	50	n/a (non-het)
chr1	181024404	181024404	G	A	hom		QUAL=5025;DP=186;AF=1.00;MQM=60	MR1	3'UTR	MR1:ENST00000282990.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*3G>A::,MR1:ENST00000367579.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3G>A::,MR1:ENST00000367580.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3G>A::,MR1:ENST00000434571.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*3G>A::	MR1:NM_001194999.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*3G>A::,MR1:NM_001195000.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3G>A::,MR1:NM_001195035.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*3G>A::,MR1:NM_001310213.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*3G>A::,MR1:NM_001531.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*3G>A::						rs3747956	0.5224	0.4004	2645,.	0.5294,0.5533,0.7515,0.2912,0.4868	0.0560			0.02,0.15	9.00					-0.4928	0.9026	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MR1 (inh=n/a oe_syn=1.02 oe_mis=1.07 oe_lof=1.35)	1.0000	188	188	n/a (non-het)
chr1	220089352	220089352	A	C	het	off-target	QUAL=1841;DP=203;AF=0.52;MQM=60	SLC30A10	intron	SLC30A10:ENST00000366926.3:intron_variant:MODIFIER:intron3/3:c.959-62T>G::,SLC30A10:ENST00000536446.1:intron_variant:MODIFIER:intron3/3:c.224-62T>G::	SLC30A10:NM_018713.2:intron_variant:MODIFIER:intron3/3:c.959-62T>G::,SLC30A10:NR_046437.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.1208-62T>G::		611146 [GENE=SLC30A10 PHENOS=Hypermanganesemia with dystonia 1,613280,Autosomal recessive];				rs2231734	0.2925	0.3142	1632,.		-0.5990			0.01,0.24	2.53					-0.0436	0.9447	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC30A10 (inh=AR oe_syn=0.98 oe_mis=0.73 oe_lof=0.00)	0.5098	51	26	1.0000
chr2	75276429	75276429	C	G	het		QUAL=4647;DP=386;AF=0.49;MQM=60	TACR1	3'UTR	TACR1:ENST00000305249.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*130G>C::	TACR1:NM_001058.4:3_prime_UTR_variant:MODIFIER:exon5/5:c.*130G>C::					MIR3 (SINE/MIR)	rs881	0.2220	0.1767	487,.		-0.3630			0.01,0.14	1.37					0.0177	0.8891	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TACR1 (inh=n/a oe_syn=0.99 oe_mis=0.90 oe_lof=0.50)	0.2917	24	7	0.0639
chr2	75425623	75425623	G	A	het		QUAL=7457;DP=670;AF=0.47;MQM=60	TACR1	intron	TACR1:ENST00000305249.5:intron_variant:MODIFIER:intron1/4:c.389+49C>T::,TACR1:ENST00000409848.3:intron_variant:MODIFIER:intron1/3:c.389+49C>T::	TACR1:NM_001058.4:intron_variant:MODIFIER:intron1/4:c.389+49C>T::,TACR1:NM_015727.3:intron_variant:MODIFIER:intron1/3:c.389+49C>T::						rs2024512	0.5409	0.5451	4975,.	0.8042,0.4415,0.4058,0.4642,0.3919	-0.9380			0.00,0.10	5.03					0.1816	0.4221	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TACR1 (inh=n/a oe_syn=0.99 oe_mis=0.90 oe_lof=0.50)	0.4634	82	38	0.5811
chr2	75425728	75425728	A	G	het		QUAL=9530;DP=799;AF=0.49;MQM=60	TACR1	synonymous	TACR1:ENST00000305249.5:synonymous_variant:LOW:exon1/5:c.333T>C:p.Phe111=:PF00001 [7 transmembrane receptor (rhodopsin family)],TACR1:ENST00000409848.3:synonymous_variant:LOW:exon1/4:c.333T>C:p.Phe111=:PF00001 [7 transmembrane receptor (rhodopsin family)]	TACR1:NM_001058.4:synonymous_variant:LOW:exon1/5:c.333T>C:p.Phe111=:,TACR1:NM_015727.3:synonymous_variant:LOW:exon1/4:c.333T>C:p.Phe111=:						rs6715729	0.5651	0.5683	5509,.	0.8609,0.4565,0.4070,0.4755,0.4001	1.1620			0.19,0.96	14.08					0.001	0.4239	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TACR1 (inh=n/a oe_syn=0.99 oe_mis=0.90 oe_lof=0.50)	0.4757	267	127	0.6030
chr2	147596973	147596973	A	G	het		QUAL=2498;DP=309;AF=0.46;MQM=60	AC103881.1	intron&non_coding_transcript	AC103881.1:ENST00000450667.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/5:n.229+1200A>G::	::intergenic_variant:MODIFIER::::						rs4411641	0.5090	0.4872	3884,.	0.6458,0.6144,0.4402,0.3990,0.4075	0.2240			0.00,0.04	5.08								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)						1.0000	1	1	1.0000
chr2	219206919	219206919	C	T	het	off-target	QUAL=12430;DP=950;AF=0.53;MQM=60	PNKD,AC021016.8	intron,intron&non_coding_transcript	PNKD:ENST00000258362.3:intron_variant:MODIFIER:intron6/8:c.709+52C>T::,PNKD:ENST00000273077.4:intron_variant:MODIFIER:intron7/9:c.781+52C>T::,AC021016.8:ENST00000411433.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.120+8964G>A::,PNKD:ENST00000436005.2:intron_variant:MODIFIER:intron6/8:c.601+52C>T::	PNKD:NM_015488.5:intron_variant:MODIFIER:intron7/9:c.781+52C>T::,PNKD:NM_022572.4:intron_variant:MODIFIER:intron6/8:c.709+52C>T::,CATIP-AS2:NR_125777.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.120+8964G>A::		609023 [GENE=PNKD PHENOS=Paroxysmal nonkinesigenic dyskinesia 1,118800,Autosomal dominant];				rs3816562	0.4800	0.5364	3483,.	0.2152,0.5844,0.6360,0.5261,0.6358	0.1850			0.05,0.35	6.75					0.142	0.1225	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PNKD (inh=AD oe_syn=0.86 oe_mis=0.94 oe_lof=0.73)	0.3913	69	27	0.0722
chr3	123010276	123010276	G	A	het	off-target	QUAL=11854;DP=1038;AF=0.48;MQM=60	ADCY5	intron	ADCY5:ENST00000309879.5:intron_variant:MODIFIER:intron17/20:c.2014-53C>T::,ADCY5:ENST00000462833.1:intron_variant:MODIFIER:intron17/20:c.3064-53C>T::,ADCY5:ENST00000491190.1:intron_variant:MODIFIER:intron19/22:c.2038-53C>T::	ADCY5:NM_001199642.1:intron_variant:MODIFIER:intron17/20:c.2014-53C>T::,ADCY5:NM_183357.2:intron_variant:MODIFIER:intron17/20:c.3064-53C>T::		600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs9809236	0.1829	0.2969	1716,.		0.7360			0.05,0.10	0.38					0.1141	0.3678	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)	0.4412	68	30	0.3961
chr3	123014877	123014877	C	T	hom	off-target	QUAL=35170;DP=1116;AF=1.00;MQM=60	ADCY5	intron	ADCY5:ENST00000309879.5:intron_variant:MODIFIER:intron17/20:c.2013+54G>A::,ADCY5:ENST00000462833.1:intron_variant:MODIFIER:intron17/20:c.3063+54G>A::,ADCY5:ENST00000491190.1:intron_variant:MODIFIER:intron19/22:c.2037+54G>A::	ADCY5:NM_001199642.1:intron_variant:MODIFIER:intron17/20:c.2013+54G>A::,ADCY5:NM_183357.2:intron_variant:MODIFIER:intron17/20:c.3063+54G>A::	regulatory_region_variant:promoter_flanking_region	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs9881951	0.7206	0.7149	8228,.		-0.6560			0.01,0.14	0.06					0.1126	0.1506	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)	1.0000	101	101	n/a (non-het)
chr3	123015094	123015094	G	C	hom	off-target	QUAL=3850;DP=167;AF=1.00;MQM=60	ADCY5	intron	ADCY5:ENST00000309879.5:intron_variant:MODIFIER:intron16/20:c.1881-31C>G::,ADCY5:ENST00000462833.1:intron_variant:MODIFIER:intron16/20:c.2931-31C>G::,ADCY5:ENST00000491190.1:intron_variant:MODIFIER:intron18/22:c.1905-31C>G::	ADCY5:NM_001199642.1:intron_variant:MODIFIER:intron16/20:c.1881-31C>G::,ADCY5:NM_183357.2:intron_variant:MODIFIER:intron16/20:c.2931-31C>G::	regulatory_region_variant:promoter_flanking_region	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs9882534		0.9967	15275,.	0.9535,0.9986,0.9999,0.9999,0.9999	-2.5510			0.02,0.10	2.02					0.1625	0.0258	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)	1.0000	118	118	n/a (non-het)
chr3	123018963	123018963	A	G	hom		QUAL=45591;DP=1441;AF=1.00;MQM=60	ADCY5	splice_region&intron	ADCY5:ENST00000309879.5:splice_region_variant&intron_variant:LOW:intron15/20:c.1850+4T>C::,ADCY5:ENST00000462833.1:splice_region_variant&intron_variant:LOW:intron15/20:c.2900+4T>C::,ADCY5:ENST00000491190.1:splice_region_variant&intron_variant:LOW:intron16/22:c.1799+4T>C::	ADCY5:NM_001199642.1:splice_region_variant&intron_variant:LOW:intron15/20:c.1850+4T>C::,ADCY5:NM_183357.2:splice_region_variant&intron_variant:LOW:intron15/20:c.2900+4T>C::		600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs4482616	0.8067	0.8069	10211,.	0.7982,0.7885,0.8768,0.8060,0.7881	-1.1070			0.01,0.10	0.05		3.93>4.57	0.000/0.006		1.2265	0.0224	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)	1.0000	143	143	n/a (non-het)
chr3	123021838	123021838	A	G	hom	off-target	QUAL=15995;DP=564;AF=1.00;MQM=60	ADCY5	intron	ADCY5:ENST00000309879.5:intron_variant:MODIFIER:intron14/20:c.1674+64T>C::,ADCY5:ENST00000462833.1:intron_variant:MODIFIER:intron14/20:c.2724+64T>C::,ADCY5:ENST00000491190.1:intron_variant:MODIFIER:intron15/22:c.1623+64T>C::	ADCY5:NM_001199642.1:intron_variant:MODIFIER:intron14/20:c.1674+64T>C::,ADCY5:NM_183357.2:intron_variant:MODIFIER:intron14/20:c.2724+64T>C::		600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs9877581	0.9834	0.9873	15299,.		-0.9570			0.00,0.06	9.50					-0.1413	0.2758	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)	1.0000	60	60	n/a (non-het)
chr3	123021870	123021870	G	C	het	off-target	QUAL=14519;DP=1120;AF=0.49;MQM=60	ADCY5	intron	ADCY5:ENST00000309879.5:intron_variant:MODIFIER:intron14/20:c.1674+32C>G::,ADCY5:ENST00000462833.1:intron_variant:MODIFIER:intron14/20:c.2724+32C>G::,ADCY5:ENST00000491190.1:intron_variant:MODIFIER:intron15/22:c.1623+32C>G::	ADCY5:NM_001199642.1:intron_variant:MODIFIER:intron14/20:c.1674+32C>G::,ADCY5:NM_183357.2:intron_variant:MODIFIER:intron14/20:c.2724+32C>G::		600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs9844212	0.4417	0.5511	4876,.	0.4767,0.3814,0.3040,0.5847,0.4717	-2.4670			0.00,0.07	0.05					0.0561	0.2741	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)	0.5086	116	59	0.9261
chr3	123047478	123047478	A	G	het		QUAL=5438;DP=581;AF=0.39;MQM=60	ADCY5	intron	ADCY5:ENST00000309879.5:intron_variant:MODIFIER:intron6/20:c.755+13T>C::,ADCY5:ENST00000462833.1:intron_variant:MODIFIER:intron6/20:c.1805+13T>C::,ADCY5:ENST00000491190.1:intron_variant:MODIFIER:intron7/22:c.704+13T>C::	ADCY5:NM_001199642.1:intron_variant:MODIFIER:intron6/20:c.755+13T>C::,ADCY5:NM_183357.2:intron_variant:MODIFIER:intron6/20:c.1805+13T>C::	regulatory_region_variant:promoter_flanking_region	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs9855635	0.2153	0.3003	1544,.	0.1223,0.1537,0.2690,0.3710,0.2535	-1.7890			0.02,0.11	0.66					0.2141	0.0101	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)	0.5340	103	55	0.5546
chr3	123047666	123047666	A	G	hom		QUAL=25127;DP=785;AF=1.00;MQM=60	ADCY5	intron	ADCY5:ENST00000309879.5:intron_variant:MODIFIER:intron5/20:c.597-17T>C::,ADCY5:ENST00000462833.1:intron_variant:MODIFIER:intron5/20:c.1647-17T>C::,ADCY5:ENST00000491190.1:intron_variant:MODIFIER:intron6/22:c.546-17T>C::	ADCY5:NM_001199642.1:intron_variant:MODIFIER:intron5/20:c.597-17T>C::,ADCY5:NM_183357.2:intron_variant:MODIFIER:intron5/20:c.1647-17T>C::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];	801997 [benign DISEASE=Dyskinesia, familial, with facial myokymia];			rs9855969	0.8852	0.8617	11707,.	0.9119,0.8026,0.9635,0.8405,0.8739	1.3380			0.59,0.88	17.23		8.97>9.78			0.1746	0.0316	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)	1.0000	109	109	n/a (non-het)
chr3	123049678	123049678	C	T	het	off-target	QUAL=5385;DP=442;AF=0.49;MQM=60	ADCY5	intron	ADCY5:ENST00000309879.5:intron_variant:MODIFIER:intron5/20:c.596+58G>A::,ADCY5:ENST00000462833.1:intron_variant:MODIFIER:intron5/20:c.1646+58G>A::,ADCY5:ENST00000491190.1:intron_variant:MODIFIER:intron6/22:c.545+58G>A::	ADCY5:NM_001199642.1:intron_variant:MODIFIER:intron5/20:c.596+58G>A::,ADCY5:NM_183357.2:intron_variant:MODIFIER:intron5/20:c.1646+58G>A::	regulatory_region_variant:promoter_flanking_region	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs4678009	0.2977	0.2121	784,.		-1.1200			0.02,0.11	0.47					0.0404	0.1224	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)	0.5192	52	27	0.8899
chr3	123049707	123049707	G	T	het	off-target	QUAL=4627;DP=658;AF=0.34;MQM=60	ADCY5	intron	ADCY5:ENST00000309879.5:intron_variant:MODIFIER:intron5/20:c.596+29C>A::,ADCY5:ENST00000462833.1:intron_variant:MODIFIER:intron5/20:c.1646+29C>A::,ADCY5:ENST00000491190.1:intron_variant:MODIFIER:intron6/22:c.545+29C>A::	ADCY5:NM_001199642.1:intron_variant:MODIFIER:intron5/20:c.596+29C>A::,ADCY5:NM_183357.2:intron_variant:MODIFIER:intron5/20:c.1646+29C>A::	regulatory_region_variant:promoter_flanking_region	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs9829332	0.2348	0.3136	1580,.	0.2475,0.1577,0.2651,0.3508,0.1985	-2.0940			0.01,0.09	0.59					-0.0449	0.1228	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)	0.5000	98	49	1.0000
chr3	123049938	123049938	A	C	hom	off-target	QUAL=759;DP=27;AF=1.00;MQM=60	ADCY5	intron	ADCY5:ENST00000309879.5:intron_variant:MODIFIER:intron4/20:c.469-75T>G::,ADCY5:ENST00000462833.1:intron_variant:MODIFIER:intron4/20:c.1519-75T>G::,ADCY5:ENST00000491190.1:intron_variant:MODIFIER:intron5/22:c.418-75T>G::	ADCY5:NM_001199642.1:intron_variant:MODIFIER:intron4/20:c.469-75T>G::,ADCY5:NM_183357.2:intron_variant:MODIFIER:intron4/20:c.1519-75T>G::	regulatory_region_variant:promoter_flanking_region	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs6806529	0.6923	0.6311	6360,.		-0.1340			0.02,0.80	14.38					-0.0104	0.9303	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)	1.0000	37	37	n/a (non-het)
chr3	123066555	123066555	-	AAGG	hom	off-target;low_conf_region	QUAL=2024;DP=226;AF=0.53;MQM=60	ADCY5	intron	ADCY5:ENST00000309879.5:intron_variant:MODIFIER:intron3/20:c.356+70_356+73dup::,ADCY5:ENST00000462833.1:intron_variant:MODIFIER:intron3/20:c.1406+70_1406+73dup::,ADCY5:ENST00000491190.1:intron_variant:MODIFIER:intron4/22:c.305+70_305+73dup::	ADCY5:NM_001199642.1:intron_variant:MODIFIER:intron3/20:c.356+70_356+73dup::,ADCY5:NM_183357.2:intron_variant:MODIFIER:intron3/20:c.1406+70_1406+73dup::	regulatory_region_variant:promoter_flanking_region	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs112525497		0.9941	15482,.						3.31					-0.0893	0.3439	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)	0.9000	40	36	n/a (non-het)
chr3	123167249	123167249	G	A	hom		QUAL=17980;DP=601;AF=1.00;MQM=60	ADCY5	synonymous	ADCY5:ENST00000462833.1:synonymous_variant:LOW:exon1/21:c.144C>T:p.Gly48=:	ADCY5:NM_183357.2:synonymous_variant:LOW:exon1/21:c.144C>T:p.Gly48=:	regulatory_region_variant:promoter,TF_binding_site_variant	600293 [GENE=ADCY5 PHENOS=Dyskinesia,familial,with facial myokymia,606703,Autosomal dominant];				rs4678027		0.9990	15124,.	0.9671,0.9978,1.0000,1.0000,0.9998	0.2620			0.23,1.00	7.05					0.0032	0.1114	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ADCY5 (inh=AD oe_syn=0.99 oe_mis=0.65 oe_lof=0.14)	1.0000	201	201	n/a (non-het)
chr3	148896430	148896430	A	G	het		QUAL=7785;DP=458;AF=0.61;MQM=60	CP	intron	CP:ENST00000264613.6:intron_variant:MODIFIER:intron15/18:c.2662-12T>C::	CP:NM_000096.4:intron_variant:MODIFIER:intron15/18:c.2662-12T>C::,CP:NR_046371.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron14/17:n.2486-12T>C::	regulatory_region_variant:promoter_flanking_region	117700 [GENE=CP PHENOS=Hypoceruloplasminemia,hereditary,604290,Autosomal recessive/Hemosiderosis,systemic,due to aceruloplasminemia,604290,Autosomal recessive/Cerebellar ataxia,604290,Autosomal recessive];	194589 [benign DISEASE=Deficiency of ferroxidase,not specified];			rs16861582	0.3423	0.3460	1924,.	0.4445,0.2079,0.3683,0.2864,0.2913	0.0930			0.18,0.20	4.74		8.45>8.38	0.000/0.004		-0.6119	0.6798	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HPS3 (inh=AR oe_syn=1.03 oe_mis=0.98 oe_lof=0.78), CP (inh=AR oe_syn=1.10 oe_mis=0.97 oe_lof=0.46)	0.5510	98	54	0.3634
chr3	148897498	148897498	-	AC	het	low_conf_region	QUAL=1277;DP=136;AF=0.31;MQM=60	CP	intron	CP:ENST00000264613.6:intron_variant:MODIFIER:intron14/18:c.2555-51_2555-50dup::	CP:NM_000096.4:intron_variant:MODIFIER:intron14/18:c.2555-51_2555-50dup::,CP:NR_046371.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron13/17:n.2379-51_2379-50dup::	regulatory_region_variant:promoter_flanking_region	117700 [GENE=CP PHENOS=Hypoceruloplasminemia,hereditary,604290,Autosomal recessive/Hemosiderosis,systemic,due to aceruloplasminemia,604290,Autosomal recessive/Cerebellar ataxia,604290,Autosomal recessive];			(AC)n (Simple_repeat)	rs71304221		0.2751	1044,.	0.1182,0.2472,0.2675,0.1835,0.1993					2.28					-0.0494	0.4222	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CP (inh=AR oe_syn=1.10 oe_mis=0.97 oe_lof=0.46)	0.1304	23	3	0.0005
chr3	148897499	148897500	AC	-	het	low_conf_region	QUAL=1277;DP=136;AF=0.30;MQM=60	CP	intron	CP:ENST00000264613.6:intron_variant:MODIFIER:intron14/18:c.2555-51_2555-50del::	CP:NM_000096.4:intron_variant:MODIFIER:intron14/18:c.2555-51_2555-50del::,CP:NR_046371.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron13/17:n.2379-51_2379-50del::	regulatory_region_variant:promoter_flanking_region	117700 [GENE=CP PHENOS=Hypoceruloplasminemia,hereditary,604290,Autosomal recessive/Hemosiderosis,systemic,due to aceruloplasminemia,604290,Autosomal recessive/Cerebellar ataxia,604290,Autosomal recessive];			(AC)n (Simple_repeat)	rs71304221		0.1586	198,.	0.1512,0.1123,0.0618,0.1846,0.1822	2.2070				1.53					0.0518	0.4535	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CP (inh=AR oe_syn=1.10 oe_mis=0.97 oe_lof=0.46)	0.3913	23	9	0.4049
chr3	148916235	148916235	T	A	hom		QUAL=97;DP=4;AF=1.00;MQM=40	CP	missense	CP:ENST00000264613.6:missense_variant:MODERATE:exon9/19:c.1632A>T:p.Glu544Asp:	CP:NM_000096.4:missense_variant:MODERATE:exon9/19:c.1632A>T:p.Glu544Asp:,CP:NR_046371.2:non_coding_transcript_exon_variant:MODIFIER:exon9/18:n.1669A>T::	regulatory_region_variant:promoter_flanking_region	117700 [GENE=CP PHENOS=Hypoceruloplasminemia,hereditary,604290,Autosomal recessive/Hemosiderosis,systemic,due to aceruloplasminemia,604290,Autosomal recessive/Cerebellar ataxia,604290,Autosomal recessive];	198992 [benign DISEASE=not specified];			rs701753	0.8622	0.9227	12247,.	0.6883,0.9558,0.9996,0.9411,0.8750	-0.0800	T(1.00)	B(0.00)	0.12,0.84	11.25	0.30				0.0853	0.0677	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CP (inh=AR oe_syn=1.10 oe_mis=0.97 oe_lof=0.46)	1.0000	162	162	n/a (non-het)
chr3	148930218	148930218	G	A	het		QUAL=1172;DP=150;AF=0.47;MQM=60	CP	intron	CP:ENST00000264613.6:intron_variant:MODIFIER:intron2/18:c.394+20C>T::	CP:NM_000096.4:intron_variant:MODIFIER:intron2/18:c.394+20C>T::,CP:NR_046371.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/17:n.431+20C>T::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant	117700 [GENE=CP PHENOS=Hypoceruloplasminemia,hereditary,604290,Autosomal recessive/Hemosiderosis,systemic,due to aceruloplasminemia,604290,Autosomal recessive/Cerebellar ataxia,604290,Autosomal recessive];				rs17847023	0.1394	0.1309	258,.	0.0205,0.1713,0.3857,0.0936,0.1469	-0.2150			0.04,0.20	10.49					0.1918	0.1109	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CP (inh=AR oe_syn=1.10 oe_mis=0.97 oe_lof=0.46)	0.5789	38	22	0.4177
chr3	148935893	148935893	A	G	het		QUAL=549;DP=62;AF=0.53;MQM=60	CP	intron	CP:ENST00000264613.6:intron_variant:MODIFIER:intron1/18:c.146+3541T>C::	CP:NM_000096.4:intron_variant:MODIFIER:intron1/18:c.146+3541T>C::,CP:NR_046371.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/17:n.183+3541T>C::		117700 [GENE=CP PHENOS=Hypoceruloplasminemia,hereditary,604290,Autosomal recessive/Hemosiderosis,systemic,due to aceruloplasminemia,604290,Autosomal recessive/Cerebellar ataxia,604290,Autosomal recessive];				rs16861636	0.1424	0.1007	238,.		0.3360			0.00,0.04	7.73							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CP (inh=AR oe_syn=1.10 oe_mis=0.97 oe_lof=0.46)	n/a (no coverage)	0	n/a (no coverage)	n/a (no coverage)
chr4	185999587	185999587	T	A	het	off-target	QUAL=583;DP=55;AF=0.55;MQM=60	RP11-386B13.3	intron&non_coding_transcript	RP11-386B13.3:ENST00000509017.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/8:n.1340+6360T>A::	LINC02436:NR_147059.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/8:n.1340+6360T>A::	regulatory_region_variant:enhancer					rs6818170	0.6675	0.6819	7483,.	0.8328,0.5467,0.4189,0.6699,0.6606	0.4470			0.00,0.11	9.82								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)						1.0000	1	1	1.0000
chr5	1394815	1394815	A	G	het		QUAL=4007;DP=288;AF=0.57;MQM=60	SLC6A3	3'UTR	SLC6A3:ENST00000270349.9:3_prime_UTR_variant:MODIFIER:exon15/15:c.*35T>C::,SLC6A3:ENST00000453492.2:3_prime_UTR_variant:MODIFIER:exon14/15:c.*35T>C::	SLC6A3:NM_001044.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*35T>C::		126455 [GENE=SLC6A3 PHENOS=Nicotine dependence,protection against,188890/Parkinsonism-dystonia,infantile,1,613135,Autosomal recessive];				rs1042098	0.2951	0.2925	1532,.	0.4599,0.1696,0.0967,0.2668,0.2278	-0.8700			0.00,0.08	4.82					-0.0206	0.8295	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A3 (inh=AR oe_syn=1.19 oe_mis=0.67 oe_lof=0.10)	0.4675	246	115	0.4709
chr5	1409127	1409127	T	C	hom		QUAL=21117;DP=695;AF=1.00;MQM=60	SLC6A3	intron	SLC6A3:ENST00000270349.9:intron_variant:MODIFIER:intron11/14:c.1498+14A>G::,SLC6A3:ENST00000453492.2:intron_variant:MODIFIER:intron10/14:c.1498+14A>G::	SLC6A3:NM_001044.5:intron_variant:MODIFIER:intron11/14:c.1498+14A>G::		126455 [GENE=SLC6A3 PHENOS=Nicotine dependence,protection against,188890/Parkinsonism-dystonia,infantile,1,613135,Autosomal recessive];	518359 [benign DISEASE=Parkinsonism-dystonia, infantile, 1];			rs429699	0.9367	0.9812	15148,.	0.9952,0.8544,0.7537,0.9990,0.9850	0.2120			0.00,0.22	0.52					0.151	0.1044	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A3 (inh=AR oe_syn=1.19 oe_mis=0.67 oe_lof=0.10)	1.0000	252	252	n/a (non-het)
chr5	1416142	1416142	C	A	het		QUAL=6609;DP=495;AF=0.55;MQM=60	SLC6A3	intron	SLC6A3:ENST00000270349.9:intron_variant:MODIFIER:intron7/14:c.1031+71G>T::,SLC6A3:ENST00000453492.2:intron_variant:MODIFIER:intron6/14:c.1031+71G>T::	SLC6A3:NM_001044.5:intron_variant:MODIFIER:intron7/14:c.1031+71G>T::		126455 [GENE=SLC6A3 PHENOS=Nicotine dependence,protection against,188890/Parkinsonism-dystonia,infantile,1,613135,Autosomal recessive];				rs40358		0.8144	10509,.		-3.3320			0.00,0.04	0.05					-0.0033	0.1294	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A3 (inh=AR oe_syn=1.19 oe_mis=0.67 oe_lof=0.10)	0.4545	55	25	0.5901
chr5	1416646	1416646	G	A	het		QUAL=302;DP=37;AF=0.57;MQM=60	SLC6A3	intron	SLC6A3:ENST00000270349.9:intron_variant:MODIFIER:intron6/14:c.928-330C>T::,SLC6A3:ENST00000453492.2:intron_variant:MODIFIER:intron5/14:c.928-330C>T::	SLC6A3:NM_001044.5:intron_variant:MODIFIER:intron6/14:c.928-330C>T::		126455 [GENE=SLC6A3 PHENOS=Nicotine dependence,protection against,188890/Parkinsonism-dystonia,infantile,1,613135,Autosomal recessive];				rs2042449	0.1865	0.2091	685,.		-1.0500			0.00,0.09	0.18					-0.0302	0.1286	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A3 (inh=AR oe_syn=1.19 oe_mis=0.67 oe_lof=0.10)	0.8000	5	4	0.3750
chr5	1443199	1443199	G	A	het		QUAL=28031;DP=1857;AF=0.54;MQM=60	SLC6A3	synonymous	SLC6A3:ENST00000270349.9:synonymous_variant:LOW:exon2/15:c.114C>T:p.Asn38=:,SLC6A3:ENST00000453492.2:synonymous_variant:LOW:exon1/15:c.114C>T:p.Asn38=:	SLC6A3:NM_001044.5:synonymous_variant:LOW:exon2/15:c.114C>T:p.Asn38=:		126455 [GENE=SLC6A3 PHENOS=Nicotine dependence,protection against,188890/Parkinsonism-dystonia,infantile,1,613135,Autosomal recessive];	522348 [benign DISEASE=Parkinsonism-dystonia, infantile, 1];			rs6350	0.0455	0.0562	49,.	0.0516,0.0343,0.0184,0.0639,0.0596	-0.2160			0.17,0.74	0.29					0.0035	0.1567	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A3 (inh=AR oe_syn=1.19 oe_mis=0.67 oe_lof=0.10)	0.4795	317	152	0.6343
chr5	57617403	57617403	G	C	het		QUAL=4537;DP=377;AF=0.50;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::					MLT1E1A (LTR/ERVL-MaLR)	rs37535		0.5798	5303,.		0.8490			0.01,0.11	1.27								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)						1.0000	1	1	1.0000
chr5	149433596	149433596	T	G	het	off-target	QUAL=4261;DP=612;AF=0.36;MQM=60	CSF1R	3'UTR	CSF1R:ENST00000286301.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*36A>C::	CSF1R:NM_001288705.2:3_prime_UTR_variant:MODIFIER:exon21/21:c.*36A>C::,CSF1R:NM_001349736.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*36A>C::,CSF1R:NM_005211.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*36A>C::,CSF1R:NR_109969.1:non_coding_transcript_exon_variant:MODIFIER:exon20/20:n.3005A>C::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];	352120 [benign DISEASE=Hereditary diffuse leukoencephalopathy with spheroids];			rs2066934	0.7967	0.8260	10677,.	0.9495,0.7787,0.7349,0.7624,0.6831	0.8170			0.00,0.11	0.71					-0.0304	0.92	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGXB3 (inh=n/a oe_syn=0.76 oe_mis=0.62 oe_lof=0.14), CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)	0.5066	302	153	1.0000
chr5	149433597	149433597	G	A	het	off-target	QUAL=4261;DP=612;AF=0.36;MQM=60	CSF1R	3'UTR	CSF1R:ENST00000286301.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*35C>T::	CSF1R:NM_001288705.2:3_prime_UTR_variant:MODIFIER:exon21/21:c.*35C>T::,CSF1R:NM_001349736.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*35C>T::,CSF1R:NM_005211.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*35C>T::,CSF1R:NR_109969.1:non_coding_transcript_exon_variant:MODIFIER:exon20/20:n.3004C>T::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];	352121 [benign DISEASE=Hereditary diffuse leukoencephalopathy with spheroids];			rs2066933	0.7959	0.8256	10662,.	0.9496,0.7784,0.7279,0.7623,0.6829	-0.2550			0.00,0.10	3.31					0.0453	0.9205	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGXB3 (inh=n/a oe_syn=0.76 oe_mis=0.62 oe_lof=0.14), CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)	0.4885	305	149	0.7465
chr5	149435608	149435608	G	C	het		QUAL=16232;DP=1322;AF=0.46;MQM=60	CSF1R	synonymous	CSF1R:ENST00000286301.3:synonymous_variant:LOW:exon19/22:c.2535C>G:p.Leu845=:PF07714 [Protein tyrosine kinase]	CSF1R:NM_001288705.2:synonymous_variant:LOW:exon18/21:c.2535C>G:p.Leu845=:,CSF1R:NM_001349736.1:synonymous_variant:LOW:exon20/23:c.2535C>G:p.Leu845=:,CSF1R:NM_005211.3:synonymous_variant:LOW:exon19/22:c.2535C>G:p.Leu845=:,CSF1R:NR_109969.1:non_coding_transcript_exon_variant:MODIFIER:exon17/20:n.2585C>G::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];	352132 [benign DISEASE=Hereditary diffuse leukoencephalopathy with spheroids];			rs56327604	0.0126	0.0310	24,.	0.0077,0.0220,0.0000,0.0471,0.0074	1.2680			0.83,0.94	10.45					-0.0383	0.9357	0	25	1328	1 / 136					HMGXB3 (inh=n/a oe_syn=0.76 oe_mis=0.62 oe_lof=0.14), CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)	0.4457	276	123	0.2015
chr5	149435759	149435759	G	A	het		QUAL=2911;DP=303;AF=0.47;MQM=60	CSF1R	intron	CSF1R:ENST00000286301.3:intron_variant:MODIFIER:intron18/21:c.2442+23C>T::	CSF1R:NM_001288705.2:intron_variant:MODIFIER:intron17/20:c.2442+23C>T::,CSF1R:NM_001349736.1:intron_variant:MODIFIER:intron19/22:c.2442+23C>T::,CSF1R:NM_005211.3:intron_variant:MODIFIER:intron18/21:c.2442+23C>T::,CSF1R:NR_109969.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron16/19:n.2492+23C>T::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];				rs216136	0.3942	0.5282	4356,.	0.1632,0.4053,0.4655,0.6025,0.5138	-0.0250			0.10,0.21	6.14					0.076	0.9342	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGXB3 (inh=n/a oe_syn=0.76 oe_mis=0.62 oe_lof=0.14), CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)	0.5258	194	102	0.6849
chr5	149437190	149437190	C	G	het	off-target	QUAL=17381;DP=1531;AF=0.45;MQM=60	CSF1R	intron	CSF1R:ENST00000286301.3:intron_variant:MODIFIER:intron15/21:c.2133-35G>C::	CSF1R:NM_001288705.2:intron_variant:MODIFIER:intron14/20:c.2133-35G>C::,CSF1R:NM_001349736.1:intron_variant:MODIFIER:intron16/22:c.2133-35G>C::,CSF1R:NM_005211.3:intron_variant:MODIFIER:intron15/21:c.2133-35G>C::,CSF1R:NR_109969.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron13/19:n.2183-35G>C::	regulatory_region_variant:promoter_flanking_region	164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];				rs216138	0.7919	0.8222	10668,.	0.9499,0.7764,0.7286,0.7583,0.6777	0.2340			0.00,0.08	6.73					0.3779	0.0236	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGXB3 (inh=n/a oe_syn=0.76 oe_mis=0.62 oe_lof=0.14), CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)	0.4947	188	93	0.9179
chr5	149441017	149441017	C	-	het	off-target;low_conf_region	QUAL=688;DP=90;AF=0.48;MQM=60	CSF1R	intron	CSF1R:ENST00000286301.3:intron_variant:MODIFIER:intron13/21:c.1858+37del::	CSF1R:NM_001288705.2:intron_variant:MODIFIER:intron12/20:c.1858+37del::,CSF1R:NM_001349736.1:intron_variant:MODIFIER:intron14/22:c.1858+37del::,CSF1R:NM_005211.3:intron_variant:MODIFIER:intron13/21:c.1858+37del::,CSF1R:NR_109969.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/19:n.2071+37del::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];				rs11286566		0.5645	3861,.	0.1862,0.4819,0.5179,0.6266,0.5560	-0.2690				0.62					0.0937	0.4258	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)	0.4194	31	13	0.3771
chr5	149456771	149456771	C	A	het	off-target	QUAL=8008;DP=679;AF=0.49;MQM=60	CSF1R	intron	CSF1R:ENST00000286301.3:intron_variant:MODIFIER:intron6/21:c.889+68G>T::,CSF1R:ENST00000543093.1:intron_variant:MODIFIER:intron5/5:c.889+68G>T::	CSF1R:NM_001288705.2:intron_variant:MODIFIER:intron5/20:c.889+68G>T::,CSF1R:NM_001349736.1:intron_variant:MODIFIER:intron7/22:c.889+68G>T::,CSF1R:NM_005211.3:intron_variant:MODIFIER:intron6/21:c.889+68G>T::,CSF1R:NR_109969.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/19:n.1102+68G>T::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];				rs2855781	0.3097	0.4464	3500,.	0.2608,0.3440,0.0792,0.5244,0.4370	0.3710			0.11,0.20	6.64				COSV53827952	0.0557	0.9037	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)	0.4146	82	34	0.1239
chr5	149456772	149456772	T	A	het	off-target	QUAL=8008;DP=679;AF=0.49;MQM=60	CSF1R	intron	CSF1R:ENST00000286301.3:intron_variant:MODIFIER:intron6/21:c.889+67A>T::,CSF1R:ENST00000543093.1:intron_variant:MODIFIER:intron5/5:c.889+67A>T::	CSF1R:NM_001288705.2:intron_variant:MODIFIER:intron5/20:c.889+67A>T::,CSF1R:NM_001349736.1:intron_variant:MODIFIER:intron7/22:c.889+67A>T::,CSF1R:NM_005211.3:intron_variant:MODIFIER:intron6/21:c.889+67A>T::,CSF1R:NR_109969.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/19:n.1102+67A>T::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];				rs60844779	0.3097	0.4463	3502,.	0.2606,0.3439,0.0792,0.5242,0.4370	0.0350			0.11,0.19	6.26				COSV53827959	0.0388	0.9035	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)	0.4167	84	35	0.1557
chr5	149457678	149457678	G	A	het		QUAL=25694;DP=2083;AF=0.47;MQM=60	CSF1R	synonymous	CSF1R:ENST00000286301.3:synonymous_variant:LOW:exon5/22:c.726C>T:p.Thr242=:PF00047 [Immunoglobulin domain],CSF1R:ENST00000543093.1:synonymous_variant:LOW:exon4/6:c.726C>T:p.Thr242=:PF00047 [Immunoglobulin domain]	CSF1R:NM_001288705.2:synonymous_variant:LOW:exon4/21:c.726C>T:p.Thr242=:,CSF1R:NM_001349736.1:synonymous_variant:LOW:exon6/23:c.726C>T:p.Thr242=:,CSF1R:NM_005211.3:synonymous_variant:LOW:exon5/22:c.726C>T:p.Thr242=:,CSF1R:NR_109969.1:non_coding_transcript_exon_variant:MODIFIER:exon4/20:n.939C>T::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];	352165 [benign DISEASE=Hereditary diffuse leukoencephalopathy with spheroids];	CM153945 [CLASS=FP MUT=ALT PHEN="Loss of enhancer activity" GENE=CSF1R];		rs2228422	0.3874	0.5103	4312,.	0.3201,0.4155,0.2189,0.5676,0.5550	0.0190			0.45,0.93	8.24					-0.5885	0.7343	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)	0.4432	176	78	0.3374
chr5	149460553	149460553	A	G	het		QUAL=22747;DP=1812;AF=0.48;MQM=60	CSF1R	synonymous	CSF1R:ENST00000286301.3:synonymous_variant:LOW:exon3/22:c.84T>C:p.Pro28=:PF13927 [Immunoglobulin domain],CSF1R:ENST00000543093.1:synonymous_variant:LOW:exon2/6:c.84T>C:p.Pro28=:PF13927 [Immunoglobulin domain]	CSF1R:NM_001288705.2:synonymous_variant:LOW:exon2/21:c.84T>C:p.Pro28=:,CSF1R:NM_001349736.1:synonymous_variant:LOW:exon4/23:c.84T>C:p.Pro28=:,CSF1R:NM_005211.3:synonymous_variant:LOW:exon3/22:c.84T>C:p.Pro28=:,CSF1R:NR_109969.1:non_coding_transcript_exon_variant:MODIFIER:exon2/20:n.297T>C::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];	352179 [benign DISEASE=Hereditary diffuse leukoencephalopathy with spheroids];			rs216123	0.3353	0.4823	4117,.	0.2921,0.3591,0.0952,0.5669,0.4657	-0.8850			0.04,0.36	4.83					0.0109	0.0919	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)	0.5077	325	165	0.9374
chr6	131148863	131148863	A	T	het		QUAL=2273;DP=183;AF=0.53;MQM=60	SMLR1	intron	SMLR1:ENST00000541421.2:intron_variant:MODIFIER:intron1/1:c.238+72A>T::	SMLR1:NM_001195597.1:intron_variant:MODIFIER:intron1/1:c.238+72A>T::						rs9388856	0.4794	0.3781	2349,.		0.0190			0.08,0.21	0.50					0.1163	0.1141	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)	0.5833	24	14	0.5413
chr6	131148891	131148891	-	AT	het	off-target	QUAL=2264;DP=258;AF=0.39;MQM=60	SMLR1	intron	SMLR1:ENST00000541421.2:intron_variant:MODIFIER:intron1/1:c.238+113_238+114dup::	SMLR1:NM_001195597.1:intron_variant:MODIFIER:intron1/1:c.238+113_238+114dup::						rs113795427		0.3951	2416,.						1.76					0.0006	0.1146	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)	0.4286	14	6	0.7905
chr6	161807855	161807855	C	G	het		QUAL=9787;DP=730;AF=0.51;MQM=60	PRKN	missense	PRKN:ENST00000338468.3:missense_variant:MODERATE:exon9/11:c.565G>C:p.Val189Leu:,PRKN:ENST00000366894.1:missense_variant:MODERATE:exon9/11:c.565G>C:p.Val189Leu:,PRKN:ENST00000366896.1:missense_variant:MODERATE:exon7/9:c.691G>C:p.Val231Leu:,PRKN:ENST00000366897.1:missense_variant:MODERATE:exon9/11:c.1054G>C:p.Val352Leu:,PRKN:ENST00000366898.1:missense_variant:MODERATE:exon10/12:c.1138G>C:p.Val380Leu:	PARK2:NM_004562.3:missense_variant:MODERATE:exon10/12:c.1138G>C:p.Val380Leu:,PARK2:NM_013987.3:missense_variant:MODERATE:exon9/11:c.1054G>C:p.Val352Leu:,PARK2:NM_013988.3:missense_variant:MODERATE:exon7/9:c.691G>C:p.Val231Leu:		602544 [GENE=PRKN PHENOS=Parkinson disease,juvenile,type 2,600116,Autosomal recessive/Ovarian cancer,somatic,167000/Adenocarcinoma of lung,somatic,211980];	41221 [benign DISEASE=Parkinson disease 2,not specified];	CM032983 [CLASS=DP MUT=ALT PHEN="Parkinson disease sporadic reduced risk" GENE=PRKN];		rs1801582	0.1721	0.1641	403,.	0.1725,0.1174,0.0786,0.1614,0.2632	-0.3990	T(0.48),T(0.48),T(0.58),T(0.46),T(0.44)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.00,0.09	11.19	0.28				-0.4265	0.1208	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRKN (inh=AR+AD oe_syn=1.15 oe_mis=1.15 oe_lof=0.55)	0.3602	261	94	0.0020
chr6	161990483	161990483	C	T	hom		QUAL=9820;DP=324;AF=1.00;MQM=60	PRKN	intron	PRKN:ENST00000338468.3:intron_variant:MODIFIER:intron6/10:c.299-35G>A::,PRKN:ENST00000366892.1:intron_variant:MODIFIER:intron7/9:c.872-35G>A::,PRKN:ENST00000366894.1:intron_variant:MODIFIER:intron6/10:c.299-35G>A::,PRKN:ENST00000366896.1:intron_variant:MODIFIER:intron4/8:c.425-35G>A::,PRKN:ENST00000366897.1:intron_variant:MODIFIER:intron6/10:c.788-35G>A::,PRKN:ENST00000366898.1:intron_variant:MODIFIER:intron7/11:c.872-35G>A::	PARK2:NM_004562.3:intron_variant:MODIFIER:intron7/11:c.872-35G>A::,PARK2:NM_013987.3:intron_variant:MODIFIER:intron6/10:c.788-35G>A::,PARK2:NM_013988.3:intron_variant:MODIFIER:intron4/8:c.425-35G>A::		602544 [GENE=PRKN PHENOS=Parkinson disease,juvenile,type 2,600116,Autosomal recessive/Ovarian cancer,somatic,167000/Adenocarcinoma of lung,somatic,211980];				rs3765474	0.5781	0.5579	4840,.	0.5323,0.4027,0.6961,0.5517,0.5583	-0.3760			0.00,0.12	4.71					0.2218	0.0179	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRKN (inh=AR+AD oe_syn=1.15 oe_mis=1.15 oe_lof=0.55)	1.0000	172	172	n/a (non-het)
chr6	161990516	161990516	G	C	hom		QUAL=14495;DP=446;AF=1.00;MQM=60	PRKN	intron	PRKN:ENST00000338468.3:intron_variant:MODIFIER:intron6/10:c.299-68C>G::,PRKN:ENST00000366892.1:intron_variant:MODIFIER:intron7/9:c.872-68C>G::,PRKN:ENST00000366894.1:intron_variant:MODIFIER:intron6/10:c.299-68C>G::,PRKN:ENST00000366896.1:intron_variant:MODIFIER:intron4/8:c.425-68C>G::,PRKN:ENST00000366897.1:intron_variant:MODIFIER:intron6/10:c.788-68C>G::,PRKN:ENST00000366898.1:intron_variant:MODIFIER:intron7/11:c.872-68C>G::	PARK2:NM_004562.3:intron_variant:MODIFIER:intron7/11:c.872-68C>G::,PARK2:NM_013987.3:intron_variant:MODIFIER:intron6/10:c.788-68C>G::,PARK2:NM_013988.3:intron_variant:MODIFIER:intron4/8:c.425-68C>G::		602544 [GENE=PRKN PHENOS=Parkinson disease,juvenile,type 2,600116,Autosomal recessive/Ovarian cancer,somatic,167000/Adenocarcinoma of lung,somatic,211980];				rs3765475	0.6895	0.6694	7120,.		0.0370			0.00,0.06	3.63					0.0167	0.0679	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRKN (inh=AR+AD oe_syn=1.15 oe_mis=1.15 oe_lof=0.55)	1.0000	115	115	n/a (non-het)
chr6	162622304	162622304	A	G	het		QUAL=7133;DP=600;AF=0.50;MQM=60	PRKN	intron	PRKN:ENST00000338468.3:intron_variant:MODIFIER:intron3/10:c.-40+61253T>C::,PRKN:ENST00000366892.1:intron_variant:MODIFIER:intron3/9:c.413-20T>C::,PRKN:ENST00000366894.1:intron_variant:MODIFIER:intron2/10:c.-161-20T>C::,PRKN:ENST00000366896.1:intron_variant:MODIFIER:intron2/8:c.172-227855T>C::,PRKN:ENST00000366897.1:intron_variant:MODIFIER:intron3/10:c.413-20T>C::,PRKN:ENST00000366898.1:intron_variant:MODIFIER:intron3/11:c.413-20T>C::	PARK2:NM_004562.3:intron_variant:MODIFIER:intron3/11:c.413-20T>C::,PARK2:NM_013987.3:intron_variant:MODIFIER:intron3/10:c.413-20T>C::,PARK2:NM_013988.3:intron_variant:MODIFIER:intron2/8:c.172-227855T>C::	regulatory_region_variant:enhancer	602544 [GENE=PRKN PHENOS=Parkinson disease,juvenile,type 2,600116,Autosomal recessive/Ovarian cancer,somatic,167000/Adenocarcinoma of lung,somatic,211980];	259433 [benign DISEASE=not specified];	CS046043 [CLASS=DP MUT=ALT PHEN="Parkinson disease association with" GENE=PRKN];		rs4709583	0.9505	0.9475	14087,.	0.9842,0.9637,0.9881,0.9182,0.8933	0.2890			0.00,0.16	4.10		9.80>10.02			-0.1093	0.0599	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRKN (inh=AR+AD oe_syn=1.15 oe_mis=1.15 oe_lof=0.55)	0.5222	90	47	0.7520
chr6	162683815	162683815	A	-	het	low_conf_region	QUAL=1124;DP=675;AF=0.12;MQM=60	PRKN	intron	PRKN:ENST00000338468.3:intron_variant:MODIFIER:intron2/10:c.-280-18del::,PRKN:ENST00000366892.1:intron_variant:MODIFIER:intron2/9:c.172-18del::,PRKN:ENST00000366894.1:intron_variant:MODIFIER:intron2/10:c.-161-61531del::,PRKN:ENST00000366896.1:intron_variant:MODIFIER:intron2/8:c.171+180527del::,PRKN:ENST00000366897.1:intron_variant:MODIFIER:intron2/10:c.172-18del::,PRKN:ENST00000366898.1:intron_variant:MODIFIER:intron2/11:c.172-18del::	PARK2:NM_004562.3:intron_variant:MODIFIER:intron2/11:c.172-18del::,PARK2:NM_013987.3:intron_variant:MODIFIER:intron2/10:c.172-18del::,PARK2:NM_013988.3:intron_variant:MODIFIER:intron2/8:c.171+180527del::		602544 [GENE=PRKN PHENOS=Parkinson disease,juvenile,type 2,600116,Autosomal recessive/Ovarian cancer,somatic,167000/Adenocarcinoma of lung,somatic,211980];			(A)n (Simple_repeat)	rs751742289		0.0497	1,.		-0.0420				0.05					0.1143	0.0905	0	232	7079	19 / 711					PRKN (inh=AR+AD oe_syn=1.15 oe_mis=1.15 oe_lof=0.55)	0.0968	93	9	0.0000
chr6	162864317	162864317	A	G	het		QUAL=4723;DP=428;AF=0.49;MQM=60	PRKN	intron	PRKN:ENST00000338468.3:intron_variant:MODIFIER:intron2/10:c.-281+25T>C::,PRKN:ENST00000366892.1:intron_variant:MODIFIER:intron2/9:c.171+25T>C::,PRKN:ENST00000366894.1:intron_variant:MODIFIER:intron2/10:c.-162+25T>C::,PRKN:ENST00000366896.1:intron_variant:MODIFIER:intron2/8:c.171+25T>C::,PRKN:ENST00000366897.1:intron_variant:MODIFIER:intron2/10:c.171+25T>C::,PRKN:ENST00000366898.1:intron_variant:MODIFIER:intron2/11:c.171+25T>C::	PARK2:NM_004562.3:intron_variant:MODIFIER:intron2/11:c.171+25T>C::,PARK2:NM_013987.3:intron_variant:MODIFIER:intron2/10:c.171+25T>C::,PARK2:NM_013988.3:intron_variant:MODIFIER:intron2/8:c.171+25T>C::		602544 [GENE=PRKN PHENOS=Parkinson disease,juvenile,type 2,600116,Autosomal recessive/Ovarian cancer,somatic,167000/Adenocarcinoma of lung,somatic,211980];				rs2075923	0.2734	0.2948	1420,.	0.3920,0.2805,0.1785,0.2310,0.2184	2.3010			0.03,0.12	5.53					-0.0102	0.0775	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRKN (inh=AR+AD oe_syn=1.15 oe_mis=1.15 oe_lof=0.55)	0.5000	98	49	1.0000
chr6	162864839	162864839	A	G	het		QUAL=469;DP=43;AF=0.79;MQM=60	PRKN	intron	PRKN:ENST00000338468.3:intron_variant:MODIFIER:intron1/10:c.-444-334T>C::,PRKN:ENST00000366892.1:intron_variant:MODIFIER:intron1/9:c.8-334T>C::,PRKN:ENST00000366894.1:intron_variant:MODIFIER:intron1/10:c.-325-334T>C::,PRKN:ENST00000366896.1:intron_variant:MODIFIER:intron1/8:c.8-334T>C::,PRKN:ENST00000366897.1:intron_variant:MODIFIER:intron1/10:c.8-334T>C::,PRKN:ENST00000366898.1:intron_variant:MODIFIER:intron1/11:c.8-334T>C::	PARK2:NM_004562.3:intron_variant:MODIFIER:intron1/11:c.8-334T>C::,PARK2:NM_013987.3:intron_variant:MODIFIER:intron1/10:c.8-334T>C::,PARK2:NM_013988.3:intron_variant:MODIFIER:intron1/8:c.8-334T>C::		602544 [GENE=PRKN PHENOS=Parkinson disease,juvenile,type 2,600116,Autosomal recessive/Ovarian cancer,somatic,167000/Adenocarcinoma of lung,somatic,211980];				rs10455909	0.2208	0.2593	1056,.		1.9240			0.05,0.20	3.92							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRKN (inh=AR+AD oe_syn=1.15 oe_mis=1.15 oe_lof=0.55)	n/a (no coverage)	0	n/a (no coverage)	n/a (no coverage)
chr7	94227276	94227276	T	G	het		QUAL=1806;DP=213;AF=0.42;MQM=60	SGCE	intron,missense	SGCE:ENST00000265735.7:intron_variant:MODIFIER:intron9/10:c.1253+811A>C::,SGCE:ENST00000415788.2:intron_variant:MODIFIER:intron10/10:c.1361+811A>C::,SGCE:ENST00000428696.2:intron_variant:MODIFIER:intron8/10:c.1226+811A>C::,SGCE:ENST00000437425.2:intron_variant:MODIFIER:intron8/9:c.1130+811A>C::,SGCE:ENST00000445866.2:missense_variant:MODERATE:exon10/12:c.1294A>C:p.Ser432Arg:PF13900 [removed],SGCE:ENST00000447873.1:intron_variant:MODIFIER:intron8/9:c.1226+811A>C::	SGCE:NM_001099400.2:intron_variant:MODIFIER:intron8/10:c.1226+811A>C::,SGCE:NM_001099401.2:missense_variant:MODERATE:exon10/12:c.1294A>C:p.Ser432Arg:,SGCE:NM_001301139.2:intron_variant:MODIFIER:intron8/9:c.1130+811A>C::,SGCE:NM_001346713.2:intron_variant:MODIFIER:intron10/11:c.1361+811A>C::,SGCE:NM_001346715.2:intron_variant:MODIFIER:intron9/10:c.1334+811A>C::,SGCE:NM_001346717.2:intron_variant:MODIFIER:intron8/9:c.1226+811A>C::,SGCE:NM_001346719.2:intron_variant:MODIFIER:intron11/12:c.1166+811A>C::,SGCE:NM_001346720.2:intron_variant:MODIFIER:intron10/11:c.980+811A>C::,SGCE:NM_001362807.2:intron_variant:MODIFIER:intron10/11:c.1139+811A>C::,SGCE:NM_001362808.2:intron_variant:MODIFIER:intron9/10:c.953+811A>C::,SGCE:NM_001362809.2:intron_variant:MODIFIER:intron7/8:c.1103+811A>C::,SGCE:NM_003919.3:intron_variant:MODIFIER:intron9/10:c.1253+811A>C::		604149 [GENE=SGCE PHENOS=Dystonia-11,myoclonic,159900,Autosomal dominant];	487363 [benign DISEASE=Myoclonic dystonia 11];	CM173553 [CLASS=R MUT=ALT PHEN="Myoclonus dystonia" GENE=SGCE];	AluSq2 (SINE/Alu)	rs10247562		0.7880	9679,.	0.9643,0.4915,0.6939,0.6891,0.5588	-0.8570	 , , , ,T(0.12), 	 , , , ,B(0.00), 	0.00,0.02	8.06	0.02				-0.2965	0.7187	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SGCE (inh=AD oe_syn=0.99 oe_mis=0.81 oe_lof=0.30)	0.5522	67	37	0.4638
chr7	94227509	94227509	G	A	het		QUAL=98;DP=15;AF=0.47;MQM=60	SGCE	intron	SGCE:ENST00000265735.7:intron_variant:MODIFIER:intron9/10:c.1253+578C>T::,SGCE:ENST00000415788.2:intron_variant:MODIFIER:intron10/10:c.1361+578C>T::,SGCE:ENST00000428696.2:intron_variant:MODIFIER:intron8/10:c.1226+578C>T::,SGCE:ENST00000437425.2:intron_variant:MODIFIER:intron8/9:c.1130+578C>T::,SGCE:ENST00000445866.2:intron_variant:MODIFIER:intron9/11:c.1254-193C>T::,SGCE:ENST00000447873.1:intron_variant:MODIFIER:intron8/9:c.1226+578C>T::	SGCE:NM_001099400.2:intron_variant:MODIFIER:intron8/10:c.1226+578C>T::,SGCE:NM_001099401.2:intron_variant:MODIFIER:intron9/11:c.1254-193C>T::,SGCE:NM_001301139.2:intron_variant:MODIFIER:intron8/9:c.1130+578C>T::,SGCE:NM_001346713.2:intron_variant:MODIFIER:intron10/11:c.1361+578C>T::,SGCE:NM_001346715.2:intron_variant:MODIFIER:intron9/10:c.1334+578C>T::,SGCE:NM_001346717.2:intron_variant:MODIFIER:intron8/9:c.1226+578C>T::,SGCE:NM_001346719.2:intron_variant:MODIFIER:intron11/12:c.1166+578C>T::,SGCE:NM_001346720.2:intron_variant:MODIFIER:intron10/11:c.980+578C>T::,SGCE:NM_001362807.2:intron_variant:MODIFIER:intron10/11:c.1139+578C>T::,SGCE:NM_001362808.2:intron_variant:MODIFIER:intron9/10:c.953+578C>T::,SGCE:NM_001362809.2:intron_variant:MODIFIER:intron7/8:c.1103+578C>T::,SGCE:NM_003919.3:intron_variant:MODIFIER:intron9/10:c.1253+578C>T::		604149 [GENE=SGCE PHENOS=Dystonia-11,myoclonic,159900,Autosomal dominant];				rs10232398	0.7630	0.7888	9871,.		-1.1440			0.00,0.07	0.66							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SGCE (inh=AD oe_syn=0.99 oe_mis=0.81 oe_lof=0.30)	0.5333	15	8	1.0000
chr7	94252752	94252752	T	G	het		QUAL=773;DP=99;AF=0.41;MQM=60	SGCE	intron	SGCE:ENST00000265735.7:intron_variant:MODIFIER:intron3/10:c.391-43A>C::,SGCE:ENST00000415788.2:intron_variant:MODIFIER:intron4/10:c.499-43A>C::,SGCE:ENST00000428696.2:intron_variant:MODIFIER:intron3/10:c.391-43A>C::,SGCE:ENST00000437425.2:intron_variant:MODIFIER:intron2/9:c.268-43A>C::,SGCE:ENST00000445866.2:intron_variant:MODIFIER:intron3/11:c.391-43A>C::,SGCE:ENST00000447873.1:intron_variant:MODIFIER:intron3/9:c.391-43A>C::	SGCE:NM_001099400.2:intron_variant:MODIFIER:intron3/10:c.391-43A>C::,SGCE:NM_001099401.2:intron_variant:MODIFIER:intron3/11:c.391-43A>C::,SGCE:NM_001301139.2:intron_variant:MODIFIER:intron2/9:c.268-43A>C::,SGCE:NM_001346713.2:intron_variant:MODIFIER:intron4/11:c.499-43A>C::,SGCE:NM_001346715.2:intron_variant:MODIFIER:intron4/10:c.499-43A>C::,SGCE:NM_001346717.2:intron_variant:MODIFIER:intron3/9:c.391-43A>C::,SGCE:NM_001346719.2:intron_variant:MODIFIER:intron5/12:c.304-43A>C::,SGCE:NM_001346720.2:intron_variant:MODIFIER:intron4/11:c.118-43A>C::,SGCE:NM_001362807.2:intron_variant:MODIFIER:intron5/11:c.304-43A>C::,SGCE:NM_001362808.2:intron_variant:MODIFIER:intron4/10:c.118-43A>C::,SGCE:NM_001362809.2:intron_variant:MODIFIER:intron2/8:c.268-43A>C::,SGCE:NM_003919.3:intron_variant:MODIFIER:intron3/10:c.391-43A>C::		604149 [GENE=SGCE PHENOS=Dystonia-11,myoclonic,159900,Autosomal dominant];	259198 [benign DISEASE=Myoclonic dystonia 11,not specified];			rs2272091	0.1448	0.1619	281,.	0.0219,0.1738,0.2330,0.1356,0.2477	0.8220			0.21,0.35	16.67					-0.171	0.7453	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SGCE (inh=AD oe_syn=0.99 oe_mis=0.81 oe_lof=0.30)	0.4174	115	48	0.0773
chr7	94273994	94273994	A	G	het		QUAL=1266;DP=110;AF=0.45;MQM=60	SGCE	intron	SGCE:ENST00000265735.7:intron_variant:MODIFIER:intron1/10:c.109+11308T>C::,SGCE:ENST00000415788.2:intron_variant:MODIFIER:intron1/10:c.110-5234T>C::,SGCE:ENST00000428696.2:intron_variant:MODIFIER:intron1/10:c.109+11308T>C::,SGCE:ENST00000437425.2:intron_variant:MODIFIER:intron1/9:c.109+11308T>C::,SGCE:ENST00000445866.2:intron_variant:MODIFIER:intron1/11:c.109+11308T>C::,SGCE:ENST00000447873.1:intron_variant:MODIFIER:intron1/9:c.109+11308T>C::	SGCE:NM_001099400.2:intron_variant:MODIFIER:intron1/10:c.109+11308T>C::,SGCE:NM_001099401.2:intron_variant:MODIFIER:intron1/11:c.109+11308T>C::,SGCE:NM_001301139.2:intron_variant:MODIFIER:intron1/9:c.109+11308T>C::,SGCE:NM_001346713.2:intron_variant:MODIFIER:intron1/11:c.110-5234T>C::,SGCE:NM_001346715.2:intron_variant:MODIFIER:intron1/10:c.110-5234T>C::,SGCE:NM_001346717.2:intron_variant:MODIFIER:intron1/9:c.109+11308T>C::,SGCE:NM_001346719.2:intron_variant:MODIFIER:intron1/12:c.-148-15T>C::,SGCE:NM_001346720.2:intron_variant:MODIFIER:intron1/11:c.-226-15T>C::,SGCE:NM_001362807.2:intron_variant:MODIFIER:intron1/11:c.-154-3718T>C::,SGCE:NM_001362808.2:intron_variant:MODIFIER:intron1/10:c.-226-15T>C::,SGCE:NM_001362809.2:intron_variant:MODIFIER:intron1/8:c.109+11308T>C::,SGCE:NM_003919.3:intron_variant:MODIFIER:intron1/10:c.109+11308T>C::	regulatory_region_variant:promoter_flanking_region	604149 [GENE=SGCE PHENOS=Dystonia-11,myoclonic,159900,Autosomal dominant];				rs35016618	0.1703	0.1676	362,.	0.1094,0.1726,0.2259,0.1322,0.2387	-1.3430			0.01,0.10	0.75					-0.6698	0.3438	0.17	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SGCE (inh=AD oe_syn=0.99 oe_mis=0.81 oe_lof=0.30)	n/a (no coverage)	0	n/a (no coverage)	n/a (no coverage)
chr7	94274032	94274032	T	C	het		QUAL=891;DP=75;AF=0.48;MQM=60	SGCE	intron	SGCE:ENST00000265735.7:intron_variant:MODIFIER:intron1/10:c.109+11270A>G::,SGCE:ENST00000415788.2:intron_variant:MODIFIER:intron1/10:c.110-5272A>G::,SGCE:ENST00000428696.2:intron_variant:MODIFIER:intron1/10:c.109+11270A>G::,SGCE:ENST00000437425.2:intron_variant:MODIFIER:intron1/9:c.109+11270A>G::,SGCE:ENST00000445866.2:intron_variant:MODIFIER:intron1/11:c.109+11270A>G::,SGCE:ENST00000447873.1:intron_variant:MODIFIER:intron1/9:c.109+11270A>G::	SGCE:NM_001099400.2:intron_variant:MODIFIER:intron1/10:c.109+11270A>G::,SGCE:NM_001099401.2:intron_variant:MODIFIER:intron1/11:c.109+11270A>G::,SGCE:NM_001301139.2:intron_variant:MODIFIER:intron1/9:c.109+11270A>G::,SGCE:NM_001346713.2:intron_variant:MODIFIER:intron1/11:c.110-5272A>G::,SGCE:NM_001346715.2:intron_variant:MODIFIER:intron1/10:c.110-5272A>G::,SGCE:NM_001346717.2:intron_variant:MODIFIER:intron1/9:c.109+11270A>G::,SGCE:NM_001346719.2:intron_variant:MODIFIER:intron1/12:c.-148-53A>G::,SGCE:NM_001346720.2:intron_variant:MODIFIER:intron1/11:c.-226-53A>G::,SGCE:NM_001362807.2:intron_variant:MODIFIER:intron1/11:c.-154-3756A>G::,SGCE:NM_001362808.2:intron_variant:MODIFIER:intron1/10:c.-226-53A>G::,SGCE:NM_001362809.2:intron_variant:MODIFIER:intron1/8:c.109+11270A>G::,SGCE:NM_003919.3:intron_variant:MODIFIER:intron1/10:c.109+11270A>G::	regulatory_region_variant:promoter_flanking_region	604149 [GENE=SGCE PHENOS=Dystonia-11,myoclonic,159900,Autosomal dominant];				rs13241095	0.1530	0.1284	311,.		-0.1680			0.02,0.17	4.50					0.0211	0.177	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SGCE (inh=AD oe_syn=0.99 oe_mis=0.81 oe_lof=0.30)	n/a (no coverage)	0	n/a (no coverage)	n/a (no coverage)
chr8	107236280	107236280	G	T	hom		QUAL=845;DP=29;AF=1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::					LTR33 (LTR/ERVL)	rs1393978	0.6096	0.5562	5348,.		-0.5990			0.00,0.05	0.10								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)						1.0000	1	1	n/a (non-het)
chr9	5921881	5921881	G	A	het		QUAL=8266;DP=688;AF=0.46;MQM=60	KIAA2026	missense	KIAA2026:ENST00000381461.2:missense_variant:MODERATE:exon7/7:c.4025C>T:p.Thr1342Ile:,KIAA2026:ENST00000399933.3:missense_variant:MODERATE:exon8/8:c.4115C>T:p.Thr1372Ile:	KIAA2026:NM_001017969.3:missense_variant:MODERATE:exon8/8:c.4115C>T:p.Thr1372Ile:						rs72697396	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0001	1.9050	D(0.02),D(0.02)	B(0.08),B(0.08)	0.39,0.53	15.18	0.03				-0.0005	0.9431	0	0	38	0 / 3					KIAA2026 (inh=n/a oe_syn=1.46 oe_mis=1.38 oe_lof=0.22)	0.5022	231	116	1.0000
chr9	79792920	79792920	G	T	hom		QUAL=2361;DP=93;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron1/68:c.100+200G>T::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron1/71:c.100+200G>T::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron1/68:c.100+200G>T::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron1/70:c.100+200G>T::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron1/70:c.100+200G>T::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron1/68:c.100+200G>T::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron1/68:c.100+200G>T::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron1/71:c.100+200G>T::	regulatory_region_variant:promoter	605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs45463897	0.0791	0.0967	176,.		-2.5480			0.02,0.35	0.25							0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	3	3	n/a (non-het)
chr9	79814799	79814799	A	G	hom	low_conf_region	QUAL=15013;DP=483;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron1/68:c.101-62A>G::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron1/71:c.101-62A>G::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron1/68:c.101-62A>G::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron1/70:c.101-62A>G::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron1/70:c.101-62A>G::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron1/68:c.101-62A>G::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron1/68:c.101-62A>G::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron1/71:c.101-62A>G::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs12552898	0.5463	0.5045	4010,.		-0.1940			0.00,0.08	0.11					0.0023	0.2153	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	54	54	n/a (non-het)
chr9	79820141	79820141	-	T	hom		QUAL=115;DP=4;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron3/68:c.188-88_188-87insT::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron3/71:c.188-88_188-87insT::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron3/68:c.188-88_188-87insT::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron3/70:c.188-88_188-87insT::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron3/70:c.188-88_188-87insT::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron3/68:c.188-88_188-87insT::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron3/68:c.188-88_188-87insT::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron3/71:c.188-88_188-87insT::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs75101662	0.6126	0.5549	4754,.						3.10					0.0362	0.3563	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	28	28	n/a (non-het)
chr9	79828403	79828406	ACCC	-	hom		QUAL=40;DP=6;AF=0.83;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron9/68:c.696+173_696+176del::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron9/71:c.696+173_696+176del::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron9/68:c.696+173_696+176del::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron9/70:c.696+173_696+176del::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron9/70:c.696+173_696+176del::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron9/68:c.696+173_696+176del::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron9/68:c.696+173_696+176del::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron9/71:c.696+173_696+176del::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];									0.6470											0	1	0	1 / 0					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	0.0000	5	0	n/a (non-het)
chr9	79828414	79828415	TT	-	hom	low_conf_region	QUAL=40;DP=6;AF=0.83;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron9/68:c.696+199_696+200del::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron9/71:c.696+199_696+200del::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron9/68:c.696+199_696+200del::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron9/70:c.696+199_696+200del::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron9/70:c.696+199_696+200del::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron9/68:c.696+199_696+200del::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron9/68:c.696+199_696+200del::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron9/71:c.696+199_696+200del::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];			AluJr (SINE/Alu)	rs527345941		0.0604	44,.		0.9580				0.74							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	0.6667	3	2	n/a (non-het)
chr9	79828516	79828516	A	G	hom		QUAL=1249;DP=51;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron9/68:c.696+286A>G::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron9/71:c.696+286A>G::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron9/68:c.696+286A>G::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron9/70:c.696+286A>G::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron9/70:c.696+286A>G::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron9/68:c.696+286A>G::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron9/68:c.696+286A>G::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron9/71:c.696+286A>G::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];			AluJr (SINE/Alu)	rs72742574	0.0479	0.0507	51,.		-1.8570			0.00,0.05	0.59							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	3	3	n/a (non-het)
chr9	79829077	79829077	A	G	hom		QUAL=1314;DP=57;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron9/68:c.697-168A>G::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron9/71:c.697-168A>G::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron9/68:c.697-168A>G::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron9/70:c.697-168A>G::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron9/70:c.697-168A>G::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron9/68:c.697-168A>G::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron9/68:c.697-168A>G::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron9/71:c.697-168A>G::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];			AluSz (SINE/Alu)	rs145189157	0.0471	0.0508	51,.		0.3490			0.01,0.11	3.33							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	14	14	n/a (non-het)
chr9	79835177	79835177	A	C	hom		QUAL=247;DP=8;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron11/68:c.883-16A>C::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron11/71:c.883-16A>C::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron11/68:c.883-16A>C::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron11/70:c.883-16A>C::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron11/70:c.883-16A>C::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron11/68:c.883-16A>C::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron11/68:c.883-16A>C::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron11/71:c.883-16A>C::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs72742584	0.0471	0.0676	51,.	0.0154,0.0293,0.0005,0.0880,0.1239	0.4050			0.28,0.23	1.45		6.56>7.47			0.1258	0.2953	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	88	88	n/a (non-het)
chr9	79835313	79835313	T	-	het		QUAL=308;DP=70;AF=0.29;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron12/68:c.989+28del::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron12/71:c.989+28del::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron12/68:c.989+28del::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron12/70:c.989+28del::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron12/70:c.989+28del::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron12/68:c.989+28del::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron12/68:c.989+28del::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron12/71:c.989+28del::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];	367349 [uncertain significance DISEASE=Choreoacanthocytosis];			rs751974264		0.3637	18,.	0.2880,0.3765,0.3331,0.3590,0.3916	-0.5550				0.00					0.0203	0.6401	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	0.2535	71	18	0.0000
chr9	79841043	79841043	T	C	hom		QUAL=124;DP=4;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron14/68:c.1224+139T>C::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron14/71:c.1224+139T>C::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron14/68:c.1224+139T>C::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron14/70:c.1224+139T>C::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron14/70:c.1224+139T>C::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron14/68:c.1224+139T>C::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron14/68:c.1224+139T>C::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron14/71:c.1224+139T>C::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs55943354	0.0479	0.0507	50,.		0.0530			0.16,0.45	14.62							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	31	31	n/a (non-het)
chr9	79852887	79852887	C	T	hom		QUAL=144;DP=6;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron17/68:c.1596-31C>T::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron17/71:c.1596-31C>T::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron17/68:c.1596-31C>T::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron17/70:c.1596-31C>T::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron17/70:c.1596-31C>T::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron17/68:c.1596-31C>T::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron17/68:c.1596-31C>T::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron17/71:c.1596-31C>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs72742601	0.0465	0.0668	50,.	0.0149,0.0295,0.0005,0.0878,0.1192	0.0710			0.00,0.16	1.55					0.0537	0.1962	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	58	58	n/a (non-het)
chr9	79862502	79862502	T	C	hom		QUAL=1196;DP=41;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron20/68:c.2037+191T>C::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron20/71:c.2037+191T>C::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron20/68:c.2037+191T>C::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron20/70:c.2037+191T>C::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron20/70:c.2037+191T>C::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron20/68:c.2037+191T>C::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron20/68:c.2037+191T>C::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron20/71:c.2037+191T>C::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs10115162	0.1891	0.2015	674,.		-0.0820			0.04,0.16	3.43							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	6	6	n/a (non-het)
chr9	79865187	79865187	G	A	hom		QUAL=1894;DP=62;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron21/68:c.2170+42G>A::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron21/71:c.2170+42G>A::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron21/68:c.2170+42G>A::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron21/70:c.2170+42G>A::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron21/70:c.2170+42G>A::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron21/68:c.2170+42G>A::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron21/68:c.2170+42G>A::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron21/71:c.2170+42G>A::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs2021998	0.1893	0.2015	675,.	0.2409,0.1107,0.0495,0.2063,0.2254	0.3390			0.03,0.19	0.75					0.1008	0.3517	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	34	34	n/a (non-het)
chr9	79875259	79875259	G	A	hom		QUAL=28;DP=6;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron23/68:c.2427+119G>A::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron23/71:c.2427+119G>A::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron23/68:c.2427+119G>A::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron23/70:c.2427+119G>A::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron23/70:c.2427+119G>A::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron23/68:c.2427+119G>A::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron23/68:c.2427+119G>A::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron23/71:c.2427+119G>A::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs879011403					-0.5740			0.00,0.09	1.15							0	30	8	1 / 0	2	"[2] auto-classification 07.11.2017%0A%0A"			VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	0.0000	7	0	n/a (non-het)
chr9	79888396	79888396	A	G	hom		QUAL=88;DP=3;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron24/68:c.2512+116A>G::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron24/71:c.2512+116A>G::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron24/68:c.2512+116A>G::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron24/70:c.2512+116A>G::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron24/70:c.2512+116A>G::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron24/68:c.2512+116A>G::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron24/68:c.2512+116A>G::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron24/71:c.2512+116A>G::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];			MER34C_ (LTR/ERV1)	rs2050831		0.8276	10857,.		-2.6870			0.00,0.06	0.34							0.2	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	33	33	n/a (non-het)
chr9	79890727	79890727	C	T	hom		QUAL=423;DP=22;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron25/68:c.2667+159C>T::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron25/71:c.2667+159C>T::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron25/68:c.2667+159C>T::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron25/70:c.2667+159C>T::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron25/70:c.2667+159C>T::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron25/68:c.2667+159C>T::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron25/68:c.2667+159C>T::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron25/71:c.2667+159C>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs7041795	0.2516	0.2659	945,.		-1.0770			0.00,0.09	0.11				COSV62425588			0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	0.8750	8	7	n/a (non-het)
chr9	79890738	79890738	A	T	hom	off-target	QUAL=225;DP=14;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron25/68:c.2667+170A>T::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron25/71:c.2667+170A>T::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron25/68:c.2667+170A>T::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron25/70:c.2667+170A>T::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron25/70:c.2667+170A>T::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron25/68:c.2667+170A>T::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron25/68:c.2667+170A>T::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron25/71:c.2667+170A>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs1206302950		0.0001	0,.		-2.3790			0.00,0.07	0.07							0	51	0	1 / 0	2	"[2] auto-classification 07.11.2017%0A%0A"			VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	0.1000	10	1	n/a (non-het)
chr9	79910407	79910407	A	G	hom	low_conf_region	QUAL=1828;DP=58;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron32/68:c.3508-51A>G::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron32/71:c.3508-51A>G::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron32/68:c.3508-51A>G::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron31/70:c.3391-51A>G::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron31/70:c.3391-51A>G::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron32/68:c.3508-51A>G::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron32/68:c.3508-51A>G::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron32/71:c.3508-51A>G::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs1317305	0.0483	0.0698	50,.	0.0137,0.0334,0.0006,0.0866,0.1208	0.0180			0.13,0.95	14.18					-0.0086	0.0725	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	38	38	n/a (non-het)
chr9	79910414	79910414	G	T	hom	low_conf_region	QUAL=1825;DP=58;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron32/68:c.3508-44G>T::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron32/71:c.3508-44G>T::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron32/68:c.3508-44G>T::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron31/70:c.3391-44G>T::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron31/70:c.3391-44G>T::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron32/68:c.3508-44G>T::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron32/68:c.3508-44G>T::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron32/71:c.3508-44G>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs1317304	0.2366	0.2772	1224,.	0.2348,0.1451,0.1467,0.3002,0.2917	-0.6280			0.00,0.07	4.54					-0.0987	0.0464	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	39	39	n/a (non-het)
chr9	79917660	79917660	C	G	hom		QUAL=1389;DP=57;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron33/68:c.3813-171C>G::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron33/71:c.3813-171C>G::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron33/68:c.3813-171C>G::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron32/70:c.3696-171C>G::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron32/70:c.3696-171C>G::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron33/68:c.3813-171C>G::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron33/68:c.3813-171C>G::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron33/71:c.3813-171C>G::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs17423381	0.0487	0.0540	55,.		-0.6870			0.02,0.16	6.91							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	11	11	n/a (non-het)
chr9	79922839	79922839	A	G	hom		QUAL=2520;DP=101;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron34/68:c.3961-22A>G::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron34/71:c.3961-22A>G::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron34/68:c.3961-22A>G::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron33/70:c.3844-22A>G::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron33/70:c.3844-22A>G::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron34/68:c.3961-22A>G::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron34/68:c.3961-22A>G::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron34/71:c.3961-22A>G::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs2275549		0.5585	4264,.	0.5007,0.6508,0.5703,0.5266,0.6262	-0.4630			0.00,0.09	2.18					-0.3167	0.2728	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	0.9818	55	54	n/a (non-het)
chr9	79930342	79930342	C	G	het		QUAL=1090;DP=86;AF=0.52;MQM=60	VPS13A	missense	VPS13A:ENST00000357409.5:missense_variant:MODERATE:exon38/69:c.4586C>G:p.Thr1529Ser:,VPS13A:ENST00000360280.3:missense_variant:MODERATE:exon38/72:c.4586C>G:p.Thr1529Ser:,VPS13A:ENST00000376634.4:missense_variant:MODERATE:exon38/69:c.4586C>G:p.Thr1529Ser:,VPS13A:ENST00000376636.3:missense_variant:MODERATE:exon37/71:c.4469C>G:p.Thr1490Ser:	VPS13A:NM_001018037.2:missense_variant:MODERATE:exon37/71:c.4469C>G:p.Thr1490Ser:,VPS13A:NM_001018038.2:missense_variant:MODERATE:exon38/69:c.4586C>G:p.Thr1529Ser:,VPS13A:NM_015186.3:missense_variant:MODERATE:exon38/69:c.4586C>G:p.Thr1529Ser:,VPS13A:NM_033305.3:missense_variant:MODERATE:exon38/72:c.4586C>G:p.Thr1529Ser:		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];	913551 [uncertain significance DISEASE=Choreoacanthocytosis];			rs72744294	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	0.1180	T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00)	0.18,0.23	4.67	0.05				-0.0111	0.3092	0.01	0	33	0 / 1	2	"[3] ahsturm1 30.09.2019%0Atest%0A[2] ahsturm1 30.09.2019%0Atest2%0A[3] ahsturm1 30.09.2019%0Atest3%0A[2] ahsturm1 10.01.2020"			VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	0.3783	230	87	0.0068
chr9	79936415	79936415	A	G	hom		QUAL=183;DP=6;AF=1.00;MQM=60	VPS13A	synonymous	VPS13A:ENST00000357409.5:synonymous_variant:LOW:exon44/69:c.5583A>G:p.Thr1861=:,VPS13A:ENST00000360280.3:synonymous_variant:LOW:exon44/72:c.5583A>G:p.Thr1861=:,VPS13A:ENST00000376634.4:synonymous_variant:LOW:exon44/69:c.5583A>G:p.Thr1861=:,VPS13A:ENST00000376636.3:synonymous_variant:LOW:exon43/71:c.5466A>G:p.Thr1822=:	VPS13A:NM_001018037.2:synonymous_variant:LOW:exon43/71:c.5466A>G:p.Thr1822=:,VPS13A:NM_001018038.2:synonymous_variant:LOW:exon44/69:c.5583A>G:p.Thr1861=:,VPS13A:NM_015186.3:synonymous_variant:LOW:exon44/69:c.5583A>G:p.Thr1861=:,VPS13A:NM_033305.3:synonymous_variant:LOW:exon44/72:c.5583A>G:p.Thr1861=:		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];	367389 [benign DISEASE=Choreoacanthocytosis,not provided];			rs17423984	0.0487	0.0716	55,.	0.0155,0.0303,0.0006,0.0907,0.1262	0.1020			0.81,0.96	9.53					0.0795	0.5247	0.28	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	115	115	n/a (non-het)
chr9	79954404	79954405	TG	-	het	low_conf_region	QUAL=1962;DP=99;AF=0.27;MQM=59	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron47/68:c.6379-27_6379-26del::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron47/71:c.6379-27_6379-26del::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron47/68:c.6379-27_6379-26del::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron46/70:c.6262-27_6262-26del::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron46/70:c.6262-27_6262-26del::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron47/68:c.6379-27_6379-26del::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron47/68:c.6379-27_6379-26del::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron47/71:c.6379-27_6379-26del::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];			(T)n (Simple_repeat)	rs1181116264					0.0000				1.45					0.2356	0.0444	0.04	10	489	2 / 37					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	0.0972	72	7	0.0000
chr9	79954405	79954405	G	T	het	low_conf_region	QUAL=1962;DP=99;AF=0.27;MQM=58	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron47/68:c.6379-27G>T::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron47/71:c.6379-27G>T::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron47/68:c.6379-27G>T::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron46/70:c.6262-27G>T::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron46/70:c.6262-27G>T::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron47/68:c.6379-27G>T::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron47/68:c.6379-27G>T::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron47/71:c.6379-27G>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];			(T)n (Simple_repeat)	rs56156608		0.0900	114,.		0.0000			0.02,0.16	0.28				COSV62425516	0.0387	0.0957	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	0.5775	71	41	0.2351
chr9	79954410	79954410	G	T	hom	low_conf_region	QUAL=3478;DP=118;AF=0.97;MQM=59	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron47/68:c.6379-22G>T::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron47/71:c.6379-22G>T::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron47/68:c.6379-22G>T::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron46/70:c.6262-22G>T::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron46/70:c.6262-22G>T::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron47/68:c.6379-22G>T::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron47/68:c.6379-22G>T::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron47/71:c.6379-22G>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];			(T)n (Simple_repeat)	rs55937672	0.4373	0.3967	1966,.		-0.6630			0.01,0.21	0.25					-0.0229	0.1468	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	69	69	n/a (non-het)
chr9	79954545	79954545	T	C	hom		QUAL=5716;DP=189;AF=1.00;MQM=60	VPS13A	synonymous	VPS13A:ENST00000357409.5:synonymous_variant:LOW:exon48/69:c.6492T>C:p.Asp2164=:,VPS13A:ENST00000360280.3:synonymous_variant:LOW:exon48/72:c.6492T>C:p.Asp2164=:,VPS13A:ENST00000376634.4:synonymous_variant:LOW:exon48/69:c.6492T>C:p.Asp2164=:,VPS13A:ENST00000376636.3:synonymous_variant:LOW:exon47/71:c.6375T>C:p.Asp2125=:	VPS13A:NM_001018037.2:synonymous_variant:LOW:exon47/71:c.6375T>C:p.Asp2125=:,VPS13A:NM_001018038.2:synonymous_variant:LOW:exon48/69:c.6492T>C:p.Asp2164=:,VPS13A:NM_015186.3:synonymous_variant:LOW:exon48/69:c.6492T>C:p.Asp2164=:,VPS13A:NM_033305.3:synonymous_variant:LOW:exon48/72:c.6492T>C:p.Asp2164=:		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];	367402 [benign DISEASE=Choreoacanthocytosis,not provided];			rs7025532	0.1627	0.1889	586,.	0.2167,0.0800,0.0346,0.1951,0.2069	-0.1050			0.53,0.96	8.89					0.0644	0.1723	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	191	191	n/a (non-het)
chr9	79955305	79955305	-	T	hom		QUAL=1265;DP=64;AF=0.95;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron49/68:c.6880-6dup::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron49/71:c.6880-6dup::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron49/68:c.6880-6dup::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron48/70:c.6763-6dup::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron48/70:c.6763-6dup::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron49/68:c.6880-6dup::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron49/68:c.6880-6dup::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron49/71:c.6880-6dup::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];	367404 [likely benign DISEASE=Choreoacanthocytosis];			rs140476942		0.2019	663,.	0.2383,0.0880,0.0347,0.2078,0.2196					0.47					0.3154	0.6001	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	0.8919	74	66	n/a (non-het)
chr9	79959015	79959015	A	G	hom	low_conf_region	QUAL=8426;DP=270;AF=0.99;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron50/68:c.7027-54A>G::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron50/71:c.7027-54A>G::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron50/68:c.7027-54A>G::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron49/70:c.6910-54A>G::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron49/70:c.6910-54A>G::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron50/68:c.7027-54A>G::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron50/68:c.7027-54A>G::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron50/71:c.7027-54A>G::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs72746022	0.0555	0.0612	71,.		-0.4690			0.02,0.14	1.05					-0.0095	0.0855	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	46	46	n/a (non-het)
chr9	79972830	79972830	C	T	het		QUAL=38;DP=20;AF=0.65;MQM=59	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron56/68:c.7953+76C>T::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron56/71:c.7953+76C>T::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron56/68:c.7953+76C>T::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron55/70:c.7836+76C>T::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron55/70:c.7836+76C>T::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron56/68:c.7953+76C>T::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron56/68:c.7953+76C>T::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron56/71:c.7953+76C>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];									-0.4220			0.01,0.16	1.97					0.1561	0.0427	0	0	1	0 / 1					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	0.0000	21	0	0.0000
chr9	79972857	79972857	G	T	het		QUAL=9;DP=34;AF=0.44;MQM=58	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron56/68:c.7953+103G>T::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron56/71:c.7953+103G>T::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron56/68:c.7953+103G>T::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron55/70:c.7836+103G>T::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron55/70:c.7836+103G>T::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron56/68:c.7953+103G>T::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron56/68:c.7953+103G>T::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron56/71:c.7953+103G>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];									0.0080			0.01,0.19	0.84							0	0	3	0 / 1					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	0.0000	17	0	0.0000
chr9	79974399	79974399	G	A	hom		QUAL=1353;DP=43;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron58/68:c.8105+81G>A::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron58/71:c.8105+81G>A::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron58/68:c.8105+81G>A::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron57/70:c.7988+81G>A::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron57/70:c.7988+81G>A::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron58/68:c.8105+81G>A::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron58/68:c.8105+81G>A::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron58/71:c.8105+81G>A::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs7043232	0.7101	0.6410	6826,.		1.0200			0.00,0.06	7.25					0.1902	0.4447	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	51	51	n/a (non-het)
chr9	79983083	79983083	G	C	hom		QUAL=308;DP=12;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000357409.5:intron_variant:MODIFIER:intron62/68:c.8553+31G>C::,VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron62/71:c.8553+31G>C::,VPS13A:ENST00000376634.4:intron_variant:MODIFIER:intron62/68:c.8553+31G>C::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron61/70:c.8436+31G>C::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron61/70:c.8436+31G>C::,VPS13A:NM_001018038.2:intron_variant:MODIFIER:intron62/68:c.8553+31G>C::,VPS13A:NM_015186.3:intron_variant:MODIFIER:intron62/68:c.8553+31G>C::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron62/71:c.8553+31G>C::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs72746094	0.0509	0.0730	57,.	0.0260,0.0311,0.0006,0.0931,0.1256	-0.0330			0.14,0.22	2.62					-0.0359	0.3767	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	75	75	n/a (non-het)
chr9	79984232	79984232	T	C	hom		QUAL=266;DP=9;AF=1.00;MQM=60	VPS13A	synonymous	VPS13A:ENST00000357409.5:synonymous_variant:LOW:exon63/69:c.8571T>C:p.Tyr2857=:,VPS13A:ENST00000360280.3:synonymous_variant:LOW:exon63/72:c.8571T>C:p.Tyr2857=:,VPS13A:ENST00000376634.4:synonymous_variant:LOW:exon63/69:c.8571T>C:p.Tyr2857=:,VPS13A:ENST00000376636.3:synonymous_variant:LOW:exon62/71:c.8454T>C:p.Tyr2818=:	VPS13A:NM_001018037.2:synonymous_variant:LOW:exon62/71:c.8454T>C:p.Tyr2818=:,VPS13A:NM_001018038.2:synonymous_variant:LOW:exon63/69:c.8571T>C:p.Tyr2857=:,VPS13A:NM_015186.3:synonymous_variant:LOW:exon63/69:c.8571T>C:p.Tyr2857=:,VPS13A:NM_033305.3:synonymous_variant:LOW:exon63/72:c.8571T>C:p.Tyr2857=:		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];	367423 [benign DISEASE=Choreoacanthocytosis,not provided];			rs17340192	0.0517	0.0721	58,.	0.0252,0.0305,0.0005,0.0908,0.1251	1.3060			0.92,0.97	7.55					0.1823	0.2032	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	0.9891	183	181	n/a (non-het)
chr9	79986057	79986057	A	G	hom		QUAL=8716;DP=283;AF=1.00;MQM=60	VPS13A	synonymous	VPS13A:ENST00000357409.5:synonymous_variant:LOW:exon67/69:c.9069A>G:p.Gly3023=:PF09333 [Autophagy-related protein C terminal domain],VPS13A:ENST00000360280.3:synonymous_variant:LOW:exon67/72:c.9069A>G:p.Gly3023=:PF09333 [Autophagy-related protein C terminal domain],VPS13A:ENST00000376634.4:synonymous_variant:LOW:exon67/69:c.9069A>G:p.Gly3023=:PF09333 [Autophagy-related protein C terminal domain],VPS13A:ENST00000376636.3:synonymous_variant:LOW:exon66/71:c.8952A>G:p.Gly2984=:PF09333 [Autophagy-related protein C terminal domain]	VPS13A:NM_001018037.2:synonymous_variant:LOW:exon66/71:c.8952A>G:p.Gly2984=:,VPS13A:NM_001018038.2:synonymous_variant:LOW:exon67/69:c.9069A>G:p.Gly3023=:,VPS13A:NM_015186.3:synonymous_variant:LOW:exon67/69:c.9069A>G:p.Gly3023=:,VPS13A:NM_033305.3:synonymous_variant:LOW:exon67/72:c.9069A>G:p.Gly3023=:		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];	367428 [benign DISEASE=Choreoacanthocytosis,not provided];			rs3737289	0.4151	0.4545	2611,.	0.3143,0.5758,0.3741,0.4327,0.5415	-0.1930			0.52,0.97	10.45					-0.053	0.1011	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	100	100	n/a (non-het)
chr9	80018376	80018376	G	C	hom		QUAL=2190;DP=72;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron69/71:c.9275+139G>C::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron68/70:c.9158+139G>C::,VPS13A:ENST00000376646.3:intron_variant:MODIFIER:intron3/5:c.83+139G>C::,VPS13A:ENST00000484581.2:intron_variant:MODIFIER:intron2/4:c.83+139G>C::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron68/70:c.9158+139G>C::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron69/71:c.9275+139G>C::	regulatory_region_variant:CTCF_binding_site	605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs12352196	0.2636	0.2966	1417,.		-2.1050			0.00,0.05	5.38							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	14	14	n/a (non-het)
chr9	80021100	80021100	T	C	hom		QUAL=618;DP=25;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron70/71:c.9399+197T>C::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron69/70:c.9282+197T>C::,VPS13A:ENST00000376646.3:intron_variant:MODIFIER:intron4/5:c.207+197T>C::,VPS13A:ENST00000484581.2:intron_variant:MODIFIER:intron3/4:c.207+197T>C::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron69/70:c.9282+197T>C::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron70/71:c.9399+197T>C::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs72748232	0.0499	0.0551	56,.		0.1070			0.03,0.13	4.73							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	13	13	n/a (non-het)
chr9	80022415	80022415	A	T	hom		QUAL=124;DP=4;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron70/71:c.9400-34A>T::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron69/70:c.9283-34A>T::,VPS13A:ENST00000376646.3:intron_variant:MODIFIER:intron4/5:c.208-34A>T::,VPS13A:ENST00000484581.2:intron_variant:MODIFIER:intron3/4:c.208-34A>T::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron69/70:c.9283-34A>T::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron70/71:c.9400-34A>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs2025846	0.5847	0.5413	4419,.	0.5598,0.5432,0.6901,0.5065,0.6046	-0.4200			0.00,0.11	7.42					0.0008	0.2079	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	82	82	n/a (non-het)
chr9	80022675	80022675	C	T	hom		QUAL=2259;DP=89;AF=1.00;MQM=60	VPS13A	intron	VPS13A:ENST00000360280.3:intron_variant:MODIFIER:intron71/71:c.9474+152C>T::,VPS13A:ENST00000376636.3:intron_variant:MODIFIER:intron70/70:c.9357+152C>T::,VPS13A:ENST00000376646.3:intron_variant:MODIFIER:intron5/5:c.282+152C>T::,VPS13A:ENST00000484581.2:intron_variant:MODIFIER:intron4/4:c.282+152C>T::	VPS13A:NM_001018037.2:intron_variant:MODIFIER:intron70/70:c.9357+152C>T::,VPS13A:NM_033305.3:intron_variant:MODIFIER:intron71/71:c.9474+152C>T::		605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];				rs62571470	0.2628	0.2916	1359,.		0.3260			0.00,0.08	0.84					-0.0215	0.3774	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	12	12	n/a (non-het)
chr9	80031144	80031144	G	A	hom		QUAL=1350;DP=51;AF=1.00;MQM=60	VPS13A	3'UTR	VPS13A:ENST00000360280.3:3_prime_UTR_variant:MODIFIER:exon72/72:c.*222G>A::,VPS13A:ENST00000376636.3:3_prime_UTR_variant:MODIFIER:exon71/71:c.*222G>A::,VPS13A:ENST00000376646.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*222G>A::,VPS13A:ENST00000484581.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*222G>A::	VPS13A:NM_001018037.2:3_prime_UTR_variant:MODIFIER:exon71/71:c.*222G>A::,VPS13A:NM_033305.3:3_prime_UTR_variant:MODIFIER:exon72/72:c.*222G>A::	regulatory_region_variant:promoter_flanking_region	605978 [GENE=VPS13A PHENOS=Choreoacanthocytosis,200150,Autosomal recessive];	367437 [benign DISEASE=Choreoacanthocytosis];			rs12343797	0.1653	0.1975	653,.		-0.9220			0.01,0.14	0.43					-0.055	0.9512	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS13A (inh=AR oe_syn=0.99 oe_mis=0.88 oe_lof=0.40)	1.0000	10	10	n/a (non-het)
chr9	90062823	90062823	A	G	hom		QUAL=13453;DP=439;AF=1.00;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs12682834	0.6368	0.6507	5562,.	0.4721,0.6890,0.6846,0.6292,0.7402	-0.5480			0.00,0.26	0.34								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)						n/a (no coverage)	0	n/a (no coverage)	n/a (no coverage)
chr9	130928633	130928633	C	T	het		QUAL=16624;DP=1373;AF=0.50;MQM=60	CIZ1	missense	CIZ1:ENST00000277465.4:missense_variant:MODERATE:exon17/17:c.2456G>A:p.Arg819Gln:,CIZ1:ENST00000325721.8:missense_variant:MODERATE:exon16/16:c.2453G>A:p.Arg818Gln:,CIZ1:ENST00000357558.5:missense_variant:MODERATE:exon18/18:c.2456G>A:p.Arg819Gln:,CIZ1:ENST00000372938.5:missense_variant:MODERATE:exon17/17:c.2540G>A:p.Arg847Gln:,CIZ1:ENST00000372948.3:missense_variant:MODERATE:exon18/18:c.2372G>A:p.Arg791Gln:,CIZ1:ENST00000372954.1:missense_variant:MODERATE:exon17/17:c.2300G>A:p.Arg767Gln:,CIZ1:ENST00000393608.1:missense_variant:MODERATE:exon17/17:c.2540G>A:p.Arg847Gln:,CIZ1:ENST00000538431.1:missense_variant:MODERATE:exon18/18:c.2618G>A:p.Arg873Gln:,CIZ1:ENST00000541172.1:missense_variant:MODERATE:exon16/16:c.2237G>A:p.Arg746Gln:	CIZ1:NM_001131015.2:missense_variant:MODERATE:exon18/18:c.2372G>A:p.Arg791Gln:,CIZ1:NM_001131016.2:missense_variant:MODERATE:exon17/17:c.2540G>A:p.Arg847Gln:,CIZ1:NM_001131017.2:missense_variant:MODERATE:exon18/18:c.2357G>A:p.Arg786Gln:,CIZ1:NM_001131018.2:missense_variant:MODERATE:exon17/17:c.2300G>A:p.Arg767Gln:,CIZ1:NM_001257975.1:missense_variant:MODERATE:exon18/18:c.2708G>A:p.Arg903Gln:,CIZ1:NM_001257976.2:missense_variant:MODERATE:exon16/16:c.2237G>A:p.Arg746Gln:,CIZ1:NM_012127.3:missense_variant:MODERATE:exon17/17:c.2540G>A:p.Arg847Gln:			413837 [benign DISEASE=Dystonia];			rs11549260	0.0086	0.0200	5,.	0.0037,0.0141,0.0000,0.0253,0.0142	0.5500	T(0.13),T(0.18),T(0.13),T(0.16),T(0.12),T(0.13),T(0.16),T(0.19),T(0.16)	B(0.02),B(0.07),B(0.02),B(0.10),B(0.13),B(0.03),B(0.10),B(0.14),B(0.10)	0.45,0.88	21.90	0.03				-0.0605	0.941	0	24	1010	3 / 79					BBLN (inh=n/a oe_syn=0.44 oe_mis=0.93 oe_lof=1.34), CIZ1 (inh=n/a oe_syn=0.93 oe_mis=0.75 oe_lof=0.25)	0.5188	345	179	0.9142
chr9	130932397	130932398	AC	-	hom		QUAL=28472;DP=921;AF=1.00;MQM=60	CIZ1	intron	CIZ1:ENST00000277465.4:intron_variant:MODIFIER:intron11/16:c.1860-12_1860-11del::,CIZ1:ENST00000325721.8:intron_variant:MODIFIER:intron10/15:c.1857-12_1857-11del::,CIZ1:ENST00000357558.5:intron_variant:MODIFIER:intron12/17:c.1860-12_1860-11del::,CIZ1:ENST00000372938.5:intron_variant:MODIFIER:intron11/16:c.1944-12_1944-11del::,CIZ1:ENST00000372948.3:intron_variant:MODIFIER:intron12/17:c.1776-12_1776-11del::,CIZ1:ENST00000372954.1:intron_variant:MODIFIER:intron11/16:c.1704-12_1704-11del::,CIZ1:ENST00000393608.1:intron_variant:MODIFIER:intron11/16:c.1944-12_1944-11del::,CIZ1:ENST00000538431.1:intron_variant:MODIFIER:intron11/17:c.1944-12_1944-11del::,CIZ1:ENST00000541172.1:intron_variant:MODIFIER:intron10/15:c.1641-12_1641-11del::	CIZ1:NM_001131015.2:intron_variant:MODIFIER:intron12/17:c.1776-12_1776-11del::,CIZ1:NM_001131016.2:intron_variant:MODIFIER:intron11/16:c.1944-12_1944-11del::,CIZ1:NM_001131017.2:intron_variant:MODIFIER:intron12/17:c.1761-12_1761-11del::,CIZ1:NM_001131018.2:intron_variant:MODIFIER:intron11/16:c.1704-12_1704-11del::,CIZ1:NM_001257975.1:intron_variant:MODIFIER:intron11/17:c.2034-12_2034-11del::,CIZ1:NM_001257976.2:intron_variant:MODIFIER:intron10/15:c.1641-12_1641-11del::,CIZ1:NM_012127.3:intron_variant:MODIFIER:intron11/16:c.1944-12_1944-11del::						rs59232258		0.6129	4570,.	0.1606,0.7536,0.5132,0.6452,0.6584	0.4000				6.18					-0.4321	0.516	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CIZ1 (inh=n/a oe_syn=0.93 oe_mis=0.75 oe_lof=0.25)	0.9892	93	92	n/a (non-het)
chr9	130938661	130938661	C	T	het		QUAL=21164;DP=1658;AF=0.51;MQM=60	CIZ1	missense	CIZ1:ENST00000277465.4:missense_variant:MODERATE:exon11/17:c.1828G>A:p.Val610Met:,CIZ1:ENST00000325721.8:missense_variant:MODERATE:exon10/16:c.1825G>A:p.Val609Met:,CIZ1:ENST00000357558.5:missense_variant:MODERATE:exon12/18:c.1828G>A:p.Val610Met:,CIZ1:ENST00000372938.5:missense_variant:MODERATE:exon11/17:c.1912G>A:p.Val638Met:,CIZ1:ENST00000372948.3:missense_variant:MODERATE:exon12/18:c.1744G>A:p.Val582Met:,CIZ1:ENST00000372954.1:missense_variant:MODERATE:exon11/17:c.1672G>A:p.Val558Met:,CIZ1:ENST00000393608.1:missense_variant:MODERATE:exon11/17:c.1912G>A:p.Val638Met:,CIZ1:ENST00000538431.1:missense_variant:MODERATE:exon11/18:c.1912G>A:p.Val638Met:,CIZ1:ENST00000541172.1:missense_variant:MODERATE:exon10/16:c.1609G>A:p.Val537Met:	CIZ1:NM_001131015.2:missense_variant:MODERATE:exon12/18:c.1744G>A:p.Val582Met:,CIZ1:NM_001131016.2:missense_variant:MODERATE:exon11/17:c.1912G>A:p.Val638Met:,CIZ1:NM_001131017.2:missense_variant:MODERATE:exon12/18:c.1729G>A:p.Val577Met:,CIZ1:NM_001131018.2:missense_variant:MODERATE:exon11/17:c.1672G>A:p.Val558Met:,CIZ1:NM_001257975.1:missense_variant:MODERATE:exon11/18:c.2002G>A:p.Val668Met:,CIZ1:NM_001257976.2:missense_variant:MODERATE:exon10/16:c.1609G>A:p.Val537Met:,CIZ1:NM_012127.3:missense_variant:MODERATE:exon11/17:c.1912G>A:p.Val638Met:						rs11549266	0.0545	0.0980	201,.	0.0197,0.0493,0.0004,0.1385,0.0719	0.6690	T(0.62),T(0.63),T(0.62),T(0.60),T(0.64),T(0.67),T(0.60),T(0.59),T(0.59)	B(0.01),B(0.14),B(0.01),B(0.01),B(0.01),B(0.04),B(0.01),B(0.01),B(0.01)	0.17,0.52	4.86	0.01				-0.0869	0.2257	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CIZ1 (inh=n/a oe_syn=0.93 oe_mis=0.75 oe_lof=0.25)	0.4649	185	86	0.6024
chr9	130939707	130939707	A	T	hom		QUAL=11094;DP=363;AF=1.00;MQM=60	CIZ1	intron	CIZ1:ENST00000277465.4:intron_variant:MODIFIER:intron10/16:c.1734+138T>A::,CIZ1:ENST00000325721.8:intron_variant:MODIFIER:intron9/15:c.1731+138T>A::,CIZ1:ENST00000357558.5:intron_variant:MODIFIER:intron11/17:c.1734+138T>A::,CIZ1:ENST00000372938.5:intron_variant:MODIFIER:intron10/16:c.1818+138T>A::,CIZ1:ENST00000372948.3:intron_variant:MODIFIER:intron11/17:c.1650+138T>A::,CIZ1:ENST00000372954.1:intron_variant:MODIFIER:intron10/16:c.1578+138T>A::,CIZ1:ENST00000393608.1:intron_variant:MODIFIER:intron10/16:c.1818+138T>A::,CIZ1:ENST00000538431.1:intron_variant:MODIFIER:intron10/17:c.1818+138T>A::,CIZ1:ENST00000541172.1:intron_variant:MODIFIER:intron9/15:c.1515+138T>A::	CIZ1:NM_001131015.2:intron_variant:MODIFIER:intron11/17:c.1650+138T>A::,CIZ1:NM_001131016.2:intron_variant:MODIFIER:intron10/16:c.1818+138T>A::,CIZ1:NM_001131017.2:intron_variant:MODIFIER:intron11/17:c.1635+138T>A::,CIZ1:NM_001131018.2:intron_variant:MODIFIER:intron10/16:c.1578+138T>A::,CIZ1:NM_001257975.1:intron_variant:MODIFIER:intron10/17:c.1908+138T>A::,CIZ1:NM_001257976.2:intron_variant:MODIFIER:intron9/15:c.1515+138T>A::,CIZ1:NM_012127.3:intron_variant:MODIFIER:intron10/16:c.1818+138T>A::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant					rs4240426		0.9897	15382,.		-0.1220			0.00,0.09	5.23							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CIZ1 (inh=n/a oe_syn=0.93 oe_mis=0.75 oe_lof=0.25)	1.0000	17	17	n/a (non-het)
chr9	130940121	130940121	G	A	hom		QUAL=19071;DP=668;AF=1.00;MQM=60	CIZ1	intron	CIZ1:ENST00000277465.4:intron_variant:MODIFIER:intron9/16:c.1537-79C>T::,CIZ1:ENST00000325721.8:intron_variant:MODIFIER:intron8/15:c.1534-79C>T::,CIZ1:ENST00000357558.5:intron_variant:MODIFIER:intron10/17:c.1537-79C>T::,CIZ1:ENST00000372938.5:intron_variant:MODIFIER:intron9/16:c.1621-79C>T::,CIZ1:ENST00000372948.3:intron_variant:MODIFIER:intron10/17:c.1453-79C>T::,CIZ1:ENST00000372954.1:intron_variant:MODIFIER:intron9/16:c.1381-79C>T::,CIZ1:ENST00000393608.1:intron_variant:MODIFIER:intron9/16:c.1621-79C>T::,CIZ1:ENST00000538431.1:intron_variant:MODIFIER:intron9/17:c.1621-79C>T::,CIZ1:ENST00000541172.1:intron_variant:MODIFIER:intron8/15:c.1318-79C>T::	CIZ1:NM_001131015.2:intron_variant:MODIFIER:intron10/17:c.1453-79C>T::,CIZ1:NM_001131016.2:intron_variant:MODIFIER:intron9/16:c.1621-79C>T::,CIZ1:NM_001131017.2:intron_variant:MODIFIER:intron10/17:c.1438-79C>T::,CIZ1:NM_001131018.2:intron_variant:MODIFIER:intron9/16:c.1381-79C>T::,CIZ1:NM_001257975.1:intron_variant:MODIFIER:intron9/17:c.1711-79C>T::,CIZ1:NM_001257976.2:intron_variant:MODIFIER:intron8/15:c.1318-79C>T::,CIZ1:NM_012127.3:intron_variant:MODIFIER:intron9/16:c.1621-79C>T::						rs4075428		0.7124	8130,.		-1.0590			0.01,0.09	3.44					0.0301	0.9214	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CIZ1 (inh=n/a oe_syn=0.93 oe_mis=0.75 oe_lof=0.25)	1.0000	43	43	n/a (non-het)
chr9	130940822	130940822	C	T	hom		QUAL=6727;DP=247;AF=1.00;MQM=60	CIZ1	intron	CIZ1:ENST00000277465.4:intron_variant:MODIFIER:intron8/16:c.1415-53G>A::,CIZ1:ENST00000325721.8:intron_variant:MODIFIER:intron7/15:c.1412-53G>A::,CIZ1:ENST00000357558.5:intron_variant:MODIFIER:intron9/17:c.1415-53G>A::,CIZ1:ENST00000372938.5:intron_variant:MODIFIER:intron8/16:c.1499-53G>A::,CIZ1:ENST00000372948.3:intron_variant:MODIFIER:intron9/17:c.1331-53G>A::,CIZ1:ENST00000372954.1:intron_variant:MODIFIER:intron8/16:c.1259-53G>A::,CIZ1:ENST00000393608.1:intron_variant:MODIFIER:intron8/16:c.1499-53G>A::,CIZ1:ENST00000538431.1:intron_variant:MODIFIER:intron8/17:c.1499-53G>A::,CIZ1:ENST00000541172.1:intron_variant:MODIFIER:intron7/15:c.1196-53G>A::	CIZ1:NM_001131015.2:intron_variant:MODIFIER:intron9/17:c.1331-53G>A::,CIZ1:NM_001131016.2:intron_variant:MODIFIER:intron8/16:c.1499-53G>A::,CIZ1:NM_001131017.2:intron_variant:MODIFIER:intron9/17:c.1316-53G>A::,CIZ1:NM_001131018.2:intron_variant:MODIFIER:intron8/16:c.1259-53G>A::,CIZ1:NM_001257975.1:intron_variant:MODIFIER:intron8/17:c.1589-53G>A::,CIZ1:NM_001257976.2:intron_variant:MODIFIER:intron7/15:c.1196-53G>A::,CIZ1:NM_012127.3:intron_variant:MODIFIER:intron8/16:c.1499-53G>A::						rs3892074	0.6873	0.6026	5908,.		0.0990			0.21,0.25	1.51					0.026	0.5142	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CIZ1 (inh=n/a oe_syn=0.93 oe_mis=0.75 oe_lof=0.25)	1.0000	102	102	n/a (non-het)
chr9	130942972	130942972	T	C	hom		QUAL=4844;DP=173;AF=0.97;MQM=60	CIZ1	intron	CIZ1:ENST00000277465.4:intron_variant:MODIFIER:intron5/16:c.682+28A>G::,CIZ1:ENST00000325721.8:intron_variant:MODIFIER:intron5/15:c.595+28A>G::,CIZ1:ENST00000357558.5:intron_variant:MODIFIER:intron6/17:c.682+28A>G::,CIZ1:ENST00000372938.5:intron_variant:MODIFIER:intron6/16:c.682+28A>G::,CIZ1:ENST00000372948.3:intron_variant:MODIFIER:intron6/17:c.682+28A>G::,CIZ1:ENST00000372954.1:intron_variant:MODIFIER:intron5/16:c.610+28A>G::,CIZ1:ENST00000393608.1:intron_variant:MODIFIER:intron6/16:c.682+28A>G::,CIZ1:ENST00000538431.1:intron_variant:MODIFIER:intron6/17:c.682+28A>G::,CIZ1:ENST00000541172.1:intron_variant:MODIFIER:intron5/15:c.379+28A>G::	CIZ1:NM_001131015.2:intron_variant:MODIFIER:intron6/17:c.682+28A>G::,CIZ1:NM_001131016.2:intron_variant:MODIFIER:intron6/16:c.682+28A>G::,CIZ1:NM_001131017.2:intron_variant:MODIFIER:intron6/17:c.667+28A>G::,CIZ1:NM_001131018.2:intron_variant:MODIFIER:intron5/16:c.610+28A>G::,CIZ1:NM_001257975.1:intron_variant:MODIFIER:intron6/17:c.772+28A>G::,CIZ1:NM_001257976.2:intron_variant:MODIFIER:intron5/15:c.379+28A>G::,CIZ1:NM_012127.3:intron_variant:MODIFIER:intron6/16:c.682+28A>G::						rs45585631	0.6927	0.6917	6105,.	0.4549,0.8066,0.9537,0.6528,0.7540	0.1480			0.05,0.15	5.71					-0.103	0.4478	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CIZ1 (inh=n/a oe_syn=0.93 oe_mis=0.75 oe_lof=0.25)	1.0000	155	155	n/a (non-het)
chr9	132576512	132576512	G	T	het		QUAL=13794;DP=1098;AF=0.49;MQM=60	TOR1A	intron	TOR1A:ENST00000351698.4:intron_variant:MODIFIER:intron4/4:c.749-11C>A::	TOR1A:NM_000113.3:intron_variant:MODIFIER:intron4/4:c.749-11C>A::		605204 [GENE=TOR1A PHENOS=Dystonia-1,torsion,128100,Autosomal dominant/Arthrogryposis multiplex congenita 5,618947,Autosomal recessive/Dystonia-1,modifier of];	255137 [benign DISEASE=Dystonia 1,not specified];			rs72755217	0.0166	0.0206	0,.	0.0038,0.0135,0.0002,0.0162,0.0649	0.1370			0.15,0.23	6.60		11.65>9.82	0.000/0.022		-0.6581	0.995	0.02	19	827	2 / 63					TOR1B (inh=n/a oe_syn=0.88 oe_mis=0.81 oe_lof=0.33), TOR1A (inh=AD oe_syn=1.01 oe_mis=0.89 oe_lof=0.56)	0.6627	83	55	0.0030
chr9	132586005	132586005	G	C	hom		QUAL=363;DP=40;AF=0.80;MQM=59	TOR1A	intron	TOR1A:ENST00000351698.4:intron_variant:MODIFIER:intron1/4:c.178+182C>G::	TOR1A:NM_000113.3:intron_variant:MODIFIER:intron1/4:c.178+182C>G::	regulatory_region_variant:promoter	605204 [GENE=TOR1A PHENOS=Dystonia-1,torsion,128100,Autosomal dominant/Arthrogryposis multiplex congenita 5,618947,Autosomal recessive/Dystonia-1,modifier of];			(CCCCAG)n (Simple_repeat)						-1.0020			0.01,0.06	3.50							0	1	34	1 / 1					TOR1A (inh=AD oe_syn=1.01 oe_mis=0.89 oe_lof=0.56), C9ORF78 (inh=n/a oe_syn=1.04 oe_mis=0.61 oe_lof=0.59)	0.0000	17	0	n/a (non-het)
chr9	132586010	132586010	T	C	het		QUAL=9;DP=38;AF=0.39;MQM=59	TOR1A	intron	TOR1A:ENST00000351698.4:intron_variant:MODIFIER:intron1/4:c.178+177A>G::	TOR1A:NM_000113.3:intron_variant:MODIFIER:intron1/4:c.178+177A>G::	regulatory_region_variant:promoter	605204 [GENE=TOR1A PHENOS=Dystonia-1,torsion,128100,Autosomal dominant/Arthrogryposis multiplex congenita 5,618947,Autosomal recessive/Dystonia-1,modifier of];			(CCCCAG)n (Simple_repeat)						-2.0550			0.00,0.06	3.43							0	0	13	0 / 1					TOR1A (inh=AD oe_syn=1.01 oe_mis=0.89 oe_lof=0.56), C9ORF78 (inh=n/a oe_syn=1.04 oe_mis=0.61 oe_lof=0.59)	0.0000	23	0	0.0000
chr9	132586046	132586046	T	C	het		QUAL=18;DP=6;AF=0.67;MQM=60	TOR1A	intron	TOR1A:ENST00000351698.4:intron_variant:MODIFIER:intron1/4:c.178+141A>G::	TOR1A:NM_000113.3:intron_variant:MODIFIER:intron1/4:c.178+141A>G::	regulatory_region_variant:promoter	605204 [GENE=TOR1A PHENOS=Dystonia-1,torsion,128100,Autosomal dominant/Arthrogryposis multiplex congenita 5,618947,Autosomal recessive/Dystonia-1,modifier of];			(CCCCAG)n (Simple_repeat)						0.0580			0.01,0.07	5.19							0	0	17	0 / 1					TOR1A (inh=AD oe_syn=1.01 oe_mis=0.89 oe_lof=0.56), C9ORF78 (inh=n/a oe_syn=1.04 oe_mis=0.61 oe_lof=0.59)	0.0000	32	0	0.0000
chr9	132586416	132586416	A	C	het		QUAL=8788;DP=682;AF=0.53;MQM=60	TOR1A,C9orf78	upstream_gene,downstream_gene	TOR1A:ENST00000351698.4:upstream_gene_variant:MODIFIER::::,C9orf78:ENST00000372447.3:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant	605204 [GENE=TOR1A PHENOS=Dystonia-1,torsion,128100,Autosomal dominant/Arthrogryposis multiplex congenita 5,618947,Autosomal recessive/Dystonia-1,modifier of];	365238 [likely benign DISEASE=Dystonia 1];			rs114150156	0.0723	0.0568	125,.	0.1808,0.0224,0.0002,0.0163,0.0670	-4.3930			0.00,1.00	4.15								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TOR1A (inh=AD oe_syn=1.01 oe_mis=0.89 oe_lof=0.56), C9ORF78 (inh=n/a oe_syn=1.04 oe_mis=0.61 oe_lof=0.59)	0.5581	43	24	0.5424
chr9	132586485	132586485	C	T	het		QUAL=27;DP=15;AF=0.27;MQM=60	TOR1A,C9orf78	upstream_gene,downstream_gene	TOR1A:ENST00000351698.4:upstream_gene_variant:MODIFIER::::,C9orf78:ENST00000372447.3:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter										-0.1920			0.00,1.00	9.10								108	34	0 / 1	2	"[2] auto-classification 08.11.2017%0A%0A"			TOR1A (inh=AD oe_syn=1.01 oe_mis=0.89 oe_lof=0.56), C9ORF78 (inh=n/a oe_syn=1.04 oe_mis=0.61 oe_lof=0.59)	0.0000	13	0	0.0002
chr9	132586552	132586552	T	A	het		QUAL=356;DP=27;AF=0.67;MQM=60	TOR1A,C9orf78	upstream_gene,downstream_gene	TOR1A:ENST00000351698.4:upstream_gene_variant:MODIFIER::::,C9orf78:ENST00000372447.3:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant					rs72755223	0.0721	0.0569	126,.		-2.6860			0.00,1.00	8.07								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TOR1A (inh=AD oe_syn=1.01 oe_mis=0.89 oe_lof=0.56), C9ORF78 (inh=n/a oe_syn=1.04 oe_mis=0.61 oe_lof=0.59)	0.4615	13	6	1.0000
chr9	135139901	135139901	T	C	het		QUAL=13425;DP=1131;AF=0.49;MQM=60	SETX	missense	SETX:ENST00000224140.5:missense_variant:MODERATE:exon26/26:c.7759A>G:p.Ile2587Val:,SETX:ENST00000372169.2:missense_variant:MODERATE:exon27/27:c.7846A>G:p.Ile2616Val:,SETX:ENST00000393220.1:missense_variant:MODERATE:exon25/25:c.7660A>G:p.Ile2554Val:	SETX:NM_001351527.1:missense_variant:MODERATE:exon26/26:c.7759A>G:p.Ile2587Val:,SETX:NM_001351528.2:missense_variant:MODERATE:exon27/27:c.7846A>G:p.Ile2616Val:,SETX:NM_015046.7:missense_variant:MODERATE:exon26/26:c.7759A>G:p.Ile2587Val:		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];	95669 [benign DISEASE=Amyotrophic lateral sclerosis type 4,Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2,not specified,not provided];	CM1417740 [CLASS=DP MUT=ALT PHEN="Alzheimer disease increased risk association with" GENE=SETX];		rs1056899	0.5387	0.4449	3790,.	0.7561,0.3160,0.7274,0.2953,0.4408	-1.1110	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.02,0.13	0.01	0.19				0.0027	0.9386	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)	0.5628	215	121	0.2108
chr9	135153668	135153668	C	T	het		QUAL=10431;DP=832;AF=0.47;MQM=60	SETX	intron	SETX:ENST00000224140.5:intron_variant:MODIFIER:intron20/25:c.6655-24G>A::,SETX:ENST00000372169.2:intron_variant:MODIFIER:intron20/26:c.6655-24G>A::,SETX:ENST00000393220.1:intron_variant:MODIFIER:intron20/24:c.6655-24G>A::	SETX:NM_001351527.1:intron_variant:MODIFIER:intron20/25:c.6655-24G>A::,SETX:NM_001351528.2:intron_variant:MODIFIER:intron20/26:c.6655-24G>A::,SETX:NM_015046.7:intron_variant:MODIFIER:intron20/25:c.6655-24G>A::		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];	260513 [benign DISEASE=not specified];			rs11243704	0.5339	0.4423	3730,.	0.7549,0.2890,0.7152,0.2944,0.4399	-1.0590			0.01,0.08	1.48					-0.1323	0.077	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)	0.4565	92	42	0.4657
chr9	135153673	135153673	T	C	het	off-target	QUAL=9704;DP=829;AF=0.47;MQM=60	SETX	intron	SETX:ENST00000224140.5:intron_variant:MODIFIER:intron20/25:c.6655-29A>G::,SETX:ENST00000372169.2:intron_variant:MODIFIER:intron20/26:c.6655-29A>G::,SETX:ENST00000393220.1:intron_variant:MODIFIER:intron20/24:c.6655-29A>G::	SETX:NM_001351527.1:intron_variant:MODIFIER:intron20/25:c.6655-29A>G::,SETX:NM_001351528.2:intron_variant:MODIFIER:intron20/26:c.6655-29A>G::,SETX:NM_015046.7:intron_variant:MODIFIER:intron20/25:c.6655-29A>G::		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];				rs11243705	0.1587	0.1649	334,.	0.0976,0.1440,0.2905,0.1651,0.1575	0.4200			0.03,0.13	8.19					-0.3891	0.1318	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)	0.4624	93	43	0.5341
chr9	135202829	135202829	T	C	hom		QUAL=10704;DP=416;AF=1.00;MQM=60	SETX	missense	SETX:ENST00000224140.5:missense_variant:MODERATE:exon10/26:c.4156A>G:p.Ile1386Val:,SETX:ENST00000372169.2:missense_variant:MODERATE:exon10/27:c.4156A>G:p.Ile1386Val:,SETX:ENST00000393220.1:missense_variant:MODERATE:exon10/25:c.4156A>G:p.Ile1386Val:	SETX:NM_001351527.1:missense_variant:MODERATE:exon10/26:c.4156A>G:p.Ile1386Val:,SETX:NM_001351528.2:missense_variant:MODERATE:exon10/27:c.4156A>G:p.Ile1386Val:,SETX:NM_015046.7:missense_variant:MODERATE:exon10/26:c.4156A>G:p.Ile1386Val:		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];	95663 [benign DISEASE=Amyotrophic lateral sclerosis type 4,Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2,not specified,not provided];			rs543573		0.7345	8039,.	0.3739,0.7950,0.3052,0.8417,0.6352	-0.6580	T(0.55),T(0.56),T(0.55)	B(0.00),B(0.00),B(0.00)	0.06,0.18	0.00	0.25				0.0067	0.1634	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)	1.0000	167	167	n/a (non-het)
chr9	135203231	135203231	C	T	hom		QUAL=2622;DP=84;AF=1.00;MQM=60	SETX	missense	SETX:ENST00000224140.5:missense_variant:MODERATE:exon10/26:c.3754G>A:p.Gly1252Arg:,SETX:ENST00000372169.2:missense_variant:MODERATE:exon10/27:c.3754G>A:p.Gly1252Arg:,SETX:ENST00000393220.1:missense_variant:MODERATE:exon10/25:c.3754G>A:p.Gly1252Arg:	SETX:NM_001351527.1:missense_variant:MODERATE:exon10/26:c.3754G>A:p.Gly1252Arg:,SETX:NM_001351528.2:missense_variant:MODERATE:exon10/27:c.3754G>A:p.Gly1252Arg:,SETX:NM_015046.7:missense_variant:MODERATE:exon10/26:c.3754G>A:p.Gly1252Arg:		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];	95662 [benign DISEASE=Amyotrophic lateral sclerosis type 4,Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2,not specified,none provided,not provided];			rs1183768	0.5561	0.7344	8030,.	0.3738,0.7949,0.3050,0.8417,0.6352	0.4900	T(0.43),T(0.43),T(0.43)	B(0.11),B(0.22),B(0.22)	0.22,0.86	18.79	0.24			COSV56383300	-0.002	0.1631	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)	0.9962	260	259	n/a (non-het)
chr9	135203409	135203409	A	C	hom		QUAL=2706;DP=84;AF=1.00;MQM=60	SETX	missense	SETX:ENST00000224140.5:missense_variant:MODERATE:exon10/26:c.3576T>G:p.Asp1192Glu:,SETX:ENST00000372169.2:missense_variant:MODERATE:exon10/27:c.3576T>G:p.Asp1192Glu:,SETX:ENST00000393220.1:missense_variant:MODERATE:exon10/25:c.3576T>G:p.Asp1192Glu:	SETX:NM_001351527.1:missense_variant:MODERATE:exon10/26:c.3576T>G:p.Asp1192Glu:,SETX:NM_001351528.2:missense_variant:MODERATE:exon10/27:c.3576T>G:p.Asp1192Glu:,SETX:NM_015046.7:missense_variant:MODERATE:exon10/26:c.3576T>G:p.Asp1192Glu:		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];	95661 [benign DISEASE=Amyotrophic lateral sclerosis type 4,Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2,not specified,none provided,not provided];			rs1185193		0.7679	9525,.	0.6419,0.8121,0.3127,0.8566,0.6539	-0.9940	T(0.42),T(0.41),T(0.41)	B(0.00),B(0.01),B(0.01)	0.09,0.19	0.00	0.27				-0.0007	0.1632	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)	0.9913	229	227	n/a (non-het)
chr9	135206460	135206460	A	G	hom		QUAL=3359;DP=100;AF=1.00;MQM=60	SETX	synonymous	SETX:ENST00000224140.5:synonymous_variant:LOW:exon9/26:c.1077T>C:p.Tyr359=:,SETX:ENST00000372169.2:synonymous_variant:LOW:exon9/27:c.1077T>C:p.Tyr359=:,SETX:ENST00000393220.1:synonymous_variant:LOW:exon9/25:c.1077T>C:p.Tyr359=:	SETX:NM_001351527.1:synonymous_variant:LOW:exon9/26:c.1077T>C:p.Tyr359=:,SETX:NM_001351528.2:synonymous_variant:LOW:exon9/27:c.1077T>C:p.Tyr359=:,SETX:NM_015046.7:synonymous_variant:LOW:exon9/26:c.1077T>C:p.Tyr359=:		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];	95658 [benign DISEASE=Amyotrophic lateral sclerosis type 4,Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2,not specified,not provided];			rs9411449	0.6266	0.7524	9101,.	0.6171,0.8059,0.3075,0.8422,0.6361	0.1510			0.20,0.41	6.05					0.2383	0.3184	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)	1.0000	117	117	n/a (non-het)
chr9	135211610	135211611	AC	-	hom	off-target	QUAL=11334;DP=380;AF=1.00;MQM=60	SETX	intron	SETX:ENST00000224140.5:intron_variant:MODIFIER:intron6/25:c.718+72_718+73del::,SETX:ENST00000372169.2:intron_variant:MODIFIER:intron6/26:c.718+72_718+73del::,SETX:ENST00000393220.1:intron_variant:MODIFIER:intron6/24:c.718+72_718+73del::	SETX:NM_001351527.1:intron_variant:MODIFIER:intron6/25:c.718+72_718+73del::,SETX:NM_001351528.2:intron_variant:MODIFIER:intron6/26:c.718+72_718+73del::,SETX:NM_015046.7:intron_variant:MODIFIER:intron6/25:c.718+72_718+73del::		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];			AluSz (SINE/Alu)	rs10573812		0.7374	8793,.		0.4810				4.72					-0.0779	0.1991	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)	1.0000	28	28	n/a (non-het)
chr9	135221597	135221597	G	A	hom	off-target	QUAL=12706;DP=403;AF=1.00;MQM=60	SETX	intron	SETX:ENST00000224140.5:intron_variant:MODIFIER:intron4/25:c.388+51C>T::,SETX:ENST00000372169.2:intron_variant:MODIFIER:intron4/26:c.388+51C>T::,SETX:ENST00000393220.1:intron_variant:MODIFIER:intron4/24:c.388+51C>T::	SETX:NM_001351527.1:intron_variant:MODIFIER:intron4/25:c.388+51C>T::,SETX:NM_001351528.2:intron_variant:MODIFIER:intron4/26:c.388+51C>T::,SETX:NM_015046.7:intron_variant:MODIFIER:intron4/25:c.388+51C>T::		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];				rs497650	0.9956	0.9991	15570,.	0.9867,0.9994,1.0000,1.0000,1.0000	0.3960			0.00,0.07	1.82					0.0481	0.5058	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)	1.0000	44	44	n/a (non-het)
chr9	140777306	140777306	C	G	het		QUAL=7513;DP=2495;AF=0.21;MQM=60	CACNA1B,RP11-188C12.3	5'UTR,missense,non_coding_transcript_exon	CACNA1B:ENST00000277549.5:5_prime_UTR_variant:MODIFIER:exon3/47:c.-1924C>G::,CACNA1B:ENST00000277551.2:missense_variant:MODERATE:exon3/47:c.501C>G:p.Asn167Lys:PF00520 [Ion transport protein],CACNA1B:ENST00000371355.4:missense_variant:MODERATE:exon3/47:c.501C>G:p.Asn167Lys:PF00520 [Ion transport protein],CACNA1B:ENST00000371357.1:missense_variant:MODERATE:exon3/46:c.501C>G:p.Asn167Lys:PF00520 [Ion transport protein],CACNA1B:ENST00000371363.1:missense_variant:MODERATE:exon3/46:c.501C>G:p.Asn167Lys:PF00520 [Ion transport protein],CACNA1B:ENST00000371372.1:missense_variant:MODERATE:exon3/47:c.501C>G:p.Asn167Lys:PF00520 [Ion transport protein],RP11-188C12.3:ENST00000371390.1:non_coding_transcript_exon_variant:MODIFIER:exon2/4:n.2674G>C::	CACNA1B:NM_000718.4:missense_variant:MODERATE:exon3/47:c.501C>G:p.Asn167Lys:,CACNA1B:NM_001243812.2:missense_variant:MODERATE:exon3/47:c.501C>G:p.Asn167Lys:,LOC100133077:NR_121583.1:non_coding_transcript_exon_variant:MODIFIER:exon2/4:n.2674G>C::		601012 [GENE=CACNA1B PHENOS=Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements,618497,Autosomal recessive];	802555 [benign DISEASE=Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements];			rs4422842		0.5000	0,.	0.5000,0.5000,0.4993,0.5000,0.5000	-1.1760	 ,D(0.01),D(0.01),D(0.01),D(0.01),D(0.01), 	 ,D(1.00),D(1.00),D(1.00),D(1.00),D(1.00), 	0.11,0.93	16.35	0.75				-0.2917	0.376	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AR oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)	0.4112	394	162	0.0854
chr9	140777370	140777370	A	C	hom	off-target	QUAL=86589;DP=2968;AF=1.00;MQM=60	CACNA1B,RP11-188C12.3	intron,non_coding_transcript_exon	CACNA1B:ENST00000277549.5:intron_variant:MODIFIER:intron3/46:c.-1895+35A>C::,CACNA1B:ENST00000277551.2:intron_variant:MODIFIER:intron3/46:c.530+35A>C::,CACNA1B:ENST00000371355.4:intron_variant:MODIFIER:intron3/46:c.530+35A>C::,CACNA1B:ENST00000371357.1:intron_variant:MODIFIER:intron3/45:c.530+35A>C::,CACNA1B:ENST00000371363.1:intron_variant:MODIFIER:intron3/45:c.530+35A>C::,CACNA1B:ENST00000371372.1:intron_variant:MODIFIER:intron3/46:c.530+35A>C::,RP11-188C12.3:ENST00000371390.1:non_coding_transcript_exon_variant:MODIFIER:exon2/4:n.2610T>G::	CACNA1B:NM_000718.4:intron_variant:MODIFIER:intron3/46:c.530+35A>C::,CACNA1B:NM_001243812.2:intron_variant:MODIFIER:intron3/46:c.530+35A>C::,LOC100133077:NR_121583.1:non_coding_transcript_exon_variant:MODIFIER:exon2/4:n.2610T>G::		601012 [GENE=CACNA1B PHENOS=Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements,618497,Autosomal recessive];				rs1110146		0.5927	2907,.	0.7046,0.5450,0.5227,0.5468,0.5441	-1.5520			0.00,0.19	7.03					0.0651	0.3905	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AR oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)	1.0000	161	161	n/a (non-het)
chr9	140881314	140881314	A	C	het		QUAL=31652;DP=3247;AF=0.40;MQM=60	CACNA1B	splice_region&intron	CACNA1B:ENST00000277549.5:splice_region_variant&intron_variant:LOW:intron15/46:c.-451+8A>C::,CACNA1B:ENST00000277551.2:splice_region_variant&intron_variant:LOW:intron15/46:c.1974+8A>C::,CACNA1B:ENST00000371355.4:splice_region_variant&intron_variant:LOW:intron15/46:c.1977+8A>C::,CACNA1B:ENST00000371357.1:splice_region_variant&intron_variant:LOW:intron15/45:c.1977+8A>C::,CACNA1B:ENST00000371363.1:splice_region_variant&intron_variant:LOW:intron15/45:c.1974+8A>C::,CACNA1B:ENST00000371372.1:splice_region_variant&intron_variant:LOW:intron15/46:c.1974+8A>C::	CACNA1B:NM_000718.4:splice_region_variant&intron_variant:LOW:intron15/46:c.1974+8A>C::,CACNA1B:NM_001243812.2:splice_region_variant&intron_variant:LOW:intron15/46:c.1974+8A>C::		601012 [GENE=CACNA1B PHENOS=Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements,618497,Autosomal recessive];				rs7034745	0.4215	0.3136	2099,.	0.5786,0.1323,0.6597,0.1897,0.3427	-1.4060			0.01,0.17	0.28			0.000/0.000		0.6256	0.0014	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AR oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)	0.5202	248	129	0.7877
chr9	140901146	140901146	A	G	het	off-target	QUAL=6291;DP=623;AF=0.47;MQM=60	CACNA1B	intron	CACNA1B:ENST00000277549.5:intron_variant:MODIFIER:intron15/46:c.-450-73A>G::,CACNA1B:ENST00000277551.2:intron_variant:MODIFIER:intron15/46:c.1975-73A>G::,CACNA1B:ENST00000371355.4:intron_variant:MODIFIER:intron15/46:c.1978-73A>G::,CACNA1B:ENST00000371357.1:intron_variant:MODIFIER:intron15/45:c.1978-73A>G::,CACNA1B:ENST00000371363.1:intron_variant:MODIFIER:intron15/45:c.1975-73A>G::,CACNA1B:ENST00000371372.1:intron_variant:MODIFIER:intron15/46:c.1975-73A>G::	CACNA1B:NM_000718.4:intron_variant:MODIFIER:intron15/46:c.1975-73A>G::,CACNA1B:NM_001243812.2:intron_variant:MODIFIER:intron15/46:c.1975-73A>G::		601012 [GENE=CACNA1B PHENOS=Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements,618497,Autosomal recessive];				rs2290580	0.4293	0.3210	2497,.		-3.2510			0.00,0.05	0.09					-0.0972	0.4623	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AR oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)	0.5098	51	26	1.0000
chr9	140911670	140911670	C	T	het		QUAL=13396;DP=1426;AF=0.39;MQM=60	CACNA1B	intron	CACNA1B:ENST00000277549.5:intron_variant:MODIFIER:intron18/46:c.-158+3983C>T::,CACNA1B:ENST00000277550.3:intron_variant:MODIFIER:intron3/3:c.203+17C>T::,CACNA1B:ENST00000277551.2:intron_variant:MODIFIER:intron18/46:c.2267+3983C>T::,CACNA1B:ENST00000371355.4:intron_variant:MODIFIER:intron18/46:c.2270+3983C>T::,CACNA1B:ENST00000371357.1:intron_variant:MODIFIER:intron18/45:c.2270+3983C>T::,CACNA1B:ENST00000371363.1:intron_variant:MODIFIER:intron18/45:c.2267+3983C>T::,CACNA1B:ENST00000371372.1:intron_variant:MODIFIER:intron18/46:c.2267+3983C>T::	CACNA1B:NM_000718.4:intron_variant:MODIFIER:intron18/46:c.2267+3983C>T::,CACNA1B:NM_001243812.2:intron_variant:MODIFIER:intron18/46:c.2267+3983C>T::		601012 [GENE=CACNA1B PHENOS=Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements,618497,Autosomal recessive];				rs7028989	0.3968	0.2939	1969,.	0.5796,0.1186,0.6368,0.1568,0.2815	-0.0080			0.10,0.95	12.80					0.1445	0.2726	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AR oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)	0.4629	175	81	0.5203
chr9	140917779	140917779	G	T	het		QUAL=20220;DP=1843;AF=0.48;MQM=60	CACNA1B	missense	CACNA1B:ENST00000277549.5:missense_variant:MODERATE:exon19/47:c.160G>T:p.Ala54Ser:,CACNA1B:ENST00000277551.2:missense_variant:MODERATE:exon19/47:c.2584G>T:p.Ala862Ser:,CACNA1B:ENST00000371355.4:missense_variant:MODERATE:exon19/47:c.2587G>T:p.Ala863Ser:,CACNA1B:ENST00000371357.1:missense_variant:MODERATE:exon19/46:c.2587G>T:p.Ala863Ser:,CACNA1B:ENST00000371363.1:missense_variant:MODERATE:exon19/46:c.2584G>T:p.Ala862Ser:,CACNA1B:ENST00000371372.1:missense_variant:MODERATE:exon19/47:c.2584G>T:p.Ala862Ser:	CACNA1B:NM_000718.4:missense_variant:MODERATE:exon19/47:c.2584G>T:p.Ala862Ser:,CACNA1B:NM_001243812.2:missense_variant:MODERATE:exon19/47:c.2584G>T:p.Ala862Ser:	regulatory_region_variant:promoter	601012 [GENE=CACNA1B PHENOS=Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements,618497,Autosomal recessive];				rs7873074	0.4269	0.3194	2460,.	0.6658,0.1239,0.6544,0.1626,0.2764	-0.1580	T(0.69),T(0.71),T(0.74),T(0.74),T(0.75),T(0.74)	B(0.14),B(0.07),B(0.17),B(0.08),B(0.08),B(0.08)	0.15,0.38	8.44	0.32				-0.0025	0.0304	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AR oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)	0.4971	173	86	1.0000
chr9	140918171	140918185	GGAGAAGGAGACCAC	-	het		QUAL=12051;DP=971;AF=0.55;MQM=60	CACNA1B	inframe_deletion,5'UTR	CACNA1B:ENST00000277549.5:inframe_deletion:MODERATE:exon19/47:c.562_576del:p.Thr188_Glu192del:,CACNA1B:ENST00000277551.2:inframe_deletion:MODERATE:exon19/47:c.2986_3000del:p.Thr996_Glu1000del:,CACNA1B:ENST00000371355.4:inframe_deletion:MODERATE:exon19/47:c.2989_3003del:p.Thr997_Glu1001del:,CACNA1B:ENST00000371357.1:inframe_deletion:MODERATE:exon19/46:c.2989_3003del:p.Thr997_Glu1001del:,CACNA1B:ENST00000371363.1:inframe_deletion:MODERATE:exon19/46:c.2986_3000del:p.Thr996_Glu1000del:,CACNA1B:ENST00000371367.5:5_prime_UTR_variant:MODIFIER:exon1/3:c.-63_-49del::,CACNA1B:ENST00000371372.1:inframe_deletion:MODERATE:exon19/47:c.2986_3000del:p.Thr996_Glu1000del:	CACNA1B:NM_000718.4:inframe_deletion:MODERATE:exon19/47:c.2986_3000del:p.Thr996_Glu1000del:,CACNA1B:NM_001243812.2:inframe_deletion:MODERATE:exon19/47:c.2986_3000del:p.Thr996_Glu1000del:	regulatory_region_variant:promoter	601012 [GENE=CACNA1B PHENOS=Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements,618497,Autosomal recessive];	802556 [benign DISEASE=Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements];		GA-rich (Low_complexity)	rs145816559		0.2924	1837,.	0.5394,0.1188,0.6306,0.1544,0.2770	5.0290				10.84					-0.3684	0.03	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AR oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)	0.5533	150	83	0.2205
chr9	140918300	140918300	G	C	het	off-target	QUAL=7633;DP=763;AF=0.45;MQM=60	CACNA1B	intron	CACNA1B:ENST00000277549.5:intron_variant:MODIFIER:intron19/46:c.644+37G>C::,CACNA1B:ENST00000277551.2:intron_variant:MODIFIER:intron19/46:c.3068+37G>C::,CACNA1B:ENST00000371355.4:intron_variant:MODIFIER:intron19/46:c.3071+37G>C::,CACNA1B:ENST00000371357.1:intron_variant:MODIFIER:intron19/45:c.3071+37G>C::,CACNA1B:ENST00000371363.1:intron_variant:MODIFIER:intron19/45:c.3068+37G>C::,CACNA1B:ENST00000371367.5:intron_variant:MODIFIER:intron1/2:c.20+37G>C::,CACNA1B:ENST00000371372.1:intron_variant:MODIFIER:intron19/46:c.3068+37G>C::,CACNA1B:ENST00000545473.1:intron_variant:MODIFIER:intron1/6:c.20+37G>C::	CACNA1B:NM_000718.4:intron_variant:MODIFIER:intron19/46:c.3068+37G>C::,CACNA1B:NM_001243812.2:intron_variant:MODIFIER:intron19/46:c.3068+37G>C::		601012 [GENE=CACNA1B PHENOS=Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements,618497,Autosomal recessive];			G-rich (Low_complexity)	rs6559259	0.3864	0.2846	1788,.	0.5327,0.1197,0.6323,0.1582,0.2787	0.7450			0.08,0.21	6.26					-0.3431	0.0421	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AR oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)	0.4464	56	25	0.5044
chr9	140938183	140938183	A	G	het	off-target	QUAL=1916;DP=167;AF=0.51;MQM=60	CACNA1B	intron	CACNA1B:ENST00000277549.5:intron_variant:MODIFIER:intron20/46:c.863-43A>G::,CACNA1B:ENST00000277551.2:intron_variant:MODIFIER:intron20/46:c.3287-43A>G::,CACNA1B:ENST00000371355.4:intron_variant:MODIFIER:intron20/46:c.3290-43A>G::,CACNA1B:ENST00000371357.1:intron_variant:MODIFIER:intron20/45:c.3290-43A>G::,CACNA1B:ENST00000371363.1:intron_variant:MODIFIER:intron20/45:c.3287-43A>G::,CACNA1B:ENST00000371372.1:intron_variant:MODIFIER:intron20/46:c.3287-43A>G::,CACNA1B:ENST00000545473.1:intron_variant:MODIFIER:intron3/6:c.365-43A>G::	CACNA1B:NM_000718.4:intron_variant:MODIFIER:intron20/46:c.3287-43A>G::,CACNA1B:NM_001243812.2:intron_variant:MODIFIER:intron20/46:c.3287-43A>G::,LOC101928786:NR_121582.1:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.250T>C::		601012 [GENE=CACNA1B PHENOS=Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements,618497,Autosomal recessive];				rs3750506	0.4577	0.3482	2634,.	0.6505,0.1451,0.6638,0.2012,0.3570	-4.1830			0.00,0.06	0.26					0.1326	0.0282	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AR oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)	0.3852	122	47	0.0142
chr9	141008876	141008876	C	T	het		QUAL=35431;DP=2950;AF=0.44;MQM=60	CACNA1B	synonymous	CACNA1B:ENST00000277549.5:synonymous_variant:LOW:exon41/47:c.3165C>T:p.Phe1055=:PF08763 [Voltage gated calcium channel IQ domain],CACNA1B:ENST00000277551.2:synonymous_variant:LOW:exon41/47:c.5583C>T:p.Phe1861=:PF08763 [Voltage gated calcium channel IQ domain],CACNA1B:ENST00000371355.4:synonymous_variant:LOW:exon41/47:c.5586C>T:p.Phe1862=:PF08763 [Voltage gated calcium channel IQ domain],CACNA1B:ENST00000371357.1:synonymous_variant:LOW:exon40/46:c.5580C>T:p.Phe1860=:PF08763 [Voltage gated calcium channel IQ domain],CACNA1B:ENST00000371363.1:synonymous_variant:LOW:exon40/46:c.5577C>T:p.Phe1859=:PF08763 [Voltage gated calcium channel IQ domain],CACNA1B:ENST00000371372.1:synonymous_variant:LOW:exon41/47:c.5583C>T:p.Phe1861=:PF08763 [Voltage gated calcium channel IQ domain]	CACNA1B:NM_000718.4:synonymous_variant:LOW:exon41/47:c.5583C>T:p.Phe1861=:,CACNA1B:NM_001243812.2:synonymous_variant:LOW:exon41/47:c.5583C>T:p.Phe1861=:		601012 [GENE=CACNA1B PHENOS=Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements,618497,Autosomal recessive];				rs2229948	0.5046	0.6808	6684,.	0.3022,0.7197,0.2710,0.7522,0.6797	-1.1370			0.08,0.96	9.04					-0.3632	0.1386	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AR oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)	0.4433	194	86	0.3099
chr9	141015019	141015019	G	C	het	off-target;low_conf_region	QUAL=4509;DP=395;AF=0.50;MQM=60	CACNA1B	intron	CACNA1B:ENST00000277549.5:intron_variant:MODIFIER:intron45/46:c.3821-64G>C::,CACNA1B:ENST00000277551.2:intron_variant:MODIFIER:intron45/46:c.6239-64G>C::,CACNA1B:ENST00000371355.4:intron_variant:MODIFIER:intron45/46:c.6242-64G>C::,CACNA1B:ENST00000371357.1:intron_variant:MODIFIER:intron44/45:c.6236-64G>C::,CACNA1B:ENST00000371363.1:intron_variant:MODIFIER:intron44/45:c.6233-64G>C::,CACNA1B:ENST00000371372.1:intron_variant:MODIFIER:intron45/46:c.6239-64G>C::	CACNA1B:NM_000718.4:intron_variant:MODIFIER:intron45/46:c.6239-64G>C::,CACNA1B:NM_001243812.2:intron_variant:MODIFIER:intron45/46:c.6239-64G>C::		601012 [GENE=CACNA1B PHENOS=Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements,618497,Autosomal recessive];				rs2278971	0.2674	0.2962	1528,.		-0.8510			0.01,0.08	1.19					-0.0195	0.0857	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AR oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)	0.5890	73	43	0.1597
chr9	141015351	141015351	A	G	het		QUAL=8213;DP=1004;AF=0.40;MQM=60	CACNA1B	intron	CACNA1B:ENST00000277549.5:intron_variant:MODIFIER:intron46/46:c.4071+18A>G::,CACNA1B:ENST00000277551.2:intron_variant:MODIFIER:intron46/46:c.6489+18A>G::,CACNA1B:ENST00000371355.4:intron_variant:MODIFIER:intron46/46:c.6492+18A>G::,CACNA1B:ENST00000371357.1:intron_variant:MODIFIER:intron45/45:c.6486+18A>G::,CACNA1B:ENST00000371363.1:intron_variant:MODIFIER:intron45/45:c.6483+18A>G::,CACNA1B:ENST00000371372.1:intron_variant:MODIFIER:intron46/46:c.6489+18A>G::	CACNA1B:NM_000718.4:intron_variant:MODIFIER:intron46/46:c.6489+18A>G::,CACNA1B:NM_001243812.2:intron_variant:MODIFIER:intron46/46:c.6489+18A>G::		601012 [GENE=CACNA1B PHENOS=Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements,618497,Autosomal recessive];				rs2278972	0.2726	0.3277	1572,.	0.2021,0.2272,0.3063,0.3823,0.3182	-1.8790			0.00,0.10	4.69					0.2294	0.0816	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AR oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)	0.5133	226	116	0.7789
chr9	141015870	141015870	T	-	het	off-target;low_conf_region	QUAL=2543;DP=646;AF=0.18;MQM=60	CACNA1B	intron	CACNA1B:ENST00000277549.5:intron_variant:MODIFIER:intron46/46:c.4072-34del::,CACNA1B:ENST00000277551.2:intron_variant:MODIFIER:intron46/46:c.6490-221del::,CACNA1B:ENST00000371355.4:intron_variant:MODIFIER:intron46/46:c.6493-34del::,CACNA1B:ENST00000371357.1:intron_variant:MODIFIER:intron45/45:c.6487-34del::,CACNA1B:ENST00000371363.1:intron_variant:MODIFIER:intron45/45:c.6484-34del::,CACNA1B:ENST00000371372.1:intron_variant:MODIFIER:intron46/46:c.6490-34del::	CACNA1B:NM_000718.4:intron_variant:MODIFIER:intron46/46:c.6490-34del::,CACNA1B:NM_001243812.2:intron_variant:MODIFIER:intron46/46:c.6490-221del::		601012 [GENE=CACNA1B PHENOS=Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements,618497,Autosomal recessive];			(T)n (Simple_repeat)	rs35987844		0.2670	728,.		0.0710				3.01					-0.0158	0.9323	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AR oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)	0.2394	71	17	0.0000
chr9	141016262	141016262	T	G	hom		QUAL=40930;DP=1365;AF=1.00;MQM=60	CACNA1B	synonymous,missense	CACNA1B:ENST00000277549.5:synonymous_variant:LOW:exon47/47:c.4413T>G:p.Thr1471=:,CACNA1B:ENST00000277551.2:missense_variant:MODERATE:exon47/47:c.6644T>G:p.Leu2215Arg:,CACNA1B:ENST00000371355.4:synonymous_variant:LOW:exon47/47:c.6834T>G:p.Thr2278=:,CACNA1B:ENST00000371357.1:synonymous_variant:LOW:exon46/46:c.6828T>G:p.Thr2276=:,CACNA1B:ENST00000371363.1:synonymous_variant:LOW:exon46/46:c.6825T>G:p.Thr2275=:,CACNA1B:ENST00000371372.1:synonymous_variant:LOW:exon47/47:c.6831T>G:p.Thr2277=:	CACNA1B:NM_000718.4:synonymous_variant:LOW:exon47/47:c.6831T>G:p.Thr2277=:,CACNA1B:NM_001243812.2:missense_variant:MODERATE:exon47/47:c.6644T>G:p.Leu2215Arg:		601012 [GENE=CACNA1B PHENOS=Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements,618497,Autosomal recessive];				rs2278973		0.9132	13100,.	0.9618,0.8791,0.7942,0.9013,0.9272	-0.6660	 ,T(0.46), , , , 	 , (0.00), , , , 	0.01,0.20	2.42	0.22				0.0221	0.93	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1B (inh=AR oe_syn=1.02 oe_mis=0.65 oe_lof=0.16)	0.9914	348	345	n/a (non-het)
chr10	78729669	78729669	A	G	het	off-target	QUAL=8153;DP=706;AF=0.45;MQM=60	KCNMA1,RP11-443A13.5	intron,intron&non_coding_transcript	KCNMA1:ENST00000286627.5:intron_variant:MODIFIER:intron19/26:c.2186+63T>C::,KCNMA1:ENST00000286628.8:intron_variant:MODIFIER:intron20/27:c.2360+63T>C::,KCNMA1:ENST00000354353.5:intron_variant:MODIFIER:intron21/28:c.2369+63T>C::,KCNMA1:ENST00000372440.1:intron_variant:MODIFIER:intron19/27:c.2186+63T>C::,KCNMA1:ENST00000372443.1:intron_variant:MODIFIER:intron19/28:c.2186+63T>C::,KCNMA1:ENST00000404771.3:intron_variant:MODIFIER:intron20/29:c.2360+63T>C::,KCNMA1:ENST00000404857.1:intron_variant:MODIFIER:intron19/27:c.2186+63T>C::,KCNMA1:ENST00000406533.3:intron_variant:MODIFIER:intron21/28:c.2372+63T>C::,RP11-443A13.5:ENST00000458661.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.426-7699A>G::,RP11-443A13.5:ENST00000598613.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.677-7699A>G::,RP11-443A13.5:ENST00000600782.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/4:n.312-5370A>G::	KCNMA1:NM_001014797.3:intron_variant:MODIFIER:intron20/28:c.2198+63T>C::,KCNMA1:NM_001161352.2:intron_variant:MODIFIER:intron20/27:c.2360+63T>C::,KCNMA1:NM_001161353.2:intron_variant:MODIFIER:intron19/27:c.2186+63T>C::,KCNMA1:NM_001271518.2:intron_variant:MODIFIER:intron19/27:c.2036+63T>C::,KCNMA1:NM_001271519.2:intron_variant:MODIFIER:intron20/28:c.2195+63T>C::,KCNMA1:NM_001322829.2:intron_variant:MODIFIER:intron20/28:c.2195+63T>C::,KCNMA1:NM_001322830.2:intron_variant:MODIFIER:intron21/30:c.2207+63T>C::,KCNMA1:NM_001322832.2:intron_variant:MODIFIER:intron19/27:c.2186+63T>C::,KCNMA1:NM_001322835.2:intron_variant:MODIFIER:intron20/29:c.2198+63T>C::,KCNMA1:NM_001322836.2:intron_variant:MODIFIER:intron20/27:c.2195+63T>C::,KCNMA1:NM_001322837.2:intron_variant:MODIFIER:intron20/28:c.2198+63T>C::,KCNMA1:NM_001322838.1:intron_variant:MODIFIER:intron21/29:c.1733+63T>C::,KCNMA1:NM_002247.4:intron_variant:MODIFIER:intron19/26:c.2186+63T>C::,KCNMA1-AS1:NR_120655.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.458-7699A>G::	regulatory_region_variant:enhancer	600150 [GENE=KCNMA1 PHENOS=Liang-Wang syndrome,618729,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,16,618596,Autosomal dominant/Cerebellar atrophy,developmental delay,and seizures,617643,Autosomal recessive/Paroxysmal nonkinesigenic dyskinesia,3,with or without generalized epilepsy,609446,Autosomal dominant];			G-rich (Low_complexity)	rs2288837	0.8558	0.8314	10868,.		-0.2220			0.01,0.13	12.41					0.0528	0.1262	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNMA1 (inh=AR+AD oe_syn=1.18 oe_mis=0.46 oe_lof=0.16)	0.5161	62	32	0.8013
chr10	78778734	78778734	G	A	het	off-target	QUAL=2019;DP=234;AF=0.48;MQM=60	KCNMA1	intron	KCNMA1:ENST00000286627.5:intron_variant:MODIFIER:intron17/26:c.2015+37C>T::,KCNMA1:ENST00000286628.8:intron_variant:MODIFIER:intron17/27:c.2015+37C>T::,KCNMA1:ENST00000354353.5:intron_variant:MODIFIER:intron17/28:c.2015+37C>T::,KCNMA1:ENST00000372440.1:intron_variant:MODIFIER:intron17/27:c.2015+37C>T::,KCNMA1:ENST00000372443.1:intron_variant:MODIFIER:intron17/28:c.2015+37C>T::,KCNMA1:ENST00000404771.3:intron_variant:MODIFIER:intron17/29:c.2015+37C>T::,KCNMA1:ENST00000404857.1:intron_variant:MODIFIER:intron17/27:c.2015+37C>T::,KCNMA1:ENST00000406533.3:intron_variant:MODIFIER:intron18/28:c.2027+37C>T::	KCNMA1:NM_001014797.3:intron_variant:MODIFIER:intron18/28:c.2027+37C>T::,KCNMA1:NM_001161352.2:intron_variant:MODIFIER:intron17/27:c.2015+37C>T::,KCNMA1:NM_001161353.2:intron_variant:MODIFIER:intron17/27:c.2015+37C>T::,KCNMA1:NM_001271518.2:intron_variant:MODIFIER:intron17/27:c.1865+37C>T::,KCNMA1:NM_001271519.2:intron_variant:MODIFIER:intron17/28:c.2015+37C>T::,KCNMA1:NM_001322829.2:intron_variant:MODIFIER:intron17/28:c.2015+37C>T::,KCNMA1:NM_001322830.2:intron_variant:MODIFIER:intron18/30:c.2027+37C>T::,KCNMA1:NM_001322832.2:intron_variant:MODIFIER:intron17/27:c.2015+37C>T::,KCNMA1:NM_001322835.2:intron_variant:MODIFIER:intron18/29:c.2027+37C>T::,KCNMA1:NM_001322836.2:intron_variant:MODIFIER:intron17/27:c.2015+37C>T::,KCNMA1:NM_001322837.2:intron_variant:MODIFIER:intron18/28:c.2027+37C>T::,KCNMA1:NM_001322838.1:intron_variant:MODIFIER:intron18/29:c.1475+37C>T::,KCNMA1:NM_002247.4:intron_variant:MODIFIER:intron17/26:c.2015+37C>T::		600150 [GENE=KCNMA1 PHENOS=Liang-Wang syndrome,618729,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,16,618596,Autosomal dominant/Cerebellar atrophy,developmental delay,and seizures,617643,Autosomal recessive/Paroxysmal nonkinesigenic dyskinesia,3,with or without generalized epilepsy,609446,Autosomal dominant];				rs16934182	0.3722	0.5474	5231,.	0.3595,0.4485,0.0068,0.6725,0.4841	0.5290			0.01,0.27	3.41					0.2217	0.2336	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNMA1 (inh=AR+AD oe_syn=1.18 oe_mis=0.46 oe_lof=0.16)	0.5060	83	42	1.0000
chr10	78868166	78868168	AAA	-	het	off-target;low_conf_region	QUAL=2098;DP=338;AF=0.33;MQM=60	KCNMA1	intron	KCNMA1:ENST00000286627.5:intron_variant:MODIFIER:intron9/26:c.1223+71_1223+73del::,KCNMA1:ENST00000286628.8:intron_variant:MODIFIER:intron9/27:c.1223+71_1223+73del::,KCNMA1:ENST00000354353.5:intron_variant:MODIFIER:intron9/28:c.1223+71_1223+73del::,KCNMA1:ENST00000372440.1:intron_variant:MODIFIER:intron9/27:c.1223+71_1223+73del::,KCNMA1:ENST00000372443.1:intron_variant:MODIFIER:intron9/28:c.1223+71_1223+73del::,KCNMA1:ENST00000404771.3:intron_variant:MODIFIER:intron9/29:c.1223+71_1223+73del::,KCNMA1:ENST00000404857.1:intron_variant:MODIFIER:intron9/27:c.1223+71_1223+73del::,KCNMA1:ENST00000406533.3:intron_variant:MODIFIER:intron9/28:c.1223+71_1223+73del::	KCNMA1:NM_001014797.3:intron_variant:MODIFIER:intron9/28:c.1223+71_1223+73del::,KCNMA1:NM_001161352.2:intron_variant:MODIFIER:intron9/27:c.1223+71_1223+73del::,KCNMA1:NM_001161353.2:intron_variant:MODIFIER:intron9/27:c.1223+71_1223+73del::,KCNMA1:NM_001271518.2:intron_variant:MODIFIER:intron8/27:c.1061+71_1061+73del::,KCNMA1:NM_001271519.2:intron_variant:MODIFIER:intron9/28:c.1223+71_1223+73del::,KCNMA1:NM_001322829.2:intron_variant:MODIFIER:intron9/28:c.1223+71_1223+73del::,KCNMA1:NM_001322830.2:intron_variant:MODIFIER:intron9/30:c.1223+71_1223+73del::,KCNMA1:NM_001322832.2:intron_variant:MODIFIER:intron9/27:c.1223+71_1223+73del::,KCNMA1:NM_001322835.2:intron_variant:MODIFIER:intron9/29:c.1223+71_1223+73del::,KCNMA1:NM_001322836.2:intron_variant:MODIFIER:intron9/27:c.1223+71_1223+73del::,KCNMA1:NM_001322837.2:intron_variant:MODIFIER:intron9/28:c.1223+71_1223+73del::,KCNMA1:NM_001322838.1:intron_variant:MODIFIER:intron10/29:c.683+71_683+73del::,KCNMA1:NM_002247.4:intron_variant:MODIFIER:intron9/26:c.1223+71_1223+73del::	regulatory_region_variant:enhancer	600150 [GENE=KCNMA1 PHENOS=Liang-Wang syndrome,618729,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,16,618596,Autosomal dominant/Cerebellar atrophy,developmental delay,and seizures,617643,Autosomal recessive/Paroxysmal nonkinesigenic dyskinesia,3,with or without generalized epilepsy,609446,Autosomal dominant];			A-rich (Low_complexity)	rs35119991		0.8505	10027,.		4.6620				17.59					-0.0574	0.1672	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNMA1 (inh=AR+AD oe_syn=1.18 oe_mis=0.46 oe_lof=0.16)	0.4086	93	38	0.0966
chr10	78944590	78944590	G	A	het		QUAL=49;DP=99;AF=0.16;MQM=60	KCNMA1	synonymous	KCNMA1:ENST00000286627.5:synonymous_variant:LOW:exon4/27:c.687C>T:p.Phe229=:PF00520 [Ion transport protein],KCNMA1:ENST00000286628.8:synonymous_variant:LOW:exon4/28:c.687C>T:p.Phe229=:PF00520 [Ion transport protein],KCNMA1:ENST00000354353.5:synonymous_variant:LOW:exon4/29:c.687C>T:p.Phe229=:PF00520 [Ion transport protein],KCNMA1:ENST00000372440.1:synonymous_variant:LOW:exon4/28:c.687C>T:p.Phe229=:PF00520 [Ion transport protein],KCNMA1:ENST00000372443.1:synonymous_variant:LOW:exon4/29:c.687C>T:p.Phe229=:PF00520 [Ion transport protein],KCNMA1:ENST00000404771.3:synonymous_variant:LOW:exon4/30:c.687C>T:p.Phe229=:PF00520 [Ion transport protein],KCNMA1:ENST00000404857.1:synonymous_variant:LOW:exon4/28:c.687C>T:p.Phe229=:PF00520 [Ion transport protein],KCNMA1:ENST00000406533.3:synonymous_variant:LOW:exon4/29:c.687C>T:p.Phe229=:PF00520 [Ion transport protein]	KCNMA1:NM_001014797.3:synonymous_variant:LOW:exon4/29:c.687C>T:p.Phe229=:,KCNMA1:NM_001161352.2:synonymous_variant:LOW:exon4/28:c.687C>T:p.Phe229=:,KCNMA1:NM_001161353.2:synonymous_variant:LOW:exon4/28:c.687C>T:p.Phe229=:,KCNMA1:NM_001271518.2:synonymous_variant:LOW:exon3/28:c.525C>T:p.Phe175=:,KCNMA1:NM_001271519.2:synonymous_variant:LOW:exon4/29:c.687C>T:p.Phe229=:,KCNMA1:NM_001322829.2:synonymous_variant:LOW:exon4/29:c.687C>T:p.Phe229=:,KCNMA1:NM_001322830.2:synonymous_variant:LOW:exon4/31:c.687C>T:p.Phe229=:,KCNMA1:NM_001322832.2:synonymous_variant:LOW:exon4/28:c.687C>T:p.Phe229=:,KCNMA1:NM_001322835.2:synonymous_variant:LOW:exon4/30:c.687C>T:p.Phe229=:,KCNMA1:NM_001322836.2:synonymous_variant:LOW:exon4/28:c.687C>T:p.Phe229=:,KCNMA1:NM_001322837.2:synonymous_variant:LOW:exon4/29:c.687C>T:p.Phe229=:,KCNMA1:NM_001322838.1:synonymous_variant:LOW:exon5/30:c.147C>T:p.Phe49=:,KCNMA1:NM_002247.4:synonymous_variant:LOW:exon4/27:c.687C>T:p.Phe229=:		600150 [GENE=KCNMA1 PHENOS=Liang-Wang syndrome,618729,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,16,618596,Autosomal dominant/Cerebellar atrophy,developmental delay,and seizures,617643,Autosomal recessive/Paroxysmal nonkinesigenic dyskinesia,3,with or without generalized epilepsy,609446,Autosomal dominant];	129328 [benign DISEASE=Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy,not specified,not provided];			rs1131824	0.4059	0.4121	3020,.	0.6370,0.2066,0.2667,0.3591,0.3254	1.4100			0.29,0.97	12.90					-0.401	0.1037	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNMA1 (inh=AR+AD oe_syn=1.18 oe_mis=0.46 oe_lof=0.16)	0.4194	155	65	0.0535
chr11	2186335	2186335	A	G	het		QUAL=4048;DP=385;AF=0.44;MQM=60	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron10/10:c.1064+127T>C::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron12/12:c.1334+127T>C::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron13/13:c.1415+127T>C::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron13/13:c.1427+127T>C::	TH:NM_000360.4:intron_variant:MODIFIER:intron12/12:c.1334+127T>C::,TH:NM_199292.3:intron_variant:MODIFIER:intron13/13:c.1427+127T>C::,TH:NM_199293.3:intron_variant:MODIFIER:intron13/13:c.1415+127T>C::	regulatory_region_variant:CTCF_binding_site	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];		CS088007 [CLASS=DFP MUT=ALT PHEN="Hypertension association with" GENE=TH];		rs2070762	0.4235	0.4232	3050,.		-0.2170			0.02,0.10	2.76							0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					INS-IGF2 (inh=n/a oe_syn=1.14 oe_mis=1.00 oe_lof=0.40), INS (inh=AD oe_syn=1.12 oe_mis=0.68 oe_lof=0.25), TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)	0.6000	30	18	0.3616
chr11	2187071	2187071	T	C	hom		QUAL=74271;DP=2408;AF=1.00;MQM=60	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron8/10:c.835-78A>G::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron10/12:c.1105-78A>G::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron11/13:c.1186-78A>G::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron11/13:c.1198-78A>G::	TH:NM_000360.4:intron_variant:MODIFIER:intron10/12:c.1105-78A>G::,TH:NM_199292.3:intron_variant:MODIFIER:intron11/13:c.1198-78A>G::,TH:NM_199293.3:intron_variant:MODIFIER:intron11/13:c.1186-78A>G::	regulatory_region_variant:promoter_flanking_region	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs6578990	0.9117	0.9141	13346,.		-0.8480			0.00,0.08	6.36					0.0168	0.9039	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					INS-IGF2 (inh=n/a oe_syn=1.14 oe_mis=1.00 oe_lof=0.40), INS (inh=AD oe_syn=1.12 oe_mis=0.68 oe_lof=0.25), TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)	1.0000	94	94	n/a (non-het)
chr11	2187398	2187398	T	G	hom		QUAL=40102;DP=1340;AF=1.00;MQM=60	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron7/10:c.778-110A>C::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron9/12:c.1048-110A>C::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron10/13:c.1129-110A>C::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron10/13:c.1141-110A>C::	TH:NM_000360.4:intron_variant:MODIFIER:intron9/12:c.1048-110A>C::,TH:NM_199292.3:intron_variant:MODIFIER:intron10/13:c.1141-110A>C::,TH:NM_199293.3:intron_variant:MODIFIER:intron10/13:c.1129-110A>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs4072823		0.9182	13460,.		-3.9320			0.00,0.08	0.27				COSV51747924	0.0109	0.8866	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					INS-IGF2 (inh=n/a oe_syn=1.14 oe_mis=1.00 oe_lof=0.40), INS (inh=AD oe_syn=1.12 oe_mis=0.68 oe_lof=0.25), TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)	1.0000	37	37	n/a (non-het)
chr11	2187439	2187439	C	A	het		QUAL=85;DP=19;AF=0.42;MQM=60	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron7/10:c.778-151G>T::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron9/12:c.1048-151G>T::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron10/13:c.1129-151G>T::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron10/13:c.1141-151G>T::	TH:NM_000360.4:intron_variant:MODIFIER:intron9/12:c.1048-151G>T::,TH:NM_199292.3:intron_variant:MODIFIER:intron10/13:c.1141-151G>T::,TH:NM_199293.3:intron_variant:MODIFIER:intron10/13:c.1129-151G>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs4072824	0.7342	0.6518	6818,.		-1.4820			0.01,0.18	3.88					-0.091	0.8845	0.13	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					INS-IGF2 (inh=n/a oe_syn=1.14 oe_mis=1.00 oe_lof=0.40), INS (inh=AD oe_syn=1.12 oe_mis=0.68 oe_lof=0.25), TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)	0.3500	20	7	0.2632
chr11	2187455	2187455	T	G	het		QUAL=184;DP=24;AF=0.50;MQM=60	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron7/10:c.778-167A>C::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron9/12:c.1048-167A>C::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron10/13:c.1129-167A>C::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron10/13:c.1141-167A>C::	TH:NM_000360.4:intron_variant:MODIFIER:intron9/12:c.1048-167A>C::,TH:NM_199292.3:intron_variant:MODIFIER:intron10/13:c.1141-167A>C::,TH:NM_199293.3:intron_variant:MODIFIER:intron10/13:c.1129-167A>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs7479936		0.6049	6191,.		0.2950			0.01,0.12	5.38					-0.0168	0.886	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					INS (inh=AD oe_syn=1.12 oe_mis=0.68 oe_lof=0.25), TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)	0.4444	18	8	0.8145
chr11	2187477	2187477	C	T	hom		QUAL=499;DP=21;AF=1.00;MQM=60	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron7/10:c.778-189G>A::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron9/12:c.1048-189G>A::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron10/13:c.1129-189G>A::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron10/13:c.1141-189G>A::	TH:NM_000360.4:intron_variant:MODIFIER:intron9/12:c.1048-189G>A::,TH:NM_199292.3:intron_variant:MODIFIER:intron10/13:c.1141-189G>A::,TH:NM_199293.3:intron_variant:MODIFIER:intron10/13:c.1129-189G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs7483805		0.9177	13433,.		-1.4920			0.00,0.09	3.04					0.0077	0.8866	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					INS (inh=AD oe_syn=1.12 oe_mis=0.68 oe_lof=0.25), TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)	1.0000	9	9	n/a (non-het)
chr11	2187482	2187482	C	G	het		QUAL=184;DP=24;AF=0.50;MQM=60	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron7/10:c.778-194G>C::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron9/12:c.1048-194G>C::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron10/13:c.1129-194G>C::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron10/13:c.1141-194G>C::	TH:NM_000360.4:intron_variant:MODIFIER:intron9/12:c.1048-194G>C::,TH:NM_199292.3:intron_variant:MODIFIER:intron10/13:c.1141-194G>C::,TH:NM_199293.3:intron_variant:MODIFIER:intron10/13:c.1129-194G>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs4072826		0.6041	6193,.		-0.9040			0.01,0.14	2.69					0.0461	0.8874	0.13	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					INS (inh=AD oe_syn=1.12 oe_mis=0.68 oe_lof=0.25), TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)	0.5000	8	4	1.0000
chr11	2187855	2187855	G	C	het		QUAL=1883;DP=188;AF=0.43;MQM=60	TH	intron,splice_region&intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron6/10:c.708-76C>G::,TH:ENST00000352909.3:splice_region_variant&intron_variant:LOW:intron8/12:c.977+8C>G::,TH:ENST00000381175.1:splice_region_variant&intron_variant:LOW:intron9/13:c.1058+8C>G::,TH:ENST00000381178.1:splice_region_variant&intron_variant:LOW:intron9/13:c.1070+8C>G::	TH:NM_000360.4:splice_region_variant&intron_variant:LOW:intron8/12:c.977+8C>G::,TH:NM_199292.3:splice_region_variant&intron_variant:LOW:intron9/13:c.1070+8C>G::,TH:NM_199293.3:splice_region_variant&intron_variant:LOW:intron9/13:c.1058+8C>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];	263250 [benign DISEASE=Autosomal recessive DOPA responsive dystonia,not specified,not provided];			rs12419447	0.1799	0.2787	1378,.	0.1327,0.2344,0.0376,0.3713,0.1664	0.1750			0.03,0.20	9.60			0.000/0.002		-0.5977	0.8931	0.08	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)	0.4070	199	81	0.0699
chr11	2188238	2188238	C	T	het		QUAL=6657;DP=534;AF=0.52;MQM=60	TH	intron,synonymous	TH:ENST00000333684.5:intron_variant:MODIFIER:intron6/10:c.707+427G>A::,TH:ENST00000352909.3:synonymous_variant:LOW:exon7/13:c.720G>A:p.Lys240=:PF00351 [Biopterin-dependent aromatic amino acid hydroxylase],TH:ENST00000381175.1:synonymous_variant:LOW:exon8/14:c.801G>A:p.Lys267=:PF00351 [Biopterin-dependent aromatic amino acid hydroxylase],TH:ENST00000381178.1:synonymous_variant:LOW:exon8/14:c.813G>A:p.Lys271=:PF00351 [Biopterin-dependent aromatic amino acid hydroxylase]	TH:NM_000360.4:synonymous_variant:LOW:exon7/13:c.720G>A:p.Lys240=:,TH:NM_199292.3:synonymous_variant:LOW:exon8/14:c.813G>A:p.Lys271=:,TH:NM_199293.3:synonymous_variant:LOW:exon8/14:c.801G>A:p.Lys267=:	regulatory_region_variant:promoter_flanking_region	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];	263258 [benign DISEASE=Autosomal recessive DOPA responsive dystonia,not specified,not provided];			rs6357	0.1546	0.2410	1085,.	0.1235,0.1627,0.0351,0.3098,0.1399	0.9300			0.41,0.97	8.25					0.04	0.9366	0.11	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)	0.4402	234	103	0.1953
chr11	2188388	2188388	G	C	hom		QUAL=193;DP=8;AF=1.00;MQM=60	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron6/10:c.707+277C>G::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron6/12:c.696-126C>G::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron7/13:c.777-126C>G::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron7/13:c.789-126C>G::	TH:NM_000360.4:intron_variant:MODIFIER:intron6/12:c.696-126C>G::,TH:NM_199292.3:intron_variant:MODIFIER:intron7/13:c.789-126C>G::,TH:NM_199293.3:intron_variant:MODIFIER:intron7/13:c.777-126C>G::	regulatory_region_variant:promoter_flanking_region	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs7942881	0.9155	0.9177	13467,.		1.1780			0.06,0.18	7.90					-0.1162	0.7825	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)	1.0000	28	28	n/a (non-het)
chr11	2188400	2188400	C	T	hom		QUAL=189;DP=8;AF=1.00;MQM=60	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron6/10:c.707+265G>A::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron6/12:c.696-138G>A::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron7/13:c.777-138G>A::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron7/13:c.789-138G>A::	TH:NM_000360.4:intron_variant:MODIFIER:intron6/12:c.696-138G>A::,TH:NM_199292.3:intron_variant:MODIFIER:intron7/13:c.789-138G>A::,TH:NM_199293.3:intron_variant:MODIFIER:intron7/13:c.777-138G>A::		191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs7925784		0.9178	13465,.		-0.7510			0.00,0.03	2.78					0.0016	0.7866	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)	1.0000	22	22	n/a (non-het)
chr11	2188436	2188436	A	G	het		QUAL=29;DP=8;AF=0.38;MQM=60	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron6/10:c.707+229T>C::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron6/12:c.696-174T>C::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron7/13:c.777-174T>C::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron7/13:c.789-174T>C::	TH:NM_000360.4:intron_variant:MODIFIER:intron6/12:c.696-174T>C::,TH:NM_199292.3:intron_variant:MODIFIER:intron7/13:c.789-174T>C::,TH:NM_199293.3:intron_variant:MODIFIER:intron7/13:c.777-174T>C::	regulatory_region_variant:CTCF_binding_site	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs67482701	0.1627	0.2485	1151,.		-0.1350			0.01,0.09	3.87					0.0157	0.7871	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)	0.5909	22	13	0.5235
chr11	2188566	2188566	C	T	hom		QUAL=1395;DP=62;AF=1.00;MQM=60	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron6/10:c.707+99G>A::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron6/12:c.695+99G>A::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron7/13:c.776+99G>A::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron7/13:c.788+99G>A::	TH:NM_000360.4:intron_variant:MODIFIER:intron6/12:c.695+99G>A::,TH:NM_199292.3:intron_variant:MODIFIER:intron7/13:c.788+99G>A::,TH:NM_199293.3:intron_variant:MODIFIER:intron7/13:c.776+99G>A::	regulatory_region_variant:CTCF_binding_site	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs7925924	0.9155	0.9178	13470,.		0.3620			0.02,0.11	4.68					-0.1014	0.2788	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)	0.9897	97	96	n/a (non-het)
chr11	2189185	2189185	G	A	het		QUAL=17566;DP=1286;AF=0.53;MQM=60	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron4/10:c.589-22C>T::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron4/12:c.577-22C>T::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron5/13:c.658-22C>T::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron5/13:c.670-22C>T::	TH:NM_000360.4:intron_variant:MODIFIER:intron4/12:c.577-22C>T::,TH:NM_199292.3:intron_variant:MODIFIER:intron5/13:c.670-22C>T::,TH:NM_199293.3:intron_variant:MODIFIER:intron5/13:c.658-22C>T::	regulatory_region_variant:CTCF_binding_site	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];	263257 [benign DISEASE=not specified];			rs4074905	0.7057	0.7209	6518,.	0.4500,0.7767,0.9625,0.6692,0.8508	-0.0730			0.00,0.10	1.38					0.0968	0.3984	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)	0.4545	275	125	0.3052
chr11	2189954	2189954	A	G	het		QUAL=6719;DP=1412;AF=0.26;MQM=58	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron2/10:c.325-59T>C::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron2/12:c.313-59T>C::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron3/13:c.394-59T>C::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron3/13:c.406-59T>C::	TH:NM_000360.4:intron_variant:MODIFIER:intron2/12:c.313-59T>C::,TH:NM_199292.3:intron_variant:MODIFIER:intron3/13:c.406-59T>C::,TH:NM_199293.3:intron_variant:MODIFIER:intron3/13:c.394-59T>C::		191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];			GA-rich (Low_complexity)	rs1301918657		0.0113	0,.		-2.6810			0.01,0.12	2.48					0.1373	0.2329	0	0	130	0 / 1					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50), MIR4686 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	0.0000	11	0	0.0010
chr11	2189958	2189958	T	G	het		QUAL=6719;DP=1412;AF=0.26;MQM=58	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron2/10:c.325-63A>C::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron2/12:c.313-63A>C::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron3/13:c.394-63A>C::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron3/13:c.406-63A>C::	TH:NM_000360.4:intron_variant:MODIFIER:intron2/12:c.313-63A>C::,TH:NM_199292.3:intron_variant:MODIFIER:intron3/13:c.406-63A>C::,TH:NM_199293.3:intron_variant:MODIFIER:intron3/13:c.394-63A>C::		191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs1024599262		0.0377	0,.		-2.5170			0.00,0.08	0.20					-0.057	0.2363	0	0	135	0 / 1					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50), MIR4686 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	0.0000	6	0	0.0313
chr11	2189963	2189963	T	G	het	low_conf_region	QUAL=1543;DP=1677;AF=0.25;MQM=58	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron2/10:c.325-68A>C::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron2/12:c.313-68A>C::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron3/13:c.394-68A>C::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron3/13:c.406-68A>C::	TH:NM_000360.4:intron_variant:MODIFIER:intron2/12:c.313-68A>C::,TH:NM_199292.3:intron_variant:MODIFIER:intron3/13:c.406-68A>C::,TH:NM_199293.3:intron_variant:MODIFIER:intron3/13:c.394-68A>C::		191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs951146589		0.0478	0,.		-2.4900			0.00,0.05	3.75				COSV60766630	-0.0266	0.2246	0	1	55	0 / 1					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50), MIR4686 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	0.0000	2	0	0.5000
chr11	2189967	2189967	C	G	het		QUAL=1543;DP=1677;AF=0.25;MQM=58	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron2/10:c.325-72G>C::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron2/12:c.313-72G>C::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron3/13:c.394-72G>C::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron3/13:c.406-72G>C::	TH:NM_000360.4:intron_variant:MODIFIER:intron2/12:c.313-72G>C::,TH:NM_199292.3:intron_variant:MODIFIER:intron3/13:c.406-72G>C::,TH:NM_199293.3:intron_variant:MODIFIER:intron3/13:c.394-72G>C::		191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs1418833032		0.0354	0,.		-1.3300			0.00,0.08	0.73					0.0024	0.2138	0	1	52	0 / 1					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50), MIR4686 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	0.0000	1	0	1.0000
chr11	2189983	2189983	C	T	het		QUAL=23493;DP=1813;AF=0.52;MQM=59	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron2/10:c.325-88G>A::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron2/12:c.313-88G>A::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron3/13:c.394-88G>A::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron3/13:c.406-88G>A::	TH:NM_000360.4:intron_variant:MODIFIER:intron2/12:c.313-88G>A::,TH:NM_199292.3:intron_variant:MODIFIER:intron3/13:c.406-88G>A::,TH:NM_199293.3:intron_variant:MODIFIER:intron3/13:c.394-88G>A::		191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs4930043	0.1430	0.2287	1005,.		0.9010			0.11,0.22	6.81					0.0741	0.1887	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50), MIR4686 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	0.5484	31	17	0.7201
chr11	2190951	2190951	C	T	het		QUAL=9633;DP=747;AF=0.50;MQM=60	TH	missense	TH:ENST00000333684.5:missense_variant:MODERATE:exon2/11:c.253G>A:p.Val85Met:,TH:ENST00000352909.3:missense_variant:MODERATE:exon2/13:c.241G>A:p.Val81Met:,TH:ENST00000381175.1:missense_variant:MODERATE:exon3/14:c.322G>A:p.Val108Met:,TH:ENST00000381178.1:missense_variant:MODERATE:exon3/14:c.334G>A:p.Val112Met:	TH:NM_000360.4:missense_variant:MODERATE:exon2/13:c.241G>A:p.Val81Met:,TH:NM_199292.3:missense_variant:MODERATE:exon3/14:c.334G>A:p.Val112Met:,TH:NM_199293.3:missense_variant:MODERATE:exon3/14:c.322G>A:p.Val108Met:	regulatory_region_variant:CTCF_binding_site	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];	21866 [benign DISEASE=Autosomal recessive DOPA responsive dystonia,not specified,not provided];			rs6356	0.4305	0.4286	2153,.	0.1322,0.4351,0.7989,0.3724,0.5581	-0.3270	T(0.26),T(0.22),T(0.25),T(0.23)	B(0.01),B(0.02),B(0.03),B(0.01)	0.08,0.19	12.34	0.18				-0.1052	0.3093	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahharmf1 07.05.2020; gnomAD: >10%"			TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50), MIR4686 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	0.4636	371	172	0.6024
chr11	2191155	2191155	T	C	hom		QUAL=12422;DP=471;AF=1.00;MQM=60	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron1/10:c.103-54A>G::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron1/12:c.91-54A>G::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron2/13:c.172-54A>G::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron2/13:c.184-54A>G::	TH:NM_000360.4:intron_variant:MODIFIER:intron1/12:c.91-54A>G::,TH:NM_199292.3:intron_variant:MODIFIER:intron2/13:c.184-54A>G::,TH:NM_199293.3:intron_variant:MODIFIER:intron2/13:c.172-54A>G::		191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs7925375		0.7035	7931,.		0.4370			0.00,0.06	5.48					-0.0482	0.2493	0.28	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50), MIR4686 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	1.0000	90	90	n/a (non-het)
chr11	6411935	6411935	T	C	het	low_conf_region	QUAL=30722;DP=1121;AF=0.43;MQM=60	SMPD1	missense	SMPD1:ENST00000299397.3:missense_variant:MODERATE:exon1/5:c.107T>C:p.Val36Ala:,SMPD1:ENST00000342245.4:missense_variant:MODERATE:exon1/6:c.107T>C:p.Val36Ala:,SMPD1:ENST00000356761.2:missense_variant:MODERATE:exon1/6:c.107T>C:p.Val36Ala:,SMPD1:ENST00000527275.1:missense_variant:MODERATE:exon1/6:c.107T>C:p.Val36Ala:	SMPD1:NM_000543.5:missense_variant:MODERATE:exon1/6:c.107T>C:p.Val36Ala:,SMPD1:NM_001007593.3:missense_variant:MODERATE:exon1/6:c.107T>C:p.Val36Ala:,SMPD1:NM_001318087.2:missense_variant:MODERATE:exon1/6:c.107T>C:p.Val36Ala:,SMPD1:NM_001318088.2:5_prime_UTR_variant:MODIFIER:exon1/6:c.-855T>C::,SMPD1:NM_001365135.2:missense_variant:MODERATE:exon1/5:c.107T>C:p.Val36Ala:,SMPD1:NR_027400.3:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.232T>C::,SMPD1:NR_134502.2:non_coding_transcript_exon_variant:MODIFIER:exon1/6:n.232T>C::	regulatory_region_variant:promoter	607608 [GENE=SMPD1 PHENOS=Niemann-Pick disease,type A,257200,Autosomal recessive/Niemann-Pick disease,type B,607616,Autosomal recessive];	93311 [benign DISEASE=Niemann-Pick disease, type A,not specified,not provided];	CM154141 [CLASS=R MUT=ALT PHEN="Niemann-Pick disease" GENE=SMPD1];	(CTGGCG)n (Simple_repeat)	rs1050228	0.5613	0.5538	3490,.	0.2162,0.7293,0.7682,0.5073,0.5655	0.5010	T(0.48),T(0.56),T(0.42),T(0.56)	B(0.00),B(0.00),B(0.00),B(0.00)	0.05,0.10	4.88	0.03				-0.0901	0.8187	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMPD1 (inh=AR oe_syn=1.10 oe_mis=1.01 oe_lof=0.73), APBB1 (inh=n/a oe_syn=0.99 oe_mis=0.79 oe_lof=0.15)	0.4514	350	158	0.3912
chr11	6411936	6411941	GCTGGC	-	het	low_conf_region	QUAL=30722;DP=1121;AF=0.43;MQM=60	SMPD1	inframe_deletion	SMPD1:ENST00000299397.3:inframe_deletion:MODERATE:exon1/5:c.138_143del:p.Ala48_Leu49del:,SMPD1:ENST00000342245.4:inframe_deletion:MODERATE:exon1/6:c.138_143del:p.Ala48_Leu49del:,SMPD1:ENST00000356761.2:inframe_deletion:MODERATE:exon1/6:c.138_143del:p.Ala48_Leu49del:,SMPD1:ENST00000527275.1:inframe_deletion:MODERATE:exon1/6:c.138_143del:p.Ala48_Leu49del:	SMPD1:NM_000543.5:inframe_deletion:MODERATE:exon1/6:c.138_143del:p.Ala48_Leu49del:,SMPD1:NM_001007593.3:inframe_deletion:MODERATE:exon1/6:c.138_143del:p.Ala48_Leu49del:,SMPD1:NM_001318087.2:inframe_deletion:MODERATE:exon1/6:c.138_143del:p.Ala48_Leu49del:,SMPD1:NM_001318088.2:5_prime_UTR_variant:MODIFIER:exon1/6:c.-824_-819del::,SMPD1:NM_001365135.2:inframe_deletion:MODERATE:exon1/5:c.138_143del:p.Ala48_Leu49del:,SMPD1:NR_027400.3:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.263_268del::,SMPD1:NR_134502.2:non_coding_transcript_exon_variant:MODIFIER:exon1/6:n.263_268del::	regulatory_region_variant:promoter	607608 [GENE=SMPD1 PHENOS=Niemann-Pick disease,type A,257200,Autosomal recessive/Niemann-Pick disease,type B,607616,Autosomal recessive];	256592 [benign DISEASE=not specified,not provided];	CD1914060 [CLASS=DM MUT=ALT PHEN="Niemann-Pick disease type B" GENE=SMPD1];	(CTGGCG)n (Simple_repeat)	rs3838786		0.2909	2050,.	0.3507,0.1545,0.1048,0.3105,0.2523	0.8620				14.85					0.0361	0.8168	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMPD1 (inh=AR oe_syn=1.10 oe_mis=1.01 oe_lof=0.73), APBB1 (inh=n/a oe_syn=0.99 oe_mis=0.79 oe_lof=0.15)	0.5752	226	130	0.1319
chr11	6413366	6413366	C	T	het		QUAL=15227;DP=1063;AF=0.52;MQM=60	SMPD1	synonymous	SMPD1:ENST00000299397.3:synonymous_variant:LOW:exon2/5:c.1071C>T:p.Ala357=:PF00149 [Calcineurin-like phosphoesterase],SMPD1:ENST00000342245.4:synonymous_variant:LOW:exon2/6:c.1071C>T:p.Ala357=:PF00149 [Calcineurin-like phosphoesterase],SMPD1:ENST00000356761.2:synonymous_variant:LOW:exon2/6:c.1071C>T:p.Ala357=:PF00149 [Calcineurin-like phosphoesterase],SMPD1:ENST00000527275.1:synonymous_variant:LOW:exon2/6:c.1068C>T:p.Ala356=:PF00149 [Calcineurin-like phosphoesterase]	SMPD1:NM_000543.5:synonymous_variant:LOW:exon2/6:c.1071C>T:p.Ala357=:,SMPD1:NM_001007593.3:synonymous_variant:LOW:exon2/6:c.1068C>T:p.Ala356=:,SMPD1:NM_001318087.2:synonymous_variant:LOW:exon2/6:c.1071C>T:p.Ala357=:,SMPD1:NM_001318088.2:missense_variant:MODERATE:exon2/6:c.110C>T:p.Pro37Leu:,SMPD1:NM_001365135.2:synonymous_variant:LOW:exon2/5:c.1071C>T:p.Ala357=:,SMPD1:NR_027400.3:non_coding_transcript_exon_variant:MODIFIER:exon2/5:n.1196C>T::,SMPD1:NR_134502.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/5:n.563+633C>T::		607608 [GENE=SMPD1 PHENOS=Niemann-Pick disease,type A,257200,Autosomal recessive/Niemann-Pick disease,type B,607616,Autosomal recessive];	93310 [benign/likely benign DISEASE=Sphingomyelin/cholesterol lipidosis,Niemann-Pick disease, type A,Niemann-Pick disease, type B,not specified,not provided];			rs72896268	0.0034	0.0051	1,.	0.0015,0.0037,0.0000,0.0081,0.0022	-0.3040			0.01,0.16	9.66					0.0885	0.7842	0	2	368	0 / 31					SMPD1 (inh=AR oe_syn=1.10 oe_mis=1.01 oe_lof=0.73), APBB1 (inh=n/a oe_syn=0.99 oe_mis=0.79 oe_lof=0.15)	0.4398	166	73	0.1214
chr11	6415064	6415064	A	G	het	off-target	QUAL=1526;DP=127;AF=0.50;MQM=60	SMPD1	intron	SMPD1:ENST00000299397.3:intron_variant:MODIFIER:intron3/4:c.1209-62A>G::,SMPD1:ENST00000342245.4:intron_variant:MODIFIER:intron4/5:c.1341-62A>G::,SMPD1:ENST00000356761.2:intron_variant:MODIFIER:intron4/5:c.1173-62A>G::,SMPD1:ENST00000527275.1:intron_variant:MODIFIER:intron4/5:c.1338-62A>G::	SMPD1:NM_000543.5:intron_variant:MODIFIER:intron4/5:c.1341-62A>G::,SMPD1:NM_001007593.3:intron_variant:MODIFIER:intron4/5:c.1338-62A>G::,SMPD1:NM_001318087.2:intron_variant:MODIFIER:intron4/5:c.1341-62A>G::,SMPD1:NM_001318088.2:intron_variant:MODIFIER:intron4/5:c.420-62A>G::,SMPD1:NM_001365135.2:intron_variant:MODIFIER:intron3/4:c.1209-62A>G::,SMPD1:NR_027400.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.1294-62A>G::,SMPD1:NR_134502.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.813-62A>G::		607608 [GENE=SMPD1 PHENOS=Niemann-Pick disease,type A,257200,Autosomal recessive/Niemann-Pick disease,type B,607616,Autosomal recessive];				rs72896272	0.0026	0.0029	0,.		-2.3580			0.01,0.09	0.52					-0.0097	0.9636	0.05	1	219	0 / 21					SMPD1 (inh=AR oe_syn=1.10 oe_mis=1.01 oe_lof=0.73), APBB1 (inh=n/a oe_syn=0.99 oe_mis=0.79 oe_lof=0.15)	0.4265	68	29	0.2284
chr11	13102890	13102890	C	A	het	off-target	QUAL=69;DP=19;AF=0.32;MQM=60	CTC-497E21.5	intron&non_coding_transcript	CTC-497E21.5:ENST00000531136.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.48-26309G>T::	::intergenic_variant:MODIFIER::::						rs2727397	0.5050	0.5693	5247,.		0.0460			0.06,0.20	5.99								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)						0.0000	2	0	0.5000
chr11	13102924	13102924	G	A	het		QUAL=62;DP=20;AF=0.30;MQM=60	CTC-497E21.5	intron&non_coding_transcript	CTC-497E21.5:ENST00000531136.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.48-26343C>T::	::intergenic_variant:MODIFIER::::						rs2583136		0.5695	5253,.		-0.4930			0.00,0.07	2.76								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)						n/a (no coverage)	0	n/a (no coverage)	n/a (no coverage)
chr11	26353991	26353991	-	A	het	low_conf_region	QUAL=3241;DP=323;AF=0.53;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron1/26:c.46+139dup::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron1/26:c.-3+22741dup::,ANO3:ENST00000531646.1:intron_variant:MODIFIER:intron1/4:c.46+139dup::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron2/27:c.-3+22741dup::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron2/27:c.229+22741dup::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron1/26:c.46+139dup::	regulatory_region_variant:promoter	610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs56225203		0.3968	2039,.						14.88							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	0.5652	23	13	0.6776
chr11	26465232	26465235	TGTC	-	het		QUAL=822;DP=171;AF=0.36;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron2/26:c.242-80_242-77del::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron2/26:c.194-80_194-77del::,ANO3:ENST00000531646.1:intron_variant:MODIFIER:intron2/4:c.242-80_242-77del::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron3/27:c.194-80_194-77del::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron3/27:c.425-80_425-77del::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron2/26:c.242-80_242-77del::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs138185345	0.0307	0.0420	44,.		0.2510				1.02					0.0056	0.2349	0	1	13	1 / 2					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	0.4857	35	17	1.0000
chr11	26465500	26465500	G	A	hom		QUAL=5353;DP=180;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron3/26:c.313+117G>A::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron3/26:c.265+117G>A::,ANO3:ENST00000531646.1:intron_variant:MODIFIER:intron3/4:c.313+117G>A::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron4/27:c.265+117G>A::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron4/27:c.496+117G>A::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron3/26:c.313+117G>A::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs4032918	0.6354	0.6701	7395,.		0.0680			0.06,0.28	2.96							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	1.0000	37	37	n/a (non-het)
chr11	26481611	26481611	G	A	hom		QUAL=3075;DP=92;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron3/26:c.314-2966G>A::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron3/26:c.266-2966G>A::,ANO3:ENST00000531646.1:intron_variant:MODIFIER:intron3/4:c.314-2966G>A::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron4/27:c.266-2966G>A::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron4/27:c.497-2966G>A::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron3/26:c.314-2966G>A::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];			MSTB (LTR/ERVL-MaLR)	rs2047099		0.9675	13976,.	0.8699,0.9807,0.9981,0.9642,0.9830	-0.2110			0.00,0.04	2.92							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	n/a (no coverage)	0	n/a (no coverage)	n/a (no coverage)
chr11	26547348	26547348	G	A	hom		QUAL=182;DP=6;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron7/26:c.737+122G>A::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron7/26:c.689+122G>A::,ANO3:ENST00000531568.1:intron_variant:MODIFIER:intron4/23:c.299+122G>A::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron8/27:c.689+122G>A::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron8/27:c.920+122G>A::,ANO3:NM_001313727.1:intron_variant:MODIFIER:intron4/23:c.299+122G>A::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron7/26:c.737+122G>A::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs430563		0.7609	9003,.		-0.2650			0.01,0.14	0.65							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	1.0000	40	40	n/a (non-het)
chr11	26547353	26547353	T	G	hom		QUAL=179;DP=6;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron7/26:c.737+127T>G::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron7/26:c.689+127T>G::,ANO3:ENST00000531568.1:intron_variant:MODIFIER:intron4/23:c.299+127T>G::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron8/27:c.689+127T>G::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron8/27:c.920+127T>G::,ANO3:NM_001313727.1:intron_variant:MODIFIER:intron4/23:c.299+127T>G::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron7/26:c.737+127T>G::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs410617	0.7770	0.7847	9601,.		-1.6280			0.00,0.09	1.65							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	1.0000	37	37	n/a (non-het)
chr11	26552679	26552679	T	A	hom		QUAL=30678;DP=959;AF=0.99;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron7/26:c.738-73T>A::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron7/26:c.690-73T>A::,ANO3:ENST00000531568.1:intron_variant:MODIFIER:intron4/23:c.300-73T>A::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron8/27:c.690-73T>A::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron8/27:c.921-73T>A::,ANO3:NM_001313727.1:intron_variant:MODIFIER:intron4/23:c.300-73T>A::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron7/26:c.738-73T>A::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs9988806	0.5767	0.5571	5050,.		-2.1680			0.00,0.11	2.13					-0.0352	0.1937	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	1.0000	38	38	n/a (non-het)
chr11	26552696	26552696	T	A	hom		QUAL=35466;DP=1072;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron7/26:c.738-56T>A::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron7/26:c.690-56T>A::,ANO3:ENST00000531568.1:intron_variant:MODIFIER:intron4/23:c.300-56T>A::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron8/27:c.690-56T>A::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron8/27:c.921-56T>A::,ANO3:NM_001313727.1:intron_variant:MODIFIER:intron4/23:c.300-56T>A::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron7/26:c.738-56T>A::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs2131696	0.5767	0.5569	5054,.		-0.4510			0.05,0.19	2.61					-0.0105	0.1855	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	1.0000	55	55	n/a (non-het)
chr11	26552702	26552702	T	C	hom		QUAL=35013;DP=1062;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron7/26:c.738-50T>C::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron7/26:c.690-50T>C::,ANO3:ENST00000531568.1:intron_variant:MODIFIER:intron4/23:c.300-50T>C::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron8/27:c.690-50T>C::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron8/27:c.921-50T>C::,ANO3:NM_001313727.1:intron_variant:MODIFIER:intron4/23:c.300-50T>C::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron7/26:c.738-50T>C::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs293937	0.9896	0.9969	15316,.	0.9596,0.9977,0.9999,0.9999,0.9998	-0.2190			0.05,0.15	0.84					0.0746	0.0669	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	1.0000	63	63	n/a (non-het)
chr11	26558841	26558841	G	A	hom		QUAL=394;DP=13;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron9/26:c.977-112G>A::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron9/26:c.929-112G>A::,ANO3:ENST00000531568.1:intron_variant:MODIFIER:intron6/23:c.539-112G>A::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron10/27:c.929-112G>A::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron10/27:c.1160-112G>A::,ANO3:NM_001313727.1:intron_variant:MODIFIER:intron6/23:c.539-112G>A::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron9/26:c.977-112G>A::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs386635		0.7134	8013,.		-0.1510			0.01,0.13	1.47							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	1.0000	32	32	n/a (non-het)
chr11	26563464	26563464	A	T	hom		QUAL=3253;DP=113;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron10/26:c.1033-30A>T::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron10/26:c.985-30A>T::,ANO3:ENST00000531568.1:intron_variant:MODIFIER:intron7/23:c.595-30A>T::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron11/27:c.985-30A>T::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron11/27:c.1216-30A>T::,ANO3:NM_001313727.1:intron_variant:MODIFIER:intron7/23:c.595-30A>T::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron10/26:c.1033-30A>T::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs410036	0.7117	0.7503	8027,.	0.6232,0.8502,0.8273,0.7310,0.7189	0.0730			0.00,0.12	1.74					-0.1286	0.2146	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	1.0000	99	99	n/a (non-het)
chr11	26563652	26563652	T	G	hom		QUAL=4979;DP=153;AF=0.99;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron11/26:c.1154+37T>G::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron11/26:c.1106+37T>G::,ANO3:ENST00000531568.1:intron_variant:MODIFIER:intron8/23:c.716+37T>G::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron12/27:c.1106+37T>G::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron12/27:c.1337+37T>G::,ANO3:NM_001313727.1:intron_variant:MODIFIER:intron8/23:c.716+37T>G::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron11/26:c.1154+37T>G::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs420143	0.7117	0.7523	8032,.	0.6237,0.8532,0.8282,0.7323,0.7190	-0.4760			0.01,0.15	4.33					-0.1213	0.3797	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	1.0000	65	65	n/a (non-het)
chr11	26568966	26568966	A	G	hom		QUAL=23504;DP=710;AF=1.00;MQM=60	ANO3	synonymous	ANO3:ENST00000256737.3:synonymous_variant:LOW:exon12/27:c.1158A>G:p.Leu386=:PF04547 [Calcium-activated chloride channel],ANO3:ENST00000525139.1:synonymous_variant:LOW:exon12/27:c.1110A>G:p.Leu370=:PF04547 [Calcium-activated chloride channel],ANO3:ENST00000531568.1:synonymous_variant:LOW:exon9/24:c.720A>G:p.Leu240=:PF04547 [Calcium-activated chloride channel],ANO3:ENST00000537978.1:synonymous_variant:LOW:exon13/28:c.1110A>G:p.Leu370=:PF04547 [Calcium-activated chloride channel]	ANO3:NM_001313726.1:synonymous_variant:LOW:exon13/28:c.1341A>G:p.Leu447=:,ANO3:NM_001313727.1:synonymous_variant:LOW:exon9/24:c.720A>G:p.Leu240=:,ANO3:NM_031418.4:synonymous_variant:LOW:exon12/27:c.1158A>G:p.Leu386=:		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs2663168	0.6751	0.6933	6916,.	0.5804,0.7140,0.8174,0.6764,0.6992	-1.2850			0.08,0.91	5.41					0.1517	0.3528	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	1.0000	154	154	n/a (non-het)
chr11	26569240	26569240	G	-	het		QUAL=1206;DP=56;AF=0.46;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron12/26:c.1289+143del::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron12/26:c.1241+143del::,ANO3:ENST00000531568.1:intron_variant:MODIFIER:intron9/23:c.851+143del::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron13/27:c.1241+143del::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron13/27:c.1472+143del::,ANO3:NM_001313727.1:intron_variant:MODIFIER:intron9/23:c.851+143del::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron12/26:c.1289+143del::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];			(TTTTTTG)n (Simple_repeat)	rs142099565	0.4774	0.4747	3573,.		-3.5130				1.13				COSV56809389			0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	0.4286	14	6	0.7905
chr11	26569240	26569240	G	T	het		QUAL=1206;DP=56;AF=0.46;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron12/26:c.1289+143G>T::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron12/26:c.1241+143G>T::,ANO3:ENST00000531568.1:intron_variant:MODIFIER:intron9/23:c.851+143G>T::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron13/27:c.1241+143G>T::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron13/27:c.1472+143G>T::,ANO3:NM_001313727.1:intron_variant:MODIFIER:intron9/23:c.851+143G>T::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron12/26:c.1289+143G>T::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];			(TTTTTTG)n (Simple_repeat)	rs2703409	0.4894	0.1848	548,.		-3.5130			0.00,0.09	3.13				COSV56809389			0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	0.5714	14	8	0.7905
chr11	26574630	26574630	A	G	hom		QUAL=1931;DP=81;AF=1.00;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron12/26:c.1290-166A>G::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron12/26:c.1242-166A>G::,ANO3:ENST00000531568.1:intron_variant:MODIFIER:intron9/23:c.852-166A>G::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron13/27:c.1242-166A>G::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron13/27:c.1473-166A>G::,ANO3:NM_001313727.1:intron_variant:MODIFIER:intron9/23:c.852-166A>G::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron12/26:c.1290-166A>G::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs380170	0.9401	0.9262	13456,.		-0.9960			0.00,0.05	4.56							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	1.0000	15	15	n/a (non-het)
chr11	26574740	26574740	T	C	hom		QUAL=22991;DP=821;AF=0.99;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron12/26:c.1290-56T>C::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron12/26:c.1242-56T>C::,ANO3:ENST00000531568.1:intron_variant:MODIFIER:intron9/23:c.852-56T>C::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron13/27:c.1242-56T>C::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron13/27:c.1473-56T>C::,ANO3:NM_001313727.1:intron_variant:MODIFIER:intron9/23:c.852-56T>C::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron12/26:c.1290-56T>C::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs395770	0.6765	0.6638	6864,.		-0.4220			0.00,0.05	7.97					-0.0173	0.072	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	1.0000	67	67	n/a (non-het)
chr11	26574783	26574783	G	-	hom	low_conf_region	QUAL=20700;DP=727;AF=0.90;MQM=60	ANO3	intron	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron12/26:c.1290-13del::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron12/26:c.1242-13del::,ANO3:ENST00000531568.1:intron_variant:MODIFIER:intron9/23:c.852-13del::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron13/27:c.1242-13del::	ANO3:NM_001313726.1:intron_variant:MODIFIER:intron13/27:c.1473-13del::,ANO3:NM_001313727.1:intron_variant:MODIFIER:intron9/23:c.852-13del::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron12/26:c.1290-13del::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];			(TGTTT)n (Simple_repeat)	rs59938249	0.9365	0.6862	6529,.	0.5202,0.5663,0.6125,0.5820,0.5990	0.0640				3.39					-0.356	0.1551	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58)	0.7049	122	86	n/a (non-het)
chr11	26581383	26581390	ACACACAC	-	het	low_conf_region	QUAL=281;DP=29;AF=0.21;MQM=60	ANO3,MUC15	intron,3'UTR	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron14/26:c.1447+89_1447+96del::,MUC15:ENST00000281268.8:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1222_*1229del::,MUC15:ENST00000436318.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1222_*1229del::,MUC15:ENST00000455601.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1222_*1229del::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron14/26:c.1399+89_1399+96del::,ANO3:ENST00000531568.1:intron_variant:MODIFIER:intron11/23:c.1009+89_1009+96del::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron15/27:c.1399+89_1399+96del::	MUC15:NM_001135091.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1222_*1229del::,MUC15:NM_001135092.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1222_*1229del::,ANO3:NM_001313726.1:intron_variant:MODIFIER:intron15/27:c.1630+89_1630+96del::,ANO3:NM_001313727.1:intron_variant:MODIFIER:intron11/23:c.1009+89_1009+96del::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron14/26:c.1447+89_1447+96del::,MUC15:NM_145650.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1222_*1229del::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];			(AC)n (Simple_repeat)	rs71047866		0.1236	215,.		0.3390				1.06					-0.0895	0.9653	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58), MUC15 (inh=n/a oe_syn=0.87 oe_mis=1.11 oe_lof=0.70)	0.3095	84	26	0.0006
chr11	26581383	26581392	ACACACACAC	-	het	low_conf_region	QUAL=281;DP=29;AF=0.21;MQM=60	ANO3,MUC15	intron,3'UTR	ANO3:ENST00000256737.3:intron_variant:MODIFIER:intron14/26:c.1447+87_1447+96del::,MUC15:ENST00000281268.8:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1220_*1229del::,MUC15:ENST00000436318.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1220_*1229del::,MUC15:ENST00000455601.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1220_*1229del::,ANO3:ENST00000525139.1:intron_variant:MODIFIER:intron14/26:c.1399+87_1399+96del::,ANO3:ENST00000531568.1:intron_variant:MODIFIER:intron11/23:c.1009+87_1009+96del::,ANO3:ENST00000537978.1:intron_variant:MODIFIER:intron15/27:c.1399+87_1399+96del::	MUC15:NM_001135091.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1220_*1229del::,MUC15:NM_001135092.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1220_*1229del::,ANO3:NM_001313726.1:intron_variant:MODIFIER:intron15/27:c.1630+87_1630+96del::,ANO3:NM_001313727.1:intron_variant:MODIFIER:intron11/23:c.1009+87_1009+96del::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron14/26:c.1447+87_1447+96del::,MUC15:NM_145650.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1220_*1229del::		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];			(AC)n (Simple_repeat)	rs71047866					0.3390				1.23					-0.0585	0.9653	0	11	84	2 / 9					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58), MUC15 (inh=n/a oe_syn=0.87 oe_mis=1.11 oe_lof=0.70)	0.2143	84	18	0.0000
chr11	108115361	108115361	T	-	hom		QUAL=2235;DP=108;AF=0.92;MQM=60	ATM	intron	ATM:ENST00000278616.4:intron_variant:MODIFIER:intron6/62:c.663-144del::,ATM:ENST00000452508.2:intron_variant:MODIFIER:intron7/63:c.663-144del::	ATM:NM_000051.3:intron_variant:MODIFIER:intron6/62:c.663-144del::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron7/63:c.663-144del::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];				rs11298747		0.9759	14398,.		-0.8400				1.34							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	2	"[2] auto-classification 12.11.2017%0A%0A"			ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)	0.8333	12	10	n/a (non-het)
chr11	108121411	108121411	T	-	het	low_conf_region	QUAL=17;DP=115;AF=0.14;MQM=60	ATM	intron	ATM:ENST00000278616.4:intron_variant:MODIFIER:intron9/62:c.1236-3del::,ATM:ENST00000452508.2:intron_variant:MODIFIER:intron10/63:c.1236-3del::	ATM:NM_000051.3:intron_variant:MODIFIER:intron9/62:c.1236-3del::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron10/63:c.1236-3del::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];	183771 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome];			rs34325032		0.1362	0,.	0.1691,0.1289,0.1796,0.1308,0.1343	-0.6140				0.06					-0.1684	0.09	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)	0.1020	98	10	0.0000
chr11	108129657	108129657	A	G	het		QUAL=315;DP=38;AF=0.45;MQM=60	ATM	intron	ATM:ENST00000278616.4:intron_variant:MODIFIER:intron15/62:c.2377-56A>G::,ATM:ENST00000452508.2:intron_variant:MODIFIER:intron16/63:c.2377-56A>G::	ATM:NM_000051.3:intron_variant:MODIFIER:intron15/62:c.2377-56A>G::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron16/63:c.2377-56A>G::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];				rs672655	0.4764	0.4879	3966,.		1.4540			0.42,0.91	17.36					0.007	0.2641	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)	0.5714	70	40	0.2820
chr11	108137775	108137775	T	A	het		QUAL=94;DP=11;AF=0.55;MQM=60	ATM	intron	ATM:ENST00000278616.4:intron_variant:MODIFIER:intron16/62:c.2467-123T>A::,ATM:ENST00000452508.2:intron_variant:MODIFIER:intron17/63:c.2467-123T>A::	ATM:NM_000051.3:intron_variant:MODIFIER:intron16/62:c.2467-123T>A::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron17/63:c.2467-123T>A::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];			AluSx1 (SINE/Alu)	rs642496		0.6503	6798,.		-1.6900			0.00,0.02	0.02							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)	0.4828	29	14	1.0000
chr11	108143182	108143182	C	T	het		QUAL=969;DP=100;AF=0.46;MQM=60	ATM	intron	ATM:ENST00000278616.4:intron_variant:MODIFIER:intron20/62:c.3078-77C>T::,ATM:ENST00000452508.2:intron_variant:MODIFIER:intron21/63:c.3078-77C>T::	ATM:NM_000051.3:intron_variant:MODIFIER:intron20/62:c.3078-77C>T::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron21/63:c.3078-77C>T::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];	439418 [benign DISEASE=Ataxia-telangiectasia syndrome];			rs664677		0.6332	6416,.		-0.1890			0.00,0.09	3.72					-0.0261	0.1958	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)	0.5417	72	39	0.5560
chr11	108150208	108150208	T	-	het		QUAL=441;DP=53;AF=0.40;MQM=60	ATM	intron	ATM:ENST00000278616.4:intron_variant:MODIFIER:intron22/62:c.3285-9del::,ATM:ENST00000452508.2:intron_variant:MODIFIER:intron23/63:c.3285-9del::	ATM:NM_000051.3:intron_variant:MODIFIER:intron22/62:c.3285-9del::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron23/63:c.3285-9del::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];	181857 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified];		(TTTG)n (Simple_repeat)	rs1799757		0.1130	283,.	0.0227,0.0614,0.0063,0.1426,0.0768	0.5990				6.99					-0.2079	0.4247	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)	0.4936	156	77	0.9362
chr11	108151707	108151707	-	A	het	low_conf_region	QUAL=3769;DP=317;AF=0.48;MQM=60	ATM	intron	ATM:ENST00000278616.4:intron_variant:MODIFIER:intron23/62:c.3403-13dup::,ATM:ENST00000452508.2:intron_variant:MODIFIER:intron24/63:c.3403-13dup::	ATM:NM_000051.3:intron_variant:MODIFIER:intron23/62:c.3403-13dup::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron24/63:c.3403-13dup::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];	181858 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified];			rs3218681		0.5603	4494,.	0.4510,0.6113,0.3791,0.5616,0.6142					0.84					-0.2853	0.3592	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)	0.3913	92	36	0.0470
chr11	108155397	108155397	G	A	het		QUAL=106;DP=24;AF=0.33;MQM=60	ATM	intron	ATM:ENST00000278616.4:intron_variant:MODIFIER:intron26/62:c.3993+197G>A::,ATM:ENST00000452508.2:intron_variant:MODIFIER:intron27/63:c.3993+197G>A::	ATM:NM_000051.3:intron_variant:MODIFIER:intron26/62:c.3993+197G>A::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron27/63:c.3993+197G>A::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];				rs654005	0.5276	0.5286	4415,.		-0.2570			0.00,0.09	1.59							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)	0.3333	9	3	0.5078
chr11	108170271	108170271	G	A	het		QUAL=667;DP=93;AF=0.45;MQM=60	ATM	intron	ATM:ENST00000278616.4:intron_variant:MODIFIER:intron33/62:c.5006-170G>A::,ATM:ENST00000452508.2:intron_variant:MODIFIER:intron34/63:c.5006-170G>A::	ATM:NM_000051.3:intron_variant:MODIFIER:intron33/62:c.5006-170G>A::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron34/63:c.5006-170G>A::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];			AluSx (SINE/Alu)	rs1150203	0.4782	0.4948	4012,.		-1.5610			0.00,0.03	0.01					-0.0233	0.1925	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)	0.2667	15	4	0.1185
chr11	108175394	108175394	T	C	het		QUAL=325;DP=34;AF=0.50;MQM=60	ATM	splice_region&intron	ATM:ENST00000278616.4:splice_region_variant&intron_variant:LOW:intron36/62:c.5497-8T>C::,ATM:ENST00000452508.2:splice_region_variant&intron_variant:LOW:intron37/63:c.5497-8T>C::	ATM:NM_000051.3:splice_region_variant&intron_variant:LOW:intron36/62:c.5497-8T>C::,ATM:NM_001351834.2:splice_region_variant&intron_variant:LOW:intron37/63:c.5497-8T>C::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];	132706 [benign/likely benign DISEASE=Triple-negative breast carcinoma,Malignant tumor of breast,Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified,none provided];			rs3092829	0.0132	0.0225	7,.	0.0057,0.0186,0.0003,0.0333,0.0061	1.1230			0.19,0.32	5.92		10.05>8.69	0.000/0.004		-0.2961	0.5689	0	41	1626	9 / 348	1	"[1] Ilnaz Sepahi 29-03-2016 batch import"			ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)	0.4857	105	51	0.8454
chr11	108175462	108175462	G	A	het		QUAL=1106;DP=88;AF=0.51;MQM=60	ATM	missense	ATM:ENST00000278616.4:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn:,ATM:ENST00000452508.2:missense_variant:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn:	ATM:NM_000051.3:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn:,ATM:NM_001351834.2:missense_variant:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn:		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];	128458 [benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified,none provided,not provided];	CM077896 [CLASS=DP MUT=ALT PHEN="Breast cancer bilateral association with" GENE=ATM];		rs1801516	0.0669	0.1136	286,.	0.0227,0.0613,0.0063,0.1435,0.0772	6.3420	T(0.08),T(0.08)	B(0.02),B(0.02)	0.98,0.99	23.40	0.12			COSV53728020	-0.2021	0.3688	0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)	0.4688	192	90	0.6101
chr11	108183167	108183167	A	G	hom		QUAL=3554;DP=111;AF=1.00;MQM=60	ATM,C11orf65	missense,intron	ATM:ENST00000278616.4:missense_variant:MODERATE:exon40/63:c.5948A>G:p.Asn1983Ser:,ATM:ENST00000452508.2:missense_variant:MODERATE:exon41/64:c.5948A>G:p.Asn1983Ser:,C11orf65:ENST00000525729.1:intron_variant:MODIFIER:intron6/6:c.641-3369T>C::	ATM:NM_000051.3:synonymous_variant:LOW:exon40/63:c.5948A>G:p.Ser1983=:,C11orf65:NM_001330368.2:intron_variant:MODIFIER:intron6/6:c.641-3369T>C::,C11orf65:NM_001351110.2:intron_variant:MODIFIER:intron8/8:c.*39-3369T>C::,ATM:NM_001351834.2:synonymous_variant:LOW:exon41/64:c.5948A>G:p.Ser1983=:		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];	133627 [benign DISEASE=Ataxia-telangiectasia syndrome,not specified];			rs659243	1.0000	1.0000	15702,.	1.0000,1.0000,1.0000,1.0000,1.0000	-1.0580	T(1.00),T(1.00), 	B(0.00),B(0.00), 	0.01,0.17	7.88	0.02				-0.1804	0.3005	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)	1.0000	167	167	n/a (non-het)
chr11	108183414	108183415	CT	-	het		QUAL=431;DP=41;AF=0.61;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616.4:intron_variant:MODIFIER:intron40/62:c.6006+191_6006+192del::,ATM:ENST00000452508.2:intron_variant:MODIFIER:intron41/63:c.6006+191_6006+192del::,C11orf65:ENST00000525729.1:intron_variant:MODIFIER:intron6/6:c.641-3617_641-3616del::	ATM:NM_000051.3:intron_variant:MODIFIER:intron40/62:c.6006+191_6006+192del::,C11orf65:NM_001330368.2:intron_variant:MODIFIER:intron6/6:c.641-3617_641-3616del::,C11orf65:NM_001351110.2:intron_variant:MODIFIER:intron8/8:c.*39-3617_*39-3616del::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron41/63:c.6006+191_6006+192del::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];			MIRb (SINE/MIR)	rs10588462		0.5155	4241,.		0.2320				4.59							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)	0.4286	7	3	1.0000
chr11	108187830	108187830	T	A	hom	low_conf_region	QUAL=107;DP=4;AF=1.00;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616.4:intron_variant:MODIFIER:intron42/62:c.6199-270T>A::,ATM:ENST00000452508.2:intron_variant:MODIFIER:intron43/63:c.6199-270T>A::,C11orf65:ENST00000525729.1:intron_variant:MODIFIER:intron6/6:c.641-8032A>T::	ATM:NM_000051.3:intron_variant:MODIFIER:intron42/62:c.6199-270T>A::,C11orf65:NM_001330368.2:intron_variant:MODIFIER:intron6/6:c.641-8032A>T::,C11orf65:NM_001351110.2:intron_variant:MODIFIER:intron8/8:c.*39-8032A>T::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron43/63:c.6199-270T>A::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];			AluJr (SINE/Alu)	rs12807529		0.9955	14792,.		-1.2780			0.00,0.08	2.38							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)	1.0000	8	8	n/a (non-het)
chr11	108196713	108196715	ATT	-	het	low_conf_region	QUAL=640;DP=75;AF=0.53;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616.4:intron_variant:MODIFIER:intron46/62:c.6808-60_6808-58del::,ATM:ENST00000452508.2:intron_variant:MODIFIER:intron47/63:c.6808-60_6808-58del::,C11orf65:ENST00000525729.1:intron_variant:MODIFIER:intron6/6:c.641-16917_641-16915del::	ATM:NM_000051.3:intron_variant:MODIFIER:intron46/62:c.6808-60_6808-58del::,C11orf65:NM_001330368.2:intron_variant:MODIFIER:intron6/6:c.641-16917_641-16915del::,C11orf65:NM_001351110.2:intron_variant:MODIFIER:intron8/8:c.*38+9232_*38+9234del::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron47/63:c.6808-60_6808-58del::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];	633055 [benign DISEASE=not specified];			rs3212322		0.4926	3951,.		3.0730				4.21					-0.0142	0.5245	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2021-03-02%0ABatch import from command line.%0AGCHBOC VUS-Task-Force classification%0A%0A[1] ahfausu1 2021-03-02%0ABatch import from command line.%0AGCHBOC VUS-Task-Force classification%0A"			ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)	0.4464	56	25	0.5044
chr11	108224697	108224697	G	A	hom		QUAL=301;DP=10;AF=1.00;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616.4:intron_variant:MODIFIER:intron60/62:c.8786+90G>A::,ATM:ENST00000452508.2:intron_variant:MODIFIER:intron61/63:c.8786+90G>A::,C11orf65:ENST00000525729.1:intron_variant:MODIFIER:intron6/6:c.640+31950C>T::	ATM:NM_000051.3:intron_variant:MODIFIER:intron60/62:c.8786+90G>A::,C11orf65:NM_001330368.2:intron_variant:MODIFIER:intron6/6:c.640+31950C>T::,C11orf65:NM_001351110.2:intron_variant:MODIFIER:intron7/8:c.695-18678C>T::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron61/63:c.8786+90G>A::,C11orf65:NR_147053.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/12:n.2301+945C>T::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];			FLAM_A (SINE/Alu)	rs179108	1.0000	0.9998	15665,.		-0.5090			0.00,0.05	5.77					0.2009	0.1628	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)	1.0000	31	31	n/a (non-het)
chr11	108224797	108224797	A	C	het	low_conf_region	QUAL=37;DP=17;AF=0.18;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616.4:intron_variant:MODIFIER:intron60/62:c.8786+190A>C::,ATM:ENST00000452508.2:intron_variant:MODIFIER:intron61/63:c.8786+190A>C::,C11orf65:ENST00000525729.1:intron_variant:MODIFIER:intron6/6:c.640+31850T>G::	ATM:NM_000051.3:intron_variant:MODIFIER:intron60/62:c.8786+190A>C::,C11orf65:NM_001330368.2:intron_variant:MODIFIER:intron6/6:c.640+31850T>G::,C11orf65:NM_001351110.2:intron_variant:MODIFIER:intron7/8:c.695-18778T>G::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron61/63:c.8786+190A>C::,C11orf65:NR_147053.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/12:n.2301+845T>G::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];			(AC)n (Simple_repeat)	rs678526	0.5861				-2.4720			0.00,0.03	0.33				COSV53731754			0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)	0.5333	15	8	1.0000
chr11	108225483	108225483	C	T	het		QUAL=3216;DP=215;AF=0.59;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616.4:intron_variant:MODIFIER:intron60/62:c.8787-55C>T::,ATM:ENST00000452508.2:intron_variant:MODIFIER:intron61/63:c.8787-55C>T::,C11orf65:ENST00000525729.1:intron_variant:MODIFIER:intron6/6:c.640+31164G>A::	ATM:NM_000051.3:intron_variant:MODIFIER:intron60/62:c.8787-55C>T::,C11orf65:NM_001330368.2:intron_variant:MODIFIER:intron6/6:c.640+31164G>A::,C11orf65:NM_001351110.2:intron_variant:MODIFIER:intron7/8:c.695-19464G>A::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron61/63:c.8787-55C>T::,C11orf65:NR_147053.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/12:n.2301+159G>A::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];				rs664982		0.5293	4432,.		-1.2540			0.00,0.06	0.82					0.0487	0.2419	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)	0.4242	99	42	0.1591
chr11	108225661	108225661	A	G	het		QUAL=15223;DP=708;AF=0.76;MQM=60	ATM,C11orf65	intron	ATM:ENST00000278616.4:intron_variant:MODIFIER:intron61/62:c.8850+60A>G::,ATM:ENST00000452508.2:intron_variant:MODIFIER:intron62/63:c.8850+60A>G::,C11orf65:ENST00000525729.1:intron_variant:MODIFIER:intron6/6:c.640+30986T>C::	ATM:NM_000051.3:intron_variant:MODIFIER:intron61/62:c.8850+60A>G::,C11orf65:NM_001330368.2:intron_variant:MODIFIER:intron6/6:c.640+30986T>C::,C11orf65:NM_001351110.2:intron_variant:MODIFIER:intron7/8:c.695-19642T>C::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron62/63:c.8850+60A>G::,C11orf65:NR_147053.2:non_coding_transcript_exon_variant:MODIFIER:exon11/13:n.2282T>C::		607585 [GENE=ATM PHENOS=Lymphoma,mantle cell,somatic/Lymphoma,B-cell non-Hodgkin,somatic/Ataxia-telangiectasia,208900,Autosomal recessive/Breast cancer,susceptibility to,114480,Somatic mutation,Autosomal dominant/T-cell prolymphocytic leukemia,somatic];				rs664143		0.6053	5780,.		-0.7070			0.00,0.06	0.18					0.0123	0.2617	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)	0.6087	69	42	0.0912
chr13	41373254	41373254	G	A	het		QUAL=22634;DP=1987;AF=0.47;MQM=60	SLC25A15	synonymous	SLC25A15:ENST00000338625.4:synonymous_variant:LOW:exon3/7:c.117G>A:p.Thr39=:PF00153 [Mitochondrial carrier protein]	SLC25A15:NM_014252.4:synonymous_variant:LOW:exon3/7:c.117G>A:p.Thr39=:,TPTE2P5:NR_038258.1:non_coding_transcript_exon_variant:MODIFIER:exon8/8:n.2229C>T::,TPTE2P5:NR_038259.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.2058C>T::	regulatory_region_variant:promoter_flanking_region	603861 [GENE=SLC25A15 PHENOS=Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome,238970,Autosomal recessive];	139125 [benign DISEASE=Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,not specified];			rs41396747	0.0629	0.0789	102,.	0.0894,0.0500,0.0163,0.0946,0.0722	-5.5490			0.08,0.45	2.69					-0.1863	0.2966	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC25A15 (inh=AR oe_syn=1.09 oe_mis=0.98 oe_lof=0.83)	0.4810	289	139	0.6771
chr13	41379272	41379272	C	T	het		QUAL=5862;DP=389;AF=0.58;MQM=60	SLC25A15	synonymous	SLC25A15:ENST00000338625.4:synonymous_variant:LOW:exon4/7:c.333C>T:p.Ala111=:PF00153 [Mitochondrial carrier protein]	SLC25A15:NM_014252.4:synonymous_variant:LOW:exon4/7:c.333C>T:p.Ala111=:,TPTE2P5:NR_038258.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.623-4412G>A::,TPTE2P5:NR_038259.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/5:n.452-4412G>A::		603861 [GENE=SLC25A15 PHENOS=Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome,238970,Autosomal recessive];	139126 [benign DISEASE=Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,not specified];			rs9577152	0.1134	0.1113	249,.	0.1978,0.0555,0.0655,0.0949,0.0913	-2.8610			0.01,0.13	3.30					-0.0447	0.2468	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC25A15 (inh=AR oe_syn=1.09 oe_mis=0.98 oe_lof=0.83)	0.4410	161	71	0.1558
chr13	52508979	52508979	C	T	het		QUAL=17628;DP=1547;AF=0.50;MQM=60	ATP7B	synonymous	ATP7B:ENST00000242839.4:synonymous_variant:LOW:exon21/21:c.4311G>A:p.Lys1437=:,ATP7B:ENST00000344297.5:synonymous_variant:LOW:exon17/17:c.3690G>A:p.Lys1230=:,ATP7B:ENST00000400366.3:synonymous_variant:LOW:exon22/22:c.3978G>A:p.Lys1326=:,ATP7B:ENST00000400370.3:synonymous_variant:LOW:exon13/13:c.3021G>A:p.Lys1007=:,ATP7B:ENST00000417240.2:synonymous_variant:LOW:exon14/14:c.1944G>A:p.Lys648=:,ATP7B:ENST00000418097.2:synonymous_variant:LOW:exon20/20:c.4116G>A:p.Lys1372=:,ATP7B:ENST00000448424.2:synonymous_variant:LOW:exon20/20:c.4077G>A:p.Lys1359=:	ATP7B:NM_000053.4:synonymous_variant:LOW:exon21/21:c.4311G>A:p.Lys1437=:,ATP7B:NM_001005918.3:synonymous_variant:LOW:exon17/17:c.3690G>A:p.Lys1230=:,ATP7B:NM_001243182.1:synonymous_variant:LOW:exon22/22:c.3978G>A:p.Lys1326=:,ATP7B:NM_001330578.1:synonymous_variant:LOW:exon20/20:c.4077G>A:p.Lys1359=:,ATP7B:NM_001330579.2:synonymous_variant:LOW:exon19/19:c.4059G>A:p.Lys1353=:		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	35732 [benign/likely benign DISEASE=Wilson disease,not specified,not provided];			rs73202048	0.0038	0.0071	1,.	0.0012,0.0028,0.0000,0.0115,0.0061	1.3490			0.66,0.55	1.30					-0.0274	0.9462	0.03	3	486	0 / 38					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)	0.5054	277	140	0.8654
chr13	52511276	52511277	AA	-	het		QUAL=868;DP=169;AF=0.33;MQM=60	ATP7B	intron	ATP7B:ENST00000242839.4:intron_variant:MODIFIER:intron19/20:c.4021+135_4021+136del::,ATP7B:ENST00000344297.5:intron_variant:MODIFIER:intron15/16:c.3400+135_3400+136del::,ATP7B:ENST00000400366.3:intron_variant:MODIFIER:intron20/21:c.3688+135_3688+136del::,ATP7B:ENST00000400370.3:intron_variant:MODIFIER:intron11/12:c.2731+135_2731+136del::,ATP7B:ENST00000417240.2:intron_variant:MODIFIER:intron12/13:c.1654+135_1654+136del::,ATP7B:ENST00000418097.2:intron_variant:MODIFIER:intron18/19:c.3826+135_3826+136del::,ATP7B:ENST00000448424.2:intron_variant:MODIFIER:intron18/19:c.3787+135_3787+136del::	ATP7B:NM_000053.4:intron_variant:MODIFIER:intron19/20:c.4021+135_4021+136del::,ATP7B:NM_001005918.3:intron_variant:MODIFIER:intron15/16:c.3400+135_3400+136del::,ATP7B:NM_001243182.1:intron_variant:MODIFIER:intron20/21:c.3688+135_3688+136del::,ATP7B:NM_001330578.1:intron_variant:MODIFIER:intron18/19:c.3787+135_3787+136del::,ATP7B:NM_001330579.2:intron_variant:MODIFIER:intron17/18:c.3769+135_3769+136del::		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];				rs57778802		0.5099	2806,.		0.1640				1.21							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)	0.2500	28	7	0.0081
chr13	52511362	52511362	C	G	het		QUAL=4155;DP=271;AF=0.60;MQM=60	ATP7B	intron	ATP7B:ENST00000242839.4:intron_variant:MODIFIER:intron19/20:c.4021+50G>C::,ATP7B:ENST00000344297.5:intron_variant:MODIFIER:intron15/16:c.3400+50G>C::,ATP7B:ENST00000400366.3:intron_variant:MODIFIER:intron20/21:c.3688+50G>C::,ATP7B:ENST00000400370.3:intron_variant:MODIFIER:intron11/12:c.2731+50G>C::,ATP7B:ENST00000417240.2:intron_variant:MODIFIER:intron12/13:c.1654+50G>C::,ATP7B:ENST00000418097.2:intron_variant:MODIFIER:intron18/19:c.3826+50G>C::,ATP7B:ENST00000448424.2:intron_variant:MODIFIER:intron18/19:c.3787+50G>C::	ATP7B:NM_000053.4:intron_variant:MODIFIER:intron19/20:c.4021+50G>C::,ATP7B:NM_001005918.3:intron_variant:MODIFIER:intron15/16:c.3400+50G>C::,ATP7B:NM_001243182.1:intron_variant:MODIFIER:intron20/21:c.3688+50G>C::,ATP7B:NM_001330578.1:intron_variant:MODIFIER:intron18/19:c.3787+50G>C::,ATP7B:NM_001330579.2:intron_variant:MODIFIER:intron17/18:c.3769+50G>C::		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	254770 [benign DISEASE=not specified,not provided];			rs9535795	0.5317	0.5663	5007,.	0.5218,0.6340,0.3955,0.5814,0.5209	-0.5090			0.00,0.13	1.15					0.106	0.1727	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)	0.4133	75	31	0.1654
chr13	52511606	52511606	G	A	het		QUAL=25988;DP=2048;AF=0.48;MQM=60	ATP7B	splice_region&intron	ATP7B:ENST00000242839.4:splice_region_variant&intron_variant:LOW:intron18/20:c.3903+6C>T::,ATP7B:ENST00000344297.5:splice_region_variant&intron_variant:LOW:intron14/16:c.3282+6C>T::,ATP7B:ENST00000400366.3:splice_region_variant&intron_variant:LOW:intron19/21:c.3570+6C>T::,ATP7B:ENST00000400370.3:splice_region_variant&intron_variant:LOW:intron10/12:c.2613+6C>T::,ATP7B:ENST00000417240.2:splice_region_variant&intron_variant:LOW:intron11/13:c.1536+6C>T::,ATP7B:ENST00000418097.2:splice_region_variant&intron_variant:LOW:intron17/19:c.3708+6C>T::,ATP7B:ENST00000448424.2:splice_region_variant&intron_variant:LOW:intron17/19:c.3669+6C>T::	ATP7B:NM_000053.4:splice_region_variant&intron_variant:LOW:intron18/20:c.3903+6C>T::,ATP7B:NM_001005918.3:splice_region_variant&intron_variant:LOW:intron14/16:c.3282+6C>T::,ATP7B:NM_001243182.1:splice_region_variant&intron_variant:LOW:intron19/21:c.3570+6C>T::,ATP7B:NM_001330578.1:splice_region_variant&intron_variant:LOW:intron17/19:c.3669+6C>T::,ATP7B:NM_001330579.2:splice_region_variant&intron_variant:LOW:intron16/18:c.3651+6C>T::		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	35727 [benign/likely benign DISEASE=Wilson disease,not specified,not provided];			rs2282057	0.5018	0.5449	4713,.	0.4748,0.4872,0.3977,0.5741,0.5104	-0.1020			0.01,0.21	0.17		4.22>7.36	0.000/0.000		1.5755	0.1602	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)	0.4245	212	90	0.1215
chr13	52515354	52515354	A	G	het		QUAL=5228;DP=460;AF=0.48;MQM=60	ATP7B	missense	ATP7B:ENST00000242839.4:missense_variant:MODERATE:exon16/21:c.3419T>C:p.Val1140Ala:PF00702 [haloacid dehalogenase-like hydrolase],ATP7B:ENST00000344297.5:missense_variant:MODERATE:exon12/17:c.2798T>C:p.Val933Ala:PF00702 [haloacid dehalogenase-like hydrolase],ATP7B:ENST00000400366.3:missense_variant:MODERATE:exon17/22:c.3086T>C:p.Val1029Ala:PF00702 [haloacid dehalogenase-like hydrolase],ATP7B:ENST00000400370.3:missense_variant:MODERATE:exon8/13:c.2129T>C:p.Val710Ala:PF00702 [haloacid dehalogenase-like hydrolase],ATP7B:ENST00000417240.2:missense_variant:MODERATE:exon9/14:c.1052T>C:p.Val351Ala:PF00702 [haloacid dehalogenase-like hydrolase],ATP7B:ENST00000418097.2:missense_variant:MODERATE:exon15/20:c.3224T>C:p.Val1075Ala:PF00702 [haloacid dehalogenase-like hydrolase],ATP7B:ENST00000448424.2:missense_variant:MODERATE:exon15/20:c.3185T>C:p.Val1062Ala:PF00702 [haloacid dehalogenase-like hydrolase]	ATP7B:NM_000053.4:missense_variant:MODERATE:exon16/21:c.3419T>C:p.Val1140Ala:,ATP7B:NM_001005918.3:missense_variant:MODERATE:exon12/17:c.2798T>C:p.Val933Ala:,ATP7B:NM_001243182.1:missense_variant:MODERATE:exon17/22:c.3086T>C:p.Val1029Ala:,ATP7B:NM_001330578.1:missense_variant:MODERATE:exon15/20:c.3185T>C:p.Val1062Ala:,ATP7B:NM_001330579.2:missense_variant:MODERATE:exon14/19:c.3167T>C:p.Val1056Ala:	regulatory_region_variant:enhancer	606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	35720 [benign DISEASE=Wilson disease,not specified,not provided];	CM044579 [CLASS=DP MUT=ALT PHEN="Wilson disease" GENE=ATP7B];		rs1801249		0.5726	5181,.	0.5495,0.6371,0.3968,0.5826,0.5213	0.1110	T(1.00),T(1.00),T(1.00),T(1.00),T(0.93),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.03),B(0.00),B(0.00),B(0.00),B(0.00)	0.00,0.17	5.84	0.19				-0.0046	0.9468	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)	0.4844	192	93	0.7596
chr13	52523808	52523808	C	T	het		QUAL=20;DP=12;AF=0.25;MQM=60	ATP7B	missense,intron	ATP7B:ENST00000242839.4:missense_variant:MODERATE:exon12/21:c.2855G>A:p.Arg952Lys:PF00122 [E1-E2 ATPase],ATP7B:ENST00000344297.5:intron_variant:MODIFIER:intron8/16:c.2244+335G>A::,ATP7B:ENST00000400366.3:missense_variant:MODERATE:exon13/22:c.2522G>A:p.Arg841Lys:PF00122 [E1-E2 ATPase],ATP7B:ENST00000400370.3:missense_variant:MODERATE:exon4/13:c.1565G>A:p.Arg522Lys:PF00122 [E1-E2 ATPase],ATP7B:ENST00000417240.2:missense_variant:MODERATE:exon6/14:c.671G>A:p.Arg224Lys:PF00122 [E1-E2 ATPase],ATP7B:ENST00000418097.2:missense_variant:MODERATE:exon12/20:c.2855G>A:p.Arg952Lys:,ATP7B:ENST00000448424.2:missense_variant:MODERATE:exon11/20:c.2621G>A:p.Arg874Lys:PF00122 [E1-E2 ATPase]	ATP7B:NM_000053.4:missense_variant:MODERATE:exon12/21:c.2855G>A:p.Arg952Lys:,ATP7B:NM_001005918.3:intron_variant:MODIFIER:intron8/16:c.2244+335G>A::,ATP7B:NM_001243182.1:missense_variant:MODERATE:exon13/22:c.2522G>A:p.Arg841Lys:,ATP7B:NM_001330578.1:missense_variant:MODERATE:exon11/20:c.2621G>A:p.Arg874Lys:,ATP7B:NM_001330579.2:missense_variant:MODERATE:exon10/19:c.2603G>A:p.Arg868Lys:		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	35708 [benign DISEASE=Wilson disease,not specified,not provided];	CM127927 [CLASS=DP MUT=ALT PHEN="Alzheimer disease association with" GENE=ATP7B];		rs732774	0.5309	0.5670	5043,.	0.5207,0.6355,0.3963,0.5824,0.5219	2.7820	T(1.00), ,T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00), ,B(0.02),B(0.03),B(0.00),B(0.00),B(0.00)	0.32,0.98	21.80	0.43				-0.079	0.438	0.08	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)	0.5188	133	69	0.7289
chr13	52524488	52524488	T	C	het		QUAL=4572;DP=376;AF=0.51;MQM=60	ATP7B	missense,intron	ATP7B:ENST00000242839.4:missense_variant:MODERATE:exon10/21:c.2495A>G:p.Lys832Arg:PF00122 [E1-E2 ATPase],ATP7B:ENST00000344297.5:missense_variant:MODERATE:exon7/17:c.2009A>G:p.Lys670Arg:PF00122 [E1-E2 ATPase],ATP7B:ENST00000400366.3:missense_variant:MODERATE:exon11/22:c.2162A>G:p.Lys721Arg:PF00122 [E1-E2 ATPase],ATP7B:ENST00000400370.3:intron_variant:MODIFIER:intron2/12:c.1286-191A>G::,ATP7B:ENST00000417240.2:missense_variant:MODERATE:exon4/14:c.311A>G:p.Lys104Arg:PF00122 [E1-E2 ATPase],ATP7B:ENST00000418097.2:missense_variant:MODERATE:exon10/20:c.2495A>G:p.Lys832Arg:PF00122 [E1-E2 ATPase],ATP7B:ENST00000448424.2:missense_variant:MODERATE:exon9/20:c.2261A>G:p.Lys754Arg:PF00122 [E1-E2 ATPase]	ATP7B:NM_000053.4:missense_variant:MODERATE:exon10/21:c.2495A>G:p.Lys832Arg:,ATP7B:NM_001005918.3:missense_variant:MODERATE:exon7/17:c.2009A>G:p.Lys670Arg:,ATP7B:NM_001243182.1:missense_variant:MODERATE:exon11/22:c.2162A>G:p.Lys721Arg:,ATP7B:NM_001330578.1:missense_variant:MODERATE:exon9/20:c.2261A>G:p.Lys754Arg:,ATP7B:NM_001330579.2:missense_variant:MODERATE:exon8/19:c.2243A>G:p.Lys748Arg:		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	35707 [benign DISEASE=Wilson disease,not specified,not provided];	CM116966 [CLASS=DFP MUT=ALT PHEN="Alzheimer disease association with" GENE=ATP7B];		rs1061472		0.5467	4749,.	0.4862,0.4914,0.3961,0.5741,0.5101	6.2090	T(0.07),T(0.14),T(0.08), ,T(0.10),T(0.08),T(0.06)	B(0.08),P(0.47),B(0.00), ,B(0.01),B(0.32),B(0.01)	0.96,0.99	23.30	0.47				-0.3525	0.1221	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)	0.4379	169	74	0.1237
chr13	52524560	52524560	C	T	het		QUAL=1335;DP=165;AF=0.44;MQM=60	ATP7B	intron	ATP7B:ENST00000242839.4:intron_variant:MODIFIER:intron9/20:c.2448-25G>A::,ATP7B:ENST00000344297.5:intron_variant:MODIFIER:intron6/16:c.1962-25G>A::,ATP7B:ENST00000400366.3:intron_variant:MODIFIER:intron10/21:c.2115-25G>A::,ATP7B:ENST00000400370.3:intron_variant:MODIFIER:intron2/12:c.1286-263G>A::,ATP7B:ENST00000417240.2:intron_variant:MODIFIER:intron3/13:c.264-25G>A::,ATP7B:ENST00000418097.2:intron_variant:MODIFIER:intron9/19:c.2448-25G>A::,ATP7B:ENST00000448424.2:intron_variant:MODIFIER:intron8/19:c.2214-25G>A::	ATP7B:NM_000053.4:intron_variant:MODIFIER:intron9/20:c.2448-25G>A::,ATP7B:NM_001005918.3:intron_variant:MODIFIER:intron6/16:c.1962-25G>A::,ATP7B:NM_001243182.1:intron_variant:MODIFIER:intron10/21:c.2115-25G>A::,ATP7B:NM_001330578.1:intron_variant:MODIFIER:intron8/19:c.2214-25G>A::,ATP7B:NM_001330579.2:intron_variant:MODIFIER:intron7/18:c.2196-25G>A::		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	254764 [benign DISEASE=Wilson disease,not specified,not provided];	CS178155 [CLASS=R MUT=ALT PHEN="Wilson disease" GENE=ATP7B];		rs9526811	0.3069	0.4049	2456,.	0.1123,0.3627,0.3392,0.4695,0.3384	1.8860			0.12,0.19	4.77					-0.1461	0.1111	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)	0.4750	80	38	0.7376
chr13	52531960	52531960	C	T	het		QUAL=2896;DP=287;AF=0.48;MQM=60	ATP7B	intron	ATP7B:ENST00000242839.4:intron_variant:MODIFIER:intron8/20:c.2356-217G>A::,ATP7B:ENST00000344297.5:intron_variant:MODIFIER:intron5/16:c.1870-217G>A::,ATP7B:ENST00000400366.3:intron_variant:MODIFIER:intron9/21:c.2023-217G>A::,ATP7B:ENST00000400370.3:intron_variant:MODIFIER:intron2/12:c.1286-7663G>A::,ATP7B:ENST00000417240.2:intron_variant:MODIFIER:intron2/13:c.172-217G>A::,ATP7B:ENST00000418097.2:intron_variant:MODIFIER:intron8/19:c.2356-217G>A::,ATP7B:ENST00000448424.2:intron_variant:MODIFIER:intron7/19:c.2122-217G>A::	ATP7B:NM_000053.4:intron_variant:MODIFIER:intron8/20:c.2356-217G>A::,ATP7B:NM_001005918.3:intron_variant:MODIFIER:intron5/16:c.1870-217G>A::,ATP7B:NM_001243182.1:intron_variant:MODIFIER:intron9/21:c.2023-217G>A::,ATP7B:NM_001330578.1:intron_variant:MODIFIER:intron7/19:c.2122-217G>A::,ATP7B:NM_001330579.2:intron_variant:MODIFIER:intron6/18:c.2104-217G>A::		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	680481 [benign DISEASE=not provided];			rs752569	0.5417	0.5723	5200,.		-0.5610			0.00,0.36	0.68							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)	0.0000	5	0	0.0625
chr13	52532039	52532039	T	C	het		QUAL=1183;DP=165;AF=0.44;MQM=60	ATP7B	intron	ATP7B:ENST00000242839.4:intron_variant:MODIFIER:intron8/20:c.2356-296A>G::,ATP7B:ENST00000344297.5:intron_variant:MODIFIER:intron5/16:c.1870-296A>G::,ATP7B:ENST00000400366.3:intron_variant:MODIFIER:intron9/21:c.2023-296A>G::,ATP7B:ENST00000400370.3:intron_variant:MODIFIER:intron2/12:c.1286-7742A>G::,ATP7B:ENST00000417240.2:intron_variant:MODIFIER:intron2/13:c.172-296A>G::,ATP7B:ENST00000418097.2:intron_variant:MODIFIER:intron8/19:c.2356-296A>G::,ATP7B:ENST00000448424.2:intron_variant:MODIFIER:intron7/19:c.2122-296A>G::	ATP7B:NM_000053.4:intron_variant:MODIFIER:intron8/20:c.2356-296A>G::,ATP7B:NM_001005918.3:intron_variant:MODIFIER:intron5/16:c.1870-296A>G::,ATP7B:NM_001243182.1:intron_variant:MODIFIER:intron9/21:c.2023-296A>G::,ATP7B:NM_001330578.1:intron_variant:MODIFIER:intron7/19:c.2122-296A>G::,ATP7B:NM_001330579.2:intron_variant:MODIFIER:intron6/18:c.2104-296A>G::		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	680479 [benign DISEASE=not provided];			rs752570	0.3267	0.3760	2566,.		-0.4880			0.03,0.45	11.53							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)	n/a (no coverage)	0	n/a (no coverage)	n/a (no coverage)
chr13	52542796	52542796	T	G	hom		QUAL=9495;DP=337;AF=1.00;MQM=60	ATP7B	intron	ATP7B:ENST00000242839.4:intron_variant:MODIFIER:intron3/20:c.1544-53A>C::,ATP7B:ENST00000344297.5:intron_variant:MODIFIER:intron3/16:c.1544-53A>C::,ATP7B:ENST00000400366.3:intron_variant:MODIFIER:intron4/21:c.1211-53A>C::,ATP7B:ENST00000400370.3:intron_variant:MODIFIER:intron2/12:c.1285+5275A>C::,ATP7B:ENST00000418097.2:intron_variant:MODIFIER:intron3/19:c.1544-53A>C::,ATP7B:ENST00000448424.2:intron_variant:MODIFIER:intron3/19:c.1544-53A>C::,ATP7B:ENST00000542656.1:intron_variant:MODIFIER:intron2/2:c.1447+1832A>C::	ATP7B:NM_000053.4:intron_variant:MODIFIER:intron3/20:c.1544-53A>C::,ATP7B:NM_001005918.3:intron_variant:MODIFIER:intron3/16:c.1544-53A>C::,ATP7B:NM_001243182.1:intron_variant:MODIFIER:intron4/21:c.1211-53A>C::,ATP7B:NM_001330578.1:intron_variant:MODIFIER:intron3/19:c.1544-53A>C::,ATP7B:NM_001330579.2:intron_variant:MODIFIER:intron3/18:c.1544-53A>C::		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	676098 [benign DISEASE=not provided];	CR137942 [CLASS=DP MUT=ALT PHEN="Alzheimer disease association with" GENE=ATP7B];		rs2147363	0.6118	0.6950	7640,.		-1.8590			0.00,0.10	0.85					-0.0631	0.2691	0.15	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93), FABP5P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	1.0000	44	44	n/a (non-het)
chr13	52544805	52544805	C	G	het		QUAL=1525;DP=150;AF=0.53;MQM=60	ATP7B	missense,intron	ATP7B:ENST00000242839.4:missense_variant:MODERATE:exon3/21:c.1366G>C:p.Val456Leu:,ATP7B:ENST00000344297.5:missense_variant:MODERATE:exon3/17:c.1366G>C:p.Val456Leu:,ATP7B:ENST00000400366.3:missense_variant:MODERATE:exon4/22:c.1033G>C:p.Val345Leu:,ATP7B:ENST00000400370.3:intron_variant:MODIFIER:intron2/12:c.1285+3266G>C::,ATP7B:ENST00000418097.2:missense_variant:MODERATE:exon3/20:c.1366G>C:p.Val456Leu:,ATP7B:ENST00000448424.2:missense_variant:MODERATE:exon3/20:c.1366G>C:p.Val456Leu:,ATP7B:ENST00000542656.1:missense_variant:MODERATE:exon2/3:c.1270G>C:p.Val424Leu:	ATP7B:NM_000053.4:missense_variant:MODERATE:exon3/21:c.1366G>C:p.Val456Leu:,ATP7B:NM_001005918.3:missense_variant:MODERATE:exon3/17:c.1366G>C:p.Val456Leu:,ATP7B:NM_001243182.1:missense_variant:MODERATE:exon4/22:c.1033G>C:p.Val345Leu:,ATP7B:NM_001330578.1:missense_variant:MODERATE:exon3/20:c.1366G>C:p.Val456Leu:,ATP7B:NM_001330579.2:missense_variant:MODERATE:exon3/19:c.1366G>C:p.Val456Leu:	regulatory_region_variant:promoter_flanking_region	606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	35702 [benign DISEASE=Wilson disease,not specified,not provided];	CM1212621 [CLASS=DFP MUT=ALT PHEN="Alzheimer disease association with" GENE=ATP7B];		rs1801244	0.3770	0.4400	2920,.	0.2262,0.3875,0.4835,0.4837,0.3472	-1.0040	T(0.45),T(0.66),T(0.46), ,T(0.50),T(0.94),T(0.35)	B(0.00),B(0.03),B(0.02), ,B(0.04),B(0.01),B(0.02)	0.04,0.18	8.76	0.12				0.0645	0.2903	0.09	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93), FABP5P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	0.4167	228	95	0.0747
chr13	52544978	52544978	T	G	het		QUAL=11707;DP=811;AF=0.57;MQM=60	ATP7B	intron	ATP7B:ENST00000242839.4:intron_variant:MODIFIER:intron2/20:c.1286-93A>C::,ATP7B:ENST00000344297.5:intron_variant:MODIFIER:intron2/16:c.1286-93A>C::,ATP7B:ENST00000400366.3:intron_variant:MODIFIER:intron3/21:c.953-93A>C::,ATP7B:ENST00000400370.3:intron_variant:MODIFIER:intron2/12:c.1285+3093A>C::,ATP7B:ENST00000418097.2:intron_variant:MODIFIER:intron2/19:c.1286-93A>C::,ATP7B:ENST00000448424.2:intron_variant:MODIFIER:intron2/19:c.1286-93A>C::,ATP7B:ENST00000542656.1:intron_variant:MODIFIER:intron1/2:c.1190-93A>C::	ATP7B:NM_000053.4:intron_variant:MODIFIER:intron2/20:c.1286-93A>C::,ATP7B:NM_001005918.3:intron_variant:MODIFIER:intron2/16:c.1286-93A>C::,ATP7B:NM_001243182.1:intron_variant:MODIFIER:intron3/21:c.953-93A>C::,ATP7B:NM_001330578.1:intron_variant:MODIFIER:intron2/19:c.1286-93A>C::,ATP7B:NM_001330579.2:intron_variant:MODIFIER:intron2/18:c.1286-93A>C::	regulatory_region_variant:promoter_flanking_region	606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	676102 [benign DISEASE=not provided];		LTR33A (LTR/ERVL)	rs3742288	0.3776	0.4197	2914,.		-0.2660			0.00,0.03	0.71					-0.0258	0.2995	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93), FABP5P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	0.4783	23	11	1.0000
chr13	52548140	52548140	A	C	het		QUAL=5276;DP=422;AF=0.51;MQM=60	ATP7B	missense	ATP7B:ENST00000242839.4:missense_variant:MODERATE:exon2/21:c.1216T>G:p.Ser406Ala:PF00403 [Heavy-metal-associated domain],ATP7B:ENST00000344297.5:missense_variant:MODERATE:exon2/17:c.1216T>G:p.Ser406Ala:PF00403 [Heavy-metal-associated domain],ATP7B:ENST00000400366.3:missense_variant:MODERATE:exon3/22:c.883T>G:p.Ser295Ala:PF00403 [Heavy-metal-associated domain],ATP7B:ENST00000400370.3:missense_variant:MODERATE:exon2/13:c.1216T>G:p.Ser406Ala:PF00403 [Heavy-metal-associated domain],ATP7B:ENST00000418097.2:missense_variant:MODERATE:exon2/20:c.1216T>G:p.Ser406Ala:PF00403 [Heavy-metal-associated domain],ATP7B:ENST00000448424.2:missense_variant:MODERATE:exon2/20:c.1216T>G:p.Ser406Ala:PF00403 [Heavy-metal-associated domain],ATP7B:ENST00000542656.1:missense_variant:MODERATE:exon1/3:c.1120T>G:p.Ser374Ala:PF00403 [Heavy-metal-associated domain]	ATP7B:NM_000053.4:missense_variant:MODERATE:exon2/21:c.1216T>G:p.Ser406Ala:,ATP7B:NM_001005918.3:missense_variant:MODERATE:exon2/17:c.1216T>G:p.Ser406Ala:,ATP7B:NM_001243182.1:missense_variant:MODERATE:exon3/22:c.883T>G:p.Ser295Ala:,ATP7B:NM_001330578.1:missense_variant:MODERATE:exon2/20:c.1216T>G:p.Ser406Ala:,ATP7B:NM_001330579.2:missense_variant:MODERATE:exon2/19:c.1216T>G:p.Ser406Ala:		606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	35701 [benign DISEASE=Wilson disease,not specified,not provided];	CM129458 [CLASS=FP MUT=ALT PHEN="Reduced copper accumulation" GENE=ATP7B];		rs1801243	0.3762	0.4450	2977,.	0.1838,0.3865,0.5333,0.4897,0.3519	-0.6680	T(0.79),T(0.49),T(0.63),T(0.52),T(0.79),T(0.63),T(0.88)	B(0.00),B(0.01),B(0.03),B(0.08),B(0.07),B(0.01),B(0.02)	0.08,0.23	7.18	0.05				0.2207	0.2899	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93)	0.4979	235	117	1.0000
chr13	52585548	52585548	G	T	hom		QUAL=7546;DP=275;AF=0.99;MQM=60	ATP7B	5'UTR	ATP7B:ENST00000242839.4:5_prime_UTR_variant:MODIFIER:exon1/21:c.-75C>A::,ATP7B:ENST00000344297.5:5_prime_UTR_variant:MODIFIER:exon1/17:c.-75C>A::,ATP7B:ENST00000400366.3:5_prime_UTR_variant:MODIFIER:exon1/22:c.-75C>A::	ATP7B:NM_000053.4:5_prime_UTR_variant:MODIFIER:exon1/21:c.-75C>A::,ATP7B:NM_001005918.3:5_prime_UTR_variant:MODIFIER:exon1/17:c.-75C>A::,ATP7B:NM_001243182.1:5_prime_UTR_variant:MODIFIER:exon1/22:c.-75C>A::,ATP7B:NM_001330578.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-75C>A::,ATP7B:NM_001330579.2:5_prime_UTR_variant:MODIFIER:exon1/19:c.-75C>A::	regulatory_region_variant:promoter	606882 [GENE=ATP7B PHENOS=Wilson disease,277900,Autosomal recessive];	312405 [benign DISEASE=Wilson disease,Congenital disorder of glycosylation,not specified];	CR129463 [CLASS=FP MUT=ALT PHEN="Increased expression" GENE=ATP7B];		rs2277448	0.5168	0.5846	5824,.		-1.3720			0.02,0.57	9.26					0.0834	0.4432	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP7B (inh=AR oe_syn=1.07 oe_mis=1.09 oe_lof=0.93), ALG11 (inh=AR oe_syn=0.90 oe_mis=1.01 oe_lof=0.85)	1.0000	243	243	n/a (non-het)
chr13	79766188	79766188	A	G	het		QUAL=154;DP=20;AF=0.50;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region					rs2988039	0.5066	0.4061	3257,.	0.7074,0.4284,0.7053,0.2530,0.3501	-0.9470			0.00,0.07	2.93								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)						n/a (no coverage)	0	n/a (no coverage)	n/a (no coverage)
chr14	55310492	55310492	G	A	het		QUAL=823;DP=117;AF=0.38;MQM=59	GCH1	intron,3'UTR,splice_region&intron	GCH1:ENST00000395514.1:intron_variant:MODIFIER:intron6/6:c.*16+227C>T::,GCH1:ENST00000491895.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*243C>T::,GCH1:ENST00000536224.2:intron_variant:MODIFIER:intron5/5:c.627-720C>T::,GCH1:ENST00000543643.2:splice_region_variant&intron_variant:LOW:intron6/6:c.*12+8C>T::	GCH1:NM_000161.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*243C>T::,GCH1:NM_001024024.1:intron_variant:MODIFIER:intron6/6:c.*16+227C>T::,GCH1:NM_001024070.2:splice_region_variant&intron_variant:LOW:intron6/6:c.*12+8C>T::,GCH1:NM_001024071.2:intron_variant:MODIFIER:intron5/5:c.627-720C>T::		600225 [GENE=GCH1 PHENOS=Hyperphenylalaninemia,BH4-deficient,B,233910,Autosomal recessive/Dystonia,DOPA-responsive,with or without hyperphenylalaninemia,128230,Autosomal recessive,Autosomal dominant];	313386 [benign DISEASE=Dystonia 5,GTP cyclohydrolase I deficiency,not specified];	CR075245 [CLASS=DFP MUT=ALT PHEN="Decreased expression" GENE=GCH1];		rs841	0.2298	0.2185	770,.	0.2059,0.3080,0.3594,0.1979,0.1237	-1.6070			0.02,0.11	0.10			0.000/0.008		0.3874	0.9585	0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahharmf1 07.05.2020; gnomAD: >20%"			GCH1 (inh=AD oe_syn=1.16 oe_mis=0.63 oe_lof=0.08)	0.4958	119	59	1.0000
chr14	74943295	74943295	T	C	het		QUAL=14150;DP=1081;AF=0.50;MQM=60	NPC2	missense&splice_region	NPC2:ENST00000434013.2:missense_variant&splice_region_variant:MODERATE:exon5/5:c.442A>G:p.Met148Val:			601015 [GENE=NPC2 PHENOS=Niemann-pick disease,type C2,607625,Autosomal recessive];				rs8021664	0.2698	0.2202	870,.	0.3330,0.3203,0.1614,0.1668,0.2573	-0.4990	T(1.00)	B(0.00)	0.00,0.05	6.48	0.12	11.03>11.43			0.6355	0.3295		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC2 (inh=AR oe_syn=1.23 oe_mis=0.59 oe_lof=0.67), MIR4709 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	0.5283	53	28	0.7838
chr14	74943426	74943426	C	A	het		QUAL=598;DP=76;AF=0.49;MQM=60	NPC2	intron	NPC2:ENST00000434013.2:intron_variant:MODIFIER:intron4/4:c.442-131G>T::			601015 [GENE=NPC2 PHENOS=Niemann-pick disease,type C2,607625,Autosomal recessive];				rs10150696	0.2656	0.2165	841,.		0.3730			0.04,0.15	2.20								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC2 (inh=AR oe_syn=1.23 oe_mis=0.59 oe_lof=0.67), MIR4709 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	0.6000	10	6	0.7539
chr14	74951000	74951000	T	G	het		QUAL=33;DP=7;AF=0.43;MQM=60	NPC2	intron	NPC2:ENST00000238633.2:intron_variant:MODIFIER:intron3/4:c.363+118A>C::,NPC2:ENST00000434013.2:intron_variant:MODIFIER:intron3/4:c.363+118A>C::,NPC2:ENST00000541064.1:intron_variant:MODIFIER:intron3/3:c.363+118A>C::,NPC2:ENST00000555619.1:intron_variant:MODIFIER:intron3/4:c.363+118A>C::,NPC2:ENST00000557510.1:intron_variant:MODIFIER:intron3/3:c.363+118A>C::	NPC2:NM_001363688.1:intron_variant:MODIFIER:intron3/3:c.363+118A>C::,NPC2:NM_006432.4:intron_variant:MODIFIER:intron3/4:c.363+118A>C::		601015 [GENE=NPC2 PHENOS=Niemann-pick disease,type C2,607625,Autosomal recessive];				rs1395152099					0.5590			0.10,0.18	5.73							0.01	0	10	0 / 1					NPC2 (inh=AR oe_syn=1.23 oe_mis=0.59 oe_lof=0.67), MIR4709 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RAP1AP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	0.0000	12	0	0.0005
chr14	74951476	74951476	A	C	het	low_conf_region	QUAL=506;DP=74;AF=0.35;MQM=60	NPC2	intron	NPC2:ENST00000238633.2:intron_variant:MODIFIER:intron2/4:c.191-186T>G::,NPC2:ENST00000434013.2:intron_variant:MODIFIER:intron2/4:c.191-186T>G::,NPC2:ENST00000541064.1:intron_variant:MODIFIER:intron2/3:c.191-186T>G::,NPC2:ENST00000555619.1:intron_variant:MODIFIER:intron2/4:c.191-186T>G::,NPC2:ENST00000557510.1:intron_variant:MODIFIER:intron2/3:c.191-186T>G::	NPC2:NM_001363688.1:intron_variant:MODIFIER:intron2/3:c.191-186T>G::,NPC2:NM_006432.4:intron_variant:MODIFIER:intron2/4:c.191-186T>G::		601015 [GENE=NPC2 PHENOS=Niemann-pick disease,type C2,607625,Autosomal recessive];			(A)n (Simple_repeat)	rs8015971		0.1892	609,.		1.4810			0.09,0.14	0.63							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC2 (inh=AR oe_syn=1.23 oe_mis=0.59 oe_lof=0.67), MIR4709 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RAP1AP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	0.6667	6	4	0.6875
chr15	72637795	72637795	T	C	hom		QUAL=39011;DP=1237;AF=1.00;MQM=60	HEXA,RP11-106M3.2,RP11-106M3.3	synonymous,non_coding_transcript_exon,3'UTR	HEXA:ENST00000268097.5:synonymous_variant:LOW:exon13/14:c.1518A>G:p.Glu506=:,RP11-106M3.2:ENST00000379915.4:non_coding_transcript_exon_variant:MODIFIER:exon5/16:n.609A>G::,HEXA:ENST00000457859.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*178A>G::,HEXA:ENST00000566304.1:synonymous_variant:LOW:exon13/14:c.1551A>G:p.Glu517=:,HEXA:ENST00000567159.1:synonymous_variant:LOW:exon13/13:c.1518A>G:p.Glu506=:,RP11-106M3.3:ENST00000570175.1:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.234T>C::	HEXA:NM_000520.6:synonymous_variant:LOW:exon13/14:c.1518A>G:p.Glu506=:,HEXA:NM_001318825.2:synonymous_variant:LOW:exon13/14:c.1551A>G:p.Glu517=:,HEXA:NR_134869.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.1303A>G::		606869 [GENE=HEXA PHENOS=GM2-gangliosidosis,several forms,272800,Autosomal recessive/Tay-Sachs disease,272800,Autosomal recessive/Hex A pseudodeficiency,272800,Autosomal recessive];	93191 [benign DISEASE=Tay-Sachs disease,not specified,none provided,not provided];			rs4777502		0.9705	12841,.	0.6046,0.9815,1.0000,0.9983,0.9991	-0.3750			0.01,0.82	19.27					-0.1684	0.9301	0.14	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HEXA (inh=AR oe_syn=0.96 oe_mis=1.07 oe_lof=0.68)	0.9929	283	281	n/a (non-het)
chr15	72638892	72638892	T	C	hom		QUAL=75696;DP=2308;AF=1.00;MQM=60	HEXA,RP11-106M3.2,RP11-106M3.3	missense,intron&non_coding_transcript,intron,non_coding_transcript_exon	HEXA:ENST00000268097.5:missense_variant:MODERATE:exon11/14:c.1306A>G:p.Ile436Val:PF00728 [Glycosyl hydrolase family 20 catalytic domain],RP11-106M3.2:ENST00000379915.4:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/15:n.422-226A>G::,HEXA:ENST00000429918.2:missense_variant:MODERATE:exon9/10:c.787A>G:p.Ile263Val:PF00728 [Glycosyl hydrolase family 20 catalytic domain],HEXA:ENST00000457859.2:intron_variant:MODIFIER:intron9/10:c.498-226A>G::,HEXA:ENST00000566304.1:missense_variant:MODERATE:exon11/14:c.1339A>G:p.Ile447Val:PF00728 [Glycosyl hydrolase family 20 catalytic domain],HEXA:ENST00000567159.1:missense_variant:MODERATE:exon11/13:c.1306A>G:p.Ile436Val:PF00728 [Glycosyl hydrolase family 20 catalytic domain],RP11-106M3.3:ENST00000570175.1:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.1331T>C::	HEXA:NM_000520.6:missense_variant:MODERATE:exon11/14:c.1306A>G:p.Ile436Val:,HEXA:NM_001318825.2:missense_variant:MODERATE:exon11/14:c.1339A>G:p.Ile447Val:,HEXA:NR_134869.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/10:n.1116-226A>G::		606869 [GENE=HEXA PHENOS=GM2-gangliosidosis,several forms,272800,Autosomal recessive/Tay-Sachs disease,272800,Autosomal recessive/Hex A pseudodeficiency,272800,Autosomal recessive];	93189 [benign DISEASE=Tay-Sachs disease,not specified,none provided,not provided];			rs1800431	0.8764	0.9703	12846,.	0.6041,0.9812,0.9997,0.9982,0.9984	-0.2010	T(0.29), ,T(0.29), ,T(0.31),T(0.30), 	B(0.00), ,B(0.00), ,B(0.00),B(0.00), 	0.14,0.23	9.88	0.23				0.084	0.5362	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HEXA (inh=AR oe_syn=0.96 oe_mis=1.07 oe_lof=0.68)	1.0000	196	196	n/a (non-het)
chr15	72668539	72668539	T	C	hom		QUAL=2427;DP=125;AF=1.00;MQM=60	HEXA,HEXA-AS1	5'UTR,non_coding_transcript_exon	HEXA:ENST00000268097.5:5_prime_UTR_variant:MODIFIER:exon1/14:c.-226A>G::,HEXA-AS1:ENST00000567598.1:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.86T>C::	HEXA-AS1:NR_027262.1:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.86T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	606869 [GENE=HEXA PHENOS=GM2-gangliosidosis,several forms,272800,Autosomal recessive/Tay-Sachs disease,272800,Autosomal recessive/Hex A pseudodeficiency,272800,Autosomal recessive];				rs4777505	0.7975	0.8238	11305,.		0.1070			0.01,0.42	10.14					0.0363	0.9411	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HEXA (inh=AR oe_syn=0.96 oe_mis=1.07 oe_lof=0.68), HEXA-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	1.0000	2	2	n/a (non-het)
chr16	28489342	28489342	G	A	het		QUAL=1197;DP=105;AF=0.57;MQM=60	CLN3	intron,intron&NMD_transcript	CLN3:ENST00000333496.9:intron_variant:MODIFIER:intron13/14:c.985-144C>T::,CLN3:ENST00000354630.5:intron_variant:MODIFIER:intron13/14:c.1006-144C>T::,CLN3:ENST00000355477.5:intron_variant:MODIFIER:intron13/14:c.913-144C>T::,CLN3:ENST00000357806.7:intron_variant:MODIFIER:intron10/11:c.760-144C>T::,CLN3:ENST00000357857.9:intron_variant:MODIFIER:intron12/13:c.895-144C>T::,CLN3:ENST00000359984.7:intron_variant:MODIFIER:intron13/14:c.1057-144C>T::,CLN3:ENST00000360019.2:intron_variant:MODIFIER:intron14/15:c.1057-144C>T::,CLN3:ENST00000395653.4:intron_variant:MODIFIER:intron11/12:c.757-144C>T::,CLN3:ENST00000535392.1:intron_variant:MODIFIER:intron11/13:c.823-144C>T::,CLN3:ENST00000565316.1:intron_variant:MODIFIER:intron12/13:c.1006-144C>T::,CLN3:ENST00000567963.1:intron_variant:MODIFIER:intron12/12:c.907-386C>T::,CLN3:ENST00000568224.1:intron_variant&NMD_transcript_variant:MODIFIER:intron11/13:c.823-144C>T::,CLN3:ENST00000569430.1:intron_variant:MODIFIER:intron15/16:c.1057-144C>T::	CLN3:NM_000086.2:intron_variant:MODIFIER:intron13/14:c.1057-144C>T::,CLN3:NM_001042432.1:intron_variant:MODIFIER:intron14/15:c.1057-144C>T::,CLN3:NM_001286104.2:intron_variant:MODIFIER:intron13/14:c.985-144C>T::,CLN3:NM_001286105.2:intron_variant:MODIFIER:intron11/12:c.757-144C>T::,CLN3:NM_001286109.2:intron_variant:MODIFIER:intron11/13:c.823-144C>T::,CLN3:NM_001286110.2:intron_variant:MODIFIER:intron12/13:c.895-144C>T::		607042 [GENE=CLN3 PHENOS=Ceroid lipofuscinosis,neuronal,3,204200,Autosomal recessive];	679913 [benign DISEASE=not provided];		AluSx (SINE/Alu)	rs28374519	0.4040	0.3362	1940,.		-0.4380			0.00,0.19	0.75							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLN3 (inh=AR oe_syn=1.13 oe_mis=1.03 oe_lof=0.59)	0.4091	22	9	0.5235
chr16	29825126	29825126	T	C	hom		QUAL=20361;DP=628;AF=1.00;MQM=60	PRRT2,AC009133.20	synonymous,intron&non_coding_transcript	PRRT2:ENST00000300797.6:synonymous_variant:LOW:exon2/2:c.751T>C:p.Leu251=:,PRRT2:ENST00000358758.7:synonymous_variant:LOW:exon2/4:c.751T>C:p.Leu251=:,PRRT2:ENST00000567659.1:synonymous_variant:LOW:exon2/3:c.751T>C:p.Leu251=:,AC009133.20:ENST00000569039.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.246-3632A>G::	PRRT2:NM_001256442.2:synonymous_variant:LOW:exon2/3:c.751T>C:p.Leu251=:,PRRT2:NM_001256443.2:synonymous_variant:LOW:exon2/2:c.751T>C:p.Leu251=:,PRRT2:NM_145239.3:synonymous_variant:LOW:exon2/4:c.751T>C:p.Leu251=:	regulatory_region_variant:promoter	614386 [GENE=PRRT2 PHENOS=Episodic kinesigenic dyskinesia 1,128200,Autosomal dominant/Seizures,benign familial infantile,2,605751,Autosomal dominant/Convulsions,familial infantile,with paroxysmal choreoathetosis,602066,Autosomal dominant];	167544 [benign DISEASE=not specified];			rs11150573	0.9918	0.9984	15449,.	0.9766,0.9991,1.0000,1.0000,1.0000	0.3360			0.03,0.52	10.07					0.0211	0.7104	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAZ (inh=n/a oe_syn=2.07 oe_mis=0.89 oe_lof=0.07), PRRT2 (inh=AD oe_syn=1.00 oe_mis=0.96 oe_lof=0.18), PAGR1 (inh=n/a oe_syn=1.05 oe_mis=0.86 oe_lof=0.11)	1.0000	368	368	n/a (non-het)
chr16	81816733	81816733	C	T	het		QUAL=2765;DP=291;AF=0.40;MQM=60	PLCG2	intron	PLCG2:ENST00000359376.3:intron_variant:MODIFIER:intron1/32:c.-47-2815C>T::	PLCG2:NM_002661.5:intron_variant:MODIFIER:intron1/32:c.-47-2815C>T::		600220 [GENE=PLCG2 PHENOS=Familial cold autoinflammatory syndrome 3,614468,Autosomal dominant/Autoinflammation,antibody deficiency,and immune dysregulation syndrome,614878,Autosomal dominant];				rs8045964	0.4241	0.4282	2839,.	0.3924,0.3658,0.2790,0.4221,0.6311	-0.4270			0.00,0.10	1.77							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)	1.0000	2	2	0.5000
chr16	81816787	81816787	T	A	hom	off-target	QUAL=8973;DP=290;AF=1.00;MQM=60	PLCG2	intron	PLCG2:ENST00000359376.3:intron_variant:MODIFIER:intron1/32:c.-47-2761T>A::	PLCG2:NM_002661.5:intron_variant:MODIFIER:intron1/32:c.-47-2761T>A::		600220 [GENE=PLCG2 PHENOS=Familial cold autoinflammatory syndrome 3,614468,Autosomal dominant/Autoinflammation,antibody deficiency,and immune dysregulation syndrome,614878,Autosomal dominant];				rs4476171		0.9994	15680,.		-1.8260			0.01,0.14	1.15							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)	n/a (no coverage)	0	n/a (no coverage)	n/a (no coverage)
chr17	42427544	42427544	-	AGTC	het	off-target	QUAL=2961;DP=424;AF=0.50;MQM=60	GRN	intron	GRN:ENST00000053867.3:intron_variant:MODIFIER:intron4/12:c.350-50_350-47dup::,GRN:ENST00000589265.1:intron_variant:MODIFIER:intron4/8:c.350-50_350-47dup::	GRN:NM_002087.3:intron_variant:MODIFIER:intron4/12:c.350-50_350-47dup::		138945 [GENE=GRN PHENOS=Ceroid lipofuscinosis,neuronal,11,614706,Autosomal recessive/Aphasia,primary progressive,607485,Autosomal dominant/Frontotemporal lobar degeneration with ubiquitin-positive inclusions,607485,Autosomal dominant];	803426 [benign DISEASE=Grn-related frontotemporal lobar degeneration with Tdp43 inclusions];			rs34424835		0.3230	1793,.						5.03					0.0717	0.9355	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GRN (inh=AR+AD oe_syn=1.13 oe_mis=0.96 oe_lof=0.27), FAM171A2 (inh=n/a oe_syn=0.76 oe_mis=0.58 oe_lof=0.12)	0.4382	89	39	0.2461
chr17	42427732	42427732	G	A	het		QUAL=6707;DP=595;AF=0.53;MQM=60	GRN	intron	GRN:ENST00000053867.3:intron_variant:MODIFIER:intron5/12:c.462+24G>A::,GRN:ENST00000589265.1:intron_variant:MODIFIER:intron5/8:c.462+24G>A::	GRN:NM_002087.3:intron_variant:MODIFIER:intron5/12:c.462+24G>A::		138945 [GENE=GRN PHENOS=Ceroid lipofuscinosis,neuronal,11,614706,Autosomal recessive/Aphasia,primary progressive,607485,Autosomal dominant/Frontotemporal lobar degeneration with ubiquitin-positive inclusions,607485,Autosomal dominant];	558917 [benign DISEASE=not provided];			rs850713	0.3514	0.2811	1217,.	0.3381,0.2205,0.4923,0.2368,0.3175	-0.8860			0.01,0.20	5.58					0.0792	0.9261	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GRN (inh=AR+AD oe_syn=1.13 oe_mis=0.96 oe_lof=0.27), FAM171A2 (inh=n/a oe_syn=0.76 oe_mis=0.58 oe_lof=0.12)	0.4779	136	65	0.6683
chr17	42428538	42428538	G	A	het		QUAL=9630;DP=704;AF=0.51;MQM=60	GRN	splice_region&intron,intron	GRN:ENST00000053867.3:splice_region_variant&intron_variant:LOW:intron8/12:c.835+7G>A::,GRN:ENST00000589265.1:intron_variant:MODIFIER:intron5/8:c.463-380G>A::	GRN:NM_002087.3:splice_region_variant&intron_variant:LOW:intron8/12:c.835+7G>A::	regulatory_region_variant:promoter_flanking_region	138945 [GENE=GRN PHENOS=Ceroid lipofuscinosis,neuronal,11,614706,Autosomal recessive/Aphasia,primary progressive,607485,Autosomal dominant/Frontotemporal lobar degeneration with ubiquitin-positive inclusions,607485,Autosomal dominant];	258553 [benign DISEASE=Grn-related frontotemporal lobar degeneration with Tdp43 inclusions,Ceroid lipofuscinosis, neuronal, 11,not specified,not provided];			rs72824736	0.0220	0.0487	56,.	0.0122,0.0174,0.0000,0.0771,0.0105	0.0830			0.10,0.09	4.26			0.000/0.000		0.2225	0.8055	0.01	84	1973	7 / 189					GRN (inh=AR+AD oe_syn=1.13 oe_mis=0.96 oe_lof=0.27), FAM171A2 (inh=n/a oe_syn=0.76 oe_mis=0.58 oe_lof=0.12)	0.4726	201	95	0.6173
chr18	11689522	11689522	T	C	het		QUAL=5556;DP=453;AF=0.57;MQM=60	GNAL	5'UTR	GNAL:ENST00000334049.6:5_prime_UTR_variant:MODIFIER:exon1/12:c.-41T>C::	GNAL:NM_182978.4:5_prime_UTR_variant:MODIFIER:exon1/12:c.-41T>C::	regulatory_region_variant:promoter	139312 [GENE=GNAL PHENOS=Dystonia 25,615073,Autosomal dominant];				rs9303742	0.3145	0.3389	2566,.	,,,0.2630,0.5000	-1.6050			0.00,0.13	11.00					-0.0099	0.1404		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNAL (inh=AD oe_syn=0.94 oe_mis=0.38 oe_lof=0.04)	0.5417	24	13	0.8388
chr18	11824880	11824880	T	A	hom		QUAL=1506;DP=54;AF=1.00;MQM=60	GNAL	intron	GNAL:ENST00000269162.5:intron_variant:MODIFIER:intron5/12:c.394-37T>A::,GNAL:ENST00000334049.6:intron_variant:MODIFIER:intron4/11:c.625-37T>A::,GNAL:ENST00000423027.3:intron_variant:MODIFIER:intron4/11:c.394-37T>A::,GNAL:ENST00000535121.1:intron_variant:MODIFIER:intron5/12:c.394-37T>A::	GNAL:NM_001142339.2:intron_variant:MODIFIER:intron5/12:c.394-37T>A::,GNAL:NM_001261443.1:intron_variant:MODIFIER:intron5/12:c.394-37T>A::,GNAL:NM_001369387.1:intron_variant:MODIFIER:intron4/11:c.394-37T>A::,GNAL:NM_182978.4:intron_variant:MODIFIER:intron4/11:c.625-37T>A::		139312 [GENE=GNAL PHENOS=Dystonia 25,615073,Autosomal dominant];				rs1647556		0.8134	7809,.	0.5841,0.9034,0.7476,0.8197,0.7789	-1.1750			0.01,0.10	1.01					0.0683	0.1386	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNAL (inh=AD oe_syn=0.94 oe_mis=0.38 oe_lof=0.04)	1.0000	70	70	n/a (non-het)
chr18	11824886	11824886	T	G	hom		QUAL=1496;DP=54;AF=1.00;MQM=60	GNAL	intron	GNAL:ENST00000269162.5:intron_variant:MODIFIER:intron5/12:c.394-31T>G::,GNAL:ENST00000334049.6:intron_variant:MODIFIER:intron4/11:c.625-31T>G::,GNAL:ENST00000423027.3:intron_variant:MODIFIER:intron4/11:c.394-31T>G::,GNAL:ENST00000535121.1:intron_variant:MODIFIER:intron5/12:c.394-31T>G::	GNAL:NM_001142339.2:intron_variant:MODIFIER:intron5/12:c.394-31T>G::,GNAL:NM_001261443.1:intron_variant:MODIFIER:intron5/12:c.394-31T>G::,GNAL:NM_001369387.1:intron_variant:MODIFIER:intron4/11:c.394-31T>G::,GNAL:NM_182978.4:intron_variant:MODIFIER:intron4/11:c.625-31T>G::		139312 [GENE=GNAL PHENOS=Dystonia 25,615073,Autosomal dominant];				rs1647557	0.6396	0.7589	7811,.	0.4279,0.8899,0.6574,0.7809,0.7083	1.8090			0.37,0.21	5.21					0.3985	0.0281	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNAL (inh=AD oe_syn=0.94 oe_mis=0.38 oe_lof=0.04)	1.0000	75	75	n/a (non-het)
chr18	11862697	11862697	T	C	het		QUAL=1675;DP=172;AF=0.51;MQM=60	GNAL	intron	GNAL:ENST00000269162.5:intron_variant:MODIFIER:intron7/12:c.546+249T>C::,GNAL:ENST00000334049.6:intron_variant:MODIFIER:intron6/11:c.777+249T>C::,GNAL:ENST00000423027.3:intron_variant:MODIFIER:intron6/11:c.546+249T>C::,GNAL:ENST00000535121.1:intron_variant:MODIFIER:intron7/12:c.546+249T>C::,GNAL:ENST00000602628.1:intron_variant:MODIFIER:intron2/7:c.-76+249T>C::	GNAL:NM_001142339.2:intron_variant:MODIFIER:intron7/12:c.546+249T>C::,GNAL:NM_001261443.1:intron_variant:MODIFIER:intron7/12:c.546+249T>C::,GNAL:NM_001261444.2:intron_variant:MODIFIER:intron2/7:c.-76+249T>C::,GNAL:NM_001369387.1:intron_variant:MODIFIER:intron6/11:c.546+249T>C::,GNAL:NM_182978.4:intron_variant:MODIFIER:intron6/11:c.777+249T>C::		139312 [GENE=GNAL PHENOS=Dystonia 25,615073,Autosomal dominant];				rs787554		0.6835	7766,.		-1.3640			0.00,0.11	3.08							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNAL (inh=AD oe_syn=0.94 oe_mis=0.38 oe_lof=0.04)	0.2222	9	2	0.1797
chr18	11864707	11864707	A	G	hom		QUAL=7209;DP=242;AF=1.00;MQM=60	GNAL	intron	GNAL:ENST00000269162.5:intron_variant:MODIFIER:intron8/12:c.620+102A>G::,GNAL:ENST00000334049.6:intron_variant:MODIFIER:intron7/11:c.851+102A>G::,GNAL:ENST00000423027.3:intron_variant:MODIFIER:intron7/11:c.620+102A>G::,GNAL:ENST00000535121.1:intron_variant:MODIFIER:intron8/12:c.620+102A>G::,GNAL:ENST00000602628.1:intron_variant:MODIFIER:intron3/7:c.-2+102A>G::	GNAL:NM_001142339.2:intron_variant:MODIFIER:intron8/12:c.620+102A>G::,GNAL:NM_001261443.1:intron_variant:MODIFIER:intron8/12:c.620+102A>G::,GNAL:NM_001261444.2:intron_variant:MODIFIER:intron3/7:c.-2+102A>G::,GNAL:NM_001369387.1:intron_variant:MODIFIER:intron7/11:c.620+102A>G::,GNAL:NM_182978.4:intron_variant:MODIFIER:intron7/11:c.851+102A>G::		139312 [GENE=GNAL PHENOS=Dystonia 25,615073,Autosomal dominant];				rs4315401	0.9647	0.9689	14765,.		-1.0730			0.00,0.06	0.14							0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNAL (inh=AD oe_syn=0.94 oe_mis=0.38 oe_lof=0.04)	1.0000	27	27	n/a (non-het)
chr18	11867297	11867297	C	T	het		QUAL=2561;DP=243;AF=0.42;MQM=60	GNAL	intron	GNAL:ENST00000269162.5:intron_variant:MODIFIER:intron9/12:c.679+72C>T::,GNAL:ENST00000334049.6:intron_variant:MODIFIER:intron8/11:c.910+72C>T::,GNAL:ENST00000423027.3:intron_variant:MODIFIER:intron8/11:c.679+72C>T::,GNAL:ENST00000535121.1:intron_variant:MODIFIER:intron9/12:c.679+72C>T::,GNAL:ENST00000602628.1:intron_variant:MODIFIER:intron4/7:c.58+72C>T::	GNAL:NM_001142339.2:intron_variant:MODIFIER:intron9/12:c.679+72C>T::,GNAL:NM_001261443.1:intron_variant:MODIFIER:intron9/12:c.679+72C>T::,GNAL:NM_001261444.2:intron_variant:MODIFIER:intron4/7:c.58+72C>T::,GNAL:NM_001369387.1:intron_variant:MODIFIER:intron8/11:c.679+72C>T::,GNAL:NM_182978.4:intron_variant:MODIFIER:intron8/11:c.910+72C>T::		139312 [GENE=GNAL PHENOS=Dystonia 25,615073,Autosomal dominant];				rs2855646	0.2542	0.2592	1196,.		-0.0070			0.00,0.08	5.80					-0.0009	0.5122	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNAL (inh=AD oe_syn=0.94 oe_mis=0.38 oe_lof=0.04)	0.4918	61	30	1.0000
chr18	11872516	11872516	T	C	het		QUAL=2632;DP=176;AF=0.59;MQM=60	GNAL	intron	GNAL:ENST00000269162.5:intron_variant:MODIFIER:intron11/12:c.931+119T>C::,GNAL:ENST00000334049.6:intron_variant:MODIFIER:intron10/11:c.1162+119T>C::,GNAL:ENST00000423027.3:intron_variant:MODIFIER:intron10/11:c.931+119T>C::,GNAL:ENST00000535121.1:intron_variant:MODIFIER:intron11/12:c.931+119T>C::,GNAL:ENST00000602628.1:intron_variant:MODIFIER:intron6/7:c.310+119T>C::	GNAL:NM_001142339.2:intron_variant:MODIFIER:intron11/12:c.931+119T>C::,GNAL:NM_001261443.1:intron_variant:MODIFIER:intron11/12:c.931+119T>C::,GNAL:NM_001261444.2:intron_variant:MODIFIER:intron6/7:c.310+119T>C::,GNAL:NM_001369387.1:intron_variant:MODIFIER:intron10/11:c.931+119T>C::,GNAL:NM_182978.4:intron_variant:MODIFIER:intron10/11:c.1162+119T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	139312 [GENE=GNAL PHENOS=Dystonia 25,615073,Autosomal dominant];				rs2071140	0.2446	0.2527	1077,.		-0.0330			0.02,0.16	4.16							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNAL (inh=AD oe_syn=0.94 oe_mis=0.38 oe_lof=0.04)	0.2500	20	5	0.0414
chr18	11872573	11872573	C	A	het		QUAL=1029;DP=88;AF=0.59;MQM=60	GNAL	intron	GNAL:ENST00000269162.5:intron_variant:MODIFIER:intron11/12:c.931+176C>A::,GNAL:ENST00000334049.6:intron_variant:MODIFIER:intron10/11:c.1162+176C>A::,GNAL:ENST00000423027.3:intron_variant:MODIFIER:intron10/11:c.931+176C>A::,GNAL:ENST00000535121.1:intron_variant:MODIFIER:intron11/12:c.931+176C>A::,GNAL:ENST00000602628.1:intron_variant:MODIFIER:intron6/7:c.310+176C>A::	GNAL:NM_001142339.2:intron_variant:MODIFIER:intron11/12:c.931+176C>A::,GNAL:NM_001261443.1:intron_variant:MODIFIER:intron11/12:c.931+176C>A::,GNAL:NM_001261444.2:intron_variant:MODIFIER:intron6/7:c.310+176C>A::,GNAL:NM_001369387.1:intron_variant:MODIFIER:intron10/11:c.931+176C>A::,GNAL:NM_182978.4:intron_variant:MODIFIER:intron10/11:c.1162+176C>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	139312 [GENE=GNAL PHENOS=Dystonia 25,615073,Autosomal dominant];				rs2071141	0.2330	0.2389	947,.		-1.8490			0.01,0.25	2.28							0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNAL (inh=AD oe_syn=0.94 oe_mis=0.38 oe_lof=0.04)	0.5000	10	5	1.0000
chr18	12348285	12348285	T	C	het		QUAL=15946;DP=1305;AF=0.47;MQM=60	AFG3L2	synonymous	AFG3L2:ENST00000269143.3:synonymous_variant:LOW:exon13/17:c.1650A>G:p.Glu550=:PF01434 [Peptidase family M41]	AFG3L2:NM_006796.3:synonymous_variant:LOW:exon13/17:c.1650A>G:p.Glu550=:		604581 [GENE=AFG3L2 PHENOS=Spastic ataxia 5,autosomal recessive,614487,Autosomal recessive/Optic atrophy 12,618977,Autosomal dominant/Spinocerebellar ataxia 28,610246,Autosomal dominant];	128287 [benign DISEASE=Spinocerebellar ataxia type 28,not specified,not provided];			rs11553521		0.7762	9507,.	0.7637,0.5679,0.6107,0.7808,0.7839	-0.0740			0.59,0.96	9.33					-0.2557	0.4903	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AFG3L2 (inh=AR+AD oe_syn=1.07 oe_mis=0.73 oe_lof=0.49)	0.4826	201	97	0.7644
chr18	12351342	12351342	C	T	het		QUAL=12118;DP=1026;AF=0.47;MQM=60	AFG3L2	synonymous	AFG3L2:ENST00000269143.3:synonymous_variant:LOW:exon11/17:c.1389G>A:p.Leu463=:PF00004 [ATPase family associated with various cellular activities (AAA)]	AFG3L2:NM_006796.3:synonymous_variant:LOW:exon11/17:c.1389G>A:p.Leu463=:		604581 [GENE=AFG3L2 PHENOS=Spastic ataxia 5,autosomal recessive,614487,Autosomal recessive/Optic atrophy 12,618977,Autosomal dominant/Spinocerebellar ataxia 28,610246,Autosomal dominant];	128286 [benign DISEASE=Spinocerebellar ataxia type 28,not specified,not provided];			rs11080572		0.7171	7832,.	0.4841,0.5561,0.6044,0.7793,0.7815	-0.9330			0.09,0.25	3.97					-0.0854	0.287	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AFG3L2 (inh=AR+AD oe_syn=1.07 oe_mis=0.73 oe_lof=0.49)	0.5000	242	121	1.0000
chr18	12358997	12358997	A	G	het	off-target	QUAL=9913;DP=799;AF=0.51;MQM=60	AFG3L2	intron	AFG3L2:ENST00000269143.3:intron_variant:MODIFIER:intron7/16:c.753-55T>C::	AFG3L2:NM_006796.3:intron_variant:MODIFIER:intron7/16:c.753-55T>C::		604581 [GENE=AFG3L2 PHENOS=Spastic ataxia 5,autosomal recessive,614487,Autosomal recessive/Optic atrophy 12,618977,Autosomal dominant/Spinocerebellar ataxia 28,610246,Autosomal dominant];				rs7407640	0.6302	0.7046	8081,.		-1.9010			0.00,0.02	0.01					-0.0055	0.8724	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AFG3L2 (inh=AR+AD oe_syn=1.07 oe_mis=0.73 oe_lof=0.49)	0.5217	69	36	0.8099
chr18	12359920	12359920	G	A	het	low_conf_region	QUAL=1494;DP=152;AF=0.42;MQM=60	AFG3L2	splice_region&intron	AFG3L2:ENST00000269143.3:splice_region_variant&intron_variant:LOW:intron7/16:c.752+6C>T::	AFG3L2:NM_006796.3:splice_region_variant&intron_variant:LOW:intron7/16:c.752+6C>T::		604581 [GENE=AFG3L2 PHENOS=Spastic ataxia 5,autosomal recessive,614487,Autosomal recessive/Optic atrophy 12,618977,Autosomal dominant/Spinocerebellar ataxia 28,610246,Autosomal dominant];	136312 [benign DISEASE=Spinocerebellar ataxia type 28,not specified,not provided];			rs8097342	0.6196	0.7145	7788,.	0.4824,0.5558,0.6056,0.7770,0.7708	-0.5940			0.01,0.07	2.52		4.20>6.19	0.000/0.000		0.2641	0.5043	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AFG3L2 (inh=AR+AD oe_syn=1.07 oe_mis=0.73 oe_lof=0.49)	0.5033	151	76	1.0000
chr18	12377177	12377177	C	G	het		QUAL=10773;DP=906;AF=0.52;MQM=60	AFG3L2	5'UTR	AFG3L2:ENST00000269143.3:5_prime_UTR_variant:MODIFIER:exon1/17:c.-96G>C::	AFG3L2:NM_006796.3:5_prime_UTR_variant:MODIFIER:exon1/17:c.-96G>C::	regulatory_region_variant:promoter,TF_binding_site_variant	604581 [GENE=AFG3L2 PHENOS=Spastic ataxia 5,autosomal recessive,614487,Autosomal recessive/Optic atrophy 12,618977,Autosomal dominant/Spinocerebellar ataxia 28,610246,Autosomal dominant];	326120 [benign DISEASE=Spinocerebellar ataxia type 28];			rs12327346	0.1883	0.1338	598,.	0.3827,0.1444,0.1518,0.0291,0.0821	-0.4970			0.01,0.48	10.54					-0.0869	0.0964	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AFG3L2 (inh=AR+AD oe_syn=1.07 oe_mis=0.73 oe_lof=0.49)	n/a (no coverage)	0	n/a (no coverage)	n/a (no coverage)
chr18	19995753	19995753	T	C	hom		QUAL=6473;DP=258;AF=1.00;MQM=60	CTAGE1	synonymous	CTAGE1:ENST00000391403.2:synonymous_variant:LOW:exon1/1:c.2022A>G:p.Pro674=:	CTAGE1:NM_172241.3:synonymous_variant:LOW:exon1/1:c.2022A>G:p.Pro674=:						rs9946145	0.6855	0.8553	10184,.	0.3488,0.8771,0.8271,0.9161,0.7923	-0.1350			0.02,0.10	0.27					0.003	0.9421	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTAGE1 (inh=n/a oe_syn=1.20 oe_mis=1.39 oe_lof=n/a)	1.0000	396	396	n/a (non-het)
chr18	19996011	19996011	G	A	het		QUAL=2864;DP=317;AF=0.47;MQM=60	CTAGE1	synonymous	CTAGE1:ENST00000391403.2:synonymous_variant:LOW:exon1/1:c.1764C>T:p.Leu588=:	CTAGE1:NM_172241.3:synonymous_variant:LOW:exon1/1:c.1764C>T:p.Leu588=:						rs7227477	0.4942	0.5056	3822,.	0.4654,0.6070,0.6150,0.4834,0.4305	0.0500			0.00,0.04	0.19					0.0059	0.9422	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTAGE1 (inh=n/a oe_syn=1.20 oe_mis=1.39 oe_lof=n/a)	0.5518	328	181	0.2128
chr18	21113285	21113285	T	C	hom		QUAL=1580;DP=49;AF=1.00;MQM=60	NPC1	intron	NPC1:ENST00000269228.5:intron_variant:MODIFIER:intron24/24:c.3754+34A>G::,NPC1:ENST00000412552.2:intron_variant:MODIFIER:intron17/17:c.2800+34A>G::	NPC1:NM_000271.5:intron_variant:MODIFIER:intron24/24:c.3754+34A>G::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type D,257220,Autosomal recessive/Niemann-Pick disease,type C1,257220,Autosomal recessive];	255700 [benign DISEASE=not specified];			rs2510344	0.5222	0.5079	3694,.	0.4801,0.6588,0.6210,0.4709,0.4986	-0.8960			0.08,0.20	2.53					0.1003	0.8809	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RMC1 (inh=n/a oe_syn=0.96 oe_mis=0.75 oe_lof=0.16), NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)	1.0000	81	81	n/a (non-het)
chr18	21119291	21119291	A	G	hom		QUAL=15780;DP=515;AF=1.00;MQM=60	NPC1	intron	NPC1:ENST00000269228.5:intron_variant:MODIFIER:intron19/24:c.2911+28T>C::,NPC1:ENST00000412552.2:intron_variant:MODIFIER:intron12/17:c.1957+28T>C::	NPC1:NM_000271.5:intron_variant:MODIFIER:intron19/24:c.2911+28T>C::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type D,257220,Autosomal recessive/Niemann-Pick disease,type C1,257220,Autosomal recessive];	255695 [benign DISEASE=not specified,not provided];			rs6507720		0.5518	4945,.	0.7131,0.6710,0.6233,0.4712,0.4977	-1.3490			0.04,0.17	3.29					0.0707	0.3576	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)	1.0000	83	83	n/a (non-het)
chr18	21119777	21119777	G	A	hom		QUAL=12387;DP=386;AF=0.99;MQM=60	NPC1	splice_region&synonymous	NPC1:ENST00000269228.5:splice_region_variant&synonymous_variant:LOW:exon18/25:c.2793C>T:p.Asn931=:,NPC1:ENST00000412552.2:splice_region_variant&synonymous_variant:LOW:exon11/18:c.1839C>T:p.Asn613=:	NPC1:NM_000271.5:splice_region_variant&synonymous_variant:LOW:exon18/25:c.2793C>T:p.Asn931=:	regulatory_region_variant:promoter_flanking_region	607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type D,257220,Autosomal recessive/Niemann-Pick disease,type C1,257220,Autosomal recessive];	21136 [benign DISEASE=Niemann-Pick disease type C1,not specified,not provided]; 867233 [likely pathogenic DISEASE=Niemann-Pick disease type C1];			rs1140458	0.4840	0.4986	3339,.	0.3778,0.6539,0.6224,0.4698,0.4867	4.7400			0.98,0.99	17.39		-0.68>-3.03	0.992/		-0.6346	0.937	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)	1.0000	270	270	n/a (non-het)
chr18	21120035	21120035	T	C	hom		QUAL=20671;DP=642;AF=1.00;MQM=60	NPC1	intron	NPC1:ENST00000269228.5:intron_variant:MODIFIER:intron17/24:c.2605-70A>G::,NPC1:ENST00000412552.2:intron_variant:MODIFIER:intron10/17:c.1651-70A>G::	NPC1:NM_000271.5:intron_variant:MODIFIER:intron17/24:c.2605-70A>G::	regulatory_region_variant:promoter_flanking_region	607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type D,257220,Autosomal recessive/Niemann-Pick disease,type C1,257220,Autosomal recessive];				rs7239575	0.5867	0.5517	4926,.		-0.4170			0.00,0.14	5.07					0.0347	0.8722	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)	1.0000	41	41	n/a (non-het)
chr18	21120382	21120382	A	-	het	low_conf_region	QUAL=53;DP=16;AF=0.25;MQM=60	NPC1	intron	NPC1:ENST00000269228.5:intron_variant:MODIFIER:intron17/24:c.2604+30del::,NPC1:ENST00000412552.2:intron_variant:MODIFIER:intron10/17:c.1650+30del::	NPC1:NM_000271.5:intron_variant:MODIFIER:intron17/24:c.2604+30del::	regulatory_region_variant:promoter_flanking_region	607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type D,257220,Autosomal recessive/Niemann-Pick disease,type C1,257220,Autosomal recessive];	522211 [benign DISEASE=Niemann-Pick disease type C1,not provided];			rs746440359		0.4115	1,.	0.3957,0.4302,0.4210,0.4030,0.4299	0.0860				0.99					-0.0835	0.5584	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)	0.1667	108	18	0.0000
chr18	21120444	21120444	T	C	hom		QUAL=1403;DP=54;AF=0.98;MQM=60	NPC1	missense	NPC1:ENST00000269228.5:missense_variant:MODERATE:exon17/25:c.2572A>G:p.Ile858Val:,NPC1:ENST00000412552.2:missense_variant:MODERATE:exon10/18:c.1618A>G:p.Ile540Val:	NPC1:NM_000271.5:missense_variant:MODERATE:exon17/25:c.2572A>G:p.Ile858Val:	regulatory_region_variant:promoter_flanking_region	607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type D,257220,Autosomal recessive/Niemann-Pick disease,type C1,257220,Autosomal recessive];	21135 [benign DISEASE=Niemann-Pick disease type C1,not specified,not provided];			rs1805082	0.4858	0.4994	3340,.	0.3780,0.6542,0.6242,0.4704,0.4898	4.9490	T(0.26),T(0.22)	B(0.02),B(0.02)	0.95,0.98	22.50	0.33				0.2347	0.5695	0.1	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)	1.0000	205	205	n/a (non-het)
chr18	21123296	21123296	-	A	hom	low_conf_region	QUAL=168;DP=16;AF=0.38;MQM=60	NPC1	intron	NPC1:ENST00000269228.5:intron_variant:MODIFIER:intron14/24:c.2245+122dup::,NPC1:ENST00000412552.2:intron_variant:MODIFIER:intron7/17:c.1291+122dup::	NPC1:NM_000271.5:intron_variant:MODIFIER:intron14/24:c.2245+122dup::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type D,257220,Autosomal recessive/Niemann-Pick disease,type C1,257220,Autosomal recessive];			AluSx (SINE/Alu)	rs34563465		0.5514	1883,.						0.80							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)	0.4444	27	12	n/a (non-het)
chr18	21123537	21123537	A	-	het	low_conf_region	QUAL=3639;DP=423;AF=0.37;MQM=60	NPC1	splice_region&intron	NPC1:ENST00000269228.5:splice_region_variant&intron_variant:LOW:intron13/24:c.2131-4del::,NPC1:ENST00000412552.2:splice_region_variant&intron_variant:LOW:intron6/17:c.1177-4del::	NPC1:NM_000271.5:splice_region_variant&intron_variant:LOW:intron13/24:c.2131-4del::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type D,257220,Autosomal recessive/Niemann-Pick disease,type C1,257220,Autosomal recessive];	403254 [benign DISEASE=Niemann-Pick disease type C1,not specified,not provided];		(A)n (Simple_repeat)	rs11299077		0.6374	5071,.	0.4657,0.4708,0.4747,0.4543,0.4657	-0.4120				0.02					-0.013	0.2369	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)	0.3711	97	36	0.0144
chr18	21124907	21124907	A	C	hom	low_conf_region	QUAL=3292;DP=100;AF=0.14;MQM=60	NPC1	intron	NPC1:ENST00000269228.5:intron_variant:MODIFIER:intron12/24:c.1947+17T>G::,NPC1:ENST00000412552.2:intron_variant:MODIFIER:intron5/17:c.993+17T>G::	NPC1:NM_000271.5:intron_variant:MODIFIER:intron12/24:c.1947+17T>G::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type D,257220,Autosomal recessive/Niemann-Pick disease,type C1,257220,Autosomal recessive];	931815 [benign DISEASE=Niemann-Pick disease type C1];			rs879174633					-0.9290			0.09,0.19	0.78					0.0534	0.0967	0	210	646	4 / 24	2	"[2] auto-classification 17.09.2017%0A%0A"		"GS150329_02:%0A22.02.2015, TCB: Poly-C im intronischen Bereich!"	NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)	0.2273	22	5	n/a (non-het)
chr18	21124945	21124945	C	G	hom		QUAL=6416;DP=256;AF=0.93;MQM=60	NPC1	missense	NPC1:ENST00000269228.5:missense_variant:MODERATE:exon12/25:c.1926G>C:p.Met642Ile:,NPC1:ENST00000412552.2:missense_variant:MODERATE:exon5/18:c.972G>C:p.Met324Ile:	NPC1:NM_000271.5:missense_variant:MODERATE:exon12/25:c.1926G>C:p.Met642Ile:		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type D,257220,Autosomal recessive/Niemann-Pick disease,type C1,257220,Autosomal recessive];	92701 [benign DISEASE=Niemann-Pick disease type C1,not specified,not provided];	CM1213781 [CLASS=DP MUT=ALT PHEN="Type 2 diabetes decreased risk" GENE=NPC1];		rs1788799		0.7422	8498,.	0.9243,0.8278,0.9346,0.6528,0.7684	3.3040	T(1.00),T(1.00)	B(0.00),B(0.00)	0.22,0.96	18.32	0.26				0.0198	0.0973	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)	1.0000	81	81	n/a (non-het)
chr18	21127910	21127910	C	T	hom		QUAL=41145;DP=1253;AF=1.00;MQM=60	NPC1	intron	NPC1:ENST00000269228.5:intron_variant:MODIFIER:intron11/24:c.1757+60G>A::,NPC1:ENST00000412552.2:intron_variant:MODIFIER:intron4/17:c.804-2797G>A::	NPC1:NM_000271.5:intron_variant:MODIFIER:intron11/24:c.1757+60G>A::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type D,257220,Autosomal recessive/Niemann-Pick disease,type C1,257220,Autosomal recessive];				rs2435307	0.4910	0.4688	3455,.		0.1120			0.00,0.09	1.32					0.032	0.3159	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)	1.0000	71	71	n/a (non-het)
chr18	21134570	21134570	A	-	het		QUAL=1186;DP=117;AF=0.39;MQM=60	NPC1	intron	NPC1:ENST00000269228.5:intron_variant:MODIFIER:intron9/24:c.1553+152del::,NPC1:ENST00000412552.2:intron_variant:MODIFIER:intron4/17:c.803+152del::	NPC1:NM_000271.5:intron_variant:MODIFIER:intron9/24:c.1553+152del::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type D,257220,Autosomal recessive/Niemann-Pick disease,type C1,257220,Autosomal recessive];			AluSx (SINE/Alu)	rs11340795		0.5606	3259,.		-0.1020				1.48							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)	0.5714	7	4	1.0000
chr18	21134570	21134571	AA	-	het		QUAL=1186;DP=117;AF=0.19;MQM=60	NPC1	intron	NPC1:ENST00000269228.5:intron_variant:MODIFIER:intron9/24:c.1553+151_1553+152del::,NPC1:ENST00000412552.2:intron_variant:MODIFIER:intron4/17:c.803+151_803+152del::	NPC1:NM_000271.5:intron_variant:MODIFIER:intron9/24:c.1553+151_1553+152del::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type D,257220,Autosomal recessive/Niemann-Pick disease,type C1,257220,Autosomal recessive];			AluSx (SINE/Alu)	rs11340795		0.0412	83,.		-0.1020				1.44							0.01	0	23	0 / 5					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)	0.0000	7	0	0.0156
chr18	21137442	21137442	A	G	hom		QUAL=87;DP=4;AF=1.00;MQM=60	NPC1	intron	NPC1:ENST00000269228.5:intron_variant:MODIFIER:intron6/24:c.882-288T>C::,NPC1:ENST00000412552.2:intron_variant:MODIFIER:intron1/17:c.81-288T>C::	NPC1:NM_000271.5:intron_variant:MODIFIER:intron6/24:c.882-288T>C::		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type D,257220,Autosomal recessive/Niemann-Pick disease,type C1,257220,Autosomal recessive];			AluSc (SINE/Alu)	rs1788760		0.7569	9175,.		-1.2880			0.00,0.03	1.87							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)	1.0000	5	5	n/a (non-het)
chr18	21140432	21140432	T	C	hom		QUAL=30650;DP=927;AF=1.00;MQM=60	NPC1	missense	NPC1:ENST00000269228.5:missense_variant:MODERATE:exon6/25:c.644A>G:p.His215Arg:	NPC1:NM_000271.5:missense_variant:MODERATE:exon6/25:c.644A>G:p.His215Arg:		607623 [GENE=NPC1 PHENOS=Niemann-Pick disease,type D,257220,Autosomal recessive/Niemann-Pick disease,type C1,257220,Autosomal recessive];	92714 [benign DISEASE=Niemann-Pick disease type C1,not specified,not provided];			rs1805081	0.2186	0.3307	1882,.	0.0702,0.2468,0.2463,0.4039,0.2779	0.5900	T(0.58)	B(0.00)	0.28,0.26	8.24	0.15				0.0146	0.1047	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPC1 (inh=AR oe_syn=1.08 oe_mis=0.89 oe_lof=0.34)	1.0000	109	109	n/a (non-het)
chr19	6495736	6495736	A	G	hom		QUAL=8977;DP=313;AF=1.00;MQM=60	TUBB4A	synonymous	TUBB4A:ENST00000264071.2:synonymous_variant:LOW:exon4/4:c.774T>C:p.Val258=:,TUBB4A:ENST00000540257.1:synonymous_variant:LOW:exon4/5:c.774T>C:p.Val258=:	TUBB4A:NM_001289123.1:synonymous_variant:LOW:exon5/5:c.927T>C:p.Val309=:,TUBB4A:NM_001289127.1:synonymous_variant:LOW:exon5/5:c.909T>C:p.Val303=:,TUBB4A:NM_001289129.1:synonymous_variant:LOW:exon5/5:c.774T>C:p.Val258=:,TUBB4A:NM_001289130.1:synonymous_variant:LOW:exon4/4:c.558T>C:p.Val186=:,TUBB4A:NM_001289131.1:synonymous_variant:LOW:exon4/4:c.558T>C:p.Val186=:,TUBB4A:NM_006087.4:synonymous_variant:LOW:exon4/4:c.774T>C:p.Val258=:		602662 [GENE=TUBB4A PHENOS=Leukodystrophy,hypomyelinating,6,612438,Autosomal dominant/Dystonia 4,torsion,autosomal dominant,128101,Autosomal dominant];	330263 [benign DISEASE=Autosomal dominant torsion dystonia 4,Leukodystrophy, hypomyelinating, 6];			rs2071347	0.6294	0.7019	7782,.	0.6893,0.7411,0.4502,0.7059,0.5406	-0.0300			0.36,0.94	7.27					0.0722	0.9708	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TUBB4A (inh=AD oe_syn=1.16 oe_mis=0.31 oe_lof=0.29)	1.0000	503	503	n/a (non-het)
chr19	13002033	13002033	A	G	hom		QUAL=4617;DP=163;AF=1.00;MQM=60	GCDH	intron,5'UTR	GCDH:ENST00000222214.5:intron_variant:MODIFIER:intron1/11:c.-35+17A>G::,GCDH:ENST00000422947.2:intron_variant:MODIFIER:intron1/11:c.-222+17A>G::,GCDH:ENST00000457854.1:intron_variant:MODIFIER:intron1/11:c.-35+17A>G::,GCDH:ENST00000591470.1:5_prime_UTR_variant:MODIFIER:exon1/11:c.-86A>G::	GCDH:NM_000159.4:intron_variant:MODIFIER:intron1/11:c.-35+17A>G::,GCDH:NM_013976.4:intron_variant:MODIFIER:intron1/11:c.-35+17A>G::,GCDH:NR_102316.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/11:n.74+17A>G::,GCDH:NR_102317.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/10:n.74+17A>G::	regulatory_region_variant:promoter,TF_binding_site_variant	608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];				rs7251834	0.9778	0.9710	14813,.		0.4280			0.00,0.27	10.32					-0.1692	0.1935	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KLF1 (inh=AD oe_syn=0.92 oe_mis=0.83 oe_lof=0.60), GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35)	1.0000	76	76	n/a (non-het)
chr19	13002400	13002400	G	C	het		QUAL=13533;DP=1207;AF=0.45;MQM=60	GCDH	intron	GCDH:ENST00000222214.5:intron_variant:MODIFIER:intron3/11:c.127+64G>C::,GCDH:ENST00000422947.2:intron_variant:MODIFIER:intron3/11:c.-61+64G>C::,GCDH:ENST00000457854.1:intron_variant:MODIFIER:intron3/11:c.127+64G>C::,GCDH:ENST00000591470.1:intron_variant:MODIFIER:intron2/10:c.127+64G>C::	GCDH:NM_000159.4:intron_variant:MODIFIER:intron3/11:c.127+64G>C::,GCDH:NM_013976.4:intron_variant:MODIFIER:intron3/11:c.127+64G>C::,GCDH:NR_102316.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/11:n.235+64G>C::,GCDH:NR_102317.1:non_coding_transcript_exon_variant:MODIFIER:exon3/11:n.299G>C::	regulatory_region_variant:promoter,TF_binding_site_variant	608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];				rs1799918	0.2532	0.3302	1549,.	0.2116,0.4451,0.1423,0.3693,0.2667	0.0810			0.05,0.12	9.29					0.041	0.5823	0.08	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KLF1 (inh=AD oe_syn=0.92 oe_mis=0.83 oe_lof=0.60), GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35)	0.3750	152	57	0.0026
chr19	13002563	13002563	T	G	het		QUAL=2653;DP=319;AF=0.44;MQM=60	GCDH	intron	GCDH:ENST00000222214.5:intron_variant:MODIFIER:intron3/11:c.128-82T>G::,GCDH:ENST00000422947.2:intron_variant:MODIFIER:intron3/11:c.-60-82T>G::,GCDH:ENST00000457854.1:intron_variant:MODIFIER:intron3/11:c.128-82T>G::,GCDH:ENST00000591470.1:intron_variant:MODIFIER:intron2/10:c.128-82T>G::	GCDH:NM_000159.4:intron_variant:MODIFIER:intron3/11:c.128-82T>G::,GCDH:NM_013976.4:intron_variant:MODIFIER:intron3/11:c.128-82T>G::,GCDH:NR_102316.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/11:n.236-82T>G::,GCDH:NR_102317.1:non_coding_transcript_exon_variant:MODIFIER:exon3/11:n.462T>G::	regulatory_region_variant:promoter	608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];				rs2242517	0.4040	0.4400	3212,.		-0.2370			0.00,0.05	8.29				COSV53434449	0.1167	0.384	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KLF1 (inh=AD oe_syn=0.92 oe_mis=0.83 oe_lof=0.60), GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35)	0.6038	53	32	0.1690
chr19	13006592	13006593	TT	-	het	low_conf_region	QUAL=399;DP=141;AF=0.16;MQM=60	GCDH	intron	GCDH:ENST00000222214.5:intron_variant:MODIFIER:intron6/11:c.506-195_506-194del::,GCDH:ENST00000422947.2:intron_variant:MODIFIER:intron6/11:c.374-195_374-194del::,GCDH:ENST00000457854.1:intron_variant:MODIFIER:intron6/11:c.506-195_506-194del::,GCDH:ENST00000591470.1:intron_variant:MODIFIER:intron5/10:c.506-195_506-194del::	GCDH:NM_000159.4:intron_variant:MODIFIER:intron6/11:c.506-195_506-194del::,GCDH:NM_013976.4:intron_variant:MODIFIER:intron6/11:c.506-195_506-194del::,GCDH:NR_102316.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/11:n.669-195_669-194del::,GCDH:NR_102317.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/10:n.922-195_922-194del::		608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];			AluSx1 (SINE/Alu)	rs56251518		0.3525	949,.		0.1400				0.50							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35), SYCE2 (inh=n/a oe_syn=0.80 oe_mis=0.76 oe_lof=0.24)	0.0000	7	0	0.0156
chr19	13006592	13006594	TTT	-	het	low_conf_region	QUAL=399;DP=141;AF=0.15;MQM=60	GCDH	intron	GCDH:ENST00000222214.5:intron_variant:MODIFIER:intron6/11:c.506-196_506-194del::,GCDH:ENST00000422947.2:intron_variant:MODIFIER:intron6/11:c.374-196_374-194del::,GCDH:ENST00000457854.1:intron_variant:MODIFIER:intron6/11:c.506-196_506-194del::,GCDH:ENST00000591470.1:intron_variant:MODIFIER:intron5/10:c.506-196_506-194del::	GCDH:NM_000159.4:intron_variant:MODIFIER:intron6/11:c.506-196_506-194del::,GCDH:NM_013976.4:intron_variant:MODIFIER:intron6/11:c.506-196_506-194del::,GCDH:NR_102316.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/11:n.669-196_669-194del::,GCDH:NR_102317.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/10:n.922-196_922-194del::		608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];			AluSx1 (SINE/Alu)	rs56251518		0.0039	0,.		0.1400				0.49							0	0	16	0 / 2					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35), SYCE2 (inh=n/a oe_syn=0.80 oe_mis=0.76 oe_lof=0.24)	0.5714	7	4	1.0000
chr19	13006685	13006685	T	C	het		QUAL=1046;DP=201;AF=0.41;MQM=60	GCDH	intron	GCDH:ENST00000222214.5:intron_variant:MODIFIER:intron6/11:c.506-121T>C::,GCDH:ENST00000422947.2:intron_variant:MODIFIER:intron6/11:c.374-121T>C::,GCDH:ENST00000457854.1:intron_variant:MODIFIER:intron6/11:c.506-121T>C::,GCDH:ENST00000591470.1:intron_variant:MODIFIER:intron5/10:c.506-121T>C::	GCDH:NM_000159.4:intron_variant:MODIFIER:intron6/11:c.506-121T>C::,GCDH:NM_013976.4:intron_variant:MODIFIER:intron6/11:c.506-121T>C::,GCDH:NR_102316.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/11:n.669-121T>C::,GCDH:NR_102317.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/10:n.922-121T>C::		608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];			AluSx1 (SINE/Alu)	rs2238641	0.2798	0.3256	1708,.		-0.8430			0.00,0.04	0.83							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35), SYCE2 (inh=n/a oe_syn=0.80 oe_mis=0.76 oe_lof=0.24)	0.4500	20	9	0.8238
chr19	13006687	13006687	G	A	het		QUAL=1046;DP=201;AF=0.41;MQM=60	GCDH	intron	GCDH:ENST00000222214.5:intron_variant:MODIFIER:intron6/11:c.506-119G>A::,GCDH:ENST00000422947.2:intron_variant:MODIFIER:intron6/11:c.374-119G>A::,GCDH:ENST00000457854.1:intron_variant:MODIFIER:intron6/11:c.506-119G>A::,GCDH:ENST00000591470.1:intron_variant:MODIFIER:intron5/10:c.506-119G>A::	GCDH:NM_000159.4:intron_variant:MODIFIER:intron6/11:c.506-119G>A::,GCDH:NM_013976.4:intron_variant:MODIFIER:intron6/11:c.506-119G>A::,GCDH:NR_102316.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/11:n.669-119G>A::,GCDH:NR_102317.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/10:n.922-119G>A::		608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];			AluSx1 (SINE/Alu)	rs12151303	0.3347	0.3764	2311,.		0.2140			0.00,0.07	1.35							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35), SYCE2 (inh=n/a oe_syn=0.80 oe_mis=0.76 oe_lof=0.24)	0.4167	24	10	0.5413
chr19	13007458	13007458	C	T	het		QUAL=1267;DP=151;AF=0.48;MQM=60	GCDH	intron	GCDH:ENST00000222214.5:intron_variant:MODIFIER:intron8/11:c.852+223C>T::,GCDH:ENST00000422947.2:intron_variant:MODIFIER:intron8/11:c.720+223C>T::,GCDH:ENST00000457854.1:intron_variant:MODIFIER:intron8/11:c.852+223C>T::,GCDH:ENST00000591470.1:intron_variant:MODIFIER:intron7/10:c.852+223C>T::	GCDH:NM_000159.4:intron_variant:MODIFIER:intron8/11:c.852+223C>T::,GCDH:NM_013976.4:intron_variant:MODIFIER:intron8/11:c.852+223C>T::,GCDH:NR_102316.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/11:n.1015+223C>T::,GCDH:NR_102317.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/10:n.1233+223C>T::		608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];	221908 [benign DISEASE=Glutaric aciduria, type 1,not provided];			rs11085825	0.2540	0.3005	1525,.		-0.0360			0.24,0.13	3.42							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35), SYCE2 (inh=n/a oe_syn=0.80 oe_mis=0.76 oe_lof=0.24)	0.5556	9	5	1.0000
chr19	13008264	13008264	C	T	het	low_conf_region	QUAL=5926;DP=682;AF=0.49;MQM=60	GCDH	intron	GCDH:ENST00000222214.5:intron_variant:MODIFIER:intron10/11:c.1082+22C>T::,GCDH:ENST00000422947.2:intron_variant:MODIFIER:intron10/11:c.950+22C>T::,GCDH:ENST00000457854.1:intron_variant:MODIFIER:intron10/11:c.1082+22C>T::,GCDH:ENST00000591470.1:intron_variant:MODIFIER:intron9/10:c.1082+22C>T::	GCDH:NM_000159.4:intron_variant:MODIFIER:intron10/11:c.1082+22C>T::,GCDH:NM_013976.4:intron_variant:MODIFIER:intron10/11:c.1082+22C>T::,GCDH:NR_102316.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/11:n.1245+22C>T::,GCDH:NR_102317.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/10:n.1463+22C>T::		608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];				rs201346843	0.0004	0.0038	0,.	0.0005,0.0033,0.0000,0.0065,0.0002	-2.7820			0.00,0.10	0.12					-0.214	0.9168	0	0	135	0 / 14					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35), SYCE2 (inh=n/a oe_syn=0.80 oe_mis=0.76 oe_lof=0.24)	0.4211	38	16	0.4177
chr19	13008607	13008607	G	T	het		QUAL=32328;DP=2762;AF=0.48;MQM=60	GCDH	synonymous	GCDH:ENST00000222214.5:synonymous_variant:LOW:exon11/12:c.1173G>T:p.Gly391=:PF00441 [Acyl-CoA dehydrogenase C-terminal domain],GCDH:ENST00000422947.2:synonymous_variant:LOW:exon11/12:c.1041G>T:p.Gly347=:PF00441 [Acyl-CoA dehydrogenase C-terminal domain],GCDH:ENST00000457854.1:synonymous_variant:LOW:exon11/12:c.1173G>T:p.Gly391=:PF00441 [Acyl-CoA dehydrogenase C-terminal domain],GCDH:ENST00000591470.1:synonymous_variant:LOW:exon10/11:c.1173G>T:p.Gly391=:PF00441 [Acyl-CoA dehydrogenase C-terminal domain]	GCDH:NM_000159.4:synonymous_variant:LOW:exon11/12:c.1173G>T:p.Gly391=:,GCDH:NM_013976.4:synonymous_variant:LOW:exon11/12:c.1173G>T:p.Gly391=:,GCDH:NR_102316.1:non_coding_transcript_exon_variant:MODIFIER:exon11/12:n.1336G>T::,GCDH:NR_102317.1:non_coding_transcript_exon_variant:MODIFIER:exon10/11:n.1554G>T::		608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];	92529 [benign DISEASE=Glutaric acidemia,Glutaric aciduria, type 1,not specified,not provided];			rs1060218	0.2504	0.3303	1491,.	0.1988,0.4473,0.1392,0.3704,0.2671	-1.1720			0.09,0.55	3.33				COSV53365943	0.0075	0.1903	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35), SYCE2 (inh=n/a oe_syn=0.80 oe_mis=0.76 oe_lof=0.24)	0.5041	242	122	1.0000
chr19	13010520	13010520	A	G	het		QUAL=11957;DP=1010;AF=0.46;MQM=60	GCDH,SYCE2	3'UTR,intron,missense	GCDH:ENST00000222214.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*165A>G::,SYCE2:ENST00000293695.7:intron_variant:MODIFIER:intron5/5:c.612+298T>C::,GCDH:ENST00000422947.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*165A>G::,GCDH:ENST00000457854.1:missense_variant:MODERATE:exon12/12:c.1250A>G:p.Gln417Arg:,GCDH:ENST00000591470.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*165A>G::	GCDH:NM_000159.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*165A>G::,SYCE2:NM_001105578.2:intron_variant:MODIFIER:intron5/5:c.612+298T>C::,GCDH:NM_013976.4:missense_variant:MODERATE:exon12/12:c.1250A>G:p.Gln417Arg:,GCDH:NR_102316.1:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.1645A>G::,GCDH:NR_102317.1:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.1863A>G::		608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];	208504 [benign DISEASE=Glutaric acidemia,Glutaric aciduria, type 1];			rs8012	0.7204	0.6313	6520,.	0.8298,0.7109,0.7796,0.5497,0.6707	0.3260	 , , ,D(0.00), 	 , , ,B(0.00), 	0.11,0.17	0.77	0.22				0.1407	0.9466	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35), SYCE2 (inh=n/a oe_syn=0.80 oe_mis=0.76 oe_lof=0.24)	0.4972	177	88	1.0000
chr19	13010643	13010643	G	T	het		QUAL=2874;DP=342;AF=0.37;MQM=60	GCDH,SYCE2	3'UTR,intron	GCDH:ENST00000222214.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*288G>T::,SYCE2:ENST00000293695.7:intron_variant:MODIFIER:intron5/5:c.612+175C>A::,GCDH:ENST00000422947.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*288G>T::,GCDH:ENST00000457854.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*86G>T::,GCDH:ENST00000591470.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*288G>T::	GCDH:NM_000159.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*288G>T::,SYCE2:NM_001105578.2:intron_variant:MODIFIER:intron5/5:c.612+175C>A::,GCDH:NM_013976.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*86G>T::,GCDH:NR_102316.1:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.1768G>T::,GCDH:NR_102317.1:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.1986G>T::		608801 [GENE=GCDH PHENOS=Glutaricaciduria,type I,231670,Autosomal recessive];	208505 [benign DISEASE=Glutaric acidemia,Glutaric aciduria, type 1,not specified];			rs9384	0.2780	0.3238	1716,.		-1.7060			0.01,0.09	1.70					-0.0638	0.9454	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GCDH (inh=AR oe_syn=1.02 oe_mis=0.95 oe_lof=0.35), SYCE2 (inh=n/a oe_syn=0.80 oe_mis=0.76 oe_lof=0.24)	0.4881	84	41	0.9132
chr19	30193721	30193721	G	A	het		QUAL=12219;DP=1289;AF=0.40;MQM=60	C19orf12	synonymous,intron	C19orf12:ENST00000323670.9:synonymous_variant:LOW:exon3/3:c.324C>T:p.Thr108=:,C19orf12:ENST00000392276.1:synonymous_variant:LOW:exon2/2:c.132C>T:p.Thr44=:,C19orf12:ENST00000392278.2:synonymous_variant:LOW:exon3/3:c.357C>T:p.Thr119=:,C19orf12:ENST00000592153.1:intron_variant:MODIFIER:intron3/3:c.291-22C>T::	C19orf12:NM_001031726.3:synonymous_variant:LOW:exon3/3:c.357C>T:p.Thr119=:,C19orf12:NM_001256046.2:intron_variant:MODIFIER:intron3/3:c.291-22C>T::,C19orf12:NM_001256047.1:synonymous_variant:LOW:exon3/3:c.324C>T:p.Thr108=:,C19orf12:NM_001282929.1:synonymous_variant:LOW:exon2/2:c.132C>T:p.Thr44=:,C19orf12:NM_001282930.2:synonymous_variant:LOW:exon2/2:c.132C>T:p.Thr44=:,C19orf12:NM_001282931.2:synonymous_variant:LOW:exon4/4:c.132C>T:p.Thr44=:,C19orf12:NM_031448.5:synonymous_variant:LOW:exon3/3:c.324C>T:p.Thr108=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	614297 [GENE=C19ORF12 PHENOS=Neurodegeneration with brain iron accumulation 4,614298,Autosomal recessive,Autosomal dominant/Spastic paraplegia 43,autosomal recessive,615043,Autosomal recessive];	128537 [benign DISEASE=Neurodegeneration with brain iron accumulation 4,not specified];			rs10424582		0.7176	8196,.	0.7766,0.4518,0.3019,0.7516,0.6448	0.1170			0.04,0.21	1.18					-0.2421	0.9596	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C19ORF12 (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.22)	0.4982	285	142	1.0000
chr19	42470962	42470962	T	G	het	low_conf_region	QUAL=152;DP=17;AF=0.71;MQM=55	ATP1A3	3'UTR	ATP1A3:ENST00000302102.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*127A>C::,ATP1A3:ENST00000543770.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*127A>C::,ATP1A3:ENST00000545399.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*127A>C::,ATP1A3:ENST00000602133.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*127A>C::	ATP1A3:NM_001256213.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*127A>C::,ATP1A3:NM_001256214.2:3_prime_UTR_variant:MODIFIER:exon23/23:c.*127A>C::,ATP1A3:NM_152296.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*127A>C::	regulatory_region_variant:promoter_flanking_region	182350 [GENE=ATP1A3 PHENOS=CAPOS syndrome,601338,Autosomal dominant/Alternating hemiplegia of childhood 2,614820,Autosomal dominant/Dystonia-12,128235,Autosomal dominant];				rs782239785		0.1239	0,.	0.0024,0.0006,0.0035,0.0104,0.0008	-0.1880			0.02,0.11	1.30				COSV57484779	-0.056	0.8328	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP1A3 (inh=AD oe_syn=1.10 oe_mis=0.29 oe_lof=0.00)	0.0000	34	0	0.0000
chr19	42471050	42471050	G	C	het		QUAL=16654;DP=1177;AF=0.58;MQM=60	ATP1A3	3'UTR	ATP1A3:ENST00000302102.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*39C>G::,ATP1A3:ENST00000543770.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*39C>G::,ATP1A3:ENST00000545399.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*39C>G::,ATP1A3:ENST00000602133.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*39C>G::	ATP1A3:NM_001256213.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*39C>G::,ATP1A3:NM_001256214.2:3_prime_UTR_variant:MODIFIER:exon23/23:c.*39C>G::,ATP1A3:NM_152296.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*39C>G::	regulatory_region_variant:promoter_flanking_region	182350 [GENE=ATP1A3 PHENOS=CAPOS syndrome,601338,Autosomal dominant/Alternating hemiplegia of childhood 2,614820,Autosomal dominant/Dystonia-12,128235,Autosomal dominant];	329400 [benign DISEASE=Dystonia 12,Alternating hemiplegia of childhood 2];			rs919390		0.6996	7653,.	0.7727,0.6100,0.8135,0.6496,0.5833	4.2940			0.95,0.94	7.68					0.0937	0.8371	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP1A3 (inh=AD oe_syn=1.10 oe_mis=0.29 oe_lof=0.00)	0.5622	185	104	0.2513
chr19	42474779	42474779	T	-	het		QUAL=47;DP=14;AF=0.29;MQM=58	ATP1A3	intron	ATP1A3:ENST00000302102.5:intron_variant:MODIFIER:intron16/22:c.2264-85del::,ATP1A3:ENST00000543770.1:intron_variant:MODIFIER:intron16/22:c.2297-85del::,ATP1A3:ENST00000545399.1:intron_variant:MODIFIER:intron16/22:c.2303-85del::,ATP1A3:ENST00000602133.1:intron_variant:MODIFIER:intron16/22:c.2174-85del::	ATP1A3:NM_001256213.1:intron_variant:MODIFIER:intron16/22:c.2297-85del::,ATP1A3:NM_001256214.2:intron_variant:MODIFIER:intron16/22:c.2303-85del::,ATP1A3:NM_152296.5:intron_variant:MODIFIER:intron16/22:c.2264-85del::		182350 [GENE=ATP1A3 PHENOS=CAPOS syndrome,601338,Autosomal dominant/Alternating hemiplegia of childhood 2,614820,Autosomal dominant/Dystonia-12,128235,Autosomal dominant];			AluY (SINE/Alu)	rs1168002399		0.0099	0,.		0.3850				0.63					0.0006	0.255	0	4	151	0 / 15					ATP1A3 (inh=AD oe_syn=1.10 oe_mis=0.29 oe_lof=0.00)	0.2424	33	8	0.0046
chr19	42474950	42474950	-	T	het		QUAL=216;DP=31;AF=0.45;MQM=60	ATP1A3	intron	ATP1A3:ENST00000302102.5:intron_variant:MODIFIER:intron16/22:c.2264-257dup::,ATP1A3:ENST00000543770.1:intron_variant:MODIFIER:intron16/22:c.2297-257dup::,ATP1A3:ENST00000545399.1:intron_variant:MODIFIER:intron16/22:c.2303-257dup::,ATP1A3:ENST00000602133.1:intron_variant:MODIFIER:intron16/22:c.2174-257dup::	ATP1A3:NM_001256213.1:intron_variant:MODIFIER:intron16/22:c.2297-257dup::,ATP1A3:NM_001256214.2:intron_variant:MODIFIER:intron16/22:c.2303-257dup::,ATP1A3:NM_152296.5:intron_variant:MODIFIER:intron16/22:c.2264-257dup::		182350 [GENE=ATP1A3 PHENOS=CAPOS syndrome,601338,Autosomal dominant/Alternating hemiplegia of childhood 2,614820,Autosomal dominant/Dystonia-12,128235,Autosomal dominant];			AluY (SINE/Alu)	rs538733809		0.0023	0,.						1.57							0	1	56	0 / 2					ATP1A3 (inh=AD oe_syn=1.10 oe_mis=0.29 oe_lof=0.00)	0.5000	4	2	1.0000
chr19	42489516	42489516	A	C	hom		QUAL=24859;DP=777;AF=1.00;MQM=60	ATP1A3	synonymous	ATP1A3:ENST00000302102.5:synonymous_variant:LOW:exon7/23:c.666T>G:p.Thr222=:PF00122 [E1-E2 ATPase],ATP1A3:ENST00000543770.1:synonymous_variant:LOW:exon7/23:c.699T>G:p.Thr233=:PF00122 [E1-E2 ATPase],ATP1A3:ENST00000545399.1:synonymous_variant:LOW:exon7/23:c.705T>G:p.Thr235=:PF00122 [E1-E2 ATPase],ATP1A3:ENST00000602133.1:synonymous_variant:LOW:exon7/23:c.576T>G:p.Thr192=:PF00122 [E1-E2 ATPase]	ATP1A3:NM_001256213.1:synonymous_variant:LOW:exon7/23:c.699T>G:p.Thr233=:,ATP1A3:NM_001256214.2:synonymous_variant:LOW:exon7/23:c.705T>G:p.Thr235=:,ATP1A3:NM_152296.5:synonymous_variant:LOW:exon7/23:c.666T>G:p.Thr222=:		182350 [GENE=ATP1A3 PHENOS=CAPOS syndrome,601338,Autosomal dominant/Alternating hemiplegia of childhood 2,614820,Autosomal dominant/Dystonia-12,128235,Autosomal dominant];	157926 [benign/likely benign DISEASE=Dystonia 12,Alternating hemiplegia of childhood 2,not specified,not provided];			rs2217342		0.9314	13631,.	0.9852,0.8576,0.8702,0.9021,0.8147	-4.1090			0.02,0.13	0.62					0.0198	0.0916	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP1A3 (inh=AD oe_syn=1.10 oe_mis=0.29 oe_lof=0.00)	1.0000	193	193	n/a (non-het)
chr19	49469087	49469087	T	C	hom		QUAL=33461;DP=1176;AF=1.00;MQM=60	FTL	synonymous	FTL:ENST00000331825.6:synonymous_variant:LOW:exon2/4:c.163T>C:p.Leu55=:PF00210 [Ferritin-like domain]	FTL:NM_000146.4:synonymous_variant:LOW:exon2/4:c.163T>C:p.Leu55=:	regulatory_region_variant:promoter	134790 [GENE=FTL PHENOS=Hyperferritinemia-cataract syndrome,600886,Autosomal dominant/Neurodegeneration with brain iron accumulation 3,606159,Autosomal dominant/L-ferritin deficiency,dominant and recessive,615604,Autosomal recessive,Autosomal dominant];	156440 [benign DISEASE=Hereditary hyperferritinemia with congenital cataracts,Neuroferritinopathy,Glycogen storage disease 0, muscle,not specified,sporadic abdominal aortic aneurysm,not provided];			rs2230267	0.4607	0.5065	4049,.	0.4794,0.5264,0.4254,0.5413,0.3964	-0.4260			0.21,0.51	13.24					0.0223	0.095	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BAX (inh=AD oe_syn=1.05 oe_mis=0.93 oe_lof=0.24), FTL (inh=AR+AD oe_syn=0.99 oe_mis=1.13 oe_lof=1.62), GYS1 (inh=AR oe_syn=0.92 oe_mis=0.76 oe_lof=0.34)	0.9943	174	173	n/a (non-het)
chr19	49469986	49469986	C	T	het		QUAL=4448;DP=338;AF=0.50;MQM=60	FTL	synonymous	FTL:ENST00000331825.6:synonymous_variant:LOW:exon4/4:c.522C>T:p.His174=:	FTL:NM_000146.4:synonymous_variant:LOW:exon4/4:c.522C>T:p.His174=:	regulatory_region_variant:promoter	134790 [GENE=FTL PHENOS=Hyperferritinemia-cataract syndrome,600886,Autosomal dominant/Neurodegeneration with brain iron accumulation 3,606159,Autosomal dominant/L-ferritin deficiency,dominant and recessive,615604,Autosomal recessive,Autosomal dominant];	329787 [benign/likely benign DISEASE=Hereditary hyperferritinemia with congenital cataracts,Neuroferritinopathy,not provided];			rs73046709	0.0006	0.0022	0,.	0.0002,0.0001,0.0001,0.0042,0.0000	-1.7050			0.49,0.91	10.63					-0.0672	0.906	0	0	134	0 / 13					BAX (inh=AD oe_syn=1.05 oe_mis=0.93 oe_lof=0.24), FTL (inh=AR+AD oe_syn=0.99 oe_mis=1.13 oe_lof=1.62), GYS1 (inh=AR oe_syn=0.92 oe_mis=0.76 oe_lof=0.34)	0.5313	160	85	0.4769
chr20	3870124	3870124	G	C	hom	low_conf_region	QUAL=19846;DP=710;AF=1.00;MQM=60	PANK2	missense,intron	PANK2:ENST00000316562.4:missense_variant:MODERATE:exon1/7:c.377G>C:p.Gly126Ala:,PANK2:ENST00000497424.1:intron_variant:MODIFIER:intron1/6:c.-246+573G>C::,PANK2:ENST00000610179.1:missense_variant:MODERATE:exon1/7:c.8G>C:p.Gly3Ala:	PANK2:NM_001324191.2:5_prime_UTR_variant:MODIFIER:exon1/8:c.-665G>C::,PANK2:NM_001324192.1:missense_variant:MODERATE:exon1/2:c.377G>C:p.Gly126Ala:,PANK2:NM_024960.6:intron_variant:MODIFIER:intron1/6:c.-246+573G>C::,PANK2:NM_153638.3:missense_variant:MODERATE:exon1/7:c.377G>C:p.Gly126Ala:,PANK2:NR_136715.2:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.91G>C::	regulatory_region_variant:promoter	606157 [GENE=PANK2 PHENOS=HARP syndrome,607236,Autosomal recessive/Neurodegeneration with brain iron accumulation 1,234200,Autosomal recessive];	96526 [benign DISEASE=Pigmentary pallidal degeneration,not specified,not provided];			rs3737084		0.8965	12648,.	0.9830,0.9319,0.8025,0.8754,0.7596	1.0190	T(1.00), ,T(1.00)	B(0.00), ,B(0.00)	0.03,0.98	20.30	0.27				0.2378	0.1295	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PANK2 (inh=AR oe_syn=1.26 oe_mis=0.97 oe_lof=0.61)	1.0000	117	117	n/a (non-het)
chr20	3888337	3888337	A	G	hom		QUAL=1819;DP=74;AF=1.00;MQM=60	PANK2	intron	PANK2:ENST00000316562.4:intron_variant:MODIFIER:intron1/6:c.629-236A>G::,PANK2:ENST00000497424.1:intron_variant:MODIFIER:intron1/6:c.-245-236A>G::,PANK2:ENST00000610179.1:intron_variant:MODIFIER:intron1/6:c.260-236A>G::	PANK2:NM_001324191.2:intron_variant:MODIFIER:intron2/7:c.-245-236A>G::,PANK2:NM_001324192.1:intron_variant:MODIFIER:intron1/1:c.629-236A>G::,PANK2:NM_001324193.2:intron_variant:MODIFIER:intron1/6:c.-537-236A>G::,PANK2:NM_024960.6:intron_variant:MODIFIER:intron1/6:c.-245-236A>G::,PANK2:NM_153638.3:intron_variant:MODIFIER:intron1/6:c.629-236A>G::,PANK2:NM_153640.3:intron_variant:MODIFIER:intron1/6:c.-245-236A>G::,PANK2:NR_136715.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.343-236A>G::		606157 [GENE=PANK2 PHENOS=HARP syndrome,607236,Autosomal recessive/Neurodegeneration with brain iron accumulation 1,234200,Autosomal recessive];				rs6116087		0.6784	7253,.		-0.9780			0.01,0.11	5.58							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PANK2 (inh=AR oe_syn=1.26 oe_mis=0.97 oe_lof=0.61)	1.0000	5	5	n/a (non-het)
chr20	3897871	3897871	A	T	hom	off-target	QUAL=184;DP=10;AF=1.00;MQM=60	PANK2	intron	PANK2:ENST00000316562.4:intron_variant:MODIFIER:intron5/6:c.1536+174A>T::,PANK2:ENST00000497424.1:intron_variant:MODIFIER:intron5/6:c.663+174A>T::,PANK2:ENST00000610179.1:intron_variant:MODIFIER:intron5/6:c.1167+174A>T::	PANK2:NM_001324191.2:intron_variant:MODIFIER:intron6/7:c.663+174A>T::,PANK2:NM_001324193.2:intron_variant:MODIFIER:intron5/6:c.228+174A>T::,PANK2:NM_024960.6:intron_variant:MODIFIER:intron5/6:c.663+174A>T::,PANK2:NM_153638.3:intron_variant:MODIFIER:intron5/6:c.1536+174A>T::,PANK2:NM_153640.3:intron_variant:MODIFIER:intron5/6:c.663+174A>T::,PANK2:NR_136715.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1107+174A>T::		606157 [GENE=PANK2 PHENOS=HARP syndrome,607236,Autosomal recessive/Neurodegeneration with brain iron accumulation 1,234200,Autosomal recessive];									-0.3070			0.00,0.08	3.54				COSV57256042			0	42	0	1 / 0	2	"[2] auto-classification 24.11.2017%0A%0A"			PANK2 (inh=AR oe_syn=1.26 oe_mis=0.97 oe_lof=0.61), MIR103A2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)	0.0000	6	0	n/a (non-het)
chr20	3903634	3903634	C	T	hom		QUAL=1192;DP=57;AF=1.00;MQM=60	PANK2	intron	PANK2:ENST00000316562.4:intron_variant:MODIFIER:intron6/6:c.1663-257C>T::,PANK2:ENST00000497424.1:intron_variant:MODIFIER:intron6/6:c.790-257C>T::,PANK2:ENST00000610179.1:intron_variant:MODIFIER:intron6/6:c.1294-257C>T::	PANK2:NM_001324191.2:intron_variant:MODIFIER:intron7/7:c.790-257C>T::,PANK2:NM_001324193.2:intron_variant:MODIFIER:intron6/6:c.355-257C>T::,PANK2:NM_024960.6:intron_variant:MODIFIER:intron6/6:c.790-257C>T::,PANK2:NM_153638.3:intron_variant:MODIFIER:intron6/6:c.1663-257C>T::,PANK2:NM_153640.3:intron_variant:MODIFIER:intron6/6:c.790-257C>T::,PANK2:NR_136715.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/6:n.1234-257C>T::	regulatory_region_variant:promoter_flanking_region	606157 [GENE=PANK2 PHENOS=HARP syndrome,607236,Autosomal recessive/Neurodegeneration with brain iron accumulation 1,234200,Autosomal recessive];				rs11906612	0.0633	0.1188	317,.		-0.0330			0.04,0.18	1.48							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PANK2 (inh=AR oe_syn=1.26 oe_mis=0.97 oe_lof=0.61), RNF24 (inh=n/a oe_syn=0.82 oe_mis=0.66 oe_lof=0.40)	1.0000	4	4	n/a (non-het)
chr20	14167283	14167283	A	G	hom		QUAL=963;DP=40;AF=0.98;MQM=60	MACROD2	intron	MACROD2:ENST00000217246.4:intron_variant:MODIFIER:intron3/16:c.271+100909A>G::,MACROD2:ENST00000310348.4:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::	MACROD2:NM_001351661.2:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::,MACROD2:NM_001351663.2:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::,MACROD2:NM_080676.6:intron_variant:MODIFIER:intron3/16:c.271+100909A>G::					L1PA16 (LINE/L1)	rs6074704	0.4792	0.5396	4941,.		-0.5350			0.01,0.34	9.25							0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MACROD2 (inh=n/a oe_syn=0.89 oe_mis=0.87 oe_lof=0.22)	n/a (no coverage)	0	n/a (no coverage)	n/a (no coverage)
chr20	48301146	48301146	G	A	hom		QUAL=3273;DP=109;AF=1.00;MQM=60	B4GALT5	intron	B4GALT5:ENST00000371711.4:intron_variant:MODIFIER:intron1/8:c.116-27907C>T::	B4GALT5:NM_004776.4:intron_variant:MODIFIER:intron1/8:c.116-27907C>T::						rs6512586	0.4681	0.5178	3527,.	0.3755,0.4483,0.3696,0.5460,0.6515	-0.9860			0.00,0.05	0.35							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					B4GALT5 (inh=n/a oe_syn=0.97 oe_mis=0.56 oe_lof=0.00)	1.0000	1	1	n/a (non-het)
chr22	38512402	38512402	G	A	het		QUAL=19418;DP=1467;AF=0.50;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron12/16:c.1743-184C>T::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron11/15:c.1581-184C>T::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron11/15:c.1581-184C>T::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron11/15:c.1581-184C>T::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron11/15:c.1581-184C>T::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron12/16:c.1743-184C>T::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron11/15:c.1581-184C>T::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron11/15:c.1581-184C>T::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron13/17:c.1209-184C>T::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron11/15:c.1065-184C>T::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron12/16:c.1047-184C>T::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron12/16:c.1743-184C>T::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];			L1ME4b (LINE/L1)	rs11089863	0.3001	0.3587	1659,.	0.2413,0.4221,0.1362,0.3662,0.4204	1.3780			0.02,0.11	6.64					-0.013	0.7667	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	0.5000	14	7	1.0000
chr22	38512562	38512562	G	A	het		QUAL=3293;DP=246;AF=0.60;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron12/16:c.1743-344C>T::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron11/15:c.1581-344C>T::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron11/15:c.1581-344C>T::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron11/15:c.1581-344C>T::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron11/15:c.1581-344C>T::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron12/16:c.1743-344C>T::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron11/15:c.1581-344C>T::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron11/15:c.1581-344C>T::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron13/17:c.1209-344C>T::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron11/15:c.1065-344C>T::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron12/16:c.1047-344C>T::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron12/16:c.1743-344C>T::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];			L1M5 (LINE/L1)	rs12167576	0.3033	0.3195	1674,.		-0.8260			0.00,0.04	2.80							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	0.8333	6	5	0.2188
chr22	38518962	38518971	CCCGCCCCTG	-	het		QUAL=544;DP=111;AF=0.48;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron11/16:c.1591+131_1591+140del::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron10/15:c.1429+131_1429+140del::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron10/15:c.1429+131_1429+140del::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron10/15:c.1429+131_1429+140del::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron10/15:c.1429+131_1429+140del::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron11/16:c.1591+131_1591+140del::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron10/15:c.1429+131_1429+140del::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron10/15:c.1429+131_1429+140del::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron12/17:c.1057+131_1057+140del::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron10/15:c.913+131_913+140del::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron11/16:c.895+131_895+140del::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron11/16:c.1591+131_1591+140del::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];				rs11570732		0.1069	200,.		0.1900				2.40							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	0.5185	27	14	1.0000
chr22	38519513	38519513	T	C	het		QUAL=627;DP=61;AF=0.57;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron10/16:c.1428-248A>G::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron9/15:c.1266-248A>G::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron9/15:c.1266-248A>G::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron9/15:c.1266-248A>G::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron9/15:c.1266-248A>G::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron10/16:c.1428-248A>G::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron9/15:c.1266-248A>G::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron9/15:c.1266-248A>G::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron11/17:c.894-248A>G::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron9/15:c.750-248A>G::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron10/16:c.732-248A>G::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron10/16:c.1428-248A>G::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];				rs2076117	0.1288	0.1080	226,.		-0.8610			0.01,0.11	2.52							0.1	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	0.0000	3	0	0.2500
chr22	38523211	38523211	G	A	het		QUAL=712;DP=63;AF=0.60;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron9/16:c.1349-755C>T::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron8/15:c.1187-755C>T::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron8/15:c.1187-755C>T::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron8/15:c.1187-755C>T::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron8/15:c.1187-755C>T::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron9/16:c.1349-755C>T::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron8/15:c.1187-755C>T::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron8/15:c.1187-755C>T::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron10/17:c.815-755C>T::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron8/15:c.671-755C>T::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron9/16:c.653-755C>T::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron9/16:c.1349-755C>T::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];				rs3788532	0.3069	0.3308	1933,.		-1.0010			0.02,0.16	2.31					-0.0334	0.9069	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	0.4444	18	8	0.8145
chr22	38523246	38523246	C	G	hom		QUAL=4346;DP=203;AF=1.00;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron9/16:c.1349-790G>C::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron8/15:c.1187-790G>C::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron8/15:c.1187-790G>C::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron8/15:c.1187-790G>C::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron8/15:c.1187-790G>C::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron9/16:c.1349-790G>C::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron8/15:c.1187-790G>C::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron8/15:c.1187-790G>C::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron10/17:c.815-790G>C::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron8/15:c.671-790G>C::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron9/16:c.653-790G>C::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron9/16:c.1349-790G>C::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];				rs3788533	0.4487	0.4501	3333,.		-2.7680			0.02,0.16	3.12					-0.0607	0.9064	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	1.0000	18	18	n/a (non-het)
chr22	38524149	38524149	G	C	het		QUAL=3245;DP=235;AF=0.60;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron9/16:c.1348+127C>G::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron8/15:c.1186+1312C>G::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron8/15:c.1186+1312C>G::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron8/15:c.1186+1312C>G::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron8/15:c.1186+1312C>G::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron9/16:c.1348+127C>G::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron8/15:c.1186+1312C>G::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron8/15:c.1186+1312C>G::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron10/17:c.814+127C>G::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron8/15:c.670+127C>G::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron9/16:c.652+1312C>G::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron9/16:c.1348+127C>G::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];				rs9622732	0.2790	0.2801	1368,.		-4.0600			0.01,0.11	0.22							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	0.5417	24	13	0.8388
chr22	38530956	38530956	G	A	het		QUAL=8695;DP=776;AF=0.47;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron6/16:c.894+39C>T::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron6/15:c.894+39C>T::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron6/15:c.894+39C>T::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron6/15:c.894+39C>T::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron6/15:c.894+39C>T::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron6/16:c.894+39C>T::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron6/15:c.894+39C>T::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron6/15:c.894+39C>T::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron7/17:c.360+39C>T::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron5/15:c.216+39C>T::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron7/16:c.360+39C>T::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron6/16:c.894+39C>T::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];				rs2272831	0.1116	0.0953	133,.	0.1068,0.0470,0.1459,0.0947,0.1422	0.1430			0.06,0.14	0.56					-0.011	0.1072	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	0.4607	89	41	0.5250
chr22	38535946	38535946	G	A	het		QUAL=4819;DP=505;AF=0.46;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron5/16:c.797+43C>T::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron5/15:c.797+43C>T::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron5/15:c.797+43C>T::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron5/15:c.797+43C>T::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron5/15:c.797+43C>T::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron5/16:c.797+43C>T::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron5/15:c.797+43C>T::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron5/15:c.797+43C>T::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron6/17:c.263+43C>T::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron4/15:c.119+3166C>T::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron6/16:c.263+43C>T::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron5/16:c.797+43C>T::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];				rs12329956	0.2798	0.3471	1472,.	0.1565,0.4157,0.1357,0.3607,0.4163	-0.2760			0.03,0.25	12.41					0.2546	0.2832	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	0.5176	85	44	0.8284
chr22	38539041	38539041	T	C	hom		QUAL=5853;DP=196;AF=1.00;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron4/16:c.609+71A>G::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron4/15:c.609+71A>G::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron4/15:c.609+71A>G::,PLA2G6:ENST00000436218.1:intron_variant:MODIFIER:intron3/3:c.425+2404A>G::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron4/15:c.609+71A>G::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron4/15:c.609+71A>G::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron4/16:c.609+71A>G::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron4/15:c.609+71A>G::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron4/15:c.609+71A>G::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron5/17:c.75+71A>G::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron4/15:c.119+71A>G::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron5/16:c.75+71A>G::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron4/16:c.609+71A>G::	regulatory_region_variant:promoter_flanking_region	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];				rs4375	0.4976	0.4654	3606,.		-0.5510			0.00,0.15	12.62					-0.0998	0.6247	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	1.0000	59	59	n/a (non-het)
chr22	38540838	38540842	ATAAA	-	het	low_conf_region	QUAL=1009;DP=44;AF=0.50;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron3/16:c.425+603_425+607del::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron3/15:c.425+603_425+607del::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron3/15:c.425+603_425+607del::,PLA2G6:ENST00000436218.1:intron_variant:MODIFIER:intron3/3:c.425+603_425+607del::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron3/15:c.425+603_425+607del::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron3/15:c.425+603_425+607del::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron3/16:c.425+603_425+607del::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron3/15:c.425+603_425+607del::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron3/15:c.425+603_425+607del::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron4/17:c.-110+603_-110+607del::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron3/15:c.-66+603_-66+607del::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron4/16:c.-110+603_-110+607del::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron3/16:c.425+603_425+607del::	regulatory_region_variant:promoter_flanking_region	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];			(ATAAA)n (Simple_repeat)	rs132935		0.1062	180,.		0.1320				0.49					-0.1368	0.3693	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	0.4091	22	9	0.5235
chr22	38540838	38540847	ATAAAATAAA	-	het	low_conf_region	QUAL=1009;DP=44;AF=0.48;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron3/16:c.425+598_425+607del::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron3/15:c.425+598_425+607del::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron3/15:c.425+598_425+607del::,PLA2G6:ENST00000436218.1:intron_variant:MODIFIER:intron3/3:c.425+598_425+607del::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron3/15:c.425+598_425+607del::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron3/15:c.425+598_425+607del::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron3/16:c.425+598_425+607del::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron3/15:c.425+598_425+607del::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron3/15:c.425+598_425+607del::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron4/17:c.-110+598_-110+607del::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron3/15:c.-66+598_-66+607del::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron4/16:c.-110+598_-110+607del::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron3/16:c.425+598_425+607del::	regulatory_region_variant:promoter_flanking_region	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];			(ATAAA)n (Simple_repeat)	rs132935		0.3396	1595,.		0.1320				0.49					-0.1516	0.3694	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	0.5000	22	11	1.0000
chr22	38541040	38541040	T	-	het	low_conf_region	QUAL=1794;DP=402;AF=0.23;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron3/16:c.425+405del::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron3/15:c.425+405del::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron3/15:c.425+405del::,PLA2G6:ENST00000436218.1:intron_variant:MODIFIER:intron3/3:c.425+405del::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron3/15:c.425+405del::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron3/15:c.425+405del::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron3/16:c.425+405del::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron3/15:c.425+405del::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron3/15:c.425+405del::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron4/17:c.-110+405del::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron3/15:c.-66+405del::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron4/16:c.-110+405del::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron3/16:c.425+405del::	regulatory_region_variant:promoter_flanking_region	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];			AluJr4 (SINE/Alu)	rs968832533					0.2800									0.0169	0.3597	0	115	1440	5 / 35	2	"[2] auto-classification 25.11.2017%0A%0A"			PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	0.1765	34	6	0.0002
chr22	38541266	38541266	T	C	het		QUAL=872;DP=94;AF=0.43;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron3/16:c.425+179A>G::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron3/15:c.425+179A>G::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron3/15:c.425+179A>G::,PLA2G6:ENST00000436218.1:intron_variant:MODIFIER:intron3/3:c.425+179A>G::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron3/15:c.425+179A>G::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron3/15:c.425+179A>G::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron3/16:c.425+179A>G::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron3/15:c.425+179A>G::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron3/15:c.425+179A>G::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron4/17:c.-110+179A>G::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron3/15:c.-66+179A>G::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron4/16:c.-110+179A>G::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron3/16:c.425+179A>G::	regulatory_region_variant:promoter_flanking_region	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];			AluJr4 (SINE/Alu)	rs1005529	0.4694	0.4444	3149,.		-0.9490			0.00,0.03	2.87							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	0.3333	12	4	0.3877
chr22	38541779	38541779	C	T	hom		QUAL=65;DP=4;AF=1.00;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron2/16:c.210-119G>A::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron2/15:c.210-119G>A::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron2/15:c.210-119G>A::,PLA2G6:ENST00000417303.2:intron_variant:MODIFIER:intron3/3:c.*41-119G>A::,PLA2G6:ENST00000435484.1:intron_variant:MODIFIER:intron3/3:c.*41-119G>A::,PLA2G6:ENST00000436218.1:intron_variant:MODIFIER:intron2/3:c.210-119G>A::,PLA2G6:ENST00000447598.2:intron_variant:MODIFIER:intron3/3:c.*41-119G>A::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron2/15:c.210-119G>A::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron2/15:c.210-119G>A::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron2/16:c.210-119G>A::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron2/15:c.210-119G>A::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron2/15:c.210-119G>A::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron3/17:c.-325-119G>A::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron2/15:c.-281-119G>A::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron3/16:c.-325-119G>A::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron2/16:c.210-119G>A::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];									-0.7000			0.02,0.18	7.29							0	9	0	1 / 0					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	0.0000	20	0	n/a (non-het)
chr22	38541936	38541936	G	A	het		QUAL=18;DP=19;AF=0.32;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron2/16:c.210-276C>T::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron2/15:c.210-276C>T::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron2/15:c.210-276C>T::,PLA2G6:ENST00000417303.2:intron_variant:MODIFIER:intron3/3:c.*41-276C>T::,PLA2G6:ENST00000435484.1:intron_variant:MODIFIER:intron3/3:c.*41-276C>T::,PLA2G6:ENST00000436218.1:intron_variant:MODIFIER:intron2/3:c.210-276C>T::,PLA2G6:ENST00000447598.2:intron_variant:MODIFIER:intron3/3:c.*41-276C>T::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron2/15:c.210-276C>T::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron2/15:c.210-276C>T::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron2/16:c.210-276C>T::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron2/15:c.210-276C>T::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron2/15:c.210-276C>T::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron3/17:c.-325-276C>T::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron2/15:c.-281-276C>T::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron3/16:c.-325-276C>T::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron2/16:c.210-276C>T::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];			AluJr (SINE/Alu)	rs4821748	0.3219	0.3237	1694,.		-0.5720			0.00,0.08	3.32							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	0.7500	4	3	0.6250
chr22	38543453	38543453	T	C	het		QUAL=10811;DP=776;AF=0.57;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron2/16:c.210-1793A>G::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron2/15:c.210-1793A>G::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron2/15:c.210-1793A>G::,PLA2G6:ENST00000417303.2:intron_variant:MODIFIER:intron3/3:c.*40+1047A>G::,PLA2G6:ENST00000435484.1:intron_variant:MODIFIER:intron3/3:c.*40+1047A>G::,PLA2G6:ENST00000436218.1:intron_variant:MODIFIER:intron2/3:c.210-1793A>G::,PLA2G6:ENST00000447598.2:intron_variant:MODIFIER:intron3/3:c.*40+1047A>G::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron2/15:c.210-1793A>G::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron2/15:c.210-1793A>G::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron2/16:c.210-1793A>G::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron2/15:c.210-1793A>G::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron2/15:c.210-1793A>G::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron3/17:c.-326+1047A>G::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron2/15:c.-281-1793A>G::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron3/16:c.-326+1047A>G::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron2/16:c.210-1793A>G::	regulatory_region_variant:promoter_flanking_region	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];				rs2284060	0.4201	0.4101	2668,.		-0.8520			0.00,0.07	4.76					0.1958	0.942	0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	n/a (no coverage)	0	n/a (no coverage)	n/a (no coverage)
chr22	38559448	38559448	C	A	het		QUAL=22030;DP=1651;AF=0.50;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron2/16:c.209+5777G>T::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron2/15:c.209+5777G>T::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron2/15:c.209+5777G>T::,PLA2G6:ENST00000417303.2:intron_variant:MODIFIER:intron2/3:c.209+5777G>T::,PLA2G6:ENST00000435484.1:intron_variant:MODIFIER:intron2/3:c.209+5777G>T::,PLA2G6:ENST00000436218.1:intron_variant:MODIFIER:intron2/3:c.209+5777G>T::,PLA2G6:ENST00000447598.2:intron_variant:MODIFIER:intron2/3:c.209+5777G>T::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron2/15:c.209+5777G>T::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron2/15:c.209+5777G>T::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron2/16:c.209+5777G>T::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron2/15:c.209+5777G>T::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron2/15:c.209+5777G>T::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron2/17:c.-457+5777G>T::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron2/15:c.-282+5777G>T::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron2/16:c.-457+5777G>T::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron2/16:c.209+5777G>T::	regulatory_region_variant:promoter_flanking_region	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];			L2b (LINE/L2)	rs731821	0.4147	0.3847	2387,.		-0.7940			0.00,0.07	2.61					-0.0212	0.217	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	n/a (no coverage)	0	n/a (no coverage)	n/a (no coverage)
chr22	38563972	38563972	T	C	het		QUAL=26150;DP=1874;AF=0.51;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron2/16:c.209+1253A>G::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron2/15:c.209+1253A>G::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron2/15:c.209+1253A>G::,PLA2G6:ENST00000417303.2:intron_variant:MODIFIER:intron2/3:c.209+1253A>G::,PLA2G6:ENST00000435484.1:intron_variant:MODIFIER:intron2/3:c.209+1253A>G::,PLA2G6:ENST00000436218.1:intron_variant:MODIFIER:intron2/3:c.209+1253A>G::,PLA2G6:ENST00000447598.2:intron_variant:MODIFIER:intron2/3:c.209+1253A>G::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron2/15:c.209+1253A>G::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron2/15:c.209+1253A>G::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron2/16:c.209+1253A>G::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron2/15:c.209+1253A>G::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron2/15:c.209+1253A>G::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron2/17:c.-457+1253A>G::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron2/15:c.-282+1253A>G::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron2/16:c.-457+1253A>G::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron2/16:c.209+1253A>G::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];			L2b (LINE/L2)	rs132988	0.1304	0.1105	234,.		0.3680			0.00,0.05	8.70					-0.1737	0.3678	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	0.5000	2	1	1.0000
chr22	38564041	38564041	C	G	het		QUAL=17726;DP=1399;AF=0.51;MQM=60	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron2/16:c.209+1184G>C::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron2/15:c.209+1184G>C::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron2/15:c.209+1184G>C::,PLA2G6:ENST00000417303.2:intron_variant:MODIFIER:intron2/3:c.209+1184G>C::,PLA2G6:ENST00000435484.1:intron_variant:MODIFIER:intron2/3:c.209+1184G>C::,PLA2G6:ENST00000436218.1:intron_variant:MODIFIER:intron2/3:c.209+1184G>C::,PLA2G6:ENST00000447598.2:intron_variant:MODIFIER:intron2/3:c.209+1184G>C::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron2/15:c.209+1184G>C::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron2/15:c.209+1184G>C::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron2/16:c.209+1184G>C::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron2/15:c.209+1184G>C::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron2/15:c.209+1184G>C::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron2/17:c.-457+1184G>C::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron2/15:c.-282+1184G>C::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron2/16:c.-457+1184G>C::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron2/16:c.209+1184G>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];			L2b (LINE/L2)	rs9622746	0.2951	0.2987	1514,.		0.0510			0.01,0.10	1.32					-0.0077	0.3741	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)	0.5000	2	1	1.0000
chr22	51063987	51063987	G	C	hom		QUAL=15088;DP=570;AF=1.00;MQM=60	ARSA	intron	ARSA:ENST00000216124.5:intron_variant:MODIFIER:intron7/7:c.1210+20C>G::,ARSA:ENST00000356098.5:intron_variant:MODIFIER:intron8/8:c.1210+20C>G::,ARSA:ENST00000395619.3:intron_variant:MODIFIER:intron8/8:c.1210+20C>G::,ARSA:ENST00000395621.3:intron_variant:MODIFIER:intron8/8:c.1210+20C>G::,ARSA:ENST00000453344.2:intron_variant:MODIFIER:intron7/7:c.952+20C>G::,ARSA:ENST00000547307.1:intron_variant:MODIFIER:intron7/7:c.1204+20C>G::,ARSA:ENST00000547805.1:intron_variant:MODIFIER:intron8/8:c.1204+20C>G::	ARSA:NM_000487.6:intron_variant:MODIFIER:intron7/7:c.1210+20C>G::,ARSA:NM_001085425.3:intron_variant:MODIFIER:intron8/8:c.1210+20C>G::,ARSA:NM_001085426.3:intron_variant:MODIFIER:intron8/8:c.1210+20C>G::,ARSA:NM_001085427.3:intron_variant:MODIFIER:intron8/8:c.1210+20C>G::,ARSA:NM_001085428.3:intron_variant:MODIFIER:intron7/7:c.952+20C>G::,ARSA:NM_001362782.2:intron_variant:MODIFIER:intron7/7:c.952+20C>G::		607574 [GENE=ARSA PHENOS=Metachromatic leukodystrophy,250100,Autosomal recessive];	93118 [benign DISEASE=not specified,not provided];			rs762674		0.8022	9361,.	0.7220,0.8629,0.9786,0.7716,0.8087	-0.0920			0.02,0.25	4.63					-0.1941	0.9407	0.13	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ARSA (inh=AR oe_syn=1.02 oe_mis=0.94 oe_lof=0.90)	0.9955	223	222	n/a (non-het)
chr22	51064039	51064039	G	C	hom		QUAL=29070;DP=1012;AF=1.00;MQM=60	ARSA	missense	ARSA:ENST00000216124.5:missense_variant:MODERATE:exon7/8:c.1178C>G:p.Thr393Ser:PF14707 [C-terminal region of aryl-sulfatase],ARSA:ENST00000356098.5:missense_variant:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser:PF14707 [C-terminal region of aryl-sulfatase],ARSA:ENST00000395619.3:missense_variant:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser:PF14707 [C-terminal region of aryl-sulfatase],ARSA:ENST00000395621.3:missense_variant:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser:PF14707 [C-terminal region of aryl-sulfatase],ARSA:ENST00000453344.2:missense_variant:MODERATE:exon7/8:c.920C>G:p.Thr307Ser:PF14707 [C-terminal region of aryl-sulfatase],ARSA:ENST00000547307.1:missense_variant:MODERATE:exon7/8:c.1172C>G:p.Thr391Ser:PF14707 [C-terminal region of aryl-sulfatase],ARSA:ENST00000547805.1:missense_variant:MODERATE:exon8/9:c.1172C>G:p.Thr391Ser:PF14707 [C-terminal region of aryl-sulfatase]	ARSA:NM_000487.6:missense_variant:MODERATE:exon7/8:c.1178C>G:p.Thr393Ser:,ARSA:NM_001085425.3:missense_variant:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser:,ARSA:NM_001085426.3:missense_variant:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser:,ARSA:NM_001085427.3:missense_variant:MODERATE:exon8/9:c.1178C>G:p.Thr393Ser:,ARSA:NM_001085428.3:missense_variant:MODERATE:exon7/8:c.920C>G:p.Thr307Ser:,ARSA:NM_001362782.2:missense_variant:MODERATE:exon7/8:c.920C>G:p.Thr307Ser:		607574 [GENE=ARSA PHENOS=Metachromatic leukodystrophy,250100,Autosomal recessive];	21184 [benign DISEASE=Metachromatic leukodystrophy,not specified,not provided];	CM910052 [CLASS=DP MUT=ALT PHEN="Phenotype modifier association with" GENE=ARSA];		rs743616	0.4056	0.4974	3982,.	0.3836,0.4184,0.2914,0.5405,0.4228	0.1010	T(0.42),T(0.42),T(0.42),T(0.42),T(0.42),T(0.42),T(0.42)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.02,0.18	11.23	0.29				-0.0274	0.2956	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ARSA (inh=AR oe_syn=1.02 oe_mis=0.94 oe_lof=0.90)	0.9971	349	348	n/a (non-het)
chr22	51064141	51064141	G	A	hom		QUAL=16683;DP=614;AF=1.00;MQM=60	ARSA	intron	ARSA:ENST00000216124.5:intron_variant:MODIFIER:intron6/7:c.1108-32C>T::,ARSA:ENST00000356098.5:intron_variant:MODIFIER:intron7/8:c.1108-32C>T::,ARSA:ENST00000395619.3:intron_variant:MODIFIER:intron7/8:c.1108-32C>T::,ARSA:ENST00000395621.3:intron_variant:MODIFIER:intron7/8:c.1108-32C>T::,ARSA:ENST00000453344.2:intron_variant:MODIFIER:intron6/7:c.850-32C>T::,ARSA:ENST00000547307.1:intron_variant:MODIFIER:intron6/7:c.1102-32C>T::,ARSA:ENST00000547805.1:intron_variant:MODIFIER:intron7/8:c.1102-32C>T::	ARSA:NM_000487.6:intron_variant:MODIFIER:intron6/7:c.1108-32C>T::,ARSA:NM_001085425.3:intron_variant:MODIFIER:intron7/8:c.1108-32C>T::,ARSA:NM_001085426.3:intron_variant:MODIFIER:intron7/8:c.1108-32C>T::,ARSA:NM_001085427.3:intron_variant:MODIFIER:intron7/8:c.1108-32C>T::,ARSA:NM_001085428.3:intron_variant:MODIFIER:intron6/7:c.850-32C>T::,ARSA:NM_001362782.2:intron_variant:MODIFIER:intron6/7:c.850-32C>T::		607574 [GENE=ARSA PHENOS=Metachromatic leukodystrophy,250100,Autosomal recessive];				rs762673	0.8007	0.8031	9064,.	0.6552,0.8597,0.9799,0.7784,0.8252	0.1850			0.01,0.13	3.36					0.1934	0.0684	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ARSA (inh=AR oe_syn=1.02 oe_mis=0.94 oe_lof=0.90)	1.0000	185	185	n/a (non-het)
chr22	51065524	51065524	C	A	het		QUAL=1736;DP=205;AF=0.40;MQM=60	ARSA	intron	ARSA:ENST00000216124.5:intron_variant:MODIFIER:intron2/7:c.466-44G>T::,ARSA:ENST00000356098.5:intron_variant:MODIFIER:intron3/8:c.466-44G>T::,ARSA:ENST00000395619.3:intron_variant:MODIFIER:intron3/8:c.466-44G>T::,ARSA:ENST00000395621.3:intron_variant:MODIFIER:intron3/8:c.466-44G>T::,ARSA:ENST00000453344.2:intron_variant:MODIFIER:intron2/7:c.208-44G>T::,ARSA:ENST00000547307.1:intron_variant:MODIFIER:intron2/7:c.460-44G>T::,ARSA:ENST00000547805.1:intron_variant:MODIFIER:intron3/8:c.460-44G>T::	ARSA:NM_000487.6:intron_variant:MODIFIER:intron2/7:c.466-44G>T::,ARSA:NM_001085425.3:intron_variant:MODIFIER:intron3/8:c.466-44G>T::,ARSA:NM_001085426.3:intron_variant:MODIFIER:intron3/8:c.466-44G>T::,ARSA:NM_001085427.3:intron_variant:MODIFIER:intron3/8:c.466-44G>T::,ARSA:NM_001085428.3:intron_variant:MODIFIER:intron2/7:c.208-44G>T::,ARSA:NM_001362782.2:intron_variant:MODIFIER:intron2/7:c.208-44G>T::	regulatory_region_variant:promoter	607574 [GENE=ARSA PHENOS=Metachromatic leukodystrophy,250100,Autosomal recessive];				rs6151413	0.0086	0.0153	1,.	0.0035,0.0038,0.0075,0.0175,0.0096	-1.5180			0.05,0.14	2.64					0.0873	0.9035	0.3	7	615	0 / 60					ARSA (inh=AR oe_syn=1.02 oe_mis=0.94 oe_lof=0.90)	0.4936	156	77	0.9362
chrX	70598956	70598956	T	-	het		QUAL=391;DP=151;AF=0.22;MQM=60	TAF1	intron	TAF1:ENST00000276072.3:intron_variant:MODIFIER:intron8/37:c.1420+97del::,TAF1:ENST00000373790.4:intron_variant:MODIFIER:intron8/37:c.1357+97del::,TAF1:ENST00000423759.1:intron_variant:MODIFIER:intron8/38:c.1420+97del::,TAF1:ENST00000449580.1:intron_variant:MODIFIER:intron8/38:c.1357+97del::	TAF1:NM_001286074.1:intron_variant:MODIFIER:intron8/38:c.1420+97del::,TAF1:NM_004606.4:intron_variant:MODIFIER:intron8/37:c.1420+97del::,TAF1:NM_138923.3:intron_variant:MODIFIER:intron8/37:c.1357+97del::,TAF1:NR_104387.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/39:n.1378+97del::,TAF1:NR_104388.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/39:n.1378+97del::,TAF1:NR_104389.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/38:n.1378+97del::,TAF1:NR_104390.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/39:n.1378+97del::,TAF1:NR_104391.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/40:n.1378+97del::,TAF1:NR_104392.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/39:n.1378+97del::,TAF1:NR_104393.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/40:n.1378+97del::,TAF1:NR_104394.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/39:n.1378+97del::,TAF1:NR_104395.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/39:n.1378+97del::		313650 [GENE=TAF1 PHENOS=Dystonia-Parkinsonism,X-linked,314250,X-linked recessive/Mental retardation,X-linked,syndromic 33,300966,X-linked recessive];			AluSp (SINE/Alu)	rs916740866		0.0652	10,19		0.2610				0.77					-0.244	0.4125	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TAF1 (inh=XLR oe_syn=1.09 oe_mis=0.44 oe_lof=0.00)	0.1579	38	6	0.0000
chrX	73641214	73641214	T	G	het		QUAL=204;DP=142;AF=0.24;MQM=59	SLC16A2	5'UTR	SLC16A2:ENST00000276033.5:5_prime_UTR_variant:MODIFIER:exon1/6:c.-37T>G::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	300095 [GENE=SLC16A2 PHENOS=Allan-Herndon-Dudley syndrome,300523,X-linked];			GA-rich (Low_complexity)	rs1381207380					0.3290			0.31,0.91	15.12					-0.1005	0.0315		2	273	0 / 1					SLC16A2 (inh=XLD oe_syn=0.88 oe_mis=0.56 oe_lof=0.00)	0.0000	77	0	0.0000
chrX	73641235	73641235	A	G	het		QUAL=120;DP=161;AF=0.33;MQM=59	SLC16A2	5'UTR	SLC16A2:ENST00000276033.5:5_prime_UTR_variant:MODIFIER:exon1/6:c.-16A>G::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	300095 [GENE=SLC16A2 PHENOS=Allan-Herndon-Dudley syndrome,300523,X-linked];			GA-rich (Low_complexity)						1.8610			0.25,0.95	17.64					-0.1166	0.0314		0	29	0 / 1					SLC16A2 (inh=XLD oe_syn=0.88 oe_mis=0.56 oe_lof=0.00)	0.0000	114	0	0.0000
chrX	73641569	73641569	T	C	het	low_conf_region	QUAL=751;DP=319;AF=0.20;MQM=60	SLC16A2	missense	SLC16A2:ENST00000276033.5:missense_variant:MODERATE:exon1/6:c.319T>C:p.Ser107Pro:,SLC16A2:ENST00000587091.1:missense_variant:MODERATE:exon1/6:c.97T>C:p.Ser33Pro:	SLC16A2:NM_006517.5:missense_variant:MODERATE:exon1/6:c.97T>C:p.Ser33Pro:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	300095 [GENE=SLC16A2 PHENOS=Allan-Herndon-Dudley syndrome,300523,X-linked];	21462 [benign DISEASE=Spastic paraplegia,Allan-Herndon-Dudley syndrome,History of neurodevelopmental disorder,not specified,not provided];		(AGCCGG)n (Simple_repeat)	rs6647476	0.6638	0.5405	2129,3968	0.6863,0.3358,0.9587,0.4064,0.6345	-0.3900	T(0.44),T(0.29)	B(0.00),B(0.40)	0.04,0.34	9.11	0.09			COSV52082293	0.0154	0.0322	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC16A2 (inh=XLD oe_syn=0.88 oe_mis=0.56 oe_lof=0.00)	0.4751	442	210	0.6338
chrX	73749319	73749319	T	G	hom		QUAL=9692;DP=300;AF=1.00;MQM=60	SLC16A2	intron	SLC16A2:ENST00000276033.5:intron_variant:MODIFIER:intron5/5:c.1621+43T>G::,SLC16A2:ENST00000587091.1:intron_variant:MODIFIER:intron5/5:c.1399+43T>G::	SLC16A2:NM_006517.5:intron_variant:MODIFIER:intron5/5:c.1399+43T>G::		300095 [GENE=SLC16A2 PHENOS=Allan-Herndon-Dudley syndrome,300523,X-linked];	159903 [likely benign DISEASE=not specified];			rs5937843	0.3438	0.6056	3021,4488	0.2084,0.4747,0.0318,0.8099,0.5055	0.3890			0.00,0.08	5.72				COSV52084469	-0.0163	0.15	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC16A2 (inh=XLD oe_syn=0.88 oe_mis=0.56 oe_lof=0.00)	1.0000	149	149	n/a (non-het)
chrX	73751023	73751023	C	G	hom		QUAL=3913;DP=168;AF=0.99;MQM=60	SLC16A2	intron	SLC16A2:ENST00000276033.5:intron_variant:MODIFIER:intron5/5:c.1622-145C>G::,SLC16A2:ENST00000587091.1:intron_variant:MODIFIER:intron5/5:c.1400-145C>G::	SLC16A2:NM_006517.5:intron_variant:MODIFIER:intron5/5:c.1400-145C>G::		300095 [GENE=SLC16A2 PHENOS=Allan-Herndon-Dudley syndrome,300523,X-linked];				rs5937844		0.5874	3005,4602		0.0520			0.07,0.15	4.08				COSV52084475			0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC16A2 (inh=XLD oe_syn=0.88 oe_mis=0.56 oe_lof=0.00)	1.0000	25	25	n/a (non-het)
chrX	133609078	133609078	T	-	het		QUAL=76;DP=114;AF=0.18;MQM=60	HPRT1	intron	HPRT1:ENST00000298556.7:intron_variant:MODIFIER:intron2/8:c.135-121del::	HPRT1:NM_000194.3:intron_variant:MODIFIER:intron2/8:c.135-121del::		308000 [GENE=HPRT1 PHENOS=Hyperuricemia,HRPT-related,300323,X-linked recessive/Lesch-Nyhan syndrome,300322,X-linked recessive];			AluJb (SINE/Alu)	rs1404583296		0.0088	0,2		-0.0730				4.52							0.01	0	44	0 / 1					HPRT1 (inh=XLR oe_syn=0.59 oe_mis=0.26 oe_lof=0.00)	0.0370	27	1	0.0000
chrX	133609110	133609110	G	A	hom		QUAL=4332;DP=197;AF=0.98;MQM=60	HPRT1	intron	HPRT1:ENST00000298556.7:intron_variant:MODIFIER:intron2/8:c.135-101G>A::	HPRT1:NM_000194.3:intron_variant:MODIFIER:intron2/8:c.135-101G>A::		308000 [GENE=HPRT1 PHENOS=Hyperuricemia,HRPT-related,300323,X-linked recessive/Lesch-Nyhan syndrome,300322,X-linked recessive];			AluJb (SINE/Alu)	rs117407	1.0000	0.9993	6930,6989		0.2730			0.01,0.13	3.68				COSV53778534			0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HPRT1 (inh=XLR oe_syn=0.59 oe_mis=0.26 oe_lof=0.00)	1.0000	42	42	n/a (non-het)
